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Most cells have the intrinsic ability to detect and defend against infection from viruses or 
bacteria, this is called the innate immune response. This response relies on the detection of 
molecular patterns unique to viruses and bacteria by host cell sensor proteins. As well as 
external threats, the innate immune response can also be activated by damage to host cells 
which results in the leakage of host cell DNA into the cytoplasm. cGAS is one such sensor 
protein which recognises DNA from invading viruses and bacteria, or self-DNA if it is 
aberrantly localised. Upon recognising DNA in the cytoplasm, cGAS activates a signalling 
cascade which results in the expression of genes to combat infection/cell damage and the 
recruitment of specialised cells of the immune system. STING is an essential molecule in this 
signalling cascade and propagates signalling started by cGAS. STING resides in a compartment 
of the cell called the endoplasmic reticulum, an interconnected membrane system within the 
cell cytoplasm, but when activated during an innate immune response it leaves the 
endoplasmic reticulum to activate downstream signalling factors. STING was initially 
identified in another cellular compartment known as the nuclear envelope, which is 
connected to the endoplasmic reticulum and encapsulates host cell DNA in the nucleus 
protecting it from the cytoplasm. However, most research has focussed on STING’s functions 
in the endoplasmic reticulum and not investigated its functions in the nuclear envelope. 
Therefore, in this study I sought to investigate STING localisation and functions within the 
nuclear envelope. 
The nuclear envelope is a double membrane system comprising inner and outer nuclear 
membranes and, in this thesis, I present work showing for the first time that STING is present 
in both the inner and outer membranes. Moreover, live-cell microscopy of fluorescently 
tagged STING reveals that it increases mobility and redistributes to the outer nuclear 
membrane upon innate immune response stimulation by DNA or a synthetic RNA which 
mimics viral infection. Previously, isolation of STING from purified nuclear envelopes coupled 
with mass spectrometry, a technique used to identify proteins, found new potential partners 
of STING at the nuclear envelope. Seventeen of these potential STING partners interact 
indirectly with key innate immune signalling factors, and so it was hypothesised that they may 
also be involved in innate immune responses through STING at the nuclear envelope. 
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Therefore, I interrogated a subset of these proteins for a role in the innate immune response, 
finding that several STING partners are novel modulators of DNA triggered innate immune 
responses. Moreover, I found that one partner is a novel antagonist of the RNA virus, 
influenza A virus, potentially shedding light on reports of STING-mediated inhibition of RNA 
viruses. Thus, the work presented in this thesis expands our knowledge of STING’s role in the 
innate immune response and adds to a growing literature which shows that STING’s functions 






The innate immune response (IIR) is the first line of defence against pathogen infection and 
relies on the recognition of pathogen associated molecules by host cell sensors. STING 
(STimulator of INterferon Genes) is the essential adaptor protein in IIRs triggered by the 
recognition of cytoplasmic double-stranded DNA, a potent signal of pathogen infection or 
host cell DNA damage. Most STING resides in the endoplasmic reticulum and propagates IIR 
signalling cascades upon binding the second messenger, cGAMP, produced by the upstream 
cytosolic DNA sensor, cGAS. However, STING was initially identified as a nuclear envelope 
transmembrane protein and yet the function of STING within the nuclear envelope has been 
relatively understudied. Therefore, in this study I sought to investigate STING localisation and 
functions within the nuclear envelope. 
The nuclear envelope is a double membrane system comprising inner and outer nuclear 
membranes and, in this thesis, I present work showing for the first time that STING is present 
in both the inner and outer membranes by immunogold electron microscopy. Moreover, live-
cell microscopy of GFP-tagged STING reveals that it increases mobility and redistributes to the 
outer nuclear membrane upon IIR stimulation by transfected dsDNA or the dsRNA mimic 
poly(I:C). Previously, immunoprecipitation of STING from isolated nuclear envelopes coupled 
with mass spectrometry identified a nuclear envelope-STING proteome consisting of known 
nuclear membrane proteins and enriched in DNA- and RNA-binding proteins. Seventeen of 
these nuclear envelope STING partners are known to bind direct interactors of the immune 
transcription factors, IRF3/7, and so it was hypothesised that these proteins could contribute 
to IIR through STING at the nuclear envelope. Therefore, I interrogated a subset of these for 
a role in IIR, finding that STING partners SYNCRIP, MEN1, DDX5, SNRNP70, RPS27A, and AATF 
are novel modulators of dsDNA triggered IIR. Moreover, through siRNA-mediated knockdown 
and CRISPR/Cas9 gene editing I found that SYNCRIP is a novel antagonist of the RNA virus, 
influenza A virus, potentially shedding light on reports of STING-mediated inhibition of RNA 
viruses. 
Thus, the work presented in this thesis expands our knowledge of STING’s role in IIR and adds 
to a growing literature which shows that STING’s functions are more extensive than its role in 










Firstly, I would like to thank The Wellcome Trust for funding my PhD and making this research 
possible. Secondly, I would like to thank my supervisor, Eric, for his guidance and support 
throughout. The freedom he gave me in the lab to experiment and learn different techniques 
has, I believe, made me a better scientist. Thanks should also go to my second supervisor, 
Martin Goldberg, and other members of my thesis committee - Bill Earnshaw, Sara Macias-
Ribela, David Gray - for their comments and critique of my work. I would also like to thank 
several collaborators and facility managers, without whom, much of this work would not have 
been possible. Special thanks to Paul Digard who welcomed me into his lab to learn all things 
Flu-related and Elly Gaunt who supervised and encouraged me while in his lab. Thank you to 
David Kelly who taught me most things microscope-related and whose cheery demeanour 
always made COIL an enjoyable place to work. Thanks to Jessica Valli who assisted FRET-FLIM 
microscopy and Martin Waterfall for FACS. Thank you to Mark Tingey and Weidong Yang who 
conducted smFRAP experiments after my many attempts to distinguish inner and outer 
nuclear membranes using various alternative fluorescence microscopy approaches failed.  
Thanks also to Christine Richardson and Martin Goldberg whose expertise and supervision 
were essential for immunogold electron microscopy. 
Next, I would like to thank all members of the Schirmer Lab, past and present, who have been 
not just colleagues but friends during my time in Eric’s lab – not only did they teach me so 
much, but they also gave me many laughs along the way. So, thank you especially to Rafal, 
Aishwarya, José, Andrea, Dario, Douglas, and Alex with whom I shared much of this journey. 
Thanks also to members of the Earnshaw, JP, Ly, and Heun labs who had to suffer my lab 
meetings, their critique and suggestions were always helpful. I would also like to thank the 
many friends I have made in the Michael Swann Building who made the day-to-day more 
enjoyable.  
Outside of the lab I would like to thank all my friends, old and new, who encouraged me and 
kept me going, particularly over these last few months where their motivating me to finish 
my thesis was especially helpful. I would like to give special thanks to my partner, Becky, for 
her unwavering support and belief in me. Finally, I would like to thank my parents and family 




3D SIM 3D Structured illumination microscopy 
AGS Aicardi-Goutieres syndrome 
AIM2 Absent in melanoma 2 
ALR AIM2-like receptor 
APC antigen-presenting cell 
ATP Adenosine triphosphate 
bp Basepairs 
CARD caspase activation and recruitment domain 
cGAS cyclic GMP-AMP synthase 
cGAMP 2'3'-Cyclic GMP-AMP 
CHIKV Chickungunya virus 
CLR C-type lectin receptor 
CRISPR clustered regularly interspaced short palindromic repeats 
CTT C'-terminal tail 
Da Dalton 
DAPI 4’,6’-diamidino-2-phenylindole 
DDX DEAD box helicase 
DENV Dengue virus 
DNA Deoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid 
EM electron microscopy 
EMCV encephalomyocarditis virus 
ER endoplasmic reticulum 
ERGIC Endoplasmic reticulum-Golgi intermediate compartment 
ESCRT endosomal sorting complex required for transport 
FLIM Fluorescence lifetime imaging 
FRAP Fluorescence recovery after photobleaching 
FRET Förster resonance energy transfer 
GFP Green fluorescent protein 
GTP Guanosine triphosphate 
h Hour 
HA haemagglutinin 
HCV hepatitis C virus 
HGPS Hutchinson-Gilford progeria syndrome 
HIV human immunodeficiency virus 
HP1 Heterochromatin protein 1 
hpi hours post-infection 
HSV herpes simplex virus 





IFNAR IFN-alpha/beta receptor 
IKK IκB kinase 
IL Interleukin 
INM Inner nuclear membrane 
IRF Interferon response factor 
ISG interferon stimulated gene 
JAK Janus kinase 
kb Kilobase 
kDa kilodalton 
LAP1/2 Lamina associated polypeptide 1/2 
LBR Lamin B receptor 
MAPK mitogen-activated protein kinase 
MAVS Mitochondrial antiviral-signalling protein 
MDA5 melanoma differentiation-associated protein 5 
min Minutes 
MOI multiplicity of infection 
mRNA Messenger RNA 
mt mitochondria 
MYXV Myxoma virus 
NDV Newcastle disease virus 
NE nuclear envelope 
NEMO NFκB essential modulator 
NES nuclear export signal 
NET Nuclear envelope transmembrane proteins 
NFκB nuclear factor kappa-light-chain-enhancer of activated B cells 
NLS nuclear localisation sequence 
nM nanomolar 
nm nanometre 
NPC Nuclear Pore Complex 
Nup nucleoporin 
OAS 2'-5'-oligoadenylate synthetase 
ONM Outer nuclear membrane 
PAMP Pathogen-associated molecular pattern 
PBS Phosphate buffer saline 
PCR Polymerase chain reaction 
PEDV Porcine Epidemic disease virus 
PFU plaque forming units 
PKR Protein kinase R 
PLA proximity ligation assay 
ix 
 
poly(I:C) (polyinosinic:polycytidylic) acid 
PRR Pattern recognition receptor 
qPCR Quantitative polymerase chain reaction 
RFP Red fluorescent protein 
RIG-I Retinoic acid-inducible gene 1 
RLR RIG-I-like receptor 
RNA Ribonucleic acid 
SASP senescence associated secretory phenotype 
SAVI STING-associated vasculopathy with onset in infancy 
SDS Sodium dodecyl-sulphate 
SeV Sendai virus 
SINV Sindbis virus 
siRNA Short interfering RNA 
smFRAP single molecule FRAP 
STAT signal transducer and activator of transcription 
STING STimulator of Interferon Genes 
TBK1 TANK-binding kinase 1 
TLR Toll-like receptor 
TNF Tumour necrosis factor 
TRAF TNF receptor associated factor 
TRIM Tripartite motif-containing protein 
U Enzyme units 
VSV vesicular stomatitis virus 
WNV West-Nile virus 
YFV Yellow fever virus 




Table of Figures 
Figure Title Page 
1.1 The Nuclear Envelope and Nuclear Pore Complex 2 
1.2 Cytosolic DNA and RNA sensing pathways 12 
1.3 STING-RFP resists detergent extraction and fails to target to the NE in 
Lamin A/C knockout MEFs 
27 
1.4 3D-Structured illumination microscopy (SIM) of STING in the NE 28 
1.5 Fluorescence Recovery After Photobleaching (FRAP) of STING in the NE 
shows STING increases mobility during HSV-1 infection or poly(I:C) 
transfection 
29 
1.6 The NE-STING proteome is enriched for chromatin organizing and 
RNA/DNA binding proteins 
30 
2.1 Doxycycline inducible STING-GFP expression 37 
2.2 Example plaque assay of A/PR8/34(H1N1) virus stock and mock infected 
MDCK cell monolayers 
43 
2.3 Example plaque assay of HSV-1 17+ virus stock and mock infected Vero cell 
monolayers 
44 
3.1 HT1080 cells and STING-GFP inducible HT1080 cells are suitable for 
studying STING localisation in the nuclear envelope 
56 
3.2 STING at the NE resists detergent extraction 58 
3.3 STING is present in INM and ONM by immunogold-EM 61 
3.4 FLIM-FRET shows STING-RFP interacts with Lamin A-GFP 64 
3.5 smFRAP shows STING-GFP redistributes from inner (INM) to outer nuclear 
membrane (ONM) during innate immune stimulation with DNA or poly(I:C) 
66 
4.1 STING nuclear envelope partners with connections to IRF3/7 transcription 
factors 
71 
4.2 Knockdown of STING partners impairs innate immune response stimulated 
luciferase reporter activation 
74 
4.3 Knockdown of STING and partner proteins in HT1080 cells 77 
4.4 Knockdown of SYNCRIP and SNRNP70 reduces IFNβ expression after 
immune stimulation with dsDNA 
80 
4.5 Knockdown of SYNCRIP, MEN1 and SNRNP70 reduces IFNβ and CCL5 
expression 8 h after immune stimulation with dsDNA 
82 
4.6 Knockdown of STING partners does not significantly affect levels of STING 
and cGAS in HT1080 cells 
83 
4.7 Knockdown of STING partners significantly reduces activation of IRF3 in 
cells stimulated with dsDNA and significantly increases activation in cells 
stimulated with poly(I:C) 
85 
4.8 Knockdown of STING partners significantly reduces nuclear accumulation 
of IRF3 in cells stimulated with dsDNA 
87 
4.9 Knockdown of STING partners and effect on herpes simplex virus (HSV-1) 
titres 
89 
4.10 Endogenous STING co-immunoprecipitates MEN1 but not SYNCRIP or 
DDX5 from whole cell lysates without crosslinking 
92 
4.11 Proximity ligation assay (PLA) suggests STING interacts with NE partners 94 
4.12 Nuclear/Cytoplasmic distribution of STING partners in mock and immune 
stimulated cells 
97 
4.13 Poly(I:C) displays a range of lengths that vary between manufacturers 101 
5.1 Influenza A virus (IAV) infects and proliferates in HT1080 cells 107 
5.2 STING restricts influenza A virus (IAV) strain PR8 but not Udorn 108 
xi 
 
5.3 STING partner SYNCRIP restricts influenza A virus (IAV) strain PR8 109 
5.4 Effect of SYNCRIP knockdown on influenza A virus (IAV) titres is increased 
in HT1080 cells infected with PR8 encoding NS1 mutants 
110 
5.5 Dual knockdown of SYNCRIP and STING results in higher viral titres 
compared to STING knockdown alone 
112 
5.6 Co-immunoprecipitation experiments do not show an interaction between 
SYNCRIP and STING during influenza A virus (PR8) infection 
114 
5.7 RNA-immunoprecipitation experiments do not show an interaction 
between SYNCRIP or STING with tested segments of influenza A virus (PR8) 
mRNA. 
116 
5.8 SYNCRIP protein levels do not change during influenza A virus (IAV) 
infection 
118 
5.9 SYNCRIP localisation during influenza A virus (IAV) infection 119 
5.10 Generation of SYNCRIP knockout HT1080 cell lines by CRISPR/Cas9 gene 
editing 
121 
5.11 Influenza A titres are significantly higher in one but not all SYNCRIP 
knockout HT1080 cell lines 
124 
5.12 Fusion Peptides of PR8 and Udorn compared to recombinant fusion 
peptide found to inhibit STING dimerization 
127 
6.1 STING contains a predicted bipartite nuclear localisation signal (NLS) 135 
6.2 The STING-GFP NE interactome is distinct from STING in the ER 137 








Declaration ............................................................................................................................................... i 
Lay Summary ........................................................................................................................................... ii 
Abstract .................................................................................................................................................. iv 
Acknowledgements ................................................................................................................................ vi 
Abbreviations ........................................................................................................................................ vii 
Table of Figures ....................................................................................................................................... x 
Contents ................................................................................................................................................ xii 
Chapter 1 ................................................................................................................................................. 1 
Introduction ............................................................................................................................................ 1 
1.1 - The Nuclear Envelope ................................................................................................................. 1 
1.2 - Protein transport to the inner nuclear membrane ..................................................................... 3 
1.3 - The innate immune system and pattern recognition ................................................................. 7 
1.3.1 - Innate immune responses to viral infection ........................................................................ 8 
1.3.2 - Detection of cytosolic viral RNA .......................................................................................... 9 
1.3.3 - Cytosolic DNA sensing and the cGAS-STING pathway ....................................................... 10 
1.3.4 - Additional DNA sensors ..................................................................................................... 15 
1.4 - Activation of the cGAS-STING pathway by self-DNA ................................................................ 17 
1.4.1 - Activation of the cGAS-STING pathway by nuclear DNA damage ..................................... 18 
1.4.2 - Activation of the cGAS-STING pathway by mitochondrial DNA ......................................... 19 
1.4.3 - The cGAS-STING pathway and auto-inflammatory disease ............................................... 20 
1.4.4 - The cGAS-STING pathway senescence and cancer ............................................................ 22 
1.5 - Additional functions of STING ................................................................................................... 24 
1.5.1 - Autophagy .......................................................................................................................... 24 
1.5.2 - STING in the restriction of RNA viruses ............................................................................. 25 
1.5.3 - STING’s mechanisms of defence in RNA virus infection .................................................... 27 
1.6 - A role for STING at the nuclear envelope ................................................................................. 29 
Chapter 2 ............................................................................................................................................... 38 
Materials and Methods ......................................................................................................................... 38 
2.1 – Materials .................................................................................................................................. 38 
2.1.1 Bacterial strains and genotypes ........................................................................................... 38 
2.1.2 - Buffers and solutions ......................................................................................................... 38 
2.1.3 - Primary Antibodies ............................................................................................................ 40 
2.1.4 - Secondary Antibodies ........................................................................................................ 41 
xiii 
 
2.1.5 - Virus stocks ........................................................................................................................ 41 
2.1.6 - Mammalian cells ................................................................................................................ 42 
2.2 - Mammalian cell culture ............................................................................................................ 42 
2.2.1 – Cell maintenance ............................................................................................................... 42 
2.2.2 – Plasmid transfection ......................................................................................................... 44 
2.2.3 – siRNA transient transfection ............................................................................................. 44 
2.2.4 – Innate immune response induction .................................................................................. 45 
2.2.5 – Dual-Luciferase Reporter Assay ........................................................................................ 46 
2.2.6 – Generation of HT1080 SYNCRIP knockout cell lines by CRISPR/Cas9 gene editing .......... 47 
2.3 – Virology methods ..................................................................................................................... 47 
2.3.1 – Influenza A virus production ............................................................................................. 47 
2.3.2 – Influenza A virus titration by plaque assay ....................................................................... 48 
2.3.3 – Infection of cells with Influenza A virus ............................................................................ 49 
2.3.4 – Herpes simplex virus-1 production ................................................................................... 50 
2.3.5 – Herpes simplex virus-1 titration by plaque assay ............................................................. 51 
2.3.6 – Infection of cells with Herpes simplex virus-1 (HSV-1) ..................................................... 51 
2.4 – Nucleic acid methods ............................................................................................................... 52 
2.4.1 – Sequencing plasmid DNA .................................................................................................. 52 
2.4.2 – RNA extraction .................................................................................................................. 52 
2.4.3 – Quantitative PCR (qPCR) ................................................................................................... 52 
2.5 – Microscopy methods ................................................................................................................ 54 
2.5.1 – Immunofluorescence ........................................................................................................ 54 
2.5.2 – Pre-fixation detergent extraction assay ............................................................................ 54 
2.5.3 – Proximity Ligation Assay (PLA) .......................................................................................... 55 
2.5.4 – Fluorescence Microscopy and analysis ............................................................................. 55 
2.5.5 – Förster-Resonance Energy Transfer (FRET) with fluorescence lifetime imaging (FLIM) 
microscopy .................................................................................................................................... 56 
2.5.6 – Single molecule Fluorescence Recovery After Photobleaching (smFRAP) microscopy .... 56 
2.5.7 – Immunogold Electron Microscopy .................................................................................... 57 
2.6 – Protein methods ...................................................................................................................... 57 
2.6.1 – Protein Extraction and Western Blotting .......................................................................... 57 
2.6.2 – Co-immunoprecipitation ................................................................................................... 58 
Chapter 3 ............................................................................................................................................... 60 
Localisation and Dynamics of STING at the Nuclear Envelope ............................................................. 60 
3.1 – Introduction ............................................................................................................................. 60 
xiv 
 
3.2 – HT1080 cells and HT1080 cells expressing inducible STING-GFP are suitable for studying 
STING localisation in the nuclear envelope ...................................................................................... 62 
3.3 – Endogenous STING resists detergent extraction in HT1080 cells ............................................ 65 
3.4 – Immunogold-EM of STING shows distribution at nuclear envelope in unstimulated and 
immune stimulated cells ................................................................................................................... 67 
3.5 – FRET with FLIM confirms that STING is in the INM but is inadequate to measure changes in 
STING distribution in response to immune stimulation ................................................................... 70 
3.6 - smFRAP microscopy shows that STING redistributes from INM to ONM upon immune 
stimulation by DNA or poly(I:C) ........................................................................................................ 74 
3.7 – Chapter Summary .................................................................................................................... 76 
Chapter 4 ............................................................................................................................................... 79 
Nuclear Envelope STING partners function in innate immune responses ........................................... 79 
4.1 – Introduction ............................................................................................................................. 79 
4.2 – Knockdown of some NE-STING partners inhibits IFNβ promoter and NF-κB driven luciferase 
reporter activation ............................................................................................................................ 81 
4.3 – STING partners are similarly knocked down in HT1080 cells so activation of endogenous IFNβ 
expression can be tested .................................................................................................................. 85 
4.4 – Knockdown of SYNCRIP and SNRNP70 significantly reduces induction of endogenous IFNβ 
mRNA as a result of immune stimulation by dsDNA but not dsRNA ................................................ 88 
4.5 – At a later time point post-immune stimulation with dsDNA, knockdown of MEN1 also 
significantly reduces expression of endogenous IFNβ ...................................................................... 91 
4.6 – Knockdown of STING partners reduces activation of IRF3 in response to DNA but not poly(I:C)
 .......................................................................................................................................................... 94 
4.7 – Knockdown of STING partners reduces accumulation of IRF3 in the nucleus following 
stimulation with dsDNA .................................................................................................................... 96 
4.8 – Knockdown of STING partners and effects on proliferation of the DNA virus, HSV-1 ............. 97 
4.9 – Attempts to co-immunoprecipitate STING with NE partners without cross-linking suggests 
they are not direct interactors ........................................................................................................ 100 
4.10 – Proximity Ligation Assay suggests STING and partners are in close proximity but requires 
further optimisation ........................................................................................................................ 103 
4.11 – Redistribution of STING partners in response to stimulation with dsDNA and poly(I:C) .... 106 
4.12 – Chapter Summary ................................................................................................................ 109 
Chapter 5 ............................................................................................................................................. 115 
SYNCRIP is a novel antagonist of influenza A virus (IAV) .................................................................... 115 
5.1 – Introduction ........................................................................................................................... 115 
5.2 – IAV infects and replicates in HT1080 cells ............................................................................. 118 
5.3 – STING restricts IAV growth in HT1080 cells ........................................................................... 120 
5.4 – SYNCRIP restricts IAV growth in HT1080 cells ........................................................................ 121 
xv 
 
5.5 – SYNCRIP knockdown effect on IAV titres is increased in cells infected with IAV (PR8) NS1 
mutants ........................................................................................................................................... 122 
5.6 – Simultaneous knockdown of SYNCRIP and STING increases IAV titres compared to 
knockdown of STING alone ............................................................................................................. 124 
5.7 – An interaction between SYNCRIP and STING during IAV infection cannot be identified by 
immunoprecipitation ...................................................................................................................... 126 
5.8 – SYNCRIP and STING do not bind IAV mRNAs from segment 5 and 7 ..................................... 128 
5.9 – SYNCRIP protein levels and localisation during IAV infection ................................................ 130 
5.10 – Generation of SYNCRIP-knockout HT1080 cells ................................................................... 135 
5.11 – IAV proliferation in SYNCRIP-knockout cells ........................................................................ 137 
5.12 – Chapter Summary ................................................................................................................ 140 
Chapter 6 ............................................................................................................................................. 145 
Discussion............................................................................................................................................ 145 
6.1 – Implications of an inner nuclear membrane pool of STING ................................................... 145 
6.2 – The nuclear envelope STING interactome is distinct from that of STING in the ER .............. 152 
6.3 – How do NE STING partners function in IIRs? ......................................................................... 161 
6.4 – How does SYNCRIP antagonise influenza A virus? ................................................................. 167 
6.5 – Final Remarks ......................................................................................................................... 170 
References .......................................................................................................................................... 172 
Appendix ............................................................................................................................................. 210 












Chapter 1  
Introduction 
 
STING (stimulator of interferon genes; also called ERIS, MITA, MPYS, and NET23) is the critical 
adaptor protein in innate immune signalling cascades triggered by cytosolic dsDNA, which 
culminate in the induction of type-I interferons (IFNs) (Ishikawa and Barber 2008; Zhong et al. 
2008; Ishikawa et al. 2009; Sun et al. 2009; Ahn and Barber 2019; Motwani et al. 2019). STING 
is a ubiquitously expressed transmembrane protein (Ishikawa and Barber 2008; Zhong et al. 
2008; Sun et al. 2009) and while early studies reported that STING localised throughout the 
endoplasmic reticulum (ER) (Ishikawa and Barber 2008; Ishikawa et al. 2009; Sun et al. 2009), 
at mitochondria (Jin et al. 2008; Zhong et al. 2008), and at the plasma membrane (Jin et al. 
2008), it is now widely stated that STING is an ER protein with a small pool interacting with 
the mitochondria likely at mitochondria-associated ER membranes (Ishikawa and Barber 
2008; Ishikawa et al. 2009; Sun et al. 2009). However, prior to its identification as an ER 
resident protein, STING was identified as a candidate nuclear envelope (NE) protein based on 
proteomics of NEs isolated from rat liver (Schirmer et al. 2003). Despite this, most research 
into STING has focussed on its role at the ER in innate immune signalling cascades triggered 
by cytosolic DNA. I am interested in investigating the localisation of STING within the NE and 
the role of STING at the NE, an area of research which has been largely neglected except by 
the Schirmer Laboratory which previously reported STING’s presence in the NE (Schirmer et 
al. 2003; Malik et al. 2010) and discovered that overexpression of STING induced a chromatin 
compaction phenotype radiating from the NE (Malik et al. 2014).  
In this chapter, I will begin by describing the NE and mechanisms by which transmembrane 
proteins are targeted there. I will then give an overview of the innate immune response and 
the role STING plays in it, as well as emerging roles for STING. Finally, I will describe the extent 
of our knowledge of STING at the NE and define the aims of this study.    
1.1 - The Nuclear Envelope  
The segregation of genomic material within a distinct cellular compartment, the nucleus, is 
the eponymous feature of eukaryotic cells, distinguishing them from prokaryotes. The 
nucleus is encapsulated by a double membrane system known as the NE, which physically 
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separates most of the cell’s genetic material (DNA) from the cytoplasm. Structurally, the NE 
consists of two lipid bilayers, the outer and inner nuclear membranes (ONM and INM) which 
are separated by an approximately 50 nm luminal space and connect at discrete locations 
forming pores between the nucleus and cytoplasm (Callan et al. 1949; Callan and Tomlin 
1950). Within these pores sit the multi-protein structures called nuclear pore complexes 
(NPCs) (Aitchison and Rout 2012; Grossman et al. 2012), which form proteinaceous channels 
that allow for regulated transport between the nucleus and cytoplasm. On its nucleoplasmic 
face, the NE is supported by the nuclear lamina, a matrix of intermediate filament lamin 
proteins which line the INM providing mechanical stability (Gerace et al. 1978; Gruenbaum 
and Foisner 2015). While on its cytoplasmic face, the ONM is contiguous with the ER and not 
only doubles as a functional subdomain of the ER studded with ribosomes, but also has ONM-
specific proteins (Crisp et al. 2006; Meinke and Schirmer 2015). Thus, the ER, ONM, and INM 
constitute a continuous membrane system (Figure 1.1 A). 
 
Figure 1.1 – The Nuclear Envelope and Nuclear Pore Complex (A) Organization of the 
mammalian nuclear envelope (NE). The NE is a double-membrane system that encapsulates 
the genome, separating the nucleoplasm from the cytoplasm. The outer nuclear membrane 
(ONM) is contiguous with the endoplasmic reticulum (ER) and connects to the inner nuclear 
membrane (INM) at multiple locations, forming pores through the NE which are stabilized by 
nuclear pore complexes (NPCs). The INM is underlined by a meshwork of intermediate filament 
lamin proteins which make up the nuclear lamina (red). Some NE transmembrane proteins 
(NETs) present in the INM interact with lamins and/or chromatin (blue) (B) Structure of the 
nuclear pore complex (NPC). NPCs function as semipermeable channels in the NE for 
nucleocytoplasmic molecular exchange. Transmembrane nucleoporins (Nups) tether the NPC 
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to the pore membrane (POM) which connects the ONM and INM with both convex and 
concave membrane curvature. In addition to the central channel of the NPC, which is lined 
with FG repeats (blue) thought to facilitate the translocation of cargoes up to ~39 nm in 
diameter across the NE, there exist ~10 nm diameter peripheral channels between the core 
scaffold of the NPC and pore membrane. Adapted from (Dixon and Schirmer 2018). 
 
Although compartmentalisation of the genome likely arose to protect DNA from potentially 
damaging metabolic enzymes, conferring a major evolutionary benefit to the first eukaryotic 
cells, proteins that reside in the NE have been shown to be involved in numerous functions, 
greatly expanding the role of the NE. Such functions include: spatial genome organisation 
(Meaburn et al. 2007; Zuleger et al. 2013; Robson et al. 2016), compartmental epigenetic 
silencing (Ye and Worman 1996; Makatsori et al. 2004; Shaklai et al. 2007; Demmerle et al. 
2012), DNA replication (Meier et al. 1991; Moir et al. 1994; Spann et al. 1997; Ellis et al. 1997; 
Kennedy et al. 2000), transcriptional regulation (Ivorra et al. 2006), mechano-transduction 
(Ho et al. 2013; Swift et al. 2013), mechanical stability (Lammerding et al. 2004; Broers et al. 
2004; Lammerding et al. 2006; Lee et al. 2007), and cell migration (Lee et al. 2007; Willis et al. 
2008). Furthermore, in the context of the innate immune response the NE functions to 
segregate DNA from cytosolically localised DNA sensors which would otherwise induce 
immune signalling against self-DNA (Motwani et al. 2019). NE localised proteins form the NE 
proteome, which despite the continuity of lipid membranes with the ER, is distinct from that 
of the ER with both INM and ONM having partially unique sets of transmembrane proteins, 
often termed NETs for Nuclear Envelope Transmembrane proteins (Schirmer et al. 2003; 
Worman and Schirmer 2015). Moreover, the NE proteome has been shown to differ notably 
between tissues with many NETs showing tissue restricted expression and localisation at the 
NE which is evidence of tissue-specific functions for NETs and highlights that the NE is more 
than just a physical barrier between the nucleus and cytoplasm (Korfali et al. 2010; Wilkie et 
al. 2011; Korfali et al. 2012; de Las Heras et al. 2013).  
1.2 - Protein transport to the inner nuclear membrane 
The NPCs are the principal route into and out of the nucleus, because of this nearly all 
molecules travelling between the cytoplasm and nucleus must pass through these channels. 
Structurally the NPC consists of multiple copies of ~30 distinct protein subunits called 
nucleoporins (Nups) which form a semipermeable channel with pseudo-eightfold symmetry 
(Gall 1967). The core of the NPC is normally considered as a three-stacked ring structure 
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surrounding a central channel, with cytoplasmic and nuclear rings sandwiching an inner spoke 
ring which anchors the NPC to the pore membrane (where ONM and INM meet) through 
transmembrane Nups (Frenkiel-Krispin et al. 2010). In addition to the core structure of the 
NPC, eight cytoplasmic filaments protrude into the cytoplasm from the cytoplasmic ring, while 
from the nuclear ring emanates the nuclear basket (Beck and Hurt 2016; von Appen and Beck 
2016). As well as the central channel, structural analysis using electron microscopy revealed 
the presence of smaller peripheral channels around the central channel adjacent to the pore 
membrane (Hinshaw et al. 1992; Beck et al. 2007) (Figure 1.1 B). 
While small molecules, including metabolites and ions, are able to diffuse freely through 
NPCs, soluble molecules larger than ~40 kDa or 5 nm, such as proteins and RNA are unable to 
pass through freely. Instead these molecules require energy-dependent mechanisms to 
traverse the NPC based on the recognition of nuclear localization signals (NLS) or nuclear 
export signals (NES) present on cargo molecules by nuclear transport receptor proteins, 
importins and exportins (Güttler and Görlich 2011; Grossman et al. 2012). These nuclear 
transport receptors mediate cargo transport across the NPC by means of hydrophobic 
interactions with phenylalanine-glycine-rich nucleoporin repeat domains (FG-repeat 
domains) present on the Nups which line the central channel. Receptor-cargo binding and 
release are dictated by a gradient of the GTPase, Ran, across the NPC. For import, cargos are 
bound in the cytoplasm by importins which translocate through the central channel of the 
NPC into the nucleus. In the nucleus, Ran bound to GTP (Ran-GTP) binds to the importin-cargo 
complex causing dissociation of the importin from its cargo. The importin-Ran-GTP complex 
then translocates to the cytoplasm where it is dissociated by action of the Ran binding 
proteins (RanBP1/2) and Ran-GTP is bound by the Ran GTPase activating protein (Ran-GAP) 
that induces hydrolysis of GTP to GDP. Ran-GDP is subsequently trafficked to the nucleus by 
the transport protein, NUTF2, and once in the nucleus Ran-GDP interacts with RCC1, a Ran 
guanine nucleotide exchange factor (GEF) which replaces GDP for GTP forming Ran-GTP. 
Conversely, for export an exportin protein binds to its cargo in the nucleus and must associate 
with Ran-GTP to form a stable export complex allowing for transport across the NPC. Once in 
the cytoplasm this complex is disassembled by RanBP1/2 and Ran-GAP resulting in the 
formation of Ran-GDP. The directionality of transport is thus dictated by differential 
localisation of Ran-GTP, with a high concentration of Ran-GTP in the nucleus maintained by 
5 
 
the chromatin-associated Ran-GEF, RCC1, and a low concentration in the cytoplasm due to 
the action of Ran-GAP (Fried and Kutay 2003; Cook et al. 2007).  
The translocation of INM bound transmembrane proteins into the nucleus appears more 
complex than that of soluble proteins, with evidence to support multiple different 
mechanisms for different proteins (Ohba et al. 2004; Saksena et al. 2004; King et al. 2006; 
Braunagel et al. 2007; Zuleger et al. 2011; Meinema et al. 2011; Ungricht et al. 2015; Dixon 
and Schirmer 2018). Since NETs are primarily thought to be co-translationally inserted into 
the ER membrane (Laba et al. 2014) they should be able to diffuse freely through the ER to 
the ONM. However, negotiating the NPC to reach the nucleus presents a greater obstacle for 
transmembrane proteins than soluble proteins. Following the route taken through the central 
channel of the NPC by soluble proteins (Fiserova et al. 2010; Yang 2013) would seem 
incompatible for a transmembrane protein as it would either require a mechanism to prevent 
co-translational insertion into the ER membrane, or a mechanism to extract them from the 
ER membrane post-translationally. Instead, transmembrane proteins are thought to transit 
through the NPC while remaining embedded in the lipid bilayer of the pore membrane. Given 
the existence of ~10 nm wide peripheral channels in the NPC adjacent to the pore membrane 
(Hinshaw et al. 1992; Beck et al. 2007; Maimon et al. 2012; Bui et al. 2013; von Appen et al. 
2015), it is thought that the nucleoplasmic mass of NETs passes through these openings while 
their transmembrane domains diffuse through the pore membrane. Indeed, it has been 
demonstrated experimentally that provided the nucleoplasmic mass of an INM targeted NET 
does not exceed ~60kDa it can still traffic from the ER to the INM (Soullam and Worman 1995; 
Ohba et al. 2004; Turgay et al. 2010; Zuleger et al. 2011; Ungricht et al. 2015). No such size 
restriction exists for soluble proteins and this would indicate that transmembrane and soluble 
proteins take different routes through the NPC.  
A number of different mechanisms for trafficking and enrichment of NETs at the INM have 
been proposed (Dixon and Schirmer 2018). The best described of which include lateral 
diffusion in the membranes of the ER and NE followed by retention at the INM, ATP-
dependent transport, and NLS-dependent receptor-mediated transport. In the lateral 
diffusion-retention model of transmembrane protein targeting to the INM, NETs diffuse 
laterally in the membranes of the ER and NE and pass through the peripheral channels of the 
NPC by undirected passive diffusion while remaining embedded in the pore membrane. NETs 
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are able to accumulate in the INM through binding to nuclear localised partners (Powell and 
Burke 1990; Smith and Blobel 1993; Soullam and Worman 1993). This model is supported by 
the observed ~60 kDa size restriction limit of the nucleoplasmic domains of INM proteins 
(Soullam and Worman 1995; Ohba et al. 2004; Turgay et al. 2010; Zuleger et al. 2011; Ungricht 
et al. 2015) and the identification of nuclear binding partners for several NETs. A major 
binding partner of INM proteins is the nuclear lamina underlying the INM which binds NETs 
including LBR (Worman et al. 1988; Ye and Worman 1994), LAP1 and LAP2 (Senior and Gerace 
1988; Foisner and Gerace 1993), emerin (Clements et al. 2000), SUN2 (Hodzic et al. 2004), and 
most of the NETs identified by proteomics (Schirmer et al. 2003) tested thus far (Malik et al. 
2010). As well as binding to the nuclear lamina, several NETs also bind to chromatin or 
chromatin-associated proteins, for example, LBR binds to heterochromatin protein 1 (HP1) 
(Ye and Worman 1996) and the LEM domain family of proteins (LAP2, emerin, Man1) bind to 
the chromatin-associated protein barrier to autointegration factor (BAF) (Brachner and 
Foisner 2011). Moreover, several NETs direct particular patterns of genome organization 
indicative of chromatin binding (Zuleger et al. 2013; Robson et al. 2016). Although, recent 
studies suggest that lateral diffusion and retention are the major determinants of protein 
targeting to the INM (Boni et al. 2015; Ungricht et al. 2015) several proteins have been 
described which require additional factors for INM localization (Zuleger et al. 2011; Katta et 
al. 2014). For example targeting of SUN2 and emerin to the INM appears to be an energy-
dependent process requiring ATP (Ohba et al. 2004; Zuleger et al. 2011; Dixon and Schirmer 
2018). Another well-described mechanism of protein transport to the INM that is used by a 
few NETs is the NLS-dependent facilitated transport mechanism. The yeast orthologues of 
human Man1 and LEM2 proteins, Heh1 and Heh2, were found to contain NLSs and 
accumulate at the INM in yeast via a receptor-mediated transport pathway (King et al. 2006; 
Lusk et al. 2007). These NLSs are separated from the transmembrane domain by an 
intrinsically disordered (ID) linker region and both NLS and ID linker are required and sufficient 
to accumulate a membrane protein at the INM in yeast (Meinema et al. 2011). Subsequently, 
the NLS and linker region of Heh2 was shown to target a membrane-embedded reporter to 
the INM in human cells suggesting that this transport mechanism could function in higher 
eukaryotes (Kralt et al. 2015). What is perhaps most striking about this receptor mediated 
transport mechanism is that importins required for translocation through the NPC are larger 
than the ~60 kDa limit for translocation through the peripheral channels of the NPC. This 
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suggests that transport must occur simultaneously through the central channel and 
peripheral channels with the NET maintained in the nuclear pore membrane. Work in yeast 
showed that a ID linker region of at least 120 amino acid residues between transmembrane 
domain and NLS is required for this transport mechanism (Meinema et al. 2011; Meinema et 
al. 2013; Laba et al. 2015). The team behind these studies proposed that this ID linker 
effectively slices through the core NPC scaffold allowing the NLS bound by importins to 
translocate through the central channel while the transmembrane domains of the NET remain 
embedded in the pore membrane. In support of this mechanism, human LBR and Lap2β, 
which contain ID-linkers and NLSs, were recently shown to simultaneously transit through the 
central channel as well as the peripheral channels of the NPC (Mudumbi et al. 2020). 
1.3 - The innate immune system and pattern recognition 
The mammalian immune system consists of two arms, innate and adaptive, the combined 
action of which drives the clearance of pathogen infection. While the innate immune system 
provides the first line of defence against invading pathogens with a fast-acting, generalised 
response to infection, the adaptive immune response is highly specific, relying on specialised 
immune cells, and often results in immunological memory. 
Innate immune responses to pathogen infection are initiated through the recognition of 
distinct ‘non-self’ components of microorganisms (pathogen associated molecular patterns 
(PAMPs)) by germline-encoded host cell sensors, known as pattern recognition receptors 
(PRRs) (Janeway, C.A. 1989; Medzhitov 2009). PAMPs are usually essential to the invading 
pathogen and evolutionarily conserved so they cannot be readily mutated to enable evasion 
of PRRs. An increasingly large number of PRRs have been identified which detect signatures 
of pathogen infection in different subcellular locations (Palm and Medzhitov 2009; 
Unterholzner 2013; Chow et al. 2015; Sparrer and Gack 2015). Toll-like receptors (TLRs) 
(Kawai and Akira 2011) and C-type lectin receptors (CLRs) (Dambuza and Brown 2015) detect 
extracellular PAMPs at the plasma membrane and in endosomal compartments and are 
predominantly expressed by specialised cells of the immune system (Dambuza and Brown 
2015). Conversely, receptors that detect intracellular PAMPs are localised in the cytoplasm 
and/or nucleus and include: the viral RNA sensing RIG-I-like receptors (RLRs) (Yoneyama et al. 
2015), cytosolic DNA sensors including cyclic GMP-AMP synthase (cGAS) (Sun et al. 2013) and 
the AIM2-like receptors (ALRs) (Unterholzner et al. 2010; Caneparo et al. 2018), and NOD-like 
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receptors (NLRs) which primarily sense intracellular bacteria (Kersse et al. 2011). In contrast 
to TLRs and CLRs these sensors are more widely expressed enabling the detection of 
intracellular infection by virtually all cell types.  
1.3.1 - Innate immune responses to viral infection 
In response to viral infection, a key mechanism of host cell antiviral defence is the induction 
of the interferon (IFN) response, following the recognition of viral PAMPs, which upregulates 
the expression of antiviral genes and pro-inflammatory cytokines to recruit specialised cells 
of the immune system to clear infection. The major PAMPs recognised by host PRRs during 
viral infection are the nucleic acids of actively replicating viruses (Sparrer and Gack 2015; Ma 
et al. 2018). Once these are detected by PRRs, signalling cascades are initiated through the 
activation of PRR family-specific adaptor proteins, which converge on a group of well 
characterized kinases. Through a series of phosphorylation events these kinases activate 
immune transcription factors, culminating in the expression of IFNs and pro-inflammatory 
cytokines and chemokines (Goubau et al. 2013; Liu et al. 2015a). In turn, secreted IFN binds 
to the surface interferon-α/β receptor (IFNAR) in an autocrine and paracrine manner leading 
to the activation of JAK-STAT signalling cascades. Activated STAT proteins dimerize and 
translocate to the nucleus where they induce the expression of IFN-stimulated genes (ISGs) 
whose products antagonize viral replication through mechanisms including viral RNA cleavage 
and the induction of apoptosis. Among ISGs are some PRRs and proteins involved in immune 
signalling cascades, resulting in a positive feedback loop and sensitising neighbouring cells for 
detection of viral infection. At the same time, secreted cytokines and chemokines regulate 
the recruitment and activation of cells of the adaptive immune system to clear viral infection 
(Schneider et al. 2014). In addition to IFN induction, some PRRs activate inflammasome 
complexes leading to activation of caspases, in particular caspase-1, and maturation of pro-
forms of IL-1β and IL-18 pro-inflammatory cytokines (Chen and Ichinohe 2015). Caspase-1 also 
cleaves the cytosolic protein gasdermin D into an N-terminal domain (GSDMD-N) and C-
terminal domain (GSDMD-C), GSDMD-N oligomerises on the cell membrane forming 
transmembrane pores resulting in cell membrane rupture and release of pro-inflammatory 
intracellular contents in a specialised form of inflammatory cell death termed pyroptosis 
(Bergsbaken et al. 2009). 
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The large array of PRRs and web of signalling cascades they initiate upon recognition of 
pathogen invasion require tight regulation, adding another layer of complexity to the innate 
immune response. Left unchecked, the excessive production of IFNs and pro-inflammatory 
cytokines can have deleterious effects on the host resulting in autoimmune disease (Kato and 
Fujita 2014; Crowl et al. 2017), while insufficient innate immune responses can result in higher 
disease severity and lethality. Key proteins involved in innate immune responses triggered 
following cytosolic RNA and DNA recognition will be discussed below. 
1.3.2 - Detection of cytosolic viral RNA 
Detection of cytosolic viral RNA occurs primarily through the RLR family of DExD/H-box 
helicases, which consists of retinoic acid-inducible gene-I (RIG-I) (Yoneyama et al. 2004), 
melanoma differentiation-associated gene 5 (MDA5) (Kang et al. 2002), and laboratory of 
genetics and physiology 2 (LGP2). All three are able to bind directly to RNA through their 
helicase and C-terminal domains, although only RIG-I and MDA-5 possess N-terminal caspase 
activation and recruitment domains (CARDs) which enable association with the CARD of the 
downstream adaptor protein MAVS (IPS-1/VISA/Cardif) located at the mitochondrial outer 
membrane (Seth et al. 2005; Kawai et al. 2005; Meylan et al. 2005). Although unable to 
activate MAVS itself, LGP2 appears to contribute to the regulation of immune responses by 
inhibiting RIG-I and supporting MDA5 signalling (Ahmad and Hur 2015). Both RIG-I and MDA5 
recognise distinct viral RNA structural features which are absent from mature host RNAs, 
preventing aberrant activation in the absence of viral infection (Schlee and Hartmann 2016). 
RIG-I primarily recognises uncapped 5’-triphosphate double-stranded RNA (dsRNA) that lacks 
overhangs (Marques et al. 2006; Hornung et al. 2006; Schlee et al. 2009), while MDA-5 is 
potently activated by very long dsRNA (>300bp) independently of any structure on the ends 
of the RNA (Gitlin et al. 2006; Kato et al. 2006; Kato et al. 2008). Upon RNA ligand binding, 
RIG-I undergoes a conformational switch from an inactive to active form, exposing its CARDs 
and forming a tetramer (Kowalinski et al. 2011; Wu et al. 2014; Zheng et al. 2015). MDA5 on 
the other hand is thought to adopt a ring-like conformation around dsRNA with monomers of 
MDA5 stacking along the dsRNA to form MDA5 filaments, with the CARDs decorating the 
outer surface of this structure and forming oligomers capable of activating MAVS (Wu et al. 
2013a). The exposed CARDs of RNA bound RIG-I/MDA5 bind the CARD of MAVS inducing the 
formation of prion-like MAVS aggregates (Hou et al. 2011) which serve as scaffolding 
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complexes for the recruitment and activation of downstream signalling components. These 
include TNF receptor-associated factors (TRAFs), TANK-binding kinase 1 (TBK1), and IκB kinase 
(IKK) complexes. TRAFs activate TBK1 and IκB kinase epsilon (IKKε) kinases which 
phosphorylate interferon regulatory factor 3 (IRF3) and IRF7 transcription factors. MAVS 
signalling complexes also recruit and activate the IKKα/β/ƴ complex. The IKKα/β/ƴ complex 
consists of three subunits, the regulatory IKKγ subunit (also known as NF-κB essential 
modulator, NEMO) and catalytic subunits IKKα and IKKβ. TRAFs mediate ubiquitination at 
MAVS signalling complexes and the K63-linked ubiquitin chains are bound by IKKγ which in 
turn recruits IKKα/β subunits which phosphorylate and activate one another. Activated 
IKKα/β/ƴ phosphorylates IκB, the inhibitor of NF-κB, which is subsequently ubiquitinated and 
targeted for proteasomal degradation. In unstimulated cells NF-κB dimers are bound by IκB 
which masks an NLS on NF-κB proteins, sequestering them in the cytoplasm and so IKKα/β/ƴ 
mediated phosphorylation of IkB releases NF-κB dimers. Active IRF3/7 and NF-κB 
transcription factors are then able to translocate to the nucleus where they induce the 
expression of type-I IFNs and pro-inflammatory cytokines (Chiang et al. 2014; Kato and Fujita 
2014; Sparrer and Gack 2015) (Figure 1.2). In addition to RLRs, a number of other sensors of 
cytosolic viral RNA exist many of which directly inhibit viral propagation upon recognition of 
RNA (Sparrer and Gack 2015; Schlee and Hartmann 2016). These include protein kinase R 
(PKR) which inhibits cellular translation and activates the inflammasome, and may act with 
RLRs to induce IFN-mediated immune responses (Levin and London 1978; Pfaller et al. 2011), 
and 2’,5’-oligoadenylate synthetase (OAS) which upon dsRNA binding synthesises 2’5’-linked 
oligoadenylate that acts as a second messenger to activate RNase L, which then degrades RNA 
in the cytoplasm (Hornung et al. 2014). RNA fragments generated by RNase L may then serve 
as ligands of the RIG-I-MAVS pathway, amplifying antiviral signalling (Malathi et al. 2007).  
1.3.3 - Cytosolic DNA sensing and the cGAS-STING pathway 
It has long been known that the introduction of DNA into cells is able to stimulate a protective 
immune response against viral infection (Rotem et al. 1963). Cytosolic DNA can arise from a 
number of sources including infection with DNA viruses or intracellular bacteria, artificial 
introduction by transfection, or host-cell DNA ‘leakage’ into the cytosol as a result of cellular 
stress or damage. However, it has only been within the last fifteen years that the molecular 
mechanisms for sensing and responding to cytosolic DNA have been uncovered, following the 
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discovery in 2006 that cytosolic DNA potently stimulates an IRF3-dependent IFN response 
independently of the endosomal DNA sensor, TLR9 (Ishii et al. 2006; Stetson and Medzhitov 
2006).  
The detection of DNA in the cytosol principally activates two immune signalling pathways, the 
cGAS-STING pathway which drives the induction of type-I IFN and the caspase-1 
inflammasome pathway. The absent in melanoma 2 (AIM2) protein is the primary cytosolic 
DNA receptor that activates the inflammasome pathway, forming an inflammasome complex 
with ASC and caspase-1 after binding DNA. The active AIM2 inflammasome controls the 
proteolytic maturation of the proinflammatory cytokines IL-1β and IL-18 and induces cell 
death through pyroptosis, a highly inflammatory form of lytic programmed cell death 
(Bürckstümmer et al. 2009; Fernandes-Alnemri et al. 2009; Hornung et al. 2009; Roberts et al. 
2010). Conversely, cGAS is the principal and best described cytosolic DNA sensor for activation 
of the cGAS-STING pathway and subsequent induction of type-I IFN (Sun et al. 2013; Ablasser 
and Chen 2019; Ahn and Barber 2019; Motwani et al. 2019).  
cGAS binds to dsDNA independently of sequence so it can be activated by dsDNA ligands 
indiscriminately of their origin, although DNA length is important with longer dsDNAs >45 bp 
allowing the formation of ladder-like networks of cGAS dimers and enabling stronger 
signalling (Luecke et al. 2017; Andreeva et al. 2017; Zhou et al. 2018). Following binding to 
dsDNA, cGAS catalyses the synthesis of a cyclic-dinucleotide (CDN) second messenger, 2’3’-
cyclic GMP-AMP (cGAMP), from ATP and GTP (Civril et al. 2013; Diner et al. 2013; Gao et al. 
2013b; Li et al. 2013c; Sun et al. 2013; Wu et al. 2013b; Ablasser et al. 2013a). Binding of 
dsDNA by cGAS results in the formation of liquid-liquid phase separated droplets, in which 
increased local concentration of cGAS and reactants result in enhanced cGAMP production 
(Du and Chen 2018). cGAMP then binds directly to STING dimers localised at the ER (Diner et 
al. 2013; Gao et al. 2013b; Ablasser et al. 2013a; Zhang et al. 2013). STING was previously 
shown to bind bacterial CDNs (Burdette et al. 2011) but binds to endogenous cGAMP with 
higher affinity (Zhang et al. 2013) and so cGAMP is a more potent ligand for stimulating STING 
activation. Binding of cGAMP or bacterial CDNs induces a conformational change in inactive 
STING dimers (Shang et al. 2012; Gao et al. 2013b; Zhang et al. 2013) leading to the formation 
of active STING dimers, which are able to pack side-by-side to form tetramers and higher-
order oligomers (Shang et al. 2019). The activation of STING through CDN binding results in 
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its translocation out of the ER, where it is retained in its resting state by the Ca2+ sensor STIM1 
(Srikanth et al. 2019). STING is transported through COPII mediated vesicular transport, via 
the ER-Golgi intermediate compartment (ERGIC), to the Golgi apparatus and eventually to 
post-Golgi vesicles and lysosomes where it is degraded (Ishikawa et al. 2009; Saitoh et al. 
2009; Dobbs et al. 2015; Gonugunta et al. 2017). This redistribution event is characteristic of 
STING activation and can be visualised clearly using fluorescence microscopy as the 
accumulation of STING in the Golgi and perinuclear foci in cells post-DNA stimulation 
(Ishikawa et al. 2009; Saitoh et al. 2009; Dobbs et al. 2015; Gonugunta et al. 2017; Franz et al. 
2018). In addition to activating STING in the cell in which it is produced, cGAMP can be 
transferred to nearby cells through gap junctions (Ablasser et al. 2013b) and packaged into 
progeny virions during viral infection to initiate STING signalling (Bridgeman et al. 2015; 
Gentili et al. 2015).  
Following activation and translocation out of the ER, STING recruits TBK1 which 
phosphorylates STING at the critical serine residues S366 and S358 (Zhong et al. 2008; Tanaka 
and Chen 2012; Liu et al. 2015a; Zhang et al. 2019). TBK1 binds to STING via its C-terminal tail 
(CTT) and phosphorylates the STING dimer adjacent to the one it is bound by virtue of STING 
dimer oligomerisation upon cGAMP binding (Tanaka and Chen 2012; Zhang et al. 2019). 
Phosphorylation of STING at S366 and S358 by TBK1 allows the recruitment of IRF3 which is 
subsequently phosphorylated by TBK1 resulting IRF3 homo-dimerization and dissociation 
from STING (Zhong et al. 2008; Tanaka and Chen 2012; Liu et al. 2015a; Zhang et al. 2019). 
This occurs via a shared mechanism between the immune adaptor proteins STING, MAVS, and 
TRIF, all of which contain a conserved pLxIS (where p is a hydrophilic residue and x is any 
residue) motif that is phosphorylated by TBK1 and subsequently bound by the positively 
charged surface of IRF3 (Liu et al. 2015a). The phosphorylation and dimerization of IRF3 
exposes a masked NLS leading to accumulation of IRF3 in the nucleus where it forms a 
complex with the transcriptional coactivators CBP/p300 and induces the expression of type-I 
IFNs and pro-inflammatory cytokines in concert with NF-κB and AP1 (ATF2/c-Jun) 
transcription factors (Lin et al. 1998; Yoneyama et al. 1998; Kumar et al. 2000; Servant et al. 
2002; Zhu et al. 2015). In addition to the recruitment and activation of IRF3, STING also directs 
the activation of NF-κB and MAPK signalling pathways, albeit to a lesser extent than IRF3 (de 
Oliveira Mann et al. 2019) (Figure 1.2). However, the mechanism through which STING 
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activates NF-κB signalling is less well understood compared to IRF3 activation through TBK1, 
and the mechanism of STING-dependent MAPK activation is not yet known. For NF-κB 
activation conflicting models have been proposed, in one TBK1 is required and functions 
upstream of NF-κB activation where it is required for full phosphorylation and activation of 
IKKα/β/ƴ (Abe and Barber 2014; Fang et al. 2017). TRIM32, TRIM56, and TRAF6 have been 
proposed to mediate the ubiquitination required for IKKα/β/ƴ recruitment and activation 
(Abe and Barber 2014; Fang et al. 2017). In the other model TBK1 is not required for NF-κB 
activation because reports have shown that the CTT of STING, which is required for TBK1 
binding and IRF3 activation, is dispensable for NF-κB activation in humans (de Oliveira Mann 
et al. 2019). Interestingly, ray-finned fish exhibit a much stronger NF-κB response following 
immune stimulation with dsDNA compared to mammals and this is explained by the finding 
that the CTT of zebrafish STING is extended compared to mammalian STING species and 
contains a domain that directly recruits TRAF6 which in turn serves to activate NF-κB (de 
Oliveira Mann et al. 2019). STING also activates the STAT6 transcription factor which interacts 
with STING upon immune stimulation and is phosphorylated by TBK1, resulting in STAT6 
dimerization and translocation to the nucleus where it induces a specific set of chemokines 
(CCL2, CCL20, and CCL26) which attract specialised immune cells to the site of infection (Chen 




Figure 1.2 - Cytosolic DNA and RNA sensing pathways. Pathogen DNA in the cytosol is 
detected by a number of host cell pattern recognition receptors (PRRs). STING homodimers at 
the endoplasmic reticulum are activated principally through binding cyclic dinucleotides such 
as the secondary messenger cGAMP produced by cGAS upon dsDNA binding. Upon activation 
STING traffics to perinuclear puncta where it becomes associated with downstream TBK1 and 
IKK kinases. These kinases in turn activate IRF3/7 and NF-κB transcription factors which 
translocate to the nucleus and induce expression of type I interferons (IFNs) and pro-
inflammatory cytokines. Viral RNA in the cytosol is detected principally by RIG-I and MDA-5 
PRRs, which in turn interact with and activate the critical adaptor protein, MAVS, at the 
mitochondrial membrane. Active MAVS polymers recruit TBK1 and IKK kinases, leading to 
IRF3/7 and NF-κB activation. 
Intriguingly, despite recognising DNA in the cytoplasm and initially being described as 
localising to the cytoplasm, it has been shown that at least a pool of cGAS and perhaps even 
the majority in some cells resides in the nucleus (Orzalli et al. 2015; Gentili et al. 2019; 
Volkman et al. 2019). A nuclear localisation of cGAS would help to explain how cGAS is able 
to function in the detection of DNA viruses nearly all of which replicate their DNA exclusively 
in the nucleus and were previously proposed to ‘leak’ DNA into the cytoplasm allowing for 
host cell detection. However, this would mean that in its resting state only a proportion of 
cGAS is present in the cytosol and able to detect cytosolic DNA. cGAS requires intact 
chromatin for nuclear localisation and is tethered to chromatin independently of DNA 
binding. Moreover, cGAS is not ‘inert’ in its tethered state but competent to detect foreign 
DNA since mutations in the cGAS tethering surface render cGAS constitutively active against 
self-DNA (Volkman et al. 2019). Thus, it has been proposed that there must be a regulatory 
step of cGAS untethering prior to assembly of cGAS onto DNA and subsequent cGAS activation 
(Volkman et al. 2019). Recent cryo-EM structures of cGAS have revealed that it is tightly 
tethered to nucleosomes via the acidic patch of H2A-H2B histone dimers which prevents it 
from binding to free DNA (Cao et al. 2020; Kujirai et al. 2020; Michalski et al. 2020). However, 
the mechanism by which cGAS is able to become untethered in order to detect DNA remains 
to be investigated, highlighting that the cGAS-STING pathway is yet to be fully elucidated.  
Since the cGAS-STING pathway is critical for the induction of type-I IFNs and pro-inflammatory 
cytokines in response to cytosolic DNA, it must be strictly regulated to enable the clearance 
of pathogen infection and to prevent aberrant or sustained activation which would result in 
immune pathology. A number of positive and negative regulators of cGAS and STING have 
been identified which ensure sufficient and prevent excessive stimulation of this pathway, 
respectively (Motwani et al. 2019). Positive regulation of the cGAS-STING pathway includes 
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the ubiquitination of STING by TRIM32 (Zhang et al. 2012) and TRIM56 (Tsuchida et al. 2010; 
Yang et al. 2018) which enhances STING’s interaction with TBK, and palmitoylation of STING 
at residues C88 and C91 in the Golgi which is required for type-I IFN induction (Mukai et al. 
2016). Conversely, in terms of negative regulation cGAS is cleaved by caspase 1 resulting in 
its degradation (Wang et al. 2017b) while STING is degraded, via autophagy, following 
activation of downstream signalling components in order to attenuate signalling (Saitoh et al. 
2009; Prabakaran et al. 2018). In addition to the direct regulation of cGAS and STING, a 
number of host cell nucleases antagonise DNA sensing through degradation of potentially 
immune stimulatory DNA that accumulates as a result of normal cellular function. These 
include the cytosolic 3’-5’ exonuclease, TREX1 (Stetson et al. 2008), and lysosomal 
endonuclease DNase II (Lan et al. 2014). 
1.3.4 - Additional DNA sensors 
In addition to cGAS several other cytosolic DNA sensors have been described which may 
induce the activation of the STING signalling pathway (Ma et al. 2018). Firstly, STING itself 
should be considered a PRR since it is able to directly bind to bacterial CDNs produced by 
bacteria during intracellular infection (Woodward et al. 2010; Burdette et al. 2011). STING is 
also able to bind directly to DNA, although whether it is able to elicit an immune response 
through binding DNA on its own remains unclear (Abe et al. 2013).  
Secondly, Interferon-γ-inducible protein 16 (IFI16), a member of the ALR family, is one such 
protein that has a role in DNA sensing and STING activation. IFI16 binds DNA in a sequence 
independent manner (Unterholzner et al. 2010; Jin et al. 2013; Morrone et al. 2014) and 
associates with STING following immune stimulation with dsDNA or herpes simplex virus 
(HSV1) infection to activate antiviral gene expression (Unterholzner et al. 2010; Horan et al. 
2013). IFI16 is localised predominantly to the nucleus but has been reported to sense 
pathogenic DNA in both the cytoplasm and nucleus (Kerur et al. 2011; Orzalli et al. 2012; 
Orzalli et al. 2013); shuttling between the two compartments depending on the acetylation 
status of its nuclear localisation sequence (NLS) (Li et al. 2012). In vitro, IFI16 oligomerises 
along naked dsDNA with optimal polymerisation requiring ~150bp of dsDNA (Morrone et al. 
2014). This may explain how IFI16 activates immune responses to viral DNA, which is ‘naked’, 
without auto-immune activation against host DNA in the nucleus, which is wrapped around 
nucleosomes separated by short DNA linker regions, 38-53 bp long. While most early studies 
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into IFI16 function used RNA interference to reduce protein expression, a study using ALR-/- 
mice, which lack all 13 ALR family members, demonstrated that ALRs are dispensable for IFNβ 
induction in response to transfected DNA in mice, and that human primary fibroblasts which 
lack IFI16 still mount normal IFN responses against HCMV infection (Gray et al. 2016). This 
calls into question how widespread the requirement for IFI16 is in inducing IFN expression in 
response to immune stimulation by cytosolic DNA and DNA viruses. However, two recent 
studies have indicated that, at least in a subset of human cells, cGAS and IFI16 act 
cooperatively to induce immune responses to cytosolic DNA and DNA viruses, with both 
proteins required for full STING activation and induction of IFN (Almine et al. 2017; Jønsson 
et al. 2017). IFI16 promotes dimerization and phosphorylation of STING following immune 
stimulation with DNA or cGAMP (Almine et al. 2017; Jønsson et al. 2017), and also acts as a 
co-factor to cGAS augmenting cGAMP production in human monocytes (Jønsson et al. 2017). 
In addition to its role in the type-I IFN response, IFI16 sensing of viral DNA in the nucleus also 
activates the inflammasome pathway via recruitment of ASC and caspase-1 (Diner et al. 2015). 
DEAD-box helicase 41 (DDX41) is another putative DNA sensor required for type-I IFN 
induction in mouse myeloid dendritic cells (mDCs) stimulated with dsDNA (Zhang et al. 2011). 
DDX41 was identified as a DNA sensor in an siRNA screen of all DExD/H-box family members 
in which knockdown of DDX41 impaired the type-I IFN and pro-inflammatory cytokine 
responses to DNA and DNA viruses (Zhang et al. 2011). DDX41 is ubiquitously expressed and 
able to bind directly to dsDNA and CDNs (Zhang et al. 2011; Parvatiyar et al. 2012; Omura et 
al. 2016) after phosphorylation by Bruton’s tyrosine kinase (BTK) (Lee et al. 2015). Following 
ligand binding, DDX41 is proposed to bind to STING at the ER and activate downstream 
signalling (Zhang et al. 2011; Parvatiyar et al. 2012). However, DDX41’s role as a PRR in innate 
immune responses to cytosolic DNA is less clear than that of cGAS or STING. Other groups 
have reported that overexpression of DDX41 has little effect on IFNβ production (Sun et al. 
2013), that knockdown of DDX41 has little effect on STING trafficking or IRF3 nuclear 
accumulation following immune stimulation with dsDNA or HSV1 (Abe et al. 2013), and that 
the crystallised DEAD domain of DDX41, which was proposed to mediate DNA/CDN binding, 
could not bind dsDNA or cyclic-di-GMP in vitro (Jiang et al. 2017). Therefore, more work will 
be required to fully explain the role of DDX41 in cytosolic DNA triggered immune responses. 
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RNA polymerase III may also function as a cytosolic DNA sensor since it is able to induce IFNβ 
production upon binding to the synthetic dsDNA mimetic, poly(dA-dT), through synthesis of 
dsRNA with a 5’ triphosphate moiety from the DNA template which serves as a ligand for the 
RIG-I-MAVS pathway (Ablasser et al. 2009; Chiu et al. 2009). Additionally, DNA damage 
response proteins, DNA-dependent protein kinase (DNA-PK, a heterotrimeric complex of 
DNA-PKcs, Ku70, and Ku80) and meiotic recombination 11 homolog A (Mre11) have also been 
reported to activate the STING pathway upon recognition of cytosolic DNA (Ferguson et al. 
2012; Kondo et al. 2013; Morchikh et al. 2017; Wang et al. 2017a). 
Finally, TLR9 which is the only TLR of the 10 identified in humans that can bind DNA also acts 
as a DNA sensor; recognising unmethylated CpG motifs in dsDNA (Hemmi et al. 2000) which 
are rarely present in mammalian genomes but found commonly in those of bacteria and DNA 
viruses. However, unlike cGAS which is widely expressed, TLR9 is expressed predominantly in 
plasmacytoid dendritic cells of the innate immune system and detects DNA in endosomal 
compartments as opposed to cytoplasm (Latz et al. 2004; Kim et al. 2008). Upon activation 
TLR9 signals through the MyD88 adaptor protein to induce expression of type-I IFNs and pro-
inflammatory cytokines (Kawai and Akira 2011). 
The abundance of DNA sensors raises the question of why so many? Although it is clear that 
cGAS functions as the ubiquitous, essential cytosolic DNA sensor upstream of STING, 
additional sensors may reflect cell specific adaptations or redundancy given that the immune 
system is frequently targeted by the invading pathogens it seeks to destroy. Furthermore, 
additional sensors may act to fine tune cGAS-STING signalling based on the localisation and 
type of immune stimulus (Ma et al. 2018; Motwani et al. 2019). Thus, it is possible that 
additional DNA sensors or modulators of cGAS-STING signalling remain to be identified. 
1.4 - Activation of the cGAS-STING pathway by self-DNA 
Since cGAS binds dsDNA irrespective of sequence the cGAS-STING pathway can be activated 
by the presence of self-DNA in the cytoplasm as well as foreign DNA from invading pathogens. 
This is normally avoided by compartmentalisation of host DNA in the nucleus and 
mitochondria and through negative regulation of the pathway to prevent accumulation of 
DNA in the cytoplasm. However, self-DNA can accumulate in the cytoplasm as a result of DNA 
damage, cell stress, or during a number of autoinflammatory diseases, leading to cGAS-STING 
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activation. Such DNA serves as a so-called danger associated molecular pattern (DAMP) which 
triggers innate immune responses. Self-DNA also gains access to the cytoplasm during 
physiological processes such as mitosis and apoptosis but in these cases does not activate the 
cGAS-STING pathway, suggesting that mechanisms must exist to transiently impair activation 
of cGAS and/or STING (Ablasser and Chen 2019). Indeed, during apoptosis, pro-apoptotic 
caspases prevent activation of immune signalling to ensure an immunologically silent cell 
death (Rongvaux et al. 2014; White et al. 2014), while in the case of mitosis cGAS is rendered 
inactive by phosphorylation and through chromatin binding which prevents cGAS 
oligomerisation and activation (Zhong et al. 2020; Li et al. 2021). Moreover, cells may dampen 
activation of the cGAS-STING pathway against transient exposure to self-DNA through repair 
processes. For example, during cell migration nuclear envelope rupture often occurs leading 
to detection of nuclear DNA by cGAS, but downstream signalling can be mitigated by rapidly 
repairing NE breaks through the ESCRT machinery (Denais et al. 2016; Raab et al. 2016). 
Activation of the cGAS-STING pathway through detection of self-DNA when such tempering 
mechanisms are insufficient or do not exist are discussed below. 
1.4.1 - Activation of the cGAS-STING pathway by nuclear DNA damage 
The cGAS-STING pathway is activated in response to prolonged exposure of nuclear DNA to 
the cytosol as a result of DNA damage. DNA damage in the nucleus often results in the 
formation of cytoplasmic micronuclei, small DNA containing organelles encapsulated by NE 
derived membranes, produced as a result of genotoxic stress and chromosome mis-
segregation during cell division (Fenech et al. 2011). The membranes of micronuclei are prone 
to rupture, likely due to a compromised nuclear lamina and/or reduced membrane repair 
capacity compared to the NE, leading to the release of self-DNA into the cytosol (Hatch et al. 
2013). cGAS is recruited to micronuclei after membrane rupture and catalyses the synthesis 
of cGAMP which in turn binds to STING triggering the induction of type-I IFN and pro-
inflammatory cytokines (Bartsch et al. 2017; Mackenzie et al. 2017; Yang et al. 2017; Harding 
et al. 2017). DNA damage also appears to activate the cGAS-STING pathway in the absence of 
micronuclei through the accumulation of cytoplasmic DNA ‘speckles’ which lack nuclear 
membranes (Lan et al. 2014; Härtlova et al. 2015; Shen et al. 2015; Erdal et al. 2017). 
Interestingly, cGAS has also been shown to be recruited to sites of DNA damage in the nucleus 
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and to suppress repair of DNA double-strand breaks through homologous recombination, a 
function that is independent of STING and cGAS catalytic activity (Liu et al. 2018).  
Recently, STING has also been shown to respond to nuclear DNA damage independently of 
cGAS (Dunphy et al. 2018). Nuclear DNA damage caused as a result of treatment with the 
topoisomerase inhibitor, etoposide, is detected by ATM and PARP1 proteins and results in the 
formation of a non-canonical STING signalling complex consisting of TRAF6, IFI16, p53, and 
STING. This complex drives an NF-κB-dominated transcriptional response as opposed to cGAS-
dependent detection of cytosolic DNA and downstream STING signalling which predominantly 
activates IRF3 signalling. Interestingly, NF-κB dependent signalling does not require STING 
phosphorylation, STING redistribution to perinuclear foci, or TBK1 activity. However, 
etoposide treatment also induced IFNβ expression, which involves IRF3 activity as well as NF-
κB, and this does require STING redistribution and TBK1 activity but is also independent of 
cGAS. Thus, nuclear DNA damage appears to elicit a cGAS-independent STING signalling 
pathway that is distinct from the detection of cytoplasmic DNA released from micronuclei 
which activates canonical cGAS-STING signalling (Dunphy et al. 2018). 
1.4.2 - Activation of the cGAS-STING pathway by mitochondrial DNA 
As well as being activated as a consequence of nuclear DNA damage, the cGAS-STING pathway 
can be activated due to the release of mitochondrial DNA (mtDNA), a symptom of cell stress. 
Since mtDNA is immunostimulatory, the cell possesses mechanisms to prevent aberrant 
immune signalling triggered by mtDNA as a result of normal physiological processes 
(Rongvaux 2018). For example, programmed cell death induced through the mitochondrial 
pathway of apoptosis leads to the release of mtDNA into the cytosol but is usually 
immunogenically silent due to the concomitant activation of caspases which inhibit the type-
I IFN response (Rongvaux et al. 2014).  Similarly, mitophagy of senescent mitochondria clears 
a source of potential immune stimulatory mtDNA which is degraded in the autophagasome 
by the DNAse II nuclease (Rongvaux 2018). 
On the other hand, during pathogen infection mtDNA can be released into the cytosol and 
trigger cGAS-STING signalling providing the cell with another mechanism of instigating an 
immune response. During a study to investigate the effect of mtDNA instability on cells, 
elicited by partial deficiency of the abundant mtDNA binding protein TFAM (transcription 
factor A, mitochondrial), it was found that mtDNA binds to and activates cGAS inducing innate 
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immune signalling (West et al. 2015). Moreover, the same study demonstrated that infection 
of murine embryonic fibroblasts (MEFs) with herpesviruses similarly resulted in TFAM 
depletion, mtDNA leakage, and activation of the cGAS-STING pathway indicating that mtDNA 
serves as a ligand for activation of immune responses during herpesvirus infection (West et 
al. 2015). Although this study found no such effect on mitochondria during infection with a 
number of RNA viruses, other studies have found that infection with Dengue virus (DENV), an 
RNA virus, causes mitochondrial damage and mtDNA leakage which is similarly detected by 
cGAS (Aguirre et al. 2017; Sun et al. 2017). Moreover, DENV encodes viral proteins which 
antagonise the host immune response through degradation of cGAS (Aguirre et al. 2017) and 
STING (Aguirre et al. 2012). Furthermore, it has recently been shown that influenza A virus 
(IAV) or encephalomyocarditis virus (EMCV) infection triggers the release of mtDNA 
stimulating the cGAS-STING pathway in human cell lines (Moriyama et al. 2019). As well as 
being released into the cytoplasm during viral infection, mtDNA is also released during 
infection by certain strains of Mycobacterium tuberculosis, triggering induction of the type-I 
IFN response through the cGAS-STING pathway (Wiens and Ernst 2016).  
1.4.3 - The cGAS-STING pathway and auto-inflammatory disease 
Although the DNA of eukaryotes is largely prevented from accessing the cytoplasm through 
compartmentalisation in the nucleus and mitochondria, a small amount appears to become 
exposed to the cytosol as a result of normal cellular processes.  However, this basal level of 
DNA leakage to the cytoplasm does not normally accumulate to levels sufficient to induce an 
immune response due to the actions of proteins which degrade DNA (Stetson et al. 2008; Lan 
et al. 2014). A growing number of autoinflammatory diseases characterised by mutations in 
several DNases which result in the accumulation of immune stimulatory DNA in the cytosol 
have been identified. These include Aicardi-Goutieres syndrome (AGS) in which high levels of 
circulating type-I IFN, a result of chronic cGAS-STING activation, cause neuronal inflammation 
(Crow and Manel 2015). AGS can be caused by mutations in a number of proteins including 
the 3’-5’ exonuclease TREX1 which degrades endogenous ssDNA and dsDNA in the cytoplasm 
(Crow et al. 2006; Stetson et al. 2008), and all components of the RNase H2 endonuclease 
complex (Crow and Manel 2015), which is responsible for removing ribonucleotides that 
become mis-incorporated into genomic DNA. Failure to remove these ribonucleotides results 
in genomic instability and the formation of micronuclei leading to cGAS-STING activation 
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(Mackenzie et al. 2016; Mackenzie et al. 2017). A similar disease has been found to be caused 
by mutations in the lysosomal endonuclease, DNase II which as well as degrading 
phagocytosed DNA in professional phagocytes also degrades DNA that results from damaged 
host cell nuclear DNA (Lan et al. 2014; Rodero 2017). As a result of DNase II mutations, DNA 
accumulates in the cytoplasm activating the cGAS-STING pathway and resulting in constitutive 
type-I IFN induction (Lan et al. 2014; Rodero 2017). The cGAS-STING pathway is also 
constitutively active in the autoinflammatory disease STING-associated vasculopathy with 
onset in infancy (SAVI) (Jeremiah et al. 2014; Liu et al. 2014; Munoz et al. 2015). SAVI is caused 
by gain-of-function mutations in STING which lead to its spontaneous activation and 
translocation out of the ER in the absence of cGAMP (Jeremiah et al. 2014; Liu et al. 2014; 
Dobbs et al. 2015). 
The cGAS-STING pathway is also implicated in several other self-DNA-driven inflammatory 
diseases beyond those caused by mutations in nucleases responsible for clearance of self-
DNA (AGS) or mutations in STING itself (SAVI). This includes myocardial infarction in which 
the cGAS-STING pathway is involved in the activation of a deleterious inflammatory response 
which occurs as a result of tissue damage and DNA leakage from dying cells (King et al. 2017). 
STING is also required for the activation of inflammatory responses in Parkinson’s disease 
mouse models through cGAS-mediated detection of mtDNA which accumulates in the 
cytoplasm due to impaired mitophagy resulting from the loss of PINK1 and parkin proteins 
which are mutated in Parkinson’s disease (Sliter et al. 2018). Additionally, the cGAS-STING 
pathway is activated in the premature aging disease, Hutchinson-Gilford progeria syndrome 
(HGPS), a laminopathy caused by mutations in the LMNA gene resulting in the production of 
a truncated lamin A protein called progerin. Cells expressing progerin show increased levels 
of DNA damage and replication stress caused by replication fork stalling and nuclease 
mediated DNA degradation; this combined with a compromised NE integrity as a result of 
progerin in the nuclear lamina results in the leakage of DNA into the cytoplasm. Cytoplasmic 
DNA is recognised by the cGAS-STING pathway resulting in the upregulation of innate immune 
response genes (Graziano et al. 2018; Kreienkamp et al. 2018; Gonzalo and Coll-Bonfill 2019). 
Interestingly this appears to be a cell intrinsic response mediated by STAT1 independently of 
IFN since HGPS fibroblasts do not express IFN. 
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1.4.4 - The cGAS-STING pathway in senescence and cancer 
As mitotic cells proliferate, they eventually reach a state of replicative senescence 
characterised by the cessation of cell division. Cellular senescence is typified by a number of 
distinctive phenotypic alterations including chromatin changes, an altered secretome, and an 
increase in cell size. Functionally cellular senescence serves as a safeguard against 
tumorigenesis since cells accumulate DNA damage and mutations over time and senescence 
prevents the continued replication of these damaged cells. More recently cellular senescence 
has also been shown to play a role in development, tissue repair, and organismal aging (Van 
Deursen 2014). The onset of senescence can be caused by cell damage or stresses that induce 
DNA damage including telomere attrition, DNA damaging agents, reactive oxygen species, 
oncogene activation, and laminopathies such as HGPS. DNA damage results in the formation 
of micronuclei and cytoplasmic chromatin fragments which are detected by the cGAS-STING 
signalling pathway initiating a type-I IFN response. cGAS-STING signalling leads to the 
senescence-associated secretory phenotype (SASP), which is characterised by the secretion 
of pro-inflammatory cytokines, growth factors, and proteases that promote the recruitment 
of immune cells to clear the pre-malignant senescent cell which harbours damaged DNA and 
could potentially develop into a cancer (Yang et al. 2017; Yum et al. 2019). In support of the 
cGAS-STING pathway playing a role in preventing tumorigenesis through inducing SASP, low 
levels of cGAS and STING expression in tumours of lung adenocarcinoma patients, 
hepatocellular carcinoma patients, and in patients with gastric cancer is linked with poor 
prognosis and decreased survival (Bu et al. 2016; Song et al. 2017; Yang et al. 2017). 
Moreover, STING and/or cGAS expression is lost in many tumour cells lines further suggesting 
that the cGAS-STING pathway is antagonistic to tumorigenesis (Sun et al. 2013; Wu et al. 
2013b; Bhatelia et al. 2014; Xia et al. 2016a; Xia et al. 2016b; Chen et al. 2017). 
When normal cells overcome cell cycle checkpoints and senescence, they become cancer cells 
which can proliferate uncontrollably. Despite originating from endogenous tissue, cancer cells 
can be recognised by the adaptive immune system and targeted for destruction. This so called 
‘anti-tumour immunity’ is dependent on cross-priming of tumour cell-specific cytotoxic CD8+ 
T cells. Activation of CD8+ T cells requires two signals from an interaction with an antigen 
presenting cell (APC) such as a dendritic cell: firstly, the cross-presentation of a tumour-
derived antigen in the context of MHC class I molecules by the APC, and secondly a co-
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stimulatory signal such as an interaction between CD86 and CD28 signalling molecules on the 
APC and CD8+ T cell, respectively. Dead tumour cells can be phagocytosed by dendritic cells 
which then present tumour-derived antigen on their cell surface in the context of MHC class 
I providing the first signal (Yum et al. 2019). At the same time, phagocytosed tumour cell DNA 
or cGAMP which escapes into the cytoplasm of dendritic cells activates the cGAS-STING 
pathway resulting in the production of type-I IFN (Woo et al. 2014) which is essential for 
activation of anti-tumour CD8+ T cells (Diamond et al. 2011; Fuertes et al. 2011) since it 
upregulates the expression of co-stimulatory signalling molecules (Marckmann et al. 2004). 
Thus, the cGAS-STING pathway in dendritic cells promotes anti-tumour immunity through the 
recognition of tumour DNA and/or tumour produced cGAMP and the production of type-I IFN 
to activate cancer killing CD8+ T cells. 
While cGAS and STING may inhibit tumorigenesis through DNA damage sensing with the 
induction of SASP and through cross-presentation of CD8+ T cells by dendritic cells which 
phagocytose dead cancer cells, prolonged inflammation induced by the cGAS-STING pathway 
can promote tumorigenesis and metastasis (Grivennikov et al. 2010). In an epithelial cancer 
model, DNA damage sensed by the cGAS-STING pathway promoted inflammation and 
carcinogenesis with STING-/- mice resistant to this skin cancer (Ahn et al. 2014). Additionally, 
in a brain metastatic cancer model cGAMP produced by brain metastatic cancer cells was 
transferred to astrocytes through gap junctions, activating STING in neighbouring astrocytes 
and inducing the production of inflammatory cytokines which in turn supported tumour 
growth (Chen et al. 2016). Therefore, the cGAS-STING pathway can also have protumour 
functions through promoting inflammation-driven tumorigenesis and metastasis.  
However, acute activation of immune responses has been shown to have a strong anti-cancer 
effect and activation of the cGAS-STING pathway is now being targeted for development of 
cancer immunotherapy (Yum et al. 2019; Yum et al. 2020). Interestingly, classic cancer 
therapies that were designed to directly target cancer cells including ionising radiation and 
chemotherapy have now been shown to indirectly activate the cGAS-STING pathway resulting 
in antitumour immunity. Local treatment of tumours with ionising radiation has long been 
known to not only reduce the size of the targeted tumour but to also reduce the size of distant 
tumours, a phenomenon known as the abscopal effect (Mole 1953). This was later shown to 
be dependent on the activation of CD8+ T cells (Lee et al. 2009) and activation of the cGAS-
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STING pathway (Deng et al. 2014; Harding et al. 2017). Radiation induces DNA damage and 
micronuclei in cancer cells which activates cGAS-STING signalling resulting in the induction of 
IFNβ promoting the cross-priming of anti-tumour CD8+ T cells. Similarly, chemotherapy which 
interferes with cell proliferation thus inhibiting tumour growth has also been found to directly 
stimulate cGAS-STING signalling resulting in activation of dendritic cells and anti-tumour CD8+ 
T cells. For example, the PARP inhibitor, Olaparib induces DNA damage and the formation of 
micronuclei resulting in the activation of cGAS-STING signalling in tumour cells and paracrine 
activation of dendritic cells (Pantelidou et al. 2019). More recently several cyclic dinucleotide 
STING agonists have been tested in tumour models in order to stimulate STING signalling and 
hence upregulate cancer immunity with promising effects. Several clinical trials are currently 
ongoing using STING agonists alone or in combination with other cancer treatments (Yum et 
al. 2019).  
1.5 - Additional functions of STING 
Beyond its role as the central adaptor protein in innate immune signalling cascades triggered 
by cytosolic DNA which induce type-I IFN and proinflammatory cytokine expression, it has 
become clear that STING has additional functions. These include the induction of autophagy 
upon trafficking to the ERGIC after binding cGAMP, a function which is independent of the 
activation of the type-I IFN pathway (Gui et al. 2019). In addition, as well as restricting the 
proliferation of DNA viruses through type-I IFN induction, STING also restricts the proliferation 
of some RNA viruses (Maringer and Fernandez-Sesma 2014; Ma and Damania 2016), although 
the mechanisms through which it does so remain to be fully elucidated.  
1.5.1 - Autophagy 
Induction of autophagy following cGAMP binding appears to be a primordial function of 
STING, pre-dating the evolution of interferons. The cGAS-STING pathway is evolutionarily 
ancient with homologs of cGAS and STING found  in the anemone species, Nematostella 
vectensis, which diverged from the human ancestor >500 million years ago (Kranzusch et al. 
2015). Interestingly, N. vectensis STING lacks the C-terminal residues present in vertebrate 
STING that are required for the activation of the type-I IFN pathway, and when expressed in 
HEK293T cells is unable to induce TBK1 activation after immune stimulation with cGAMP (Gui 
et al. 2019). However, both N. vectensis and human STING lacking the C-terminal activation 
25 
 
domain, STING1-340, are able to induce the conversion of microtubule-associated protein 
1A/1B-light chain 3 (LC3) into a lipidated form LC3-II, a key step in the formation of 
autophagosomes, following immune stimulation by DNA transfection or cGAMP delivery. 
Upon cGAMP binding, STING translocates to the ERGIC which serves as the membrane source 
for LC3 lipidation. LC3 lipidation following cGAMP stimulation requires WD repeat domain 
phosphoinositide-interacting protein 2 (WIPI2) and autophagy protein 5 (ATG5) (Gui et al. 
2019). Autophagy induced by STING activation is proposed to provide a mechanism of 
cytosolic DNA and pathogen clearance through delivery of DNA/pathogen containing 
autophagosomes to lysosomes for degradation and by doing so provides the cell with an 
additional means of pathogen defence (Gui et al. 2019). Moreover, it has been shown that 
the cGAS-STING pathway activates autophagy in response to infection of macrophages with 
Mycobacterium tuberculosis (Watson et al. 2012; Watson et al. 2015) and Gram-positive 
bacteria (Moretti et al. 2017).  
1.5.2 - STING in the restriction of RNA viruses  
As has already been noted, the cGAS-STING pathway can function in the restriction of RNA 
viruses despite these viruses containing no DNA of their own, in the case of DENV through 
detection of mtDNA leakage as a result of viral infection (Aguirre et al. 2017; Sun et al. 2017). 
Furthermore, retroviruses, including HIV, can activate the cGAS-STING pathway through 
detection or viral cDNA after reverse-transcription (Gao et al. 2013a; Lahaye et al. 2013; 
Rasaiyaah et al. 2013; Jakobsen et al. 2013), provided cDNA escapes the viral capsid in the 
cytoplasm. However, normally the HIV viral capsid shields cDNA from the host cell cytoplasm 
and delivers cDNA directly into the nucleus upon binding NPCs (Jacques et al. 2016; Sumner 
et al. 2017). Such cases of STING antagonism of RNA viruses involve the canonical activation 
of the cGAS-STING pathway and the induction of type-I IFN.  
Further evidence of antiviral STING functions during RNA virus infection comes from studies 
which have shown that the replication of multiple positive- and negative-sense RNA viruses 
is enhanced in the absence of STING (Ishikawa and Barber 2008; Zhong et al. 2008; Ishikawa 
et al. 2009; Sun et al. 2009; Nazmi et al. 2012; Aguirre et al. 2012; Nitta et al. 2013; Yi et al. 
2015; Holm et al. 2016; Ding et al. 2018; Franz et al. 2018). These include the negative-sense 
viruses: Vesicular stomatitis virus (VSV) (Ishikawa and Barber 2008; Zhong et al. 2008; 
Ishikawa et al. 2009; Holm et al. 2016; Franz et al. 2018), Sendai virus (SeV) (Zhong et al. 2008), 
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Newcastle disease virus (NDV) (Sun et al. 2009), Japanese encephalitis virus (JEV) (Nazmi et 
al. 2012), and Influenza A virus (IAV) (Franz et al. 2018) and the positive-sense viruses: DENV 
(Yu et al. 2012; Aguirre et al. 2012), Hepatitis C Virus (HCV) (Nitta et al. 2013; Yi et al. 2015), 
Sindbis Virus (SINV) (Franz et al. 2018), and Zika virus (ZIKV) (Ding et al. 2018). Moreover, 
several studies have reported that STING is activated during RNA virus infection and required 
for full induction of type-I IFN responses, indicating a role for STING in antagonising RNA 
viruses (Ishikawa and Barber 2008; Zhong et al. 2008; Sun et al. 2009; Sun et al. 2012; Yu et 
al. 2012; Aguirre et al. 2012; Holm et al. 2016). Although, others have argued that STING is 
not required for type-IFN induction in response to RNA virus infection (Ishikawa et al. 2009; 
Li et al. 2013b; Franz et al. 2018). Furthermore, it has been shown that the 3’ UTR RNA of HCV 
can trigger a STING-dependent response in hepatocytes (Ding et al. 2013). However, STING 
does not bind directly to the dsRNA mimic poly(I:C) in vitro (Abe et al. 2013), nor does it 
dimerise and undergo translocation to perinuclear foci after RNA virus infection or poly(I:C) 
stimulation (Franz et al. 2018). Therefore, how STING functions in immune responses against 
RNA viruses remains less clear than its counteraction of DNA viruses through the cGAS-STING 
pathway induction of type-I IFN. 
In support of STING contributing to antiviral responses against RNA viruses, several RNA 
viruses antagonise STING implying that STING function restricts viral proliferation (Ishikawa 
et al. 2009; Sun et al. 2012; Yu et al. 2012; Aguirre et al. 2012; Ding et al. 2013; Nitta et al. 
2013; Xing et al. 2013; Chen et al. 2014; Yi et al. 2015; Holm et al. 2016; Ding et al. 2018). 
Several members of the Flaviviridae family of viruses have been shown to target STING. 
Intriguingly, human STING amino acids 125-222 were found to exhibit significant homology 
to flavivirus non-structural protein NS4B and NS4B of yellow fever virus (YFV) has been shown 
to bind STING and block RIG-I and STING-dependent signalling (Ishikawa et al. 2009), while 
HCV NS4B also binds to STING and prevents its interaction with MAVS (Nitta et al. 2013) or 
TBK1 (Ding et al. 2013) inhibiting IFN induction. Although the DENV-2 NS4B protein has not 
been found to inhibit IFN induction (Rodriguez-Madoz et al. 2010), the DENV viral protease 
complex NS2B3 has been shown to inhibit IFN induction through binding and cleaving human 
STING (but not murine STING) (Yu et al. 2012; Aguirre et al. 2012; Stabell et al. 2018). Zika 
virus (ZIKV) is another flavivirus which antagonises STING in human cells (Ding et al. 2018). 
This study found that human, but not mouse, STING is cleaved by NS2B3 proteases encoded 
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by a number of flaviviruses, including DENV, WNV, JEV, and ZIKV, but not YFV (Ding et al. 
2018). This is due to the amino acid differences between human and mouse STING at the 
identified cleavage site, which in humans consists of RG residues at amino acids 78/79 
compared to QG in mouse (Ding et al. 2018; Stabell et al. 2018). 
The Coronaviridae family of RNA viruses also target STING to inhibit IFN responses. Several 
coronaviruses have been shown to inhibit STING-dependent type-I IFN production through a 
conserved mechanism. The human coronavirus HCoV-NL63 and SARS-CoV papain-like 
proteases PLP2-TM and PLpro-TM, respectively, interact with STING, inhibiting STING 
dimerization and K63-linked polyubiquitination, the formation of STING signalling complexes 
and induction of type-I IFN (Clementz et al. 2010; Sun et al. 2012; Chen et al. 2014). Similarly, 
the PLP2 protein of the coronavirus porcine epidemic diarrhoea virus (PEDV) also interacts 
with STING and disrupts  K63-linked polyubiquitination of STING antagonising IFN expression 
(Xing et al. 2013).  
Finally, IAV is the only negative-sense RNA virus which has so far been shown to antagonise 
STING activation and type-I IFN induction. The IAV fusion peptide, which constitutes the N-
terminal region of IAV hemagglutinin (HA) and is required for viral membrane fusion in host 
cell endosomes, binds STING directly and this appears to inhibit STING dimerization and 
activation selectively in response to viral membrane fusion (Holm et al. 2016). 
1.5.3 - STING’s mechanisms of defence in RNA virus infection 
Several mechanisms have been proposed to explain STING’s role during RNA virus infection. 
Firstly, STING interacts with the RNA sensor RIG-I and downstream adaptor MAVS, but not 
the RNA sensor MDA-5, and interaction with RIG-I increases with RNA virus infection 
(Ishikawa and Barber 2008; Zhong et al. 2008). Since MAVS is localised to the mitochondria, a 
separate cellular pool of STING located at the mitochondria or mitochondria-associated ER 
membranes (MAM) may be involved in RNA virus sensing (Zhong et al. 2008; Ishikawa et al. 
2009; Ran et al. 2014). Thus, STING contributes to immune responses against RNA viruses 
sensed by RIG-I, such as VSV, SeV, NDV, JEV, and HCV, but not those sensed exclusively by 
MDA5, such as encephalomyocarditis virus (ECMV), likely through recruitment of TBK1 and 
IRF3 following activation via interaction with RIG-I and MAVS complexes localised at the MAM 
or mitochondria (Ishikawa and Barber 2008; Zhong et al. 2008; Ishikawa et al. 2009; Maringer 
and Fernandez-Sesma 2014; Ran et al. 2014). 
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cGAS may also be involved in sensing RNA virus infection as it appears to be a potent 
restriction factor of several positive-sense single-stranded RNA viruses (SINV, YFV, VEEV, 
CHIKV, WNV), plausibly through regulating the basal expression level of some antiviral genes 
due to continuous low-level activation of the cGAS-STING pathway through endogenous 
ligands (Schoggins et al. 2011; Schoggins et al. 2014). Alternatively, cGAS may sense viral RNA 
ligands directly triggering activation of STING; cGAS has been shown to bind a synthetic 50mer 
dsRNA, although this did not result in the generation of cGAMP (Civril et al. 2013) and cGAS 
does not bind polyI:C in vitro (Sun et al. 2013). Therefore, whether cGAS contributes to 
cytosolic RNA sensing directly seems unlikely. 
A further STING-dependent but cGAS-independent RNA virus sensing pathway has been 
proposed in which STING is stimulated through sensing fusion of viral and host cell 
membranes (Holm et al. 2012; Holm et al. 2016). Knockout of STING but not cGAS was found 
to impair the production of type-I IFN in cells infected with SeV, NDV, or IAV, and in STING 
deficient mice led to elevated VSV replication (Holm et al. 2016). Intriguingly, infection of cells 
deficient for MAVS with these viruses still led to increased STING dimer formation indicative 
of STING activation. Moreover, MAVS-deficient cells still produced a significant residual IFNβ 
response when infected with SeV, NDV, or IAV compared to control cells and this residual 
response was lost when STING was knocked down by shRNA and cells were infected with IAV 
(Holm et al. 2016). This suggests that STING is able to evoke some level of immune response 
against RNA viruses independently of pathways dependent on cGAS or MAVS. The authors of 
the study also found that type-I IFN induction can be triggered by fusogenic liposomes in a 
STING-dependent but cGAS-independent manner (Holm et al. 2012; Holm et al. 2016). Such 
liposomes fuse with cell membranes, mimicking membrane fusion events such as those that 
occur during enveloped viral infection. Intriguingly, this membrane fusion triggered STING 
activation and type-I IFN induction is selectively antagonised by the IAV fusion peptide, likely 
through direct interaction with STING and inhibition of STING dimerization, while DNA 
induced IFN responses are unaffected by IAV fusion peptide (Holm et al. 2016). The exact 
mechanism through which membrane fusion is sensed and how those signals are transduced 
to activate STING remains poorly understood but appears to involve phospholipase C-ƴ (PLC-
ƴ) and phosphatidylinositol-3-OH kinase (PI(3)K) (Holm et al. 2012).  
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Another recent study has suggested that STING inhibits translation in response to RNA virus 
infection, and in this way antagonises viral proliferation (Franz et al. 2018). Franz et al. found 
that type-I IFN induction or ISG expression as a result of RNA virus infection did not depend 
on STING, however, in agreement with other studies, the absence of STING results in higher 
viral titres with RNA virus infection indicating that STING antagonises RNA viral infection. They 
found that translation of exogenous and viral mRNAs is more efficient in the absence of STING 
and that STING restricts translation globally in response to poly(I:C) transfection or VSV 
infection. This STING-dependent restriction of translation was found to require RIG-I but not 
MAVS leading to a model whereby RLRs have two antiviral effector functions during RNA virus 
infection. Firstly, RLRs upon ligand detection activate MAVS to induce type-I IFN and secondly, 
through STING a response is initiated to restrict translation. The mechanism through which 
STING influences translation is not yet known but appears to be distinct from PKR mediated 
translational suppression and the translocon (Franz et al. 2018). 
It is clear then that STING functions in the restriction of RNA viruses. Although, there is good 
evidence that STING contributes to immune responses triggered by RNA viruses through 
interacting with RIG-I and MAVS (Ishikawa and Barber 2008; Zhong et al. 2008; Ishikawa et al. 
2009; Maringer and Fernandez-Sesma 2014; Ran et al. 2014), and that STING restricts viral 
translation in a manner dependent on RIG-I (Franz et al. 2018), mechanistic details remain to 
be fully elucidated. Furthermore, how STING is activated in response to viral membrane fusion 
is unknown (Holm et al. 2016) and whether STING contributes to IFN induction in response to 
RNA virus infection remains contentious. Finally, it remains to be clarified whether such 
mechanisms act in combination and whether other, as-yet undescribed mechanisms of RNA 
virus detection resulting in STING activation exist (Maringer and Fernandez-Sesma 2014; Ma 
and Damania 2016). 
1.6 - A role for STING at the nuclear envelope 
Although, STING clearly localises to the peripheral ER, it also localises at the NE as seen by 
immunofluorescence (Ishikawa and Barber 2008; Ishikawa et al. 2009; Sun et al. 2009; Chen 
et al. 2011). While a NE localisation could indicate the presence of STING in either the ONM 
or INM (or indeed both), there is reason to believe that STING could function as an integral 
INM protein especially when considering the localisation of other well-known INM proteins 
(Batrakou et al. 2009). For example, lamin B receptor (LBR) is one of the earliest described 
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NETs (Worman et al. 1988; Ye and Worman 1994) with several NE specific functions: binding 
Lamin B, binding chromatin, HP1 binding, and regulating NE structure (Olins et al. 2010). 
However, LBR also localises to the ER where it acts as a sterol reductase (Clayton et al. 2010). 
Similarly, the INM protein, emerin, which functions in mechanotransduction, cellular polarity 
organisation, chromatin tethering, cell signalling, and gene expression also localises to the 
ONM and peripheral ER where it interacts with the cytoskeleton (Salpingidou et al. 2007). 
Thus, it is not inconceivable that STING could have multiple localisations and different 
functions specific to those localisations. Indeed, as well as localising to the ER where it 
functions in immune response signalling triggered by cytosolic DNA, STING is also reported to 
associate with mitochondria-associated ER membranes and the mitochondria where it is 
thought to regulate IFN responses triggered by viral RNA through interacting with RIG-I and 
MAVS (Zhong et al. 2008; Ishikawa et al. 2009; Ran et al. 2014). 
STING’s identification in NE preparations isolated from rat liver (as NET23) occurred prior to 
the discovery of its critical role in the cytosolic dsDNA-triggered IFN response and its reported 
localisation in the ER (Schirmer et al. 2003). However, work in the Schirmer lab on potential 
NE-specific roles for STING did not begin until after this discovery. In an initial study to 
determine the localisation of NETs within the NE, a STING-RFP construct was shown to target 
to the NE and to resist detergent extraction from the NE in contrast to the ER protein, 
calreticulin (Figure 1.3 A). Since the nuclear lamina is resistant to such pre-fixation extraction 
with detergent, a similar biochemical resistance to extraction of a NET typically indicates an 
INM association (Malik et al. 2010). One caveat of this method is that some NETs present only 
in the ONM can also resist detergent extraction due to interactions with cytoskeletal filaments 
such as the Nesprin family of proteins (Rajgor and Shanahan 2013) and so resistance to 
detergent extraction alone does not necessarily indicate INM localisation. In the same study 
STING-RFP did not localise at the NE in Lamin A/C knockout (LMNA-/-) murine embryonic 
fibroblasts (MEFs) whereas in LMNA+/+ MEFs STING-RFP was clearly present in the NE by 
fluorescence microscopy again suggesting an INM localisation and interaction with the 
nuclear lamina (Figure 1.3 B).  Together this data suggests that as well as accessing the ONM 
by virtue of being an ER-localised protein, STING may also be targeted to the INM in a manner 
dependent on Lamin A/C expression. However, another experiment in the same study 
indicated that STING-RFP was present only in the ONM and not the INM. Using 3D structured 
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illumination microscopy (3D-SIM) which can distinguish INM localisation of a NET from ONM 
localisation (Schermelleh et al. 2008), based on whether fluorescent signal is in the same 
plane of the NE with either the nucleoplasmic facing, Nup153, or cytoplasmic facing Nup358, 
STING-RFP expressed in HT1080 cells appeared to localise exclusively to the ONM in the same 
plane as Nup358. Therefore, the localisation of STING within the NE remained ambiguous. 
Later in another study by the lab which set out to identify NETs that might be involved in 
organising chromatin, the overexpression of STING in HeLa or HT1080 cells was found to 
promote chromatin compaction (Malik et al. 2014). Moreover, endogenous levels of STING 
expression were found to correlate with degree of chromatin compaction in different cell 
types and overexpression of STING altered the epigenetic state of chromatin with an increase 
in repressive histone modifications and a decrease in histone modifications associated with 
active chromatin. This was the first study to indicate a NE function for STING, with histone 
modifications and chromatin compaction radiating from the nuclear periphery over the time-
course of STING expression. 
 
Figure 1.3 – STING-RFP resists detergent extraction and fails to target to the NE in Lamin 
A/C knockout MEFs (A) STING-RFP (red) transiently expressed in HT1080 cells stably 
expressing Lamin A-GFP (green) (LmA) resists detergent pre-extraction in the NE. Calreticulin-
GFP (coloured red) transiently expressed in HT1080 cells expressing Lamin A-RFP (green) (LmA) 
shows complete loss of staining in detergent pre-extracted cells compared to direct 
formaldehyde fixed cells (B) STING-RFP fails to target to the NE in Lamin A/C knockout MEFs 




A subsequent repetition of the 3D-SIM experiment using a STING-GFP construct expressed in 
HT1080 cells and examining a larger number of cells revealed that in some cells STING 
localised to the INM (in the same plane as Nup153) while in other cells STING localised to the 
ONM (in the same plane as Nup358) (Figure 1.4). This prompted the hypothesis that STING 
may change localisation within the NE based on innate immune response induction triggered 
by plasmid DNA used for transient expression of the STING-GFP construct. However, whether 
an immune response was induced was not investigated. Separately, STING-GFP mobility 
within the NE was found to increase during HSV1 infection or after transfection of the dsRNA 
mimic, poly(I:C), as measured by fluorescence recovery after photobleaching (FRAP). This 
experiment used an HT1080 cell line stably expressing an inducible STING-GFP construct to 
avoid immune stimulation caused by transient transfection of plasmid DNA. (Figure 1.5). This 
further implies that STING localisation within the NE might change during an immune 
response. However, again whether cells were infected was not confirmed (i.e. by staining 
against a viral protein) and similarly HSV1 infection would be expected to induce 
redistribution of STING to perinuclear foci, although it is possible that this is antagonised by 
HSV1 infection or not seen at two hours post infection. 
Figure 1.4 - 3D-Structured illumination microscopy (SIM) of STING in the NE. (A) Schematic 
showing Nup153 and Nup358 localization in the NPC, Nup153 is in the nuclear pore basket on 
the nucleoplasmic face of the NPC while Nup358 is in the cytoplasmic filaments of the NPC on 
the cytoplasmic side of the NPC. (B) STING-GFP (green) transiently expressed in HT1080 cells 
localizes at the inner nuclear membrane (INM) with Nup153 (red) in some cells and at the 
outer nuclear membrane (ONM) with Nup358 (red) in other cells. Upper panel controls: LAP2β-
GFP is in the INM and Sec61β-GFP in the ONM. Lower panels: STING is in the inner nuclear 
membrane in some cells and the outer in others when HT1080 cells are transiently transfected 





Figure 1.5 – Fluorescence Recovery After Photobleaching (FRAP) of STING in the NE shows 
STING increases mobility during HSV-1 infection or poly(I:C) transfection. (A) FRAP of STING-
GFP in control (mock-infected) and HSV-1 infected cells (2 hpi) showing redistribution of STING-
GFP into photobleached area (marked by white box). Scale bar, 5 μM. (B) Fluorescence 
recovery curves from three replicate experiments as in a. Another NE protein, NET55, is shown 
as a control that does not change its dynamics with HSV-1 infection. CTL, control; HSV1, HSV-
1 infected. (C) Bar plot comparing the average half recovery times (t1/2) between the control 
and HSV-1 infected cells. Error bars show +/- standard deviation (student’s T test, * p ≤ 0.05). 
(D) FRAP of STING-GFP in cells 2 h after poly(I:C)-treatment, photobleaching an area within 
the white outlined box. Scale bar = 5 µm. (E) Bar plot comparing the average half recovery 
times (t1/2) between the untreated control and the poly(I:C) treated cells. Error bars show +/- 
standard deviation (student’s T test, * p ≤ 0.05).  Figure adapted from Dixon et al. 2020. 




To investigate potential NE-specific functions of STING, a proteomics approach was chosen to 
identify candidate partner proteins and generate a dataset on which my thesis is founded. 
Putative interaction partners were identified by immunoprecipitation of C-terminally tagged 
STING-GFP from NE preparations isolated from HEK293T cells transiently expressing a STING-
GFP construct. It was hypothesised that such NE STING interactors may have been missed in 
previous STING proteomics analyses using whole cell lysates due to the difficulty in removing 
transmembrane proteins from the INM, which requires stringent extraction conditions in 
order to disrupt protein interactions with the nuclear lamina (Malik et al. 2010). Therefore, a 
reversible cross-linking approach was employed, whereby isolated NEs were cross-linked 
prior to immunoprecipitation using an anti-GFP antibody, which allowed for more rigorous 
extraction conditions while preserving protein-protein interactions (Figure 1.6 A). In parallel, 
mock transfected HEK293T cells were subject to the same procedure as a control dataset. 
After immunoprecipitation, cross-linking was reversed (Figure 1.6 B), and samples were sent 




Figure 1.6 – The NE-STING proteome is enriched for chromatin organizing and RNA/DNA 
binding proteins. (A) Schematic showing NE isolation and cross-linking approach for co-
immunoprecipitation experiment. NEs were isolated from HEK293T cells expressing STING-GFP 
or mock transfected cells. The NEs were crosslinked with orthophenanthroline copper, 
fragmented by sonication and STING-GFP crosslinked proteins recovered by 
immunoprecipitation with GFP antibodies. The crosslinking was reversed to release these 
other proteins and their identity determined by mass spectrometry. (B) Cross-linking of NEs 
with orthophenanthroline copper chases most STING-GFP to multimeric species >200 kDa 
while a smaller portion appears at 55 kDa presumably due to intramolecular crosslinks. DTT-
induced reversal of crosslinking restores all STING-GFP to its expected molecular weight at ~69 
kDa. (C) Gene ontology (GO) biological process classification for STING-GFP enriched NE 
partners. The representation of the GO-terms by number of genes in the total human genome 
is shown on the left while on the right are the terms as represented in the most enriched 
proteins of the STING-GFP sample (as determined by two-fold enriched normalised spectral 
counts in the STING-GFP sample over the mock sample, ad further restricted to include only 
proteins detected by at least two peptides or by one peptide but at least two spectra). (D) 
Volcano plot showing all proteins identified in the mass spectrometry experiment plotted by 
degree of enrichment in each sample (log2((dnormS.STING+0.001)/(dnormS.mock+0.001))) 
against overall abundance (log10((dnormS.mock+dnormS.STING)*1e+05)). The strongest 
STING-GFP interactors are highlighted in blue and include 17 proteins which interact with six 
known interactors of the IRF3/7 transcription factors (highlighted in orange and labelled). (E) 
Whether any of the putative STING NE partners identified from the reversibly crosslinked NEs 
were known to interact with IRF3/7 was searched for using the HPRD interactome database. 
17 of the putative STING NE partners (blue) had reported interactions with 6 proteins (white 
boxes) reported to bind IRF3/7 transcription factors (grey) central to IIR activation. Figure 
adapted from Dixon et al. 2020. Experiment performed by Poonam Malik, analyzed by Jose de 
las Heras, volcano plot and STING-partner-IRF3/7 interaction plot created by me. 
 
To determine the most likely STING-GFP interactors from this dataset, reliably identified 
spectra were normalised according to protein mass to obtain the relative abundance of 
proteins in each sample (dnormS). Spectra that were two-fold enriched in the STING-GFP 
sample compared to the mock sample were then identified and this set of proteins was 
further restricted to include only proteins detected by at least two peptides in the STING-GFP 
sample yielding 198 proteins. To this set of proteins an additional 22 proteins were added 
that were detected by only one peptide but had at least two spectra giving a final set of 220 
proteins (see Appendix Table 1). The Gene Ontology (GO)-biological process terms associated 
with this set of proteins was compared to the GO terms associated with the proteins of the 
total human genome revealing an enrichment of proteins with GO-terms for 
chromatin/chromosome organisation and RNA/DNA binding (Figure 1.6 C). The mass 
spectrometry dataset plotted by enrichment in either STING-GFP or mock samples and 
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relative abundance with the top 220 proteins enriched in the STING-GFP sample highlighted 
in blue/orange is shown (Figure 1.6 D). Due to STING’s known role as an adaptor protein in 
cytosolic dsDNA stimulated immune responses, whether any of the proteins identified in the 
mass spectrometry were known to interact with IRF3/7 immune transcription factors was 
investigated by searching the Human Protein Reference Database (HPRD, Johns Hopkins 
University) and visualised using Cytoscape. This revealed that 17 proteins identified as 
interactors of STING in the NE had indirect interactions with IRF3/7 through six known IRF3/7 
interactors (Figure 1.6 E). All of these STING interactors have gene ontology (GO) terms 
associated with either DNA or RNA binding and we hypothesised that they could be involved 
in the sensing of nucleic acids during an innate immune response.  
Although STING is typically considered an ER protein, immunofluorescence published by other 
groups and the Schirmer lab clearly shows that a pool of STING localises to the NE and 
proteomics from the Schirmer identified STING as a NE protein. However, the exact 
localisation of STING within the NE, INM compared to ONM remains to be determined.  
1.7 Aims 
Data discussed above show that STING is present in the NE and indicate that it may access the 
INM and that STING mobility in the NE increases following immune stimulation, therefore the 
first aim of this project was: (1) To determine STING’s localisation within the NE and assess 
whether this changes in response to different immune stimuli. An INM localisation of STING 
could explain STING’s restriction of nuclear replicating herpesviruses (Ishikawa et al. 2009; 
Orzalli et al. 2012; West et al. 2015; Reinert et al. 2016), and STING’s involvement in the 
sensing of host cell nuclear DNA damage (Dunphy et al. 2018), since such mechanisms would 
not require transmission of a signal outside of the nucleus but could instead activate STING 
at the INM.  
Having identified a set of putative NE STING interactors and found that 17 of these proteins 
have links to IRF3/7 transcription factors the second aim was: (2) To test whether any of these 
STING partners are involved in innate immune responses. Putative partner proteins of NE 
STING with known links to IRF3/7 transcription factors could be involved in activation of STING 
signalling from within the nucleus, and NE partners with GO-terms for RNA binding could be 
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involved in STING’s restriction of RNA viruses, the mechanisms of which remain incompletely 




Chapter 2  
Materials and Methods 
 
2.1 – Materials 
2.1.1 Bacterial strains and genotypes  
DH5alpha: F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF) U169 hsdR17(rK- mK+) λ– 
StrataClone Solopack: F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 
Δ(lacZYA-argF) U169 hsdR17(rK- mK+) λ–. (Stratagene, 240207) 
2.1.2 - Buffers and solutions 
Table 2.1 – Buffers used 
Buffer/Solution name Composition 




1 % tryptone 
0.5 % yeast extract 
10 mM NaCl 
pH 7.4 





65 mM Na2PO4 
8.8 mM KH2PO4 
137 mM NaCl 
2.7 mM KCl 
pH 7.4 
Tris Buffer Saline (TBS) 
 
 
20 mM Tris 
137 mM NaCl 
pH 7.6 
TAE 40 mM Tris 
20 mM acetic acid 
1 mM EDTA 
DMEM Dulbecco’s Modified Eagle 
Medium (Sigma-Aldrich, D5796) 
Opti-MEM Opti-MEM® I Reduced Serum 
Medium (Gibco, 31985062) 
MEM (2X) 
 
Modified Eagle Medium (2X) 
(Gibco, 11935046) 
SDS-PAGE running buffer 
 
 
25 mM Tris pH 8.3 
192 mM glycine 
0.1 % SDS 
2X Laemmli buffer 
 
 
100 mM Tris pH 6.8 
4 % SDS 
20 % glycerol 
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10 % 2-mercaptoethanol 
0.05 % bromophenol blue 
Alkaline Lysis Buffer I 
 
50 mM Tris pH 8.0 
10 mM EDTA 
Alkaline Lysis Buffer II 
 
200 mM NaOH 
1 % SDS 






150 mM NaCl 
5 mM EDTA pH 8.0 
50 mM Tris pH 8.0 
1 % IGEPAL® CA630 (NP40 
alternative) 








0.14 % BSA  
1-10 μg/mL TPCK trypsin 
(Worthington Biochemical 
Corporation)  
100 units/mL penicillin  
100 μg/mL streptomycin 






1.2 % Avicell 
0.5X DMEM 
0.14% BSA  
1nµg/mL TPCK trypsin 
100 units/mL penicillin  
100 μg/mL streptomycin 




100 units/mL penicillin  
100 μg/mL streptomycin 





4 % FBS 
200 units/mL penicillin 
200 μg/mL streptomycin 
2 % Crystal Violet solution 
 
2 g Crystal violet (Sigma-Aldrich) 
dissolved in 25 % methanol 
0.1M PHEM Buffer 
 
120 mM PIPES, 20 mM EGTA, 50 








2.1.3 - Primary Antibodies 









SNRNP70 Rabbit 1:1000 1:2000 48, 62 Abcam (ab51266) 
DDX5 Goat 1:1000 1:2000 65 Abcam (ab10261) 
RPS27A Rabbit - 1:250 18 Abcam (ab172293) 
SYNCRIP 
(7A11.2) 
Mouse 1:500 1:1000 59-70 Merck Millipore (#MAB11004) 
SYNCRIP 
(18E4) 
Mouse 1:500 1:1000 59-70 Merck Millipore (#05-1517) 
MEN1 Rabbit 1:500 1:1000 68 Abcam (ab2605) 
AATF Rabbit - 1:500 70 Abcam (ab39631) 
Nup153 Mouse 1:250 1:1000 154 Abcam (ab24700) 
STING 
(AF6516) 
Sheep 1:200 1:1000 37 R&D Systems (AF6516) 
STING 
(D2P2F) 
Rabbit 1:500 1:1000 37 Cell Signaling Technology 
(#13647) 
cGAS Rabbit - 1:500 62 Atlas Antibodies (HPA031700) 
cGAS 
(D1D3G) 








Rabbit - 1:500 50 Abcam (ab76493) 
Lamin B2 Guinea 
Pig 
1:200 - - (Schirmer et al. 2001) 
Lamin A/C 
(3262) 
Rabbit - 1:1000 69/62  (Schirmer et al. 2001) 
α-tubulin Sheep - 1:1000 50 Cytoskeleton Inc. (#ATN02) 
γ-tubulin Mouse - 1:5000 48 Sigma-Aldrich (T6557) 
Histone H3 Mouse - 1:2000 17 Abcam (ab10799) 
NF-κB p65 
(L8F6) 
Mouse 1:500 - - Cell Signaling Technology 
(#6956) 
MAVS Rabbit 1:50 - - Cell Signaling Technology 
(#3993) 
NP Rabbit 1:1000 1:1000 55 Paul Digard (A2915) 
NS1 Rabbit 1:250 1:500 25 Paul Digard (NS1-RBD) 
FLAG Mouse - 1:500 - Sigma-Aldrich (F1804) 
GFP Rabbit - 1:1000 - Life Technologies (A-11122) 





2.1.4 - Secondary Antibodies 
Table 2.3 – Secondary antibodies used in this study 
Antigen Host Dye/conjugate Dilution Source 
Anti-mouse Donkey Alexa Fluor 488 1:1000 Invitrogen #A21202 
Anti-mouse Donkey Alexa Fluor 568 1:1000 Invitrogen #A10037 
Anti-mouse Donkey Alexa Fluor 647 1:1000 Invitrogen #A31571 
Anti-rabbit Donkey Alexa Fluor 488 1:1000 Invitrogen #A21206 
Anti-rabbit Donkey Alexa Fluor 568 1:1000 Invitrogen #A10042 
Anti-rabbit Donkey Alexa Fluor 647 1:1000 Invitrogen #A31573 
Anti-goat Donkey Alexa Fluor 488 1:1000 Invitrogen #A11055 
Anti-goat Donkey Alexa Fluor 594 1:1000 Invitrogen #A11058 
Anti-guinea 
pig 
Goat Alexa Fluor 647 1:1000 Invitrogen #A21450 
Anti-mouse Donkey IRDye®680RD 1:1000 Licor #926-68072 
Anti-mouse Donkey IRDye®800CW 1:1000 Licor #926-32212 
Anti-rabbit Donkey IRDye®680RD 1:1000 Licor #926-68073 
Anti-rabbit Donkey IRDye®800CW 1:1000 Licor #926-32213 
Anti-goat Donkey IRDye®680RD 1:1000 Licor #925-68074 
Anti-goat Donkey IRDye®800CW 1:1000 Licor #926-32214 
Anti-sheep Donkey 6 nm gold 1:50 Aurion #806.344 
Anti-rabbit Goat 5 nm gold 1:50 Aurion #806.011 
Anti-rabbit Donkey PLA® Probe PLUS 1:5 Sigma-Aldrich #DUO92002 
Anti-mouse Donkey PLA® Probe PLUS 1:5 Sigma-Aldrich #DUO92001 
Anti-goat Donkey PLA® Probe 
MINUS 
1:5 Sigma-Aldrich #DUO92006 
 
2.1.5 - Virus stocks 
The wild-type strain of herpes simplex virus-1 (HSV-1) used in this study was 17+. Wild-type 
strains of influenza A virus used in this study were A/PR8/34(H1N1) and A/Udorn/72(H3N2). 
Viral stocks of A/PR8/34(H1N1) were generated using a reverse genetics system as described 
in (De Wit et al. 2004) with plasmids and HEK293T and MCDK cells used for viral growth a gift 
from Professor Paul Digard (Roslin Institute, Edinburgh). Viral stocks of A/Udorn/72(H3N2) 
were a gift from Eleanor Gaunt (Paul Digard, Roslin Institute, Edinburgh). A/PR8/34(H1N1) 
NS1 mutant strains R38K41A and N81 were also generated using a reverse genetics system 
and swapping the plasmid encoding wild type NS1 for respective mutant NS1, these plasmids 
were a gift from Professor Paul Digard (Roslin Institute, Edinburgh). 
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2.1.6 - Mammalian cells 
HT1080 fibroblasts, BHK-21 cells, and U2OS cells were obtained from ATCC. HEK293FT cells 
were a gift from Justina Cholewa-Waclaw (Adrian Bird, WCCB), these cells are derived from a 
fast-growing clone of HEK293T cells stably expressing the SV40 large T antigen from the 
pCMVSPORT6Tag.neo plasmid. HEK293T cells, A549 cells, and MDCK cells were a gift from 
Professor Paul Digard (Roslin Institute, Edinburgh). An HT1080 cell line stably expressing a 
doxycycline inducible STING-GFP construct was created by Mike Robson (Eric Schirmer, 
WCCB) using a lentiviral vector system (pLVX-TRE3G backbone, Clontech). 
2.2 - Mammalian cell culture 
2.2.1 – Cell maintenance 
All cells were cultured at 37 °C in a humid atmosphere with 5 % CO2. HT1080, HEK293T, A549, 
Vero, and MDCK cells were grown in DMEM supplemented with 10 % fetal bovine serum 
(FBS), 100 units/mL penicillin and 100 μg/mL streptomycin. HT1080, HEK293T, A549, and Vero 
cells were passaged when they reached ~70-80 % confluency, typically every 2-3 days, in a 
1:10 dilution by trypsinisation. MDCK cells were passaged upon reaching 100 % confluency.  
HEK293FT cells and HT1080 cells stably expressing a doxycycline inducible STING-GFP 
construct were grown in DMEM supplemented with 10 % FBS, 100 units/mL penicillin, 100 μg 
streptomycin, and 0.5 mg/mL geneticin (G418) to maintain selection of pCMVSPORT6Tag.neo 
and STING-GFP integrated cells, respectively. These cells lines were passaged when they 
reached ~70-80 % confluency by 1:10 dilution using trypsinisation. STING-GFP HT1080 cells 
were treated with 0.05 µg/mL doxycycline for 20 h prior to use in experiments in order to 
induce STING expression before use in experiments. This concentration of doxycycline and 
length of treatment enriched for HT1080 cells expressing low levels of STING-GFP and 
prolonged treatment with doxycycline or the use of higher concentrations resulted in higher 
levels of STING-GFP expression and the formation of aggregates in the ER (Figure 2.1 A). 
Recently it was revealed that such STING aggregates are a form of phase-separation and 
prevent overactivation of innate immune responses (Yu et al. 2021) (Figure 2.1 B and C). 
BHK-21 cells were maintained in Glasgow Modified Eagle’s Medium (GMEM, Invitrogen), 
supplemented with 2 mM L-glutamine, 10 % new-born calf serum, 10 % tryptose phosphate 




Figure 2.1 – Doxycycline inducible STING-GFP expression. (A) HT1080 cells stably expressing 
a doxycycline inducible STING-GFP construct were treated with low levels of doxycycline (0.05 
µg/mL) to induce STING-GFP expression. Prolonged exposure with doxycycline or induction 
using higher concentrations increased the formation of STING-GFP ER aggregates which 
presumably represent phase condensates of STING in the ER. (B) STING condensates grow 
larger with increasing STING expression. HEK293T cells transfected with full-length STING-GFP 
(FL) or STINGd309-379-GFP (dIDR), after 12 h live cell imaging was performed with micrographs 
showing the indicated timepoints starting 12 h post-transfection. STING condensates form and 
grow larger in cells transfected with STING-GFP (FL) but do not form in cells transfected with 
STINGd309-379-GFP (dIDR) which lacks the intrinsically disordered region of STING required for 
the formation of condensates. (C) Electron microscopy of STING condensates reveals a puzzle-
like membrane structure in the ER, formed by STING aggregation. (B) and (C) adapted from 
(Yu et al. 2021). 
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2.2.2 – Plasmid transfection 
For FRET-FLIM experiments HEK293T cells were transfected with plasmids containing STING-
RFP, Lamin A-GFP, or an RFP-GFP tandem construct using Lipofectamine® 2000 (Invitrogen) 
according to the manufacturer’s instructions. Briefly, 70,000 cells were seeded on 13 mm 
glass coverslips (VWR International) per well of a 24-well plate in a volume of 1 mL growth 
medium the day before transfection in order to be at ~50 % confluency at the time of 
transfection. The next day 0.5 μg of plasmid DNA and 1 μL of Lipofectamine® 2000 reagent 
were diluted separately in 25 μL of Opti-MEM for each well of a 24-well plate that was to be 
transfected, vortexed briefly, and incubated for 5 minutes at room temperature. After 5 
minutes DNA and Lipofectamine® 2000 reagent were combined, mixed, and incubated at 
room temperature for a further 20 minutes. During this time, the volume of growth medium 
in each well of the 24-well plate was adjusted to 0.5 mL. After 20 minutes the DNA-lipovesicle 
mixture was added to cells in a drop-wise manner so as not to disturb adherent cells. For co-
immunoprecipitation experiments using SYNCRIP Q1/Q3-FLAG and STING-GFP constructs 
HEK293T cells were similarly transfected using Lipofectamine® 2000 but in a 10 cm tissue 
culture dish with volumes scaled accordingly. 
2.2.3 – siRNA transient transfection 
HT1080 cells were seeded at 300,000 cells/well of a 6-well plate on the day before 
knockdown. The next day knockdown was performed using the siRNA duplexes listed in Table 
2.4 and jetPRIME transfection reagent (POLYPLUS) according to the manufacturer’s 
instructions, for a final concentration of 50 nM siRNA, 4 μL jetPRIME, 200 μL jetPRIME buffer 
per well. For STING knockdown a mixture of siRNA#1 and siRNA#2 were used for a final 
concentration of 50 nM. siRNA was added to jetPRIME buffer and vortexed to mix before the 
addition of jetPRIME reagent. The mixture was then vortexed again and incubated for 15 
minutes at room temperature before addition to cells in a drop-wise manner. 24 hours after 
knockdown cells were trypsinised and re-seeded 1:2 in 6-well plates for Western blotting and 
qPCR experiments, or at 50,000 cells/well of a 24-well plate on 13 mm glass coverslips for 
immunofluorescence, or without coverslips for virus infection experiments. Cells were used 
in experiments 48 hours after siRNA treatment. HEK293FT cells were treated similarly except 
they were seeded at 400,000 cells/well of a 6-well plate and for luciferase assays 24 hours 
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after initial siRNA treatment cells were replated at 50,000 cells/well of a 48-well plate for 
subsequent co-transfection of luciferase assay plasmids and a repetition of siRNA treatment. 
Table 2.4 – siRNA duplexes used in this study 




Sense – AAUUCUCCGAACGUGUCACGU[dT][dT] 
Antisense - ACGUGACACGUUCGGAGAAUU[dT][dT] 
Sigma Aldrich (UK) 
SYNCRIP Sense - CUAUCGUGGUGGAUAUGAAGA[dT][dT] 
Antisense - UCUUCAUAUCCACCACGAUAG[dT][dT] 
Sigma Aldrich (UK) 
MEN1 Sense - GAUCAUGCCUGGGUAGUGUU[dU][dG] 
Antisense - AACACAUACCCAGGCAUGAUC[dC][dU] 
Sigma Aldrich (UK) 
DDX5 
 
Sense – CCCAAUAAGACUUUAGAAGUA[dT][dT] 
Antisense - UACUUCUAAAGUCUUAUUGGG [dT][dT] 
Sigma Aldrich (UK) 
SNRNP70 
 
Sense – GGUCUACAGUAAGCGGUCA[dT][dT] 
Antisense - UGACCGCUUACUGUAGACC [dT][dT] 
Sigma Aldrich (UK) 
RPS27A 
 
Sense – UUAGUCGCCUUCGUCGAGA[dT][dT] 
Antisense - UCUCGACGAAGGCGACUAA [dT][dT] 
Sigma Aldrich (UK) 
TCERG1 Sense – GGAGUUGCACAAGAUAGUU[dT][dT] 
Antisense – AACUAUCUUGUGCAACUCC[dT][dT] 
Sigma Aldrich (UK) 
AATF Sense – AAGCGCUCUGCCUACCGAGUU[dT][dT} 
Antisense – AACUCGGUAGGCAGAGCGCUU[dT][dT] 
Sigma Aldrich (UK) 
STING Sense#1 – GCACCUGUGUCCUGGAGUA[dT][dT] 
Antisense#1 – UACUCCAGGACACAGGUGC[dT][dT] 
 
Sense#2 – GCAUCAAGGAUCGGGUUUA[dT][dT] 
Antisense#2 – UAAACCCGAUCCUUGAUGC[dT][dT] 
Sigma Aldrich (UK) 
 
2.2.4 – Innate immune response induction 
To stimulate innate immune responses for Western blotting and qPCR experiments, cells 
seeded at 300,000 cells/well in a 6 well-plate the day before immune stimulation. 24 hours 
later cells were transfected with 10 μg poly(I:C) (Sigma), 5 μg pcDNA3.1, or transfection 
reagent alone (mock) using 4 μL Lipofectamine® 2000 transfection reagent in 200 μL Opti-
MEM added to cells in 2 mL culture medium to stimulate an innate immune response. For 
immunofluorescence experiments cells were seeded at 50,000 cells/well of a 24-well plate 
the day before immune stimulation and 24 hours later were transfected with 2 μg poly(I:C) 
(Sigma), 1 μg pcDNA3.1, or transfection reagent alone (mock) using 1 μL Lipofectamine® 2000 
transfection reagent in 50 μL Opti-MEM added to cells in 0.5 mL culture medium. Transfection 
of cGAMP was also performed using Lipofectamine® 2000 for a final concentration of 2 μg/mL 
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for HT1080 cells and up to 10 μg/mL for HEK293T cells. Cells were then processed for 
experiments after the time indicated in figure legends. 
2.2.5 – Dual-Luciferase Reporter Assay 
24 hours after an initial siRNA knockdown transfection of HEK293FT cells seeded in 6-well 
plates, 50,000 cells were seeded per well of a 48-well plate. After another 24 hours, cells were 
co-transfected with plasmids expressing luciferase reporter constructs (IFNβ promoter- P. 
pyralis luciferase or NF-κB/AP1- P. pyralis luciferase at 30 ng and HSV-thymidine kinase 
promoter- R. reniformis luciferase (pRL-TK) at 5 ng) and either cGAS and STING (20 ng each) 
or empty vector DNA (pcDNA3.1 at 40ng). Luciferase plasmids were a gift from Professor Greg 
Towers (Division of Infection and Immunity, UCL, London). For each well, 1 µL of Fugene6 
transfection reagent (Promega) was incubated with 25 µL of Opti-MEM for 5 minutes at room 
temperature, separately plasmid constructs and 280 ng of the required siRNA oligos (second 
knockdown) were also diluted in 25 µL of Opti-MEM for 5 minutes at room temperature. After 
5 minutes, the transfection reagent Opti-MEM mixture and plasmid/siRNA Opti-MEM mixture 
were combined, and this final mixture was incubated for a further 20 minutes at room 
temperature. After 20 minutes, the transfection reagent-plasmid/siRNA Opti-MEM mixture 
was added to cells with each well containing 150 µL fresh growth medium. After 24 hours 
growth medium was exchanged for 300 µL fresh growth medium. 
To measure luminescence produced by luciferase activity, cells were harvested 96 hours after 
the initial siRNA knockdown transfection (48 hours after plasmid transfection). Media was 
removed and cells were washed in PBS before re-suspension in 75 µL 1X Passive Lysis Buffer 
(PLB; Dual-Luciferase Reporter Kit, Promega). Cells were incubated in PLB for 15 minutes at 
room temperature and further homogenised by pipetting. 25 µL of the homogenised lysate 
was transferred to a well on a 96-well plate and luminescence signal was detected using a 
Modulus Microplate Multimode Reader (Turner Biosystems). The plate reader was 
programmed to inject 40 µl of Luciferase Assay Substrate re-suspended in Luciferase Assay 
Buffer II and 35 µl of 1X Stop&Glo Reagent (Dual-Luciferase Reporter Kit, Promega) per well, 
with a 2 second delay between injections and 10 second measurement period after each 
injection. Luminescence signal produced by IFNβ/NF-κB- P. pyralis luciferase was divided by 
pRL-TK- R. reniformis luciferase luminescence signal to control for variation in transfection 
efficiency and cell number. Relative fold induction was calculated by dividing the P. pyralis/R. 
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reniformis luminescence ratio of reporter constructs in cells transfected with STING and cGAS 
plasmids by the P. pyralis/R. reniformis luminescence ratio in control cells transfected with 
empty vector DNA instead of STING and cGAS and so lacking a functional cGAS-STING 
pathway. 
2.2.6 – Generation of HT1080 SYNCRIP knockout cell lines by CRISPR/Cas9 gene editing 
Two guide RNAs (gRNA) targeting exons 3 and 6 of the SYNCRIP gene in the human genome 
were selected using the Synthego CRISPR Design Tool (Synthego, USA). gRNA#1 (5’-
CACCGCAGTGATCTCTCTCATGTTC-3’)  and gRNA#2 (5’-CACCGTTGTACAAAAGAAGCAGCTC-3’) 
were cloned into individual pX458 plasmids according to the Zhang lab method (Ran et al. 
2013). HT1080 cells were transfected with plasmids encoding gRNA#1 or gRNA#2 using 
Lipofectamine® 2000 and fluorescence activated cell sorting (FACS) was used 24 hours after 
transfection to select for GFP-positive single cells. Single cells were sorted into wells of a 96-
well plate containing 100 μL FBS. After sorting, 100 μL cell growth medium was added to wells 
and single cell colonies were grown up and screened for SYNCRIP knockout by Western 
blotting and sequencing of the SYNCRIP gene. 
2.3 – Virology methods 
2.3.1 – Influenza A virus production 
Influenza A virus (IAV) A/PR8/34(H1N1) stocks were generated using a pDUAL 8 plasmid 
reverse genetics system, as described previously (De Wit et al. 2004), in which each of the 8 
genome segments of IAV are encoded by a separate plasmid. A/PR8/34(H1N1) NS1 mutant 
strains R38K41A and N81 were also generated using the same reverse genetics system but 
swapping the plasmid encoding wild type segment 8 (NS) for a plasmid encoding mutant NS1 
(R38K41A or N81, which consists of only the first 81 amino acid residues of NS1). To prepare 
a p0 stock, 250 ng of each of the 8 pDUAL plasmids (0.5 μL of a 500 ng/μL stock encoding IAV 
genome segments 1-8) was added to 100 μL Opti-MEM and separately 4 μL of Lipofectamine® 
2000 was diluted in 100 μL Opti-MEM. Both tubes were mixed gently and incubated 
separately for 5 minutes at room temperature, the Lipofectamine® 2000/Opti-MEM mixture 
was then added to the DNA/Opti-MEM mixture, gently mixed by pipetting and incubated for 
20 minutes at room temperature. At the same time as preparing p0 stock, a mock virus 
negative control stock was prepared by omitting the pDUAL plasmid encoding segment 1. 
48 
 
During this incubation, 1 mL of HEK293T cells at a concentration of 1,000,000 cells/mL was 
added per well of a 6 well-plate. Transfection mixes were then added to HEK293T cells in 
suspension in a drop-wise manner. The next day medium on HEK293T cells was changed to 2 
mL of virus growth medium (VGM) (serum free DMEM, supplemented with 0.14 % BSA (1:50 
from a 7 % BSA stock prepared in sterile distilled water), and 1 μg/mL of TPCK trypsin 
(Worthington Biochemical Corporation) (1:1000 from a 1 mg/mL stock diluted in PBS), 100 
units/mL penicillin and 100 μg/mL streptomycin). After 48-72 hours supernatants were 
harvested and 1 mL aliquots prepared in 2 mL screw capped tubes, these were centrifuged 
for 1 minute at 13,000 xg to pellet any cells and stored at -80 °C.  
To make a p1 working virus stock, p0 stocks prepared in HEK293T cells were used to infect 
MDCK cells in a T-25 flask. MDCK cells were seeded the day before at 5,000,000 cells/flask in 
10 mL growth medium. Cell monolayers were washed 2X with 10 mL serum free DMEM 
supplemented with 100 units/mL penicillin and 100 μg/mL streptomycin. After removing the 
last wash 1 mL of 100 μL p0 stock diluted in 1 mL VGM was added to cells, the flask gently 
washed to ensure even coverage and cells incubate for 1 hour at 37 °C. After this incubation, 
5 mL of VGM was added to flasks and cells were incubate for 48 hours. After 48 hours, 
provided there was significant cytopathic effect (CPE), supernatants were harvested into a 15 
mL tube, centrifuged at 3,000 xg for 5 minutes, aliquoted into screw capped tubes, and stored 
at -80 °C. 
2.3.2 – Influenza A virus titration by plaque assay 
In order to determine influenza A virus stock concentrations plaque assays were used. Two 
days before titration MDCK cells were seeded in 6-well plates at ~750,000 cells/well (typically 
1X confluent T-150 flask could be used to seed 8X 6-well plates). After two days, confluent 
monolayers of MDCK cells were infected with serially diluted virus stocks. Assuming that wild-
type A/PR8/34(H1N1) grows to a titre of 1 x108 plaque forming units (PFU)/mL stocks were 
serially diluted to 1:1 x108 and serial 1 in 10 dilutions of 1:1000-1:1 x108 were used for the 6 
wells of a 6-well plate. MDCK cells were washed 2X with 1 mL/well serum free DMEM, after 
the last wash was removed 800 μL of virus dilution was added per well and plates were 
incubated for 1 hour at 37 °C. After this incubation cells were overlaid with 2 mL overlay 
medium (1:1 mixture of DMEM and 2.4 % Avicell ((RC-591 NF) diluted in distilled water and 
autoclaved), supplemented with 0.14 % BSA, 1 μg/mL TPCK trypsin, 100 units/mL penicillin, 
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and 100 μg/mL streptomycin). Cells were then incubated for 48 hours at 37 °C, ensuring that 
plates were not disturbed in this time.  After 48 hours, overlay medium was removed and cell 
monolayers were fixed with 2 mL/well 3.7 % formaldehyde (diluted in PBS) for 30 minutes. 
Fixative was then removed, and cells were stained with 0.01 % toluidine blue for 1 hour at 
room temperature. Stain was then removed, and cells monolayers were rinsed with water 
and left to dry. Quantification of viral titres was determined by counting the number of 
plaques in a well with a dilution that gave between 10 and 100 plaques (Figure 2.2). PFU/mL 
was determined by multiplying the number of plaques by the dilution factor and correcting 
for the volume of virus added.   
 
Figure 2.2 – Example plaque assay of A/PR8/34(H1N1) virus stock and mock infected MDCK 
cell monolayers. Plaques formed on MDCK cells were counted for the well corresponding to a 
10-7 dilution of p1 virus stock (yellow circle). No plaques formed in mock infected wells since 
no virus is produced in the absence of one of the IAV genome segments. To determine an 
accurate titre, virus stocks were titrated in triplicate. 
2.3.3 – Infection of cells with Influenza A virus  
For determination of IAV proliferation in cells and immunofluorescence experiments, 100,000 
HT1080 cells were seeded per well of a 24-well plate the day before infection (on 13 mm glass 
coverslips for immunofluorescence experiments). For time-course experiments, a separate 
well was required per time-point being analysed. On the day of infection cells were washed 
2X with 0.5 mL SFM and cells in one well of a 24-well plate per condition (e.g. siRNA 
treatment) was counted to determine the number of cells. SFM was removed and IAV was 
added at the specified multiplicity of infection (MOI = (stock virus titre (PFU/mL)*volume of 
titre to use)/number of cells) in a final volume of 200 μL SFM. Cells were incubated for 1 hour 
at 37 °C to allow for viral particles to adsorb to cells. After 1 hour, cells were washed with 0.5 
mL SFM to remove free virus and then overlaid with 0.5 mL VGM. Supernatants were collected 
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at indicated timepoints (with 0 hours post infection beginning after overlay of VGM) and 
stored at -80 °C until virus titration by plaque assays to determine viral proliferation. For 
immunofluorescence experiments, after the adsorption incubation cells and washing cells 
were overlaid with VGM -TPCK Trypsin since this tended to result in cells detaching from 
coverslips. Cells were then fixed in 3.7 % formaldehyde (in PBS) for 15 minutes before 
proceeding with immunofluorescence. For Western blotting and co-immunoprecipitation 
experiments cells were seeded the day before infection at 500,000 cells/well of a 6-well plate 
and 3,000,000 cells in a 10 cm dish, respectively. On the day of infection cells were washed 
with SFM, counted, and infected with MOI indicated in figure legends, for 6-well plates virus 
was adsorbed to cells in a final volume of 800 μL SFM while for 10 cm dishes virus was 
adsorbed to cells in a final volume of 3 mL SFM. After 1 hour incubation to allow virus to 
adsorb to cells, cell monolayers were washed with SFM and overlaid with VGM – TPCK Trypsin 
(2 mL/well of a 6-well plate and 10 mL in a 10 cm dish). At desired time points post-infection 
cells for Western blotting were washed with PBS and lysed directly in 200 μL 2X Laemlli buffer. 
For co-immunoprecipitation experiments cells were washed with ice-cold PBS and lysed in 1 
mL Co-immunoprecipitation lysis buffer with freshly added protease inhibitors.  
2.3.4 – Herpes simplex virus-1 production  
HSV-1 wild type strain 17+ viral stocks were generated in BHK-21 cells. The day before 
infection 1,500,000 cells were seeded in a 60 mm plate. The next day cells were infected with 
HSV-1 stocks at an MOI of 0.005, cell growth medium was removed, and virus was added in a 
final volume of 0.7 mL cell growth medium. To generate a mock virus stock, cells were 
‘inoculated’ in parallel with 0.7 mL cell growth medium. Cells were incubated at 37 °C for 1 
hour to allow virus to adsorb to cells, plates were gently rocked every 15 minutes to ensure 
an even coverage of the cell monolayer, before adding an additionally 3 mL growth medium 
and incubating cells for a further 2-3 days at 37 °C (until extensive CPE is observed). Cells were 
then scraped into the cell medium with a cell scraper and transferred into a 15 mL screw-cap 
tube and sonicated for 30 seconds in a water bath sonicator at 4 °C to release cell bound virus. 
Virus suspension was then centrifuged for 12 minutes at 5,000 xg to pellet cell debris and 
supernatant was aliquoted into 0.5 mL aliquots in 2 mL screw cap tubes and stored at -80 °C. 
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2.3.5 – Herpes simplex virus-1 titration by plaque assay  
In order to determine HSV-1 stock concentrations plaque assays were used to determine viral 
titre (PFU/mL). The day before infection 200,000 Vero cells were seeded per well of 12-well 
plate, after 24 hours or when cells reached 90 % confluence cells were infected with 10-fold 
serial dilutions of HSV-1 diluted in SFM (10-1 to 10-8). Cell growth medium was removed from 
wells and 100 μL of virus dilution was added per well, with each virus dilution used to infect 
cells in duplicate. Plates were then incubated for 1 hour at 37 °C, gently rocking the plate 
every 15 minutes. After 1 hour, virus inoculum was removed, and cells were overlaid with 2 
mL of overlay medium (1:1 mix of 2X MEM growth medium and 1.2 % Avicell (RC-591 NF) 
(diluted in distilled water and autoclaved)). Plates were then incubated for 3 days at 37 °C 
before fixation and staining. Overlay medium was removed and cells were fixed for 30 
minutes in 3.7 % formaldehyde (diluted in PBS). Fixative was then removed, and cells were 
stained with 2 % crystal violet solution for 1 hour at room temperature. Stain was then 
removed, and cells monolayers were rinsed with water and left to dry. Quantification of viral 
titres was determined by counting the number of plaques in a well with a dilution that gave 
between 10 and 100 plaques (Figure 2.3). PFU/mL was determined by multiplying the number 
of plaques by the dilution factor and correcting for the volume of virus added.   
 
Figure 2.3 – Example plaque assay of HSV-1 17+ virus stock and mock infected Vero cell 
monolayers. Plaques formed on Vero cells. No plaques formed in mock infected wells. To 
determine an accurate titre, virus stocks were titrated in triplicate. 
2.3.6 – Infection of cells with Herpes simplex virus-1 (HSV-1)  
The day before infection 100,000 cells were seeded per well of a 24-well plate. The next day 
one well of cells for each siRNA knockdown condition was counted and cell monolayers were 
infected at an MOI of 5 with virus stocks or mocks diluted in SFM for a final volume of 200 μL 
per well.  After 1 hour of adsorption, cells were wash 2X with PBS to remove free virus and 
0.5 mL of cell culture medium was added to wells. At the desired timepoints cells were 
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scraped into cell medium, suspensions were transferred into 1.5 mL tubes, and stored at -80 
°C. In order to determine viral titres in each sample plaque assays were used, virus/cell 
suspensions were subject to 3X freeze thaw-cycles with samples vortexed after each sample 
prior to use in plaque assays. 
2.4 – Nucleic acid methods 
2.4.1 – Sequencing plasmid DNA 
Plasmids SYNCRIP (Q1)-FLAG (RC228458) and SYNCRIP (Q3)-FLAG (RC217902) (OriGene 
Technologies) were verified before use in experiments by sequencing. BigDyeTM Terminator 
v3.1 Cycle Sequencing kit (Applied Biosystems #4337455) was used, and reactions were sent 
for sequencing by Edinburgh Genomics (University of Edinburgh). Provided chromatograms 
were analysed using SnapGene® 4.3.11 software (SnapGene). 
2.4.2 – RNA extraction  
RNA extraction was performed using TRIzolTM reagent (Invitrogen, #15596026). Cell culture 
medium was removed, and cells were lysed directly in 0.5 mL TRIzolTM per well of a 6-well 
plate, cells were scraped, and the lysate homogenised by pipetting and transferred to a 1.5 
mL tube. After incubation at room temperature for 5 minutes, 0.1 mL of chloroform was 
added, the mixture was shaken vigorously for 30 seconds, and incubation continued for a 
further 5 minutes at room temperature. Samples were then centrifuged at 12,000 xg for 15 
minutes at 4 °C, after which the upper aqueous phase was transferred to a new tube and 
mixed with 0.25 mL isopropanol. After a 10-minute incubation at room temperature the 
mixture was centrifuged 12,000 xg for 10 minutes at 4 °C. The supernatant was discarded, 
and pelleted RNA was washed with 70 % ethanol. After air drying at room temperature for 5 
minutes pellets were resuspended in 20 μL RNase-free water. Alternatively, RNA extraction 
was achieved using RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. 
RNA yield was determined using a NanoDrop 2000c spectrophotometer and RNA integrity 
assessed by agarose gel electrophoresis. 
2.4.3 – Quantitative PCR (qPCR)  
cDNA was generated using SuperScriptTM II Reverse Transcriptase (Invitrogen #18064022) 
First-Strand cDNA Synthesis protocol. Oligo(dT)18, dNTPs, and 2 μg total RNA were incubated 
at 65 °C for 5 minutes before the addition of 5X First-Strand Buffer, 10 mM DTT, and 40 U 
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RNaseOUTTM. After a brief mix and incubation at 42 °C for 2 minutes, 200 U SuperScriptTM II 
Reverse Transcriptase was added, mixed, and incubated at 42 °C for 3 hours, before a 15-
minute heat inactivation step at 70 °C. cDNA was diluted with 180 μL of nuclease-free water 
to give a final volume of 200 μL and then stored at -20 °C until use. 
For qPCR reactions, 20 μL reactions containing 8.4 μL of diluted cDNA, 400 nM each of forward 
and reverse primers (see Table 2.5) and 1X LightCycler® 480 SYBR Green I Master (Roche) 
were prepared in a 96-well LightCycler® 480 Multiwell Plate. Polymerase chain reactions were 
carried out in a LightCyler® 480 using the program detailed in Table 2.6 and expression data 
was analysed using LightCycler® 480 Software v1.5.0.39 (Roche). Ct values were exported to 
Microsoft Excel and ΔCt expression values calculated (2-(Ct target-Ct reference)). 
Table 2.5 – Primers used for qPCR  














Table 2.6 – Thermocycling conditions for qPCR 




Acquisition (per °C) 
Preincubation, 1 cycle      
95  05:00   
Amplification, 45 cycles     
95  00:10   
51  00:15   
72 Single 00:20  1 
Melting Curve, 1 cycle     
95  00:05   
65  01:00 2.2  
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97 Continuous   5 
Cooling, 1 cycle     
22  00:30 2.2  
 
2.5 – Microscopy methods 
2.5.1 – Immunofluorescence  
Adherent cells were grown on 13 mm coverslips No. 1.5 (VWR International) and washed with 
PBS to remove cell debris and cell growth medium prior to fixation with 3.7 % formaldehyde, 
1X PBS for 15 minutes at room temperature. Alternatively, where indicated, cells were fixed 
with ice-cold 100 % methanol at -20 °C for 15 minutes. After fixation cells were washed twice 
with PBS and permeabilised for 7 minutes with 0.2 % Triton-X-100 in PBS and then washed 3 
times in PBS. Coverslips were blocked with 4 % bovine serum albumin (BSA), 1X PBS for 30 
minutes at room temperature and subsequently incubated with primary antibody (dilutions 
listed in Table 2.2) overnight at 4 °C or for 1 hour at room temperature. Coverslips were 
washed 3 times in PBS and incubated with appropriate secondary antibodies conjugated to 
Alexa Fluor® dyes (listed in Table 2.3) and 4,6-diamidino-2 phenylindole, dihydrochloride 
(DAPI) at a final concentration of 2 μg/mL, for 30 minutes at room temperature. Coverslips 
were washed 3 times in PBS and mounted on slides with Fluoromount-G® (SouthernBiotech) 
or VECTASHIELD® (Vector Labs). Alternatively, for immunofluorescence experiments using 
anti-STING (D2P2F) antibody (Cell Signaling Technology) staining was performed according to 
(Almine et al. 2017), with cells fixed in methanol at -20 °C, permeabilised for 12 minutes in 
0.5 % Triton-X-100 in PBS and blocked with 5 % FBS, 0.2 % Tween-20 in PBS. Cells were stained 
with primary antibodies overnight at room temperature and incubated with secondary 
antibodies for 3 hours at room temperature. 
2.5.2 – Pre-fixation detergent extraction assay 
Adherent cells grown on 13 mm coverslips No 1.5 (VWR International) were washed with PBS 
and then extracted prior to fixation with 0.1 % Triton-X-100 for 1 minute at room 
temperature, washed with PBS, and then incubated with 0.1 % Triton-X-100 again for 1 
minute. Cells were then washed with PBS and fixed in 100 % methanol at -20 °C for 15 
minutes. In parallel cells were directly fixed without extraction. Downstream 
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immunofluorescence was performed as described for anti-STING (D2P2F) antibody (Cell 
Signaling Technology) 
2.5.3 – Proximity Ligation Assay (PLA) 
Proximity Ligation Assays were performed using Duolink® PLA reagents following the 
manufacturer’s instructions (Duolink® In Situ Red Starter Kit, DUO92103, and Duolink® In Situ 
PLA® Probe Anti-Rabbit PLUS, DUO92002, Sigma-Aldrich). Adherent cells grown on 13 mm 
coverslips No 1.5 (VWR International) were fixed and permeabilised as for 
immunofluorescence staining. Cells were then blocked in Duolink® Blocking Solution (Sigma-
Aldrich) for 1 hour at 37 °C in a humidity chamber. Coverslips were then incubated with 
indicated primary antibodies diluted in Duolink® Antibody Diluent (Sigma-Aldrich) overnight 
at 4 °C in a humidity chamber. The next day coverslips were washed in Duolink® Wash Buffer 
A (Sigma-Aldrich) and incubated with Duolink® PLA Probes (PLUS and MINUS for specific 
antibody pair used for primary antibody incubation) for 1 hour at 37 °C in a humidity chamber. 
Coverslips were washed with Duolink® Wash Buffer A and incubated with Duolink® Ligase in 
Ligation buffer for 30 minutes at 37 °C in a humidity chamber. Coverslips were washed with 
Duolink® Wash Buffer A and then incubated with Duolink® Polymerase in Amplification buffer 
for 100 minutes at 37 °C in a humidity chamber. Finally, coverslips were washed with Duolink® 
Wash Buffer B and mounted on slides with Fluoromount-G® with DAPI (SouthernBiotech).  
2.5.4 – Fluorescence Microscopy and analysis 
Images were acquired on a Zeiss Axio Imager equipped with alpha-Plan ApoChromat 1.46 NA 
100x objective, Marzhauser 8 slide motorised stage, Hamamatsu Flash sCMOS camera, and 
CooLED pE-300 Lightsource, using MicroManager image acquisition software. Image analysis 
was performed in ImageJ (FIJI) (Schindelin et al. 2012). For nuclear/cytoplasmic distribution 
analysis mean nuclear localised signal was determined using a DAPI mask to select ROI, mean 
cytoplasmic signal was determined using a mask based on auto-thresholding of signal with 
DAPI mask subtracted to select ROI.  To calculate PLA foci per cell, PLA foci were counted by 
thresholding based on signal intensity followed by the ‘analyse particles’ function of ImageJ 
and this number was divided by the number of DAPI stained nuclei per field of view. 
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2.5.5 – Förster-Resonance Energy Transfer (FRET) with fluorescence lifetime imaging (FLIM) 
microscopy  
HEK293T cells were seeded at 70,000 cells on 13 mm glass coverslips No. 1.5 in a well of a 24-
well plate. The next day cells were transiently transfected with plasmids encoding Lamin A-
GFP, an RFP-GFP tandem construct, or Lamin A-GFP and STING-RFP (Malik et al. 2010). After 
24 hours cells were fixed for 15 minutes in 3.7 % formaldehyde before washing in PBS and 
mounting in Vectashield®. Imaging was performed on a Leica SP5 SMD confocal laser scanning 
microscope equipped with PicoHarp 300 (TCSPC module and picosecond event timer) and 
single photon avalanche detectors (SPAD). Leica application suite with FLIM wizard software 
and integrated Symphotime software were used for single photon counting acquisition and 
FLIM measurements were carried out for 5 minutes per field of view. FLIM data was analysed 
using FLIMfit 5.1.1 software (Imperial College London) with an instrument response function 
(IRF) calculated from a AlexaFluor 488 fluorescent reference slide. 
2.5.6 – Single molecule Fluorescence Recovery After Photobleaching (smFRAP) microscopy  
Imaging was performed on an Olympus IX81 microscope equipped with a 1.4-NA 100x oil-
immersion apochromatic objective (UPLSAPO 100XO, Olympus). An ObisTM solid state 488-nm 
(Coherent Inc) was passed through dichroic filters (Di01- R405/488/561/635-25x36, Semrock) 
and emission filters (NF01- 405/488/561/635-25X5.0, Semrock) as well as a circular variable 
metallic neutral density filter (Newport) and directed into the microscope using a micrometer 
stage (Newport). HT1080 cells stably expressing doxycycline inducible STING-GFP were plated 
on No. 0 cover glass 35-mm dishes with 14 mm Microwell (MatTek). After overnight induction 
of STING-GFP expression with 0.05 μg/mL doxycycline, 2 hours before imaging cells were 
transfected via lipofection agent Transit-X2 (Mirus Bio LLC) with plasmid DNA, poly(I:C), or 
transfection reagent alone (mock). Growth media was replaced with Transport Buffer (20 mM 
HEPES, 110 mM KOAc, 5 mM NaOAc, 2 mM MgOAc, and 1 mM EGTA, pH 7.3) 30 minutes prior 
to imaging to slow membrane movements and reduce autofluorescence. Imaging was 
performed on the Nuclear Envelope region opposite the bulk of the peripheral ER. The region 
was photobleached for 1 minute at 5 mW and then imaged for 30 seconds at 50 μW. An 
optical chopper rotating at 2-Hz was utilized during capture to allow for fluorescence 
recovery. Images were captured using the Slidebook software package (Intelligent Imaging 
Innovation). Data were analyzed using the ImageJ (FIJI) plugin GDSC SMLM (Single Molecule 
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Light Microscopy ImageJ Plugins, University of Sussex) (Herbert 2014) and OriginPro 2019 
(OriginLab).  smFRAP microscopy was performed by collaborator Mark Tingey (Weidong Yang, 
Temple University) 
2.5.7 – Immunogold Electron Microscopy 
HT1080 cells or HT1080 cells stably expressing inducible STING-GFP induced overnight with 
doxycycline were fixed for 2 minutes by the addition of a 2X fixation buffer (8 % formaldehyde, 
0.2 M PHEM buffer) to culture medium (1:1), this was then replaced with 1X fixation buffer 
(4 % formaldehyde, 0.1 M PHEM buffer, 0.05 % glutaraldehyde) and fixation continued for 2 
hours. Cells were then scraped into the fixation buffer and transferred to microfuge tubes, 
before pelleting and washing with PBS. Cell pellets were stored in PBS prior to sectioning and 
immunostaining. Cell pellets were embedded in 10 % gelatin in 0.1 M phosphate buffer, pH 
7.4 before being infused overnight with 15 % polyvinylpyrrolidone (PVP), 1.7 M sucrose in 0.1 
M phosphate buffer, pH 7.4. Liquid nitrogen frozen pellets were sectioned on a cryo-
ultramicrotome (UC7 with FC7 cryo-attachment; Leica). Immunoelectron microscopy was 
performed using the Tokuyasu method (Tokuyasu 1973). Cryosections were thawed, rinsed 
with 1 % glycine in PBS, and blocked with 1 % BSA in PBS.  For endogenous STING staining, 
grids were incubated with anti-STING antibody at 1:7 dilution (AF6516, R&D Systems), rinsed 
in PBS, then incubated with a 6 nm donkey anti–sheep IgG antibody conjugated to 6 nm 
colloidal gold (Aurion). For STING-GFP expressing cells grids were incubated with a rabbit anti-
GFP antibody at 1:20 dilution (Abcam), rinsed in PBS, then incubated with a 5 nm goat anti–
rabbit IgG antibody conjugated to 5 nm colloidal gold (Aurion). Grids were then rinsed in PBS, 
transferred to 1 % glutaraldehyde (Agar Scientific) in PBS, washed in water, and embedded in 
2 % methyl cellulose containing 0.4 % uranyl acetate (Agar Scientific). Imaging was performed 
at 100 kV with a Hitachi H7600 TEM and Xarosa 20 Megapixel camera.  
 
2.6 – Protein methods 
2.6.1 – Protein Extraction and Western Blotting 
For Western blotting, cell monolayers were washed with PBS and cells were lysed directly in 
2X Laemmli buffer (with the addition of NA3VO4 and NaF for detection of phosphorylated 
proteins). Samples were sonicated using a probe sonicator (Ultrasonic Atomizer VCX ATFT 1 
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second on/1 second off amplitude 20 %) to shear DNA and then boiled for 5 minutes at 95 °C 
before separation by SDS-PAGE. Proteins were transferred onto nitrocellulose membranes by 
wet-transfer and subsequently membranes were blocked in blocking buffer (5 % milk powder 
(w/v) in TBS with 0.05% Tween-20) for 1 hour at room temperature. For detection of 
phosphorylated proteins, 5 % BSA (w/v) was used in place of milk powder. Membranes were 
incubated with primary antibodies diluted in blocking buffer at the dilutions indicated in Table 
2.2 overnight at 4 °C. The next day membranes were washed 3 times in TBS, 0.05 % Tween-
20 and incubated with secondary antibodies diluted in blocking buffer at the dilutions 
indicated in Table 2.2 for 1 hour at room temperature. Membranes were washed 3 times in 
TBS, 0.05% Tween-20, and antibody labelling detected using a Li-Cor Odyssey Quantitative 
Fluorescence Imager. Image Studio 5.2 software (Li-Cor) was used for Western blot analysis 
and normalisation of protein levels detected in samples. 
2.6.2 – Co-immunoprecipitation 
For co-immunoprecipitation experiments HT1080 or HEK293FT cells were treated as indicated 
in figure legends with regard to innate immune stimulation or infection and transient 
expression of plasmid constructs. Cells were seeded in 10 cm dishes to be ~80 % confluent at 
the time of immune stimulation or viral infection. At the indicated time points post-immune 
stimulation/viral infection cells were washed with ice-cold PBS and then lysed directly in 1 mL 
ice-cold Co-immunoprecipitation Lysis Buffer (150 mM NaCl, 5 mM EDTA pH 8.0, 50 mM Tris 
pH 8.0, 1 % IGEPAL® CA630, supplemented with 2 μg/mL Aprotinin, 10 μg/mL Leupeptin, 1 
μg/mL Pepstatin A, and 1 mM PMSF). Lysis buffer was supplemented with RNase inhibitors 
when analysing immunoprecipitation of influenza A virus RNA. Cells were scraped into lysis 
buffer, transferred to a 1.5 mL tube, and incubated on ice for 10 minutes. Lysates were passed 
through a 25 G needle 5 times using a syringe to shear DNA, and incubation continued on ice 
for a further 10 minutes. Lysates were centrifuged at 13,000 xg for 10 minutes at 4 °C and 
supernatant transferred to a new tube. 250 μL of cell lysate was made up to 1 mL with lysis 
buffer and incubated with 2 μg of primary antibody overnight at 4 °C with gentle rocking on 
a nutator. The next day, 30 μL of protein A/G DynabeadsTM 50 % bead slurry was added to cell 
lysate-antibody mix as appropriate (Protein A, for rabbit IgG, Protein G, for goat, sheep, or 
mouse IgG) and incubated at 4 °C for 30 minutes with gentle rocking on a nutator. Pellets 
were washed 5 times with 0.5 mL cell lysis buffer and resuspended in 20 μL 2X Laemmli buffer, 
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vortexed, and then centrifuged. Samples were boiled at 95 °C for 5 minutes and analysed by 
SDS-PAGE with Western blotting. Alternatively, for analysis of RNA bound by 
immunoprecipitated protein, pellets were resuspended in TRIzolTM and RNA extraction 
performed. Isolated RNA was reverse transcribed as described for qPCR and PCR performed 





Chapter 3  
Localisation and Dynamics of STING at the Nuclear Envelope 
 
3.1 – Introduction 
Although STING was first reported as a nuclear envelope (NE) protein in a proteomics study 
(Schirmer et al. 2003), nearly all studies have focused on its role in the ER since it was 
identified as the critical adaptor protein in innate immune signalling induced by the presence 
of cytoplasmic dsDNA (Ishikawa and Barber 2008; Ishikawa et al. 2009; Almine et al. 2017; 
Jønsson et al. 2017; Dunphy et al. 2018; Yang et al. 2018; Srikanth et al. 2019). Thus, I 
considered that before engaging studies on a nuclear envelope role, I should first establish its 
localization and dynamics in the nuclear envelope. Proteomics identified STING in the NE 
(Schirmer et al. 2003; Korfali et al. 2010), however, it could be limited to the outer nuclear 
membrane (ONM), which is continuous with the ER, and not access the inner nuclear 
membrane (INM). The lumen separating the INM and ONM is only ~50 nm and so it is difficult 
to distinguish INM from ONM localisation by fluorescence microscopy approaches as this is 
below the resolution limit of most fluorescence microscopy. Previous attempts to determine 
if STING is present in the ONM or INM proved inconclusive with some data arguing STING was 
in the INM but other data suggesting it exclusively resides in the ONM (Malik et al. 2010). In 
order to investigate STING’s localisation within the NE, this study used a combination of 
different assays to assess whether STING was present in the inner (INM) or outer nuclear 
membrane (ONM), in parallel with other candidate NETs (Malik et al. 2010). One method 
commonly used to determine whether a protein is present in the INM is the use of detergent 
extraction to remove ER and ONM proteins prior to fixation. INM proteins that interact with 
the intermediate filament lamin network underlying the INM are typically retained by 
detergent extraction because nuclear lamin polymers resist even harsh extraction conditions 
with as much as 1 M NaCl and 1M urea. In Malik et al. 2010 pre-extraction of cells with Triton 
X-100 to remove membranes and soluble proteins prior to fixation showed that in HT1080 
cells stably expressing lamin A-GFP and transiently expressing a STING-RFP construct, STING 
remained at the nuclear envelope in contrast to the ER protein calreticulin (Figure 1.3). Since 
the nuclear lamina is resistant to such pre-extraction with detergent, a similar biochemical 
resistance to extraction of a nuclear envelope transmembrane protein (NET) typically 
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indicates an INM association. One caveat of this method is that some NETs present only in 
the ONM can also resist detergent extraction due to interactions with cytoskeletal filaments 
such as the Nesprin family of proteins (Rajgor and Shanahan 2013). According to the diffusion-
retention hypothesis, binding to the nuclear lamina is thought to be the mechanism by which 
NETs accumulate at the INM (Soullam and Worman 1995). Therefore, whether STING 
localised to the NE in a Lamin A dependent manner was also tested. In Lamin A/C knockout 
(LMNA-/-) murine embryonic fibroblasts (MEFs) STING-RFP did not localise to the NE whereas 
in LMNA+/+ MEFs STING-RFP was clearly present in the NE by fluorescence microscopy further 
suggesting an INM localisation and interaction with the nuclear lamina (Figure 1.3).  
The same study also used a super resolution fluorescence microscopy technique, 3D 
structured illumination microscopy (3D SIM), which can distinguish INM from ONM 
localisation (Schermelleh et al. 2008), to determine STING and other NET proteins localisation 
withing the NE. Whether proteins localise to the INM or ONM can be determined based on 
whether fluorescent signal in the same plane of the NE with either the nucleoplasmic facing, 
Nup153, or cytoplasmic facing Nup358. Surprisingly, although STING-RFP resisted detergent 
extraction and did not localise to the NE in LMNA-/- MEFs, by 3D-SIM it localised 
predominantly in the same plane as Nup358 indicating ONM localisation. However, 
subsequent repetition of this experiment using a STING-GFP construct and examining a larger 
number of cells revealed that in some cells STING localised to the INM while in other cells 
STING localised to the ONM (Figure 1.4) This prompted the hypothesis that STING localisation 
in the NE may be altered by immune stimulation since in these experiments cells were 
transiently transfected with plasmid DNA which might induce activation of cGAS-STING 
signalling. A potential criticism of these experiments is that they all used STING constructs 
tagged with RFP/GFP and overexpressed in cells, so it is possible that both tagging, and 
overexpression alter the localisation of STING. 
Given the ambiguity surrounding STING localisation within the NE, in this chapter I set out to 
determine the localisation of STING within the NE and to investigate whether this changes 
during the course of an innate immune response to a variety of stimuli. This chapter will 
describe several approaches which demonstrate that STING resides in both the INM and 
ONM, and moreover that STING in the INM redistributes to the ONM following immune 
stimulation with either dsDNA or the dsRNA mimic poly(I:C).  
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3.2 – HT1080 cells and HT1080 cells expressing inducible STING-GFP are suitable for 
studying STING localisation in the nuclear envelope 
In order to study STING localisation and dynamics within the NE, it was first necessary to 
determine a suitable cell line to use. Given STING’s critical function in the innate immune 
response to cytosolic DNA and its role in the response to host cell DNA damage (Dunphy et 
al. 2018), it is unsurprisingly found expressed in a wide variety of tissues (Ishikawa and Barber 
2008), because almost any cell can suffer genomic damage or be vulnerable to pathogen 
infection. However, many immortalised and tumour cell lines have defective cytosolic DNA 
triggered innate immune signalling pathways compared to primary cells which are able to 
mount full DNA-activated antiviral responses. This in part is due to the nature by which cell 
lines gained their immortality. For example, it has been shown that cell lines immortalised by 
‘DNA tumour viruses’, including HeLa cells and human embryonic kidney 293 (HEK 293) cells, 
express viral oncoproteins which antagonize the cGAS-STING pathway (Lau et al. 2015). In the 
case of HeLa cells, which were derived from a cervical carcinoma caused by infection with 
human papillomavirus 18 (HPV18) (Boshart et al. 1984), expression of the viral oncogene E7 
inhibits the cGAS-STING pathway, while for HEK293 cells, immortalised by transformation 
with human adenovirus 5 (hAd5) DNA (Graham et al. 1977), the hAd5 E1A protein blocks 
cGAS-STING pathway activation. Intriguingly this occurs through a common mechanism of 
binding STING via the conserved (LXCXE) protein motif of these oncoproteins, which is also 
essential for binding and inhibition of the retinoblastoma (Rb) tumour suppressor protein (Lau 
et al. 2015).  In addition, expression of STING and cGAS is reduced or lost in many cell lines 
resulting in variable levels of responsiveness to immune stimulation by cytosolic DNA (Sun et 
al. 2009; Sun et al. 2013; Malik et al. 2014; Xia et al. 2016a; Deschamps and Kalamvoki 2017a).  
Therefore, I first sought to determine a suitable cell line to use for studying STING dynamics 
at the NE. Western blotting for endogenous STING and cGAS expression in HT1080, A549, 
HEK293FT, and HEK293T cell lines was used to assess protein levels and revealed that only 
HT1080 cells expressed detectable levels of both STING and cGAS (Figure 3.1 A). This agrees 
with previous reports that cGAS and STING expression are low in HEK293T cells and that STING 
is expressed in HT1080 cells (Sun et al. 2009; Sun et al. 2013; Orzalli et al. 2015). To confirm 
that HT1080 cells express a functional endogenous cGAS-STING pathway, HT1080 cells were 
transfected with empty vector DNA (pcDNA3.1) or the synthetic RNA mimetic poly(I:C) to 
induce an innate immune response. Two hallmarks of STING activation in response to dsDNA 
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immune stimulation were measured: the redistribution of STING to perinuclear foci and the 
accumulation of the transcription factor IRF3 in the nucleus. As expected, in response to the 
presence of cytosolic dsDNA STING accumulated in perinuclear foci, while in response to 
transfection with poly(I:C) no redistribution of STING was evident when compared to 
unstimulated cells (Ishikawa et al. 2009; Franz et al. 2018) (Figure 3.1 B and C). IRF3 also 
accumulated in the nuclei of cells stimulated with dsDNA indicating that signalling 
downstream of STING activation is intact. This data supports a previous report showing that 
HT1080 cells induce IFNβ expression in response to immune stimulation with cGAMP 
suggesting that the STING pathway if functional in HT1080 cells (Wang et al. 2016). The 
accumulation of IRF3 in the nucleus of poly(I:C) stimulated cells suggests that the cytosolic 
dsRNA sensing pathway consisting of RIG-I/MDA-5 and MAVS is also intact in HT1080 cells 
because this pathway also activates IRF3 (Figure 3.1 B). To confirm specificity of STING 
antibody staining, two different STING antibodies were used for immunofluorescence, one a 
monoclonal antibody raised in sheep which is compatible with formaldehyde fixed cells only 
(Figure 3.1 B) while the other, a monoclonal raised in rabbit, is compatible with methanol 
fixed cells only (Figure 3.1 C). Both antibodies showed the same pattern of STING staining, 
although the antibody requiring methanol fixed cells tended to stain more strongly. Co-
staining of cells with an anti-Nup153 antibody to label the NE highlights the presence of a NE-
pool of STING in addition to its distribution throughout the ER (Figure 3.1 B and C), which is 
present in both sets of fixed cells. In order to be able to follow STING dynamics in real-time, 
without the need to transiently introduce plasmid DNA for expression of fluorescently 
labelled proteins, which would induce an innate immune response against the cytoplasmic 
plasmid DNA, a stable doxycycline-inducible STING-GFP HT1080 cell line was used. STING-GFP 
behaved similarly to endogenous STING, accumulating in perinuclear foci after immune 
stimulation with plasmid DNA but not with poly(I:C), while IRF3 accumulates in the nucleus of 
both dsDNA and poly(I:C) stimulated cells (Figure 3.1 D). Finally, to check the specificity of the 
STING antibodies used for immunofluorescence, western blotting was performed with both 
antibodies on lysates of cells treated with siRNAs against STING or a non-target control siRNA. 
Both antibodies recognise a single protein band, of a molecular weight close to the predicted 
~42 kDa of STING, which is depleted in cells treated with siRNAs against STING (Figure 3.1 E). 
Therefore, this experiment shows that HT1080 cells and HT1080 cells stably expressing STING-
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GFP under the control of an inducible promoter are both suitable cell lines for studying STING 
NE localisation and dynamics. 
 
Figure 3.1 – HT1080 cells and STING-GFP inducible HT1080 cells are suitable for studying 
STING localisation in the nuclear envelope. (A) HT1080 cells express detectable levels of 
STING and cGAS by western blot. A549 cells do not express detectable levels of STING while 
HEK293T and HEK293FT cells do not express detectable levels of cGAS and have lower levels 
of STING. (B) Immunofluorescence using STING antibody AF6516, compatible only with 
formaldehyde fixation, shows that STING redistributes to perinuclear foci 2 h post-transfection 
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of plasmid DNA (dsDNA) but not dsRNA (poly(I:C)). IRF3 accumulates in the nucleus of cells 
stimulated by transfection of dsDNA or poly(I:C) indicating the initiation of an innate immune 
response. Co-staining with anti-Nup153 antibody highlights partial NE localisation of STING. 
(C) Immunofluorescence using STING antibody D2P2F, compatible only with methanol fixation, 
confirms that STING redistributes to peri-nuclear foci 2 h post-transfection of dsDNA but not 
poly(I:C) and that a pool of STING is present in the NE, marked by Nup153 staining. (D) A 
doxycyline-inducible STING-GFP construct expressed in HT1080 cells behaves similarly to 
endogenous STING, accumulating in perinuclear foci after dsDNA stimulation and partially 
localising to the NE. dsDNA and RNA sensing pathways remain functional in this cell line as 
shown by the accumulation of IRF3 in the nucleus after dsDNA/poly(I:C) transfection. (E) 
Western blotting confirms that STING AF6516 and D2P2F antibodies are specific for STING, 
detecting a single band which is depleted by STING specific siRNAs. Scale bars = 10 μm. 
3.3 – Endogenous STING resists detergent extraction in HT1080 cells 
Although previous evidence indicated that STING was present in the INM due to its ability to 
resist detergent extraction prior to fixation (Malik et al. 2010), these experiments were 
carried out using overexpression constructs of STING-RFP and Lamin A-GFP and so it is 
possible the overexpression or protein tagging affected STING’s normal localisation in the NE. 
Therefore, the same detergent extraction assay was employed to test if endogenous STING 
also resisted detergent extraction and whether this was affected by immune stimulation. If 
STING is present in the INM and interacts with the nuclear lamina it should resist detergent 
extraction while if STING is present only in the ONM it should be removed by detergent 
extraction unless it interacts with detergent extraction resistant cytoskeletal components or 
nesprin proteins in the ONM which also resist detergent extraction. HT1080 cells were mock 
transfected of transfected with dsDNA or poly(I:C) in order to stimulate an innate immune 
response and after 2 h either fixed directly or first extracted with 0.1% Triton-X 100 detergent 
to remove cell membranes and then fixed. STING in the NE resisted detergent extraction as 
shown by the presence of a nuclear rim stain for STING and loss of STING ER staining in 
detergent extracted cells compared to directly fixed cells (Figure 3.2). In cells stimulated with 
dsDNA such NE staining was lost, as was expected given that STING accumulates in peri-
nuclear foci after dsDNA stimulation. These foci also tended to resist detergent extraction 
likely as a consequence of a more stable STING structure formed by STING aggregation 
through side-to-side packing at these foci (Ergun et al. 2019; Shang et al. 2019). Finally, in cells 
stimulated with poly(I:C) STING NE staining was still detectable in detergent extracted cells, 
indicating that the nuclear pool persists during immune stimulation.  
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As a complementary approach to determining INM vs ONM localisation a digitonin 
permeabilization assay was considered. This assay takes advantage of the fact that digitonin 
preferentially permeabilises cholesterol-rich cell membranes such as the plasma membrane 
but not ER and NE membranes which contain little cholesterol and remain intact (Ginsbach 
and Fahimi 1987). Therefore, antibody labelling in digitonin permeabilised cells cannot access 
the nucleus so only protein residing in the ER and ONM will be stained (Adam et al. 1990). 
Conversely Triton-X 100 shows no such preference and permeabilises all cell membranes, thus 
antibody staining in Triton-X 100 permeabilised cells can label proteins in the INM as well as 
ER and ONM. By comparing antibody staining in fixed cells permeabilised with digitonin to 
fixed cells permeabilised with Triton-X 100 an increase staining in Triton-X 100 permeabilised 
cells implies a pool of protein in the INM. However, the STING (D2P2F) antibody used in the 
pre-fixation detergent extraction assay requires methanol fixation which disrupts cell 
membrane integrity. While this is fine if detergent permeabilization is performed before 
fixation such as in the pre-fixation detergent extraction assay this antibody could not be used 
with a digitonin permeabilization assay since this requires detergent permeabilization after 
fixation. The STING (AF6516) antibody which is compatible with formaldehyde fixed cells only 
could have been used in a digitonin permeabilization assay. However, since this antibody 
stained less strongly than the D2P2F antibody, I did not think it likely that a difference in 
antibody staining in digitonin or Triton-X 100 permeabilised cells would easily be discerned, 




Figure 3.2 – STING at the NE resists detergent extraction. Left panels, HT1080 cells fixed 
directly in methanol (MeOH fixed) show STING and Lamin B2 localisation by 
immunofluorescence in cells 2 h post mock, DNA, or poly(I:C) transfection. Right panels, 
HT1080 cells extracted with 0.1% Triton X-100 prior to methanol fixation show that STING at 
the NE resists detergent extraction similarly to Lamin B2. Scale bar = 10 μm. 
3.4 – Immunogold-EM of STING shows distribution at nuclear envelope in unstimulated 
and immune stimulated cells 
Since all evidence of STING’s presence in the INM up to this point has been indirect, electron 
microscopy (EM) coupled with immunogold labelling of endogenous STING was employed to 
directly determine STING localisation in the NE. Immunogold-EM is widely considered the 
gold-standard for determining localisation of a protein within the NE since the high resolution 
of EM allows for determination of protein residence in either INM or ONM. In immunogold-
EM, cells are stained with primary antibody and a secondary antibody conjugated to a gold 
nanoparticle. Gold particle density is much greater than organic material and so gold particles 
appear as the strongest signal, a dark spot in electron micrographs. HT1080 cells were fixed 
directly in 4 % formaldehyde plus 0.05 % glutaraldehyde in 0.1 M PHEM buffer, to allow for 
preservation of cell membranes, before sectioning and labelling with anti-STING antibody 
(AF6516), followed by a secondary antibody conjugated to 6 nm gold particles. Example 
micrographs show labelling of endogenous STING close to both INM and ONM, as well as 
localising throughout the cytoplasm in close proximity to ER membranes as would be 
expected for STING localisation in resting cells (Figure 3.3 A, yellow arrows). Gold particles up 
to 50 nm away from the NE were counted since this distance accounts for the size of the C-
terminus of STING (~4.3 nm) (Ouyang et al. 2012), antibody length (~16 nm x2)(Harris et al. 
1997), and gold particle size (6 nm diameter). Immunogold labelling shows a 0.79:1 
distribution of endogenous STING between ONM (122 particles) and INM (142 particles) 
(Figure 3.3 E). In addition to gold particles clearly associated with either INM or ONM a 
number of gold particles appeared either in transit through NPCs (18 particles) or to be in the 
lumen between INM and ONM (16 particles). Given that the C-terminus of STING, against 
which the anti-STING antibody is targeted, is cytoplasmic/nucleoplasmic such ‘luminal’ 
particles are likely either on the INM or ONM side of the NE but due to sectioning artefacts 
falsely appear to be luminal and so cannot be ascribed clearly to one or the other. Although 
labelling of endogenous STING for immunogold-EM was successful, particle counts were quite 
low indicating that either STING abundance is low in HT1080s or that epitopes were masked 
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by the fixation process. Indeed, immunofluorescence of cells fixed with glutaraldehyde and 
formaldehyde in parallel to those for immunogold EM shows variable staining against STING 
with some cells staining more strongly than others (Figure 3.3 B top panels). Staining using 
another antibody against STING (D2P2F) in HT1080 cells fixed with methanol suggests that 
this is likely due to an issue of epitope masking resulting from the extended fixation in 
formaldehyde and glutaraldehyde required for EM, since all cells fixed with methanol and 
stained with STING (D2P2F) show robust labelling (Figure 3.3 B bottom panels). Since particle 
counts for endogenous STING labelling were low, the distribution of STING in an inducible 
STING-GFP HT1080 cell line was also determined by immunogold EM. Example micrographs 
show that like endogenous STING, STING-GFP localises to both the INM and ONM as well as 
ER (Figure 3.3 C). Staining of samples prepared for immunogold-EM with gold-conjugated 
secondary antibodies only, yielded very few detectable gold particles, indicating that there is 
little background staining caused by the secondary antibodies (Figure 3.3 D). Intriguingly, 
STING-GFP accumulated more in the ONM than INM compared to endogenous STING with a 
ratio of roughly 1.46:1 (ONM:INM) (Figure 3.3 E); however, a much greater number of gold 
particles were classed as ‘luminal’ compared to the endogenous labelling which could also 
account for this difference. Regardless, it is clear that the presence of STING in the INM is not 
an artefact of overexpression since overexpression increases the ONM pool. Finally, I wanted 
to test whether STING distribution in the NE changed during an innate immune response. 
Therefore, samples fixed 2 h post-immune stimulation with transfected DNA were also 
analysed for distribution of STING-GFP in the NE. Despite a generally lower abundance of 
STING-GFP in the NE in DNA stimulated samples, likely due to translocation of STING to 
perinuclear foci (see Figure 3.1), the ratio of STING-GFP in the INM compared to the ONM was 
the same as in unstimulated cells (Figure 3.3 F). The overall drop in STING NE levels with DNA 
stimulation might indicate that NE localised STING (both INM and ONM) also functions in the 
innate immune response to cytosolic DNA since it must redistribute from the INM in the same 




Figure 3.3 – STING is present in INM and ONM by immunogold-EM. (A) Example micrographs 
of HT1080 cells stained with STING (AF6516) antibody and gold-conjugated secondary 
antibody show that endogenous STING localises to both inner and outer membranes of the 
nuclear envelope (NE), as well as to the endoplasmic reticulum (ER). Yellow arrows highlight 
gold particles corresponding to STING labelling. Black arrows indicate nuclear pore complexes 
(NPC). N = nucleus, C = cytoplasm. (B) Example images of immunofluorescence staining 
against STING on samples fixed in parallel to samples for EM (top panels, PFA + 0.05 % 
glutaraldehyde) or cells fixed with methanol and stained with STING (D2P2F) antibody. Scale 
bars = 10 μm. (C) Example micrographs of HT1080 cells expressing STING-GFP stained with 
anti-GFP antibody and gold-conjugated secondary antibody, show that STING-GFP localises to 
INM, ONM, and ER. N = nucleus, C = cytoplasm. (D) Example micrograph of cells prepared for 
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immunogold-EM stained with only gold-conjugated secondary antibody. (E) Quantification of 
gold particles within 50 nm of the NE from endogenous STING and STING-GFP samples, lumen 
particles in between INM and ONM, NPC particles in close proximity to nuclear pore. (F) 
Quantification of gold particles as in (E) but for STING-GFP samples that were mock stimulated 
or fixed 2 h after stimulation with DNA. Sectioning and immunogold labelling performed by 
Christine Richardson and image acquisition and analysis by me. 
3.5 – FRET with FLIM confirms that STING is in the INM but is inadequate to measure 
changes in STING distribution in response to immune stimulation 
While the pre-fixation detergent extraction assay and immunogold-EM establish a pool of 
STING at the INM, the detergent extraction assay is not quantitative and with the 
immunogold-EM it is not practical to image enough cells to accurately establish the 
distribution of STING in the NE with various immune stimuli. Therefore, I proposed to use 
Förster-resonance energy transfer (FRET) with fluorescence lifetime imaging (FLIM) in order 
to track STING localisation at the NE during innate immune responses against different 
immune stimuli. FRET is a physical phenomenon in which an excited ‘donor’ fluorophore can 
transfer energy in a non-radiative fashion to a nearby ‘acceptor’ fluorophore resulting in the 
emission of energy (fluorescence) by the acceptor. FRET can occur provided the emission 
spectrum of the donor overlaps sufficiently with the excitation spectrum of the acceptor 
(>30%) and that the two proteins are within the 1-10 nM distance of each other required for 
FRET to occur and is characterised by the FRET efficiency (E) (Bajar et al. 2016). Given the 
requirement for fluorophores to be within 10 nM of each other for FRET to occur, FRET 
between two tagged proteins infers a protein-protein interaction. In FLIM-FRET, the 
fluorescence lifetime (τ), defined as the average time that a fluorophore remains in its excited 
state, is measured by detecting individual photons using a fast single-photon detector. 
Following excitation, a fluorophore will return to the ground state through both radiative 
(photon emission) and nonradiative decay. By measuring the τ of donor fluorophore alone 
(τD) or donor fluorophore in the presence of a suitable acceptor fluorophore (τDA), whether or 
not FRET occurs can be determined since donor emission will be quenched by FRET interaction 
decreasing the donor lifetime. The FRET E is described by the equation: E = 1 – (τDA/τD)(Bajar 
et al. 2016). FLIM yields images with pixel intensity values given by τ and so also gives 
information about where interactions occur. 
I proposed that measuring FRET E could provide a measure of changes in INM/ONM 
distribution of STING by using HEK293T cells transiently co-transfected with an acceptor 
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STING-RFP construct and Lamin A-GFP donor construct. Since STING does not target to the NE 
in cells lacking Lamin A (Malik et al. 2010), and resists detergent extraction indicating an 
interaction with the nuclear lamina, and is in close proximity to the INM by immunogold-EM, 
I reasoned it likely that STING interacts with Lamin A and that FRET between them would be 
possible. If STING is in the ONM and unable to interact with Lamin A then no FRET should 
occur and the fluorescence lifetime of excited GFP molecules should be unaffected (Figure 
3.4 A1), on the other hand if STING is in the INM it should be close enough to Lamin A-GFP for 
it to transfer energy to the STING-RFP, thus reducing the fluorescence lifetime of GFP (Figure 
3.4 A2). Lamin A-GFP and STING-RFP were confirmed to localise to the NE and ER/NE 
respectively (Figure 3.4 B) and fluorescence lifetimes were measured for Lamin A-GFP alone, 
Lamin A-GFP in the presence of STING-RFP, and for a tandem GFP-RFP construct (positive 
control). Example images of GFP donor construct localisation, regions of interest (ROI) used 
for measurement of fluorescence lifetime values, and fluorescent lifetime intensity values are 
shown (Figure 3.4 C) and the average fluorescence lifetime values for each cell are plotted 
(Figure 3.4 D) showing a significant reduction in mean fluorescence lifetime for both GFP-RFP 
tandem construct and Lamin A-GFP in the presence of STING-RFP compared to Lamin A-GFP 
alone. A mean fluorescence lifetime of 2.281 ns for Lamin A-GFP fits well within the range of 
fluorescence lifetimes reported for GFP expressed alone in HeLa cells of between 2.2 and 2.4 
ns at pH values ranging between 6.5 and 7.5 (Nakabayashi et al. 2008). Mean FRET E for the 
GFP-RFP tandem construct is 0.141 (E = 1 - (1959/2281)) and for Lamin A-GFP + STING-RFP is 
0.061 (E = 1 - (2142/2281)) or 14.1 % and 6.1 % respectively. Using the reported Förster radius 
(r0), which is the distance at which 50 % FRET occurs, for an EGFP-mCherry pair of 5.4 nm the 
distance between the GFP and RFP can be calculated using the following equation(Bajar et al. 
2016): 





which gives a mean distance of 7.3 nm and 8.5 nm between the GFP and RFP fluorophores of 
the GFP-RFP tandem sample and Lamin A-GFP + STING-RFP sample, respectively.  
Having confirmed that STING-RFP is in close enough proximity to Lamin A-GFP for FRET to 
occur, confirming localisation of STING-RFP to the INM, I next wanted to test whether the 
fluorescence lifetime of Lamin A-GFP in the presence of STING-RFP was affected by the 
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induction of an innate immune response to dsDNA or poly(I:C), as a proxy for STING-RFP 
localisation in the NE. HEK293T cells were chosen specifically for this assay since they do not 
express detectable levels of cGAS (Figure 3.1) and are thus defective in sensing cytoplasmic 
dsDNA. Therefore, plasmid DNA could be transiently transfected into HEK293T cells without 
initiating an innate immune response. After expression of STING-RFP, an innate immune 
response could then be induced by transfecting cGAMP to activate STING and subsequent 
downstream signalling or by transfecting poly(I:C) to induce an immune response to dsRNA. 
cGAMP transfection was confirmed to activate endogenous STING in HT1080 cells, as shown 
by the redistribution of STING to perinuclear foci and the accumulation of IRF3 in the nucleus 
of cells transfected with cGAMP (Figure 3.4 E). However, STING-RFP did not accumulate in 





Figure 3.4 – FLIM-FRET shows STING-RFP interacts with Lamin A-GFP. (A) Schematic showing 
(1) effect on Lamin A-GFP fluorescence lifetime if STING-RFP is only present in the outer nuclear 
membrane (ONM), or (2) reduction of fluorescence lifetime if STING-RFP is present in the inner 
nuclear membrane (INM) and interacts with Lamin A-GFP. (B) Targeting of STING-RFP and 
Lamin A-GFP in HEK293T cells. (C) Example micrographs of HEK293T cells transfected with 
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Lamin A-GFP (negative control), GFP-RFP (positive control), and Lamin A-GFP + STING-RFP 
constructs used for FLIM-FRET measurements. Left panels = confocal image of donor 
localisation, middle panels = region of interest (ROI) for FLIM measurements, right panels = 
fluorescence lifetime intensity image, heatmap: red (high) – blue (low) fluorescence lifetime. 
(D) Mean fluorescence lifetimes (τ) values generated from ROIs (whole nucleus for Lamin A-
GFP, whole cell for GFP-RFP), each point is a single ROI. Ordinary one-way ANOVA with 
Dunnett’s multiple comparison test, **** p ≤ 0.0001. Error bars show standard deviation. (E) 
Transfection of cGAMP activates STING in HT1080 cells, causing STING to redistribute to 
perinuclear foci and IRF3 to accumulate in the nucleus. (F) cGAMP transfection in HEK293T 
cells does not result in STING-RFP accumulation in perinuclear foci. Scale bars = 10 µm. 
3.6 - smFRAP microscopy shows that STING redistributes from INM to ONM upon immune 
stimulation by DNA or poly(I:C) 
As an alternative approach to measure STING distribution in the NE following immune 
stimulation, a fluorescence recovery after photobleaching (FRAP) assay was employed. A 
specialised form of  FRAP which can track single molecules (smFRAP) and determine the 
distribution of nuclear envelope transmembrane proteins in the NE (INM vs ONM) was 
recently developed by the Yang Lab (Mudumbi et al. 2016). In smFRAP a single point of 0.5 
μm diameter on the nuclear envelope is photobleached to ablate GFP fluorescence of a GFP-
tagged nuclear envelope transmembrane (NET) protein of interest. Individual GFP-NETs that 
diffuse into this area from outside the photobleached region are then tracked using a 
regulated on-off laser excitation. By tracking hundreds of FRAP events the distribution of GFP-
NET between INM and ONM can then be determined (Mudumbi et al. 2016). In collaboration 
with a student in the Yang lab, Mark Tingey, this technique was employed to measure the 
distribution of STING-GFP in our inducible STING-GFP HT1080 cell line in mock, poly(I:C), and 
dsDNA stimulated cells (Figure 3.5 A). The ratio of STING-GFP in the ONM:INM was found to 
be 1.39:1 in mock stimulated cells (Figure 3.5 A and C) which very closely matches the 
ONM:INM ratio of STING-GFP in mock stimulated cells determined by immunogold-EM 
(Figure 3.3 F) of 1.45:1 (176:121 particles). Post-stimulation with poly(I:C) or dsDNA, there is 
a significant increase in the ONM:INM ratio of STING-GFP, 4.44:1 and 4.07:1 respectively 
(Figure 3.5 A). Given that STING is known to redistribute from the ER and accumulate in 
perinuclear foci post-DNA stimulation the increased ONM:INM ratio after dsDNA transfection 
is unsurprising and likely reflects a redistribution of STING from the INM to the ONM and 
subsequent loss of STING from the ONM as it translocates out of the ER (Figure 3.5 D). Indeed, 
there is also a significant increase in the diffusion coefficient for STING-GFP in cells stimulated 
with DNA compared to mock stimulated cells, which means there is an increase in mobility of 
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STING-GFP in the NE (Figure 3.5 B and C). More surprising is the increased ONM:INM ratio for 
STING-GFP in cells stimulated with poly(I:C) because no changes in STING distribution are seen 
by conventional fluorescence microscopy in cells stimulated with poly(I:C) (see (Franz et al. 
2018) and Figure 3.1). STING-GFP mobility in the NE also increased after immune stimulation 
with poly(I:C) as seen by the increased diffusion coefficient (Figure 3.5 B and C). Since there 
is no apparent loss of STING at the NE in cells stimulated with poly(I:C) by 
immunofluorescence this increased ONM:INM ratio and mobility is interpreted as a 
redistribution of STING-GFP from the INM to the ONM (Figure 3.5 D). 
 
Figure 3.5 – smFRAP shows STING-GFP redistributes from inner (INM) to outer nuclear 
membrane (ONM) during innate immune stimulation with DNA or poly(I:C). (A) ONM:INM 
ratio of STING-GFP in the nuclear envelope in cells 2 h after mock, poly(I:C), or dsDNA 
transfection. Each point represents the distribution at a single point in a cell with hundreds of 
individual STING-GFP molecules measured to determine ONM:INM distribution. Ordinary one-
way ANOVA with Dunnett’s multiple comparison test, **** p ≤ 0.0001, ** p ≤ 0.01. Mean ratio 
value shown by line, error bars show standard deviation. (B) Mobility of STING-GFP in nuclear 
envelope of the same samples and measurement points from (A). Ordinary one-way ANOVA 
with Dunnett’s multiple comparison test, * p ≤ 0.05. Mean diffusion coefficient shown by line, 
error bars show standard deviation.  (C) Summary of data plotted in (A) and (B), mean values 
+/- standard error. Distance between INM and ONM (membrane width) based on individual 
STING-GFP molecules measured and number of STING-GFP molecules (points) measured is 
also given. (D) Schematic showing interpretation of distribution of STING-GFP molecules 
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(green spots) in the nuclear envelopes of conditions tested. smFRAP microscopy performed by 
Mark Tingey (Weidong Yang, Temple University), graphing and statistical analysis by me. 
3.7 – Chapter Summary 
In this chapter I have shown that HT1080 cells retain a functional cGAS-STING cytoplasmic 
dsDNA sensing pathway and that both these and HT1080 cells stably expressing an inducible 
STING-GFP construct are suitable for studying STING localisation in unstimulated and 
DNA/polyI:C stimulated cells. Using immunogold-EM, I have shown that STING is present in 
both the inner and outer membranes of the NE with an ONM:INM ratio of 0.79:1 for 
endogenous STING in unstimulated cells, a result supported by the finding that endogenous 
STING in the NE resists detergent extraction. Moreover, I have shown that STING-GFP similarly 
targets to INM and ONM by immunogold-EM and that STING-RFP is able to FRET with Lamin 
A-GFP when co-expressed in HEK293T cells, confirming Lamin A as a STING interaction partner 
identified in a previous co-immunoprecipitation experiment coupled with mass spectrometry. 
Although, this FLIM-FRET set-up proved not to be suitable for measuring STING redistribution 
during an immune response, a separate microscopy technique, smFRAP, showed that in 
response to DNA and RNA stimuli STING-GFP redistributes from the INM to ONM. That STING 
redistributes from INM to ONM in response to immune stimulate with poly(I:C) is a surprising 
finding given that STING shows no general change in localisation following poly(I:C) 
stimulation by conventional immunofluorescence microscopy. Given that STING has been 
shown to restrict multiple RNA viruses (Ishikawa and Barber 2008; Zhong et al. 2008; Ishikawa 
et al. 2009; Maringer and Fernandez-Sesma 2014; Ran et al. 2014) and to inhibit cellular 
translation in response to VSV infection or poly(I:C) transfection (Franz et al. 2018) this finding 
could provide insight about the mechanism through which STING exerts these effects. 
One of the outstanding questions raised by these experiments is how does STING in the INM 
respond to cytoplasmic immune stimuli? In the case of dsDNA immune stimulation, it is likely 
that cGAMP produced by cGAS upon dsDNA binding in the cytoplasm, can freely diffuse 
through the NPC due to its small size and bind to STING located at the INM. In the case of 
poly(I:C) which is a dsRNA-like complex consisting of synthetic polymers of a range of lengths, 
how the sensing of the poly(I:C) stimulus results in a redistribution of STING from the INM is 
unknown. STING does not bind directly to poly(I:C) in vitro (Abe et al. 2013), nor does it 
dimerise and undergo translocation to perinuclear foci after poly(I:C) stimulation (Franz et al. 
2018). Transfection of poly(I:C) stimulates multiple dsRNA sensing pathways because it 
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delivers poly(I:C) into the endosomal compartments where it is sensed by TLR3 and eventually 
cytoplasm where it is sensed by RIG-I and MDA-5 cytoplasmic dsRNA sensors(Palchetti et al. 
2015). How this sensing can then be transferred to STING is not clear, however, STING 
interacts with the RIG-I and the downstream adaptor protein MAVS, and STING interaction 
with RIG-I increases with RNA virus infection (Ishikawa and Barber 2008; Zhong et al. 2008). 
Since MAVS is localised to the mitochondria, a separate cellular pool of STING located at the 
mitochondria or mitochondria-associated ER membranes could be involved in sensing 
poly(I:C) in the cytoplasm (Zhong et al. 2008; Ishikawa et al. 2009; Ran et al. 2014). How such 
sensing is propagated to STING at the INM, however, is not obvious. Interestingly, sensing of 
poly(I:C) by TLR-3 in endosomal compartments has been shown to stimulate apoptosis while 
binding of poly(I:C) by RIG-I and MDA-5 triggers IRF3-mediated signalling and upregulation of 
IFNβ. It is possible that activation of one or both of these signalling pathways activate STING 
at the INM resulting in a redistribution to the ONM. Future experiments should look at 
whether poly(I:C) mediated redistribution of STING at the NE requires TLR3, RIG-I, and MDA-
5 dsRNA sensors as well as TRIF and MAVS adaptor proteins. Another important question 
raised is how is STING retained at the INM? One of the mechanisms thought to retain NET 
proteins at the INM is binding to the nuclear lamina or chromatin proteins such as LBR binding 
to HP1 or LEM-domain proteins binding to BAF (Burke and Stewart 2013). Whether STING is 
retained in the INM by direct interaction with a specific nuclear localised partner should be 
investigated further. STING targeting to the NE was lost in LMNA-/- MEFs (Malik et al. 2010) 
and in my experiments STING-RFP was able to FRET with Lamin A-GFP suggesting an 
interaction with Lamin A. Whether STING also forms interactions with specific chromatin 
proteins such as BAF or HP1 and the nature of the STING-Lamin A interaction should be 
investigated, for example by investigating STING NE localisation in Lamin A mutant cell lines. 
Additionally, STING mutants could be tested for NE targeting.  
While immunogold EM shows unequivocally that endogenous STING is present in the INM 
and ONM of HT1080 cells, this data could be strengthened by looking at STING NE localisation 
in additional cell lines such as the monocytic THP-1 cell line which has been shown to have 
high levels of STING expression (Sun et al. 2009). Finally, the use of a CRISPR/Cas9 engineered 
HT1080 cell line in which STING is tagged with GFP could be used to confirm smFRAP results 






Chapter 4  
Nuclear Envelope STING partners function in innate immune 
responses 
4.1 – Introduction 
Having confirmed that STING is present in both inner and outer nuclear membranes in the 
previous chapter, I next set out to test whether putative NE partners of STING that were 
identified previously in a reversible crosslinking proteomics study in the Schirmer lab (Figure 
1.6 and Figure 4.1 A) and found to have known indirect links to IRF3/7 transcription factors, 
could be involved in innate immune responses (IIR). Whether these proteins are directly or 
indirectly interacting with STING cannot be stated for certain since crosslinking and 
immunoprecipitation will preserve both direct and indirect interactions. All of these proteins 
referred to from now on as ‘NE STING partners’ are known RNA or DNA binding proteins, 
which prompted the hypothesis that they could function as direct sensors of pathogen RNA 
or DNA in the nucleus and form part of a signalling network with STING at the NE.  
Interestingly, many of these partners have only been reported to bind RNA, which suggests 
that they could support a mechanism for STING in mediating IIR against RNA ligands. This 
finding is particularly provocative considering that STING functions in the restriction of RNA 
viruses (Ishikawa and Barber 2008; Zhong et al. 2008; Ishikawa et al. 2009; Maringer and 
Fernandez-Sesma 2014; Ran et al. 2014) and is targeted during RNA virus infection (Ishikawa 
et al. 2009; Sun et al. 2012; Yu et al. 2012; Aguirre et al. 2012; Ding et al. 2013; Nitta et al. 
2013; Xing et al. 2013; Chen et al. 2014; Yi et al. 2015; Holm et al. 2016; Ding et al. 2018), but 
the exact mechanisms through which STING antagonises RNA viruses remain to be elucidated 
(Holm et al. 2016; Franz et al. 2018). Therefore, it was hypothesised that RNA-binding 
partners of STING in the NE may provide a mechanism through which STING antagonises 
RNA viruses. For example, by recognising viral RNA and subsequently activating STING. 
Similarly, DNA-binding partners of STING in the NE could have a role in STING mediated 
immune signalling stimulated by dsDNA ligands or infection with DNA viruses.  
Since the majority of the NE STING partner proteins are encoded by essential genes, according 
to a CRISPR mediated knockout screen to characterise essential genes in the human genome 
(Wang et al. 2015) (Figure 4.1 B), siRNA knockdown was proposed in order to screen partner 
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proteins for a role in IIR since short-term knockdown of a protein is likely to be less lethal than 
a knockout and generation of knockout cell lines would not be possible for essential genes. In 
order to prioritise the list of partners to test, a literature search was conducted to see if any 
of the proteins had previously been reported to be involved in immune responses. KPNB1 and 
KPNA2 were not chosen since they encode Importin β1 and Importin α2 respectively, which 
are required for transport of proteins containing a nuclear localisation signal (NLS) (Grossman 
et al. 2012), such as IRF3/7 (Kumar et al. 2000; Zhu et al. 2015), and so their knockdown would 
impair the type-I IFN response indirectly. Meanwhile, several of the NE STING partners 
appeared to be particularly promising candidates because they were already reported to have 
some function relating to viral infection or host cell immune responses.  The involvement of 
several of these proteins in viral infection or immune responses is described below. SYNCRIP, 
also known as hnRNP Q, has been shown to facilitate hepatitis C virus (HCV) replication and 
associate with viral RNA(Kim et al. 2004; Liu et al. 2009), as well as being involved in the 
replication of the coronavirus, murine hepatitis virus (MHV) (Choi et al. 2004). SYNCRIP is also 
a member of the GAIT complex which is involved in transcript-specific translational inhibition 
in myeloid cells stimulated with IFNƴ (Mukhopadhyay et al. 2009; Arif et al. 2012; Arif et al. 
2018). Menin/MEN1, the protein encoded by the MEN1 gene, is a tumour suppressor and 
regulates multiple signalling pathways including inhibiting the activity of NF-κB (Heppner et 
al. 2001) and AP1 (JunD) transcription factors (Agarwal et al. 1999). It has also been found to 
play a role in maintaining T cell function (Suzuki et al. 2018) and regulating the immune 
response of CD8+ T cells to infection(Yamada et al. 2016). DDX5 is a DEAD-box RNA helicase 
and a positive regulator of the replication of multiple RNA viruses including HCV, Japanese 
encephalitis virus (JEV) and human immunodeficiency virus 1 (HIV-1) (Goh et al. 2004; Li et al. 
2013a; Zhou et al. 2013; Cheng et al. 2018). Conversely, DDX5 appears to be a negative 
regulator of DNA viruses and restricts Myxoma virus (MYXV) replication in human cell lines 
(Rahman et al. 2017), as well as Hepatitis B virus (HBV) replication in human cancer cells (HeLa 
and A549) (Zhang et al. 2016). RPS27A expression increases significantly during HBV infection 
potentially suggesting a role in IIR (Fatima et al. 2012). TCERG1 facilitates HIV-1 transcription 
and viral replication (Coiras et al. 2013). AATF, also known as CHE-1, is a central regulator of 
p53 in the DNA damage response where it prevents p53-mediated apoptosis (Bruno et al. 




Figure 4.1 – STING nuclear envelope partners with connections to IRF3/7 transcription 
factors. (A) Network of interactions between STING nuclear envelope partners identified by 
mass spectrometry (blue) and known IRF3/7 interactors (white) according to the Human 
Protein Reference Database. Partner proteins reported to bind RNA only (dark blue), DNA only 
(light blue), or RNA and DNA (green). (B) STING interactors and IRF3/7 interactors ranked as 
essential genes (Y – yes or N – no) according to a CRISPR knockout screen of the human 
genome(Wang et al. 2015). 
In this chapter I describe several assays I have used to test whether the novel STING partners 
identified by coimmunoprecipitation of cross-linked material from isolated NEs, with an 
indirect link to IRF3/7 transcription factors, contribute to dsDNA and dsRNA triggered immune 
responses. I also describe whether their knockdown has an impact on proliferation of the DNA 
virus, herpes simplex virus 1 (HSV-1). Next, I will show co-immunoprecipitation experiments 
and proximity ligation assays using endogenous proteins in order to confirm STING-partner 
interactions.  Finally, I present data to show that some of these partner proteins, found to 
contribute to dsDNA/dsRNA triggered IIR, change localisation in response to immune 
stimulation similarly to the behaviour shown for STING in the previous chapter. 
4.2 – Knockdown of some NE-STING partners inhibits IFNβ promoter and NF-κB driven 
luciferase reporter activation 
Since interactome data from the HPRD showed an indirect link between STING partners and 
IRF3/7 transcription factors, I hypothesised that these partners could, as a result of being RNA 
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and/or DNA binding proteins, through an interaction with STING activate IRF3/7 to stimulate 
interferon production and activate IIR. Therefore, I screened several STING partners for a role 
in activating an IFNβ promoter driven luciferase reporter or an NF-κB/AP1 transcription factor 
activated luciferase reporter. The induction of IFNβ is one of the primary responses fibroblast 
cells have in response to cytosolic dsDNA/dsRNA detection, with secreted IFNβ signalling in 
an autocrine and paracrine manner resulting in the upregulation of antiviral genes. The IFNβ 
promoter requires the cooperative assembly of IRF3/7, NF-κB, and AP1 transcription factors 
for gene expression to be induced (Honda et al. 2006). The NF-κB luciferase reporter 
meanwhile consists of the chicken ovotransferrin gene minimal promoter downstream of κB 
sites which can be bound and activated by either NF-κB or AP1 transcription factor binding. 
HEK293FT cells, which lack a functional cGAS-STING response to cytosolic dsDNA due to 
undetectable levels of cGAS expression and low levels of STING expression (Zhang et al. 2013; 
Malik et al. 2014) (Figure 3.1 A), were used in this assay so that only cells co-transfected with 
cGAS and STING plasmids have a functional cGAS-STING pathway.  
In this assay cells are transfected with either a luciferase reporter construct consisting of the 
Phonitus pyralis luciferase gene under the control of the IFNβ promoter or a promoter 
activated by NF-κB/AP1 transcription factor binding, as well as plasmids for cGAS and STING 
expression. The expression of cGAS and STING reconstitutes the innate immune signalling 
pathway against cytosolic dsDNA, resulting in an immune response induced by the same 
plasmids used for protein expression, and the activation of luciferase reporters. Co-
transfection of a Renilla reniformis luciferase reporter under the control of the HSV-thymidine 
kinase promoter, which provides constitutive weak expression, allows for normalisation of P. 
pyralis luciferase signal to R. reniformis luciferase signal and controls for reporter plasmid 
transfection efficiency (Figure 4.2 A). The fold induction of the firefly luciferase reporter in 
cells transfected with STING and cGAS plasmids compared to control cells transfected with 
empty vector DNA instead of STING and cGAS and so lacking a functional cGAS-STING pathway 
for IIR against cytosolic dsDNA is then calculated. Thus, the assay system also effectively tests 
the STING dependence of the effects of its partners as luciferase levels in the absence of 
transfected cGAS-STING are also measured as a control.  
Prior to transfection of luciferase assay plasmids, cells were treated with siRNAs against the 
STING partners. Knockdowns were confirmed by Western blotting with treatment resulting in 
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robust knockdown of most partners (Figure 4.2 B). Several of the antibodies recognised 
multiple bands on the Western blots. SYNCRIP has multiple isoforms in mammalian cells (Liu 
et al. 2009; Vu et al. 2017) (UniProtKB, O60506 human SYNCRIP/hnRNP Q) and 
immunoblotting against SYNCRIP in HEK293FT cell lysates identified multiple distinct bands. 
The predicted molecular weights of the most abundant SYNCRIP isoforms are 69 kDa (Q3), 65 
kDa (Q2), and 62 kDa (Q1) and siRNA treatment mostly reduced the abundance of the lowest 
molecular weight band detected. The highest molecular weight band detected is likely the 
closely related protein, hnRNP R, which shares considerable homology (81.2 %) with SYNCRIP, 
and the antibody used for detection of SYNCRIP is also known to detect hnRNP R (detected as 
~80 kDa band) (Mizutani et al. 2000; Mourelatos et al. 2001; Choi et al. 2004; Vu et al. 2017; 
Cappelli et al. 2018). The middle band is likely isoforms Q3 and Q2, while the lower band 
isoform Q1. Two bands were detected for MEN1, the major isoform of which is 68 kDa 
(UniProtKB, O00255 human MEN1), and both were depleted by siRNA treatment. A single 
band was detected for DDX5 at the expected molecular weight of ~60 kDa (UniProtKB, P17844 
human DDX5), and was significantly depleted by siRNA treatment. Blotting against SNRNP70 
detected two major bands, the larger of which likely corresponds to the biggest isoform of 
SNRNP70 (predicted molecular weight ~52 kDa, UniProtKB, P08621 human SNRNP70) since 
this was depleted by siRNA treatment. Immunoblotting against RPS27A detected a single 
band at the predicted molecular weight of ~18 kDa (UniProtKB – P62979 human RPS27A) 
which was successfully depleted by siRNA treatment. Two bands were detected when staining 
for AATF, the lower band of which matches the predicted molecular weight of ~63 kDa 
(UniProtKB – Q9NY61 human AATF): both bands showed a partial depletion with siRNA 
treatment.  
In agreement with previous reports (Ishikawa and Barber 2008; Zhong et al. 2008; Fang et al. 
2017), cGAS and STING expression resulted in robust activation of the IFNβ luciferase reporter 
and comparatively weaker activation of the NF-κB luciferase reporter, ~60-fold and ~35-fold 
respectively in control siRNA treated cells. siRNA mediated knockdowns of MEN1, DDX5, 
SNRNP70, or RPS27A were found to significantly reduce IFNβ promoter driven luciferase 
expression compared to siRNA control treated cells (siCTL), indicating that these proteins may 
contribute to induction of IFNβ following immune stimulation by cytoplasmic dsDNA (Figure 
4.2 C). Knockdown of the same proteins was also tested for an effect on induction of a 
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luciferase reporter activated by binding of NF-κB. In addition to knockdown of MEN1, DDX5, 
SNRNP70, and RPS27A, siRNA mediated knockdown of SYNCRIP and AATF was found to 
significantly reduce NF-κB activated reporter induction compared to siCTL treated cells 
(Figure 4.2 D). This suggests that these proteins might affect different aspects of immune 
signalling cascades with SYNCRIP and AATF exerting a greater effect on the NF-κB and AP1 
signalling pathways than on the IRF3/7 signalling pathway. Knockdown of TCERG1 did not 
have a significant effect on activation of either luciferase reporters and so was not 
investigated further. 
 
Figure 4.2 – Knockdown of STING partners impairs innate immune response stimulated 
luciferase reporter activation. (A) Schematic of dual luciferase reporter assay showing 
plasmids transfected into HEK293FT cells. pcDNA3.1 =empty vector DNA, cGAS and STING = 
plasmids expressing cGAS and STING in pcDNA3.1 vectors, pRL-TK-Renilla = Renilla reniformis 
luciferase gene under the control of thymidine kinase promoter, p-Luciferase = Phonitus pyralis 
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luciferase gene under the control of IFNβ promoter or a promoter activated by NFκB and AP1 
transcription factor binding (pCONA = minimal promoter from chicken conalbumin gene). (B) 
Western blotting confirms knockdown of STING partners in HEK293FT cells by siRNA 
treatment, siCTL = non-target control siRNA, * = non-specific protein band. Blots 
representative of three independent experiments. (C) Relative fold induction of IFNβ promoter 
driven luciferase gene in cells transfected with cGAS and STING plasmids normalised to 
pcDNA3.1 empty vector transfected in cells treated with control siRNA (siCTL) or siRNAs 
against STING partners. Ordinary one-way ANOVA with Dunnett’s multiple comparisons, ** p 
< 0.01, *** p < 0.001, ns = not significant p > 0.05. n = 3. Error bars show standard deviation.  
(D) Relative fold induction of NFκB/AP1 transcription factor driven luciferase gene in cells 
transfected with cGAS and STING plasmids normalised to pcDNA3.1 empty vector transfected 
in cells treated with control siRNA (siCTL) or siRNAs against STING partners. Ordinary one-way 
ANOVA with Dunnett’s multiple comparisons, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns 
= not significant p > 0.05. n = 3.  Error bars show standard deviation.   
4.3 – STING partners are similarly knocked down in HT1080 cells so activation of 
endogenous IFNβ expression can be tested 
The luciferase assay relied on reconstitution of cGAS and STING expression in HEK293FT cells 
as well as the co-transfection of luciferase expression plasmids. The advantage of this was the 
ability to test STING dependence of effects; however, a drawback of this approach is that 
there could be variability in STING and cGAS expression as a consequence of variation in 
transfection efficiency or indirect effects of partner knockdown prior to plasmid transfection. 
For example, the ribosomal protein RPS27A is required for ribosome biogenesis and has extra-
ribosomal functions in promoting cellular proliferation, cell-cycle progression, and inhibition 
of apoptosis (Wang et al. 2014a). Thus, its knockdown could impair production of cGAS and 
STING proteins. Additionally, the timing of immune stimulation was not tightly controlled in 
this experiment because luciferase activity was measured 48 h after plasmid transfection. This 
means that the cGAS-STING pathway would be activated at some point between expression 
of cGAS and STING proteins and the detection of the plasmid DNA from which they were 
expressed. Thus, whether STING partner proteins affect earlier, or later steps of immune 
signalling pathways cannot be determined from this assay. 
Therefore, I wanted to support the results of the luciferase assay by measuring endogenous 
IFN production in response to immune stimulation in STING expressing cells treated with 
siRNAs against the STING partners. Since HT1080 cells have a functional cGAS-STING pathway 
and produce IFNβ (Krishnamurthy et al. 2006) I chose to use this cell line to measure IFNβ 
production in response to immune stimulation. As a control to compare the effects of STING 
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partner knockdowns on IFNβ production to, cells were also treated with siRNAs against STING 
to inhibit IFNβ production. 
First, a robust reduction of STING or STING partners following siRNA treatment in HT1080 
cells was confirmed by Western blotting (Figure 4.3 A, quantified in B), with the same 
antibodies largely detecting the same bands in HT1080 cells as seen in HEK293FT cells. There 
are at least 5 known isoforms of SYNCRIP produced by alternative splicing and Western 
blotting detected 3 or 4 immunoreactive bands for SYNCRIP in HEK293T cell lysates and 
HT1080 cells lysates (Figure 4.2 B and Figure 4.3 A). Note that 3 or 4 bands were resolved for 
both cell lysates and it was not the case that one cell line expressed only 3 immunoreactive 
bands and the other 4. Instead, 4 immunoreactive bands were not always resolved because 
two of the bands ran very close together on 10 % SDS-PAGE. The second highest molecular 
weight band ~70 kDa likely represent the 69 kDa (Q3) isoform, with the lowest molecular 
weight band the 62 kDa (Q1) isoform, and the middle band which is not depleted by siRNA 
treatment the 65 kDa (Q2) isoform (the highest molecular weight band detected at ~80 kDa 
is probably hnRNP R(Mizutani et al. 2000; Mourelatos et al. 2001; Choi et al. 2004; Vu et al. 
2017; Cappelli et al. 2018)). Quantification of protein knockdown measured by western blot 
shows a significant depletion of 60-80 % for all partner proteins and >80 % for STING (Figure 
4.3 B). Note that for protein bands detected by SYNCRIP antibody, presumed Q3 and Q2 
isoform signal was quantified together as bands were not always well enough resolved to 
quantify separately. It is therefore difficult to say the exact extent to which isoform Q3 is 
depleted, however, it is clear that the cytoplasmic Q1 isoform is almost completely reduced 
by siRNA treatment. Immunofluorescence staining for STING and partner proteins in cells 
treated with partner specific siRNAs or a control siRNA was next performed to confirm protein 
depletion seen in Western blots. Since we had hypothesised that partners could function as 
nuclear sensors of viral RNA or DNA, immunofluorescence was also used to determine that 
these STING partners identified from a NE fraction localised at least partially at the NE/nucleus 
(Figure 4.3 C). MEN1, DDX5, and SNRNP70 localised predominantly to the nucleus in 
agreement with previous reports (La et al. 2004; Wang et al. 2009; Stejskalova and Stane 
2014) and siRNA knockdown greatly depleted any nuclear staining. The different isoforms of 
SYNCRIP are reported to localise to different cellular compartments, with the Q1 isoform 
predominantly cytoplasmic while Q2 and Q3 are mostly nuclear, while the highly homologous 
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hnRNP R is also a nuclear protein (Chen et al. 2008; Cappelli et al. 2018). In agreement with 
western blotting, siRNA treatment against SYNCRIP primarily depleted the cytoplasmic signal, 




Figure 4.3 – Knockdown of STING and partner proteins in HT1080 cells. (A) Western blotting 
of HT1080 cells treated with non-target control siRNA (siCTL) or siRNAs against STING and 
STING partners. Blots representative of three independent experiments. * = non-specific 
protein band. (B) Quantification of STING and partner protein levels from Western blotting in 
cells treated with target siRNAs normalised to cells treated with siCTL. SYN = SYNCRIP. 
Q1/Q2/Q3 = major SYNCRIP isoforms. Two-tailed unpaired t-tests. ** p < 0.01, *** p < 0.001, 
**** p < 0.0001, ns = not significant p > 0.05. n = 3. Error bars show standard deviation. (C) 
Immunofluorescence of STING and STING partners in HT1080 cells treated with STING and 
STING partner specific siRNAs or siCTL, shows protein localisation and confirms siRNA 
mediated knockdown. Scale = 10 µM. 
4.4 – Knockdown of SYNCRIP and SNRNP70 significantly reduces induction of endogenous 
IFNβ mRNA as a result of immune stimulation by dsDNA but not dsRNA 
Having confirmed siRNA mediated knockdown of proteins in HT1080 cells, I next measured 
endogenous IFNβ expression by qPCR following IIR stimulation. Induction of IFNβ expression 
is one of the central response’s fibroblasts have following detection of cytosolic DNA or viral 
RNA and thus provides a good assay to measure perturbation of innate immune signalling 
pathways. I tested the effect of knockdown of individual STING partners (SYNCRIP, MEN1, 
DDX5, and SNRNP70) or STING on IFNβ expression in HT1080 cells by measuring IFNβ mRNA 
levels 4 h after immune stimulation with dsDNA or the dsRNA mimic poly(I:C) (Figure 4.4). The 
effect of TCERG1 knockdown was not tested since it did not have an effect in the luciferase 
assays. The effect of knocking down RPS27A was also not tested since RPS27A knockdown 
caused high levels of cell death likely because it encodes a fusion protein of ubiquitin and the 
ribosomal subunit S27a which are essential to cell functioning.  
Knockdown of STING by siRNA treatment significantly reduced the expression of IFNβ, ~80 %, 
following immune stimulation with DNA but not RNA compared to control siRNA treated cells 
measured 4 h after transfection of dsDNA/poly(I:C) (Figure 4.4A and B) in agreement with 
previous studies showing that STING is essential for IFNβ induction in response to cytosolic 
dsDNA (Ishikawa and Barber 2008; Ishikawa et al. 2009; Holm et al. 2016; Franz et al. 2018). 
A 4 h post-immune stimulation timepoint was chosen because STING activation, as marked 
by phosphorylation and accumulation in perinuclear foci, occurs rapidly (within 1 h) of dsDNA 
transfection (Ishikawa and Barber 2008; Ishikawa et al. 2009; Holm et al. 2016; Franz et al. 
2018). Also, I wanted to test whether STING partners had an effect early on in the innate 
immune response since we were predicting that they could function as sensors of 
dsDNA/dsRNA. Knockdown of SNRNP70, similarly to STING, reduced expression of IFNβ 
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triggered by DNA immune stimulation, albeit ~50 % compared to ~80 % reduction in STING 
knockdown cells. This suggests that SNRNP70 is involved in innate immune responses to 
cytosolic dsDNA in agreement with luciferase assay results. Knockdown of SYNCRIP also 
significantly reduced expression of IFNβ triggered by DNA immune stimulation, ~50 %. This 
was slightly surprising because SYNCRIP knockdown did not have a significant effect on 
activation of the IFNβ promoter driven luciferase reporter and only had a significant effect on 
induction on the NF-κB/AP1 activated luciferase reporter in HEK293T cells. However, IFNβ 
promoter driven luciferase reporter activation was slightly lower in SYNCRIP knockdown cells 
compared to control knockdown cells and it is possible that this effect was not detected as 
significant due to a large variance between biological repeats. Alternatively, it might be that 
SYNCRIP exerts its function on IFNβ induction earlier on after stimulation with dsDNA and this 
is compensated for in its absence later on and so was not detected in the luciferase assay. 
Knockdown of MEN1 and DDX5 had no effect of endogenous IFNβ expression following 
immune stimulation with DNA. These differences could be a result of the different cell lines 
used (HEK293FT and HT1080) or may indicate that any effect on IFNβ induction may occur at 
a later timepoint since endogenous levels were measured 4 h after immune stimulation in 
HT1080 cells compared with 48 h after transfection of cGAS and STING plasmids in HEK293FT 
cells.  
A reduction in IFNβ expression was only seen for SYNCRIP and SNRNP70 knockdown cells 
following immune stimulation with DNA but not poly(I:C), as was the case with STING 
knockdown cells (Figure 4.4 A and B). This suggests that SYNCRIP and SNRNP70, similarly to 
STING, modulate the IFN response to cytosolic dsDNA but not dsRNA. Knockdown of MEN1 
also had no effect on IFNβ expression triggered by poly(I:C), however, knockdown of DDX5 
significantly increased expression of IFNβ induced by poly(I:C) transfection which would 
suggest that DDX5 is inhibitory to innate immune responses stimulated by dsRNA.  
Finally, it should be noted that siRNA treatment alone did not induce IFNβ expression (see 
Mock stimulated columns) indicating that the siRNAs used in this study are not themselves 
immune stimulatory (Figure 4.4 A and B). To ensure mRNA used to generate cDNA for qPCR 
experiments was not degraded during the extraction process, RNA was run on agarose gels 
to check integrity before reverse transcription to generate cDNA (Figure 4.4 C). The efficiency 
of primers used for qPCR (IFNβ, target gene and GAPDH, housekeeping gene for 
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normalisation) was also checked prior to use with both confirmed to have high efficiency, 
97.28 % (slope – 3.389, amplification factor 1.97) and 94.88 % (slope – 3.451, amplification 





Figure 4.4 – Knockdown of SYNCRIP and SNRNP70 reduces IFNβ expression after immune 
stimulation with dsDNA. IFNβ mRNA levels in HT1080 cells transfected with dsDNA (A) or 
poly(I:C) (B) (RNA isolated 4 h post-transfection) after treatment with siRNAs against STING 
and partners or non-target control siRNA (siCTL). Mean IFNβ mRNA expression normalised to 
GAPDH and shown relative to expression in siCTL cells stimulated with dsDNA (A) or poly(I:C) 
(B). Ordinary one-way ANOVAs with Dunnett’s multiple comparisons, * p < 0.05, *** p < 0.001, 
**** p < 0.0001, ns = not significant p > 0.05. n = 3. Error bars show standard deviation.   (C) 
Representative RNA gel showing integrity of total RNA isolated from mock, dsDNA, and 
poly(I:C) stimulated cells. 28S and 18S rRNA bands indicate RNA integrity. (D) Standard curves 
for GAPDH and IFNβ primers used in qPCR experiments shown in (A) and (B), calculated using 
serial dilutions of cDNA from siCTL + DNA sample. Slope value allows calculation of primer 
efficiency (efficiency = (10^(-1/slope value)-1)*100  and amplification factor = 10^(-1/slope 
value). 
4.5 – At a later time point post-immune stimulation with dsDNA, knockdown of MEN1 also 
significantly reduces expression of endogenous IFNβ  
In the luciferase assay in HEK293FT cells knockdown of MEN1 and DDX5 strongly reduced 
induction of the IFNβ promoter driven luciferase reporter. However, 4 h after immune 
stimulation with dsDNA no effect was seen on endogenous IFNβ mRNA levels by qPCR for 
MEN1 and DDX5 in HT1080 cells. Since in the luciferase assay, reporter induction was 
measured 48 h post-transfection of luciferase assay plasmids, it is possible that an effect of 
MEN1 or DDX5 knockdown is only seen at a later timepoint post-immune stimulation. 
Therefore, endogenous IFNβ mRNA levels were measure by qPCR 8 h after immune 
stimulation with dsDNA in STING partner knockdown cells. 8 h was chosen because STING 
activation and subsequent degradation has been reported to occur within 12 h of stimulation 
with dsDNA (Konno et al. 2013; Prabakaran et al. 2018), with IFNβ mRNA levels similarly 
peaking within 12 h (Shirota et al. 2006). As was the case 4 h post-transfection of dsDNA, 
knockdown of STING, SYNCRIP, and SNRNP70 caused a significant reduction in IFNβ 
expression (Figure 4.5 A). At this timepoint cells treated with siRNA against MEN1 also showed 
a significant reduction, ~50 %, in IFNβ expression compared to control cells, in agreement 
with luciferase assay data. Knockdown of DDX5 caused the opposite effect with a significant 
increase in IFNβ expression compared to control siRNA treated cells, suggesting that DDX5 is 
an inhibitor of dsDNA (Figure 4.5 A) and dsRNA (Figure 4.4 B) triggered IFN responses. Since 
a change in mRNA level doesn’t necessarily translate into a difference in protein level, I also 
attempted to measure IFNβ protein levels in culture medium 12 h after dsDNA stimulation 
using an ELISA kit. However, no IFNβ protein was detected, and I did not have reagents to 
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repeat this experiment. It is possible that I should have measured IFNβ protein levels at a later 
timepoint since HT1080 cells have been shown to secrete IFNβ (Krishnamurthy et al. 2006). 
To confirm that knockdown of STING partners affects IIR to dsDNA I also measured mRNA 
levels of the pro-inflammatory cytokine, CCL5/RANTES, following immune stimulation with 
dsDNA in STING or STING partner knockdown cells. CCL5 is a chemotactic cytokine secreted 
by cells to recruit specialised cells of the immune system and similarly to IFNβ its expression 
is induced by IRF and NF-κB transcription factors (Gürtler et al. 2014). In agreement with IFNβ 
data, knockdown of STING, SYNCRIP, MEN1, or SNRNP70 caused a significant reduction in 
CCL5 expression compared to siRNA control treated cells, > 80 % for STING knockdown and 
~50–60 % for partner knockdown, while no significant difference was seen in cells treated 
with siRNA against DDX5 (Figure 4.5 B). Primers used for CCL5 amplification showed high 
efficiency, 90.53 % (slope – 3.572, amplification factor 1.91) (Figure 4.5 C).  
 
Figure 4.5 – Knockdown of SYNCRIP, MEN1 and SNRNP70 reduces IFNβ and CCL5 expression 
8 h after immune stimulation with dsDNA. (A) IFNβ or (B) CCL5 mRNA levels in HT1080 cells 
transfected with dsDNA (RNA isolated 8 h post-transfection) after treatment with siRNAs 
against STING and partners or non-target control siRNA (siCTL). Mean mRNA expression 
normalised to GAPDH and shown relative to expression in siCTL cells stimulated with dsDNA. 
Ordinary one-way ANOVAs with Dunnett’s multiple comparisons, ** p < 0.01, *** p < 0.001, 
**** p < 0.0001, ns = not significant p > 0.05. n = 3. Error bars show standard deviation.  (C) 
Standard curves for CCL5 primers used in qPCR experiments shown (B), calculated using serial 
dilutions of cDNA from siCTL + DNA sample. Slope value allows calculation of primer efficiency 
(efficiency = (10^(-1/slope value)-1)*100  and amplification factor = 10^(-1/slope value). 
siRNA treatment of cells can result in off-target effects whereby in addition to targeting the 
desired mRNA for depletion, an unrelated mRNA is also silenced due to some 
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complementarity between the siRNA ‘guide’ strand and mRNA other than desired target 
(Bartoszewski and Sikorski 2019). Therefore, to rule out the possibility that siRNAs against 
STING partner proteins affected expression of STING and cGAS, Western blotting was 
performed to quantitate protein abundance of STING and cGAS. As expected, siRNA 
treatment against STING significantly reduced STING protein levels without affecting cGAS 
when compared to siRNA control treated cells. Knockdown of STING partners did not 
significantly affect STING or cGAS protein levels when compared to control treated cells 
(Figure 4.6 A and B). However, the siRNA against DDX5 caused a partial reduction in STING 
protein levels compared to the control, but not at a level that was statistically significant or 
indeed as much as siRNA treatment specific to STING (Figure 4.6 A). An alternative 
explanation for the reduction in STING protein levels seen in DDX5 knockdown cells could be 
that DDX5 is involved in promoting STING protein stability or gene expression. While this was 
not pursued further here it could be worth investigating in the future since STING and cGAS 
are known to be downregulated in many immortalised cell lines through ill-defined 
mechanisms (Sun et al. 2009; Sun et al. 2013; Malik et al. 2014; Xia et al. 2016a; Deschamps 
and Kalamvoki 2017a) and so DDX5 could conceivably be involved in such processes. 
 
Figure 4.6 – Knockdown of STING partners does not significantly affect levels of STING and 
cGAS in HT1080 cells. Representative western blost showing STING (A) or cGAS (B) protein 
levels in HT1080 cells treated with siRNAs against STING and partners or non-target control 
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siRNA (siCTL). Quantification showing mean STING protein levels relative to siCTL cells 
normalised according to tubulin loading control. Ordinary one-way ANOVA with Dunnett’s 
multiple comparisons, * p < 0.05. n = 3 (A) n = 1 (B). Error bars show standard deviation. 
4.6 – Knockdown of STING partners reduces activation of IRF3 in response to DNA but not 
poly(I:C) 
Having found that STING partners contributed to the induction of IFNβ and CCL5 in response 
to cytosolic DNA, I wanted to examine which parts of the immune signalling pathway triggered 
by cytosolic dsDNA were being affected. To do this I first looked at the activation of immune 
transcription factor IRF3, since STING partners were proposed to have indirect links to IRF3/7 
and because IRF3 is one of the transcription factors which induces CCL5 (Lin et al. 1998) and 
IFNβ expression (Honda et al. 2006). IRF3 normally resides in the cytoplasm as a monomeric 
protein but following activation of cGAS-STING, RIG-I/MDA-5-MAVS, or TLR3/4-TRIF pathways 
it is recruited to active STING, MAVS, or TRIF signalling complexes and phosphorylated by 
TBK1 (Liu et al. 2015a). Subsequently phosphorylated IRF3 (pIRF3) dissociates from adaptor 
proteins and forms homodimers which translocate to the nucleus and activate type-I IFN and 
pro-inflammatory cytokine expression (Yoneyama et al. 1998; Liu et al. 2015a). Western 
blotting with an antibody specific to phosphorylated-IRF3 (S386) allowed for determination 
of IRF3 activation following immune stimulation with dsDNA or poly(I:C) (Figure 4.7 A, B, and 
D). As expected, knockdown of STING significantly reduced IRF3 phosphorylation at 4 h after 
DNA triggered immune stimulation compared to control cells, but had no effect on IRF3 
phosphorylation in cells stimulated with poly(I:C) (Figure 4.7 B - E). Knockdown of SYNCRIP, 
MEN1, and SNRNP70 also reduced levels of phosphorylated-IRF3 in cells stimulated with 
dsDNA (Figure 4.7 B and C). Interestingly, knockdown of DDX5 also reduced levels of 
phosphorylated-IRF3 in dsDNA stimulated cells despite DDX5 knockdown increasing levels of 
IFNβ mRNA in dsDNA stimulated cells (Figure 4.5 A). This suggests that DDX5’s effect on IFNβ 
induction is not through IRF3 activation. Knockdown of SYNCRIP and MEN1 had no effect on 
activation of IRF3 in poly(I:C) stimulated cells in agreement with qPCR data, suggesting that 
SYNCRIP and MEN1 knockdown effects are specific to dsDNA stimulated IIR (Figure 4.7 D and 
E). Meanwhile, knockdown of both DDX5 and SNRNP70 significantly increased levels of 
phosphorylated-IRF3 in cells stimulated with poly(I:C). This is consistent with IFNβ qPCR data 
for DDX5 but not SNRNP70 which saw no difference in IFNβ expression at 4 h after stimulation 
with poly(I:C). This difference could be due to the timepoint at which IFNβ expression was 




Figure 4.7 – Knockdown of STING partners significantly reduces activation of IRF3 in cells 
stimulated with dsDNA and significantly increases activation in cells stimulated with 
poly(I:C). (A) Representative western blot showing levels of activated IRF3 (phosphorylated 
IRF3, pIRF3 (S386)), total IRF3, and histone H3 in mock stimulated cells treated with siRNAs 
against STING and partners. (B) Representative western blot showing levels of activated IRF3 
(phosphorylated IRF3, pIRF3 (S386)), total IRF3, and histone H3 in cells treated with siRNAs 
against STING and partners and stimulated with dsDNA. (C) Quantification of activated IRF3 
(pIRF3(S386)) in mock and cells stimulated with DNA for 4 h, protein levels relative to control 
siRNA (siCTL) cells stimulated with DNA. pIRF3 levels normalised to H3. Ordinary one-way 
ANOVA with Dunnett’s multiple comparisons, ** p < 0.01, *** p < 0.001, **** p < 0.0001. n = 
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3. Mean values are plotted and error bars show standard deviation. (D) Representative 
western blot showing levels of activated IRF3 (phosphorylated IRF3, pIRF3 (S386)), total IRF3, 
and histone H3 in cells treated with siRNAs against STING and partners and stimulated with 
poly(I:C). (E) Quantification of activated IRF3 (pIRF3(S386)) in mock and cells stimulated with 
poly(I:C) for 4 h. Protein levels are shown relative to control siRNA (siCTL) cells stimulated with 
poly(I:C). pIRF3 levels normalised to H3. Ordinary one-way ANOVA with Dunnett’s multiple 
comparisons, ** p < 0.01, *** p < 0.001, ns = not significant p > 0.05. n = 3. Mean values are 
plotted and error bars show standard deviation. 
4.7 – Knockdown of STING partners reduces accumulation of IRF3 in the nucleus following 
stimulation with dsDNA 
As another means of measuring the activation of IRF3 and to look at activation of NF-κB in 
cells treated with siRNAs against STING and partners following immune stimulation with DNA, 
I also measured accumulation of IRF3 and NF-κB in the nucleus of cells by 
immunofluorescence. In unstimulated cells IRF3 exists as an unphosphorylated monomer 
dispersed throughout the cytoplasm. Following immune stimulation with dsDNA or poly(I:C) 
IRF3 is phosphorylated, dimerises, and translocated to the nucleus (Kato and Fujita 2014; Liu 
et al. 2015a; Sparrer and Gack 2015). Similarly, in unstimulated cells NF-κB is inactive and 
resides in the cytoplasm, following immune stimulation with dsDNA or poly(I:C) NF-κB is 
activated and translocated to the nucleus (Abe et al. 2013; Kato and Fujita 2014; Sparrer and 
Gack 2015). Transfection of dsDNA or poly(I:C) activates cytosolic DNA/RNA sensing 
pathways, inducing the activation of IRF3 and NF-κB and resulting in their accumulation in the 
nucleus where they induce expression of target genes (Figure 4.8 A). In cells stimulated with 
poly(I:C) both IRF3 and NF-κB accumulated in the nucleus, while in DNA stimulated cells most 
only accumulated IRF3 in the nucleus, in agreement with findings that the cGAS-STING 
pathway predominantly activates IRF3 (Abe and Barber 2014; Liu et al. 2015b; Dobbs et al. 
2015; Dunphy et al. 2018). Accordingly, I quantified the percentage of cells with nuclear 
accumulation of IRF3 and NF-κB in cells treated with siRNAs against STING and partner 
proteins following immune stimulation with dsDNA (Figure 4.8 B and C). Knockdown of STING 
drastically inhibited the nuclear accumulation of IRF3 while knockdown of all STING partners 
tested similarly reduced accumulation of IRF3 in the nucleus compared to siRNA control 
treated cells, although to a lesser extent (Figure 4.8 B and D). Knockdown of STING and 
partners largely had no effect on accumulation of NF-κB in the nucleus following immune 
stimulation with dsDNA, barring knockdown of DDX5 which caused a slight increase in nuclear 
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accumulation of NF-κB (Figure 4.8 C). This could explain the increase in IFNβ expression in 
cells knocked down for DDX5 despite a reduction in levels of activated IRF3 since both NF-κB 
and IRF3 are required to induce IFNβ expression.  
 
Figure 4.8 – Knockdown of STING partners significantly reduces nuclear accumulation of 
IRF3 in cells stimulated with dsDNA. (A) Localisation of NF-κB (p65) and IRF3 transcription 
factors in mock, dsDNA, and poly(I:C) stimulated cells. Quantification of cells with nuclear 
accumulation of IRF3 (B) or NF-κB (p65) (C) in cells treated with siRNAs against STING and 
partners following immune stimulation with dsDNA. > 100 cells and 10 fields of view quantified 
for each condition. (D) Example micrographs showing accumulation of IRF3 in the nucleus of 
cells treated with siRNAs against STING and partners or control siRNAs (siCTL) and stimulated 
with dsDNA.  Scale = 10 µM. 
4.8 – Knockdown of STING partners and effects on proliferation of the DNA virus, HSV-1 
Having confirmed that knockdown of STING partners has an effect on dsDNA triggered IIR as 
shown by an alteration in IRF3 activation, IFNβ transcript levels, and CCL5 transcript levels, I 
wanted to test whether any of the STING partners affect the proliferation of a virus with a 
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DNA genome. For this I used herpes simplex virus (HSV-1), which has a dsDNA genome, 
because it has already been shown to be restricted by the cGAS-STING pathway (Ishikawa et 
al. 2009; Gao et al. 2013a; Sun et al. 2013) with STING-/- mice susceptible to lethal infection 
with HSV-1 (Ishikawa et al. 2009). HT1080 cells treated with siRNAs against STING or partners 
were infected with HSV-1 and viral titres measured by plaque assay at various timepoints 
post-infection (Figure 4.9 A). Surprisingly, STING knockdown did not have an impact on HSV-
1 viral titres compared to control siRNA treated cells with titres almost identical at 12 hours 
post infection (hpi) and siCTL titres modestly higher at 18 hpi (Figure 4.9 B). 
This finding may be explained by recent work which shows that the dependence on STING for 
restriction of HSV-1 in mice and murine cell lines is not shared in the HT1080 human cell line 
I used in this experiment (Latif et al. 2020). In this study, Latif et al. dissected the relative 
contributions of TLR3-TRIF and cGAS-STING signalling pathways in the restriction of HSV-1 in 
human and murine cell lines. This work built on a previous report from the same group which 
uncovered a requirement for the adaptor protein, TRIF, in the cGAS-STING signalling pathway 
(Wang et al. 2016). TRIF is the essential adaptor protein for the endosomal dsRNA sensor, 
TLR3, and is also required for the endosomal branch of TLR4 signalling, which recognise 
lipopolysaccharide (LPS) (Yamamoto et al. 2002; Fitzgerald et al. 2003). Similarly to STING, 
activation of TRIF leads to IFNβ expression through TBK1 and IRF3 (Liu et al. 2015a). In their 
previous work, TRIF was found to be required for STING mediated IIR with TRIF interacting 
directly with STING to promote its dimerization and translocation to perinuclear foci following 
immune stimulation with cyclic dinucleotide STING ligands. Moreover, HSV-1 grew to higher 
titres in TRIF-/-  MEFs and TRIF-/- mice were susceptible to lethal infection (Wang et al. 2016). 
Viral infection is a far more complex immune stimulus than transfected DNA or RNA and 
triggers multiple signalling pathways culminating in the induction of type-I IFNs and pro-
inflammatory cytokines. Infection with HSV-1 is sensed by both the dsDNA sensing cGAS-
STING pathway and the dsRNA sensing TLR-3 pathway. As a dsDNA virus, the genome of HSV-
1 serves as a ligand to stimulate cGAS-STING signalling as does the leakage of mitochondrial 
or nuclear DNA as a consequence of viral infection (West et al. 2015; Roers et al. 2016). While, 
like most if not all viruses, HSV-1 produces dsRNA during replication and this, as well as 
cellular dsRNA released from dead infected cells, can be endocytosed activating TLR3 in 
neighbouring cells (Nguyen et al. 2017; Sato et al. 2018; Dauber et al. 2019). Now in their 
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recent report Latif et al. show that in L929 and NB41A3 mouse cell lines, HSV-1 is primarily 
attenuated by cGAS-STING pathway, while in HT1080 and HeLa-M human cells lines HSV-1 is 
primarily attenuated by the TL3-TRIF pathway. Thus, this work could explain why STING 
knockdown did not affect HSV-1 viral titres compared to control knockdown in HT1080 cells 
in my experiments.  
HSV-1 has been shown to antagonise the cGAS-STING pathway through multiple mechanisms 
with several viral proteins found to inhibit STING signalling (Zheng 2018). For example, the 
viral protein ICP27 has been reported to bind activated STING-TBK1 complexes thereby 
preventing activation of IRF3 (Christensen et al. 2016). Additionally, the tegument protein 
UL46 (VP11/12) has also been reported bind both STING and TBK1 and inhibit downstream 
immune responses (Deschamps and Kalamvoki 2017b). Furthermore, HSV-1 is also able to 
antagonise STING activation through the viral protein ƴ134.5 which binds STING and inhibits 
its translocation to perinuclear foci and thus activation of IRF3 and IFNβ expression (Pan et al. 
2018). Another example is the HSV-1 tegument protein UL41, an endoribonuclease also 
known as the virion host shut off protein (vhs), which also targets the cGAS-STING pathway 
with UL41 causing a reduction in cGAS mRNA levels possibly through selective degradation of 
cGAS mRNA via its RNase activity (Su and Zheng 2017). Thus, it is possible that HSV-1 is so 
effectively able to inhibit STING-mediated signalling that whether or not STING is present 
does not affect viral proliferation in HT1080 cells. 
Knockdown of STING partners, MEN1 or SNRNP70, similarly had little to no effect on HSV-1 
viral titres compared to control treated cells, while knockdown of SYNCRIP or DDX5 caused a 
slight reduction in viral titres compared to control treated cells (Figure 4.9). In the case of 
SYNCRIP knockdown, titres were ~4x lower at 12 hpi and ~2x lower at 18 hpi, while for DDX5 
knockdown titres were ~6x lower at 12 hpi and ~5x lower at 18 hpi. For DDX5, since 
knockdown increases levels on phosphorylated-IRF3 and IFNβ mRNA in DNA stimulated cells, 
this would explain an inhibition of HSV-1 viral titres. However, this experiment was only 
performed once because after realising that STING knockdown would not be a sufficient 
positive-control in HT1080 cells, likely due to the minimal contribution of the cGAS-STING 
pathway to restricting HSV-1 in this cell line (Latif et al. 2020), whether NE STING partners 
affect HSV-1 proliferation could not readily be determined. Therefore, the data should be 
interpreted cautiously. Nonetheless, I decided to include it here since knockdown of DDX5 in 
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particular reduced HSV-1 viral titres compared to control knockdown cells and this correlates 
well with DDX5 being a negative regulator of dsDNA triggered IIR. 
 
Figure 4.9 – Knockdown of STING partners and effect on herpes simplex virus (HSV-1) titres. 
(A) Time-course experiment showing HSV-1 titres measured by plaque assay across 24 h in 
HT1080 cells treated with siRNAs against STING and partners and infected with HSV-1 at a 
multiplicity of infection (MOI) of 5. (B) Bar charts showing HSV-1 titres in cells from time-
course shown in (A) at timepoints when virus is still in an exponential phase of growth at 12 h 
and 18 h post infection (hpi). PFU/mL = plaque forming units per mL. y-axis plotted using a log 
scale. n =1.  
4.9 – Attempts to co-immunoprecipitate STING with NE partners without cross-linking 
suggests they are not direct interactors  
Since STING partners SYNCRIP, MEN1, DDX5, and SNRNP70 were all found to influence IIR, I 
next wanted to confirm STING-partner interactions from the NE co-immunoprecipitation 
experiment. In the original experiment an overexpressed STING-GFP construct was used 
because good STING antibodies were not yet available, and a reversible crosslinking approach 
was used because the conditions for extracting NETs from the NE are necessarily harsh due 
to both membrane insertion and association with the insoluble intermediate filament lamin 
polymer. Now that better commercial antibodies are available, I wanted to test if I could 
pulldown these partners without cross-linking and using endogenous STING. Additionally, I 
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wanted to test the hypothesis that STING-partner interactions increase following immune 
stimulation with dsDNA or poly(I:C). 
Co-immunoprecipitation of STING and partners was performed using rabbit monoclonal or 
sheep polyclonal antibodies against endogenous STING or in the other direction with 
antibodies against several partners in HT1080 cells (mouse monoclonal anti-SYNCRIP, rabbit 
polyclonal anti-MEN1, goat polyclonal anti-DDX5, rabbit polyclonal anti-SNRNP70). I 
successfully immunoprecipitated STING, SYNCRIP, MEN1, and DDX5 from whole cell lysates 
(Figure 4.10 A - C), but the antibody against SNRNP70 proved unsuitable for 
immunoprecipitation (Figure 4.10 D). However, anti-STING antibody failed to co-
immunoprecipitate partners SYNCRIP and DDX5 and only very weakly pulled-down MEN1, 
while none of SYNCRIP, MEN1, or DDX5 pulled-down STING (Figure 4.10 A – C). I postulated 
that since STING partners were found to influence IIRs stimulated by dsDNA or poly(I:C) an 
interaction with STING may only be seen by Western blot during IIR against dsDNA or poly(I:C) 
as this may enhance a weak interaction that was only seen by the mass spectrometry used in 
the original experiment. Therefore, co-immunoprecipitation was performed 2 h post-immune 
stimulation with dsDNA and/or poly(I:C) based on which immune stimuli partners were found 
to affect IIR. However, no co-immunoprecipitation was found in any immune stimulated 
conditions and in the case of MEN1 where there had been some co-immunoprecipitation of 
MEN1 with an anti-STING antibody in unstimulated cells this was lost in dsDNA stimulated 
cells (Figure 4.10 B). These results, while not supportive of the original pulldown experiment, 
may be due to be very transient interactions between STING and partners that were 
preserved by cross-linking used in the original experiment, but are disrupted by the buffers 
tested for co-immunoprecipitation (initially RIPA buffer: 150 mM NaCl, 50 mM Tris pH 8.0, 1% 
NP-40, 0.5 % sodium deoxycholate, 0.1 % SDS + protease inhibitors (data not shown) followed 
by NP-40 buffer: 150 mM NaCl, 50 mM Tris pH 8.0, 5mM EDTA, 1% NP-40 + protease 
inhibitors). Indeed, the original reasoning for using cross-linking when immunoprecipitating 
STING from NEs was that extraction from the NE often requires harsh conditions to disrupt 
interactions with the nuclear lamina and so extraction conditions that are too mild would 
maintain STING-partner interactions in the NE, but would not isolate STING and its partners 
from NE so that they would not be recovered in these experiments. Rather, the ER pool and 
the more minor NE pool that is not restricted by lamina interactions would be recovered. By 
102 
 
using reversible cross-linking STING in the NE could be extracted while preserving weaker 
interactions with partner proteins. Moreover, I performed co-immunoprecipitation 
experiments using whole cell lysates and since STING localises throughout the ER and only 
partially to the NE this could have inhibited detection of NE-STING interactions. Therefore, it 
would be appropriate to perform isolation of nuclei with and without cross-linking if repeating 
immunoprecipitation experiments using antibodies against endogenous proteins. A control 
experiment comparing the amount of STING extracted from nuclear and cytoplasmic fractions 
in buffers used for pulldown should be performed prior to this, since the percentage of STING 
extracted under these conditions could then be compared to the total amount of STING in 
the respective fractions solubilised directly in SDS-PAGE sample buffer. This might allow for 
optimisation of a pulldown buffer suitable for extracting STING from the NE but mild enough 
to preserve protein-protein interactions.  
 
Figure 4.10 – Endogenous STING co-immunoprecipitates MEN1 but not SYNCRIP or DDX5 
from whole cell lysates without crosslinking. (A) Immunoprecipitation (IP) of endogenous 
STING or SYNCRIP from HT1080 whole cell lysates shows that antibodies are suitable for IP but 
does not confirm an interaction between SYNCRIP and STING. (B) IP of endogenous STING and 
MEN1 from HT1080 whole cell lysates shows that antibodies are suitable for IP and indicate 
that MEN1 interacts with STING (α-STING IP’s MEN1 although α-MEN1 fails to IP STING) in 
unstimulated cells, but not cells stimulated with dsDNA. (C) IP of endogenous STING and DDX5 
from HT1080 whole cell lysates shows that antibodies are suitable for IP but does not confirm 
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an interaction between DDX5 and STING. (D) Antibody against SNRNP70 is not suitable for IP. 
IgG HC, Immunoglobulin G heavy chain. m-IgG, mouse-IgG. r-IgG, rabbit-IgG. Immunoblots 
representative of ≥ 2 independent experiments. 
4.10 – Proximity Ligation Assay suggests STING and partners are in close proximity but 
requires further optimisation 
Due to the many possible reasons for a negative result with co-immunoprecipitation 
experiments, I tried using a proximity ligation assay (PLA) as an alternative means of 
confirming STING-partner interactions. PLA relies on antibody staining against two target 
proteins; primary antibodies (raised in different species) against target proteins are first 
incubated with samples, these are then detected by secondary antibodies conjugated to 
complementary DNA oligos (PLA probes). DNA oligos can be hybridised providing they are 
within close proximity (~40 nm) to each other. Rolling circle amplification is used to generate 
an amplicon tethered to the PLA probes which can subsequently be detected by hybridisation 
of fluorescently labelled detection probes. These can be visualised by fluorescent microscopy 
as discreet foci where an interaction occurs (Bagchi et al. 2015). Since PLA does not require 
extraction of protein and instead detects interactions in situ, I postulated that it could be used 
overcome issues around suitability of buffers for confirming STING-partner interactions 
encountered using co-immunoprecipitation. 
PLA was performed with secondary antibody staining alone as a negative control to quantitate 
background signal, with very few foci ~2 detected per cell (quantified by DAPI stain) (Figure 
4.11 A, top panels). As a positive control for PLA, antibody staining was performed against 
MAVS and STING (AF6516 polyclonal sheep antibody) which are known to co-
immunoprecipitate (Zhong et al. 2008), yielding ~25 PLA foci per cell. PLA performed for 
SYNCRIP and STING, MEN1 and STING, and SNRNP70 and STING all gave >30 PLA foci per cell 
(Figure 4.11 A). PLA could not be performed for DDX5 and STING because both primary 
antibodies were raised in sheep. Immunofluorescence staining performed in parallel to PLA 
using the same blocking and primary antibody staining steps shows that all STING partner and 
STING staining was as expected in cells, with MAVS staining labelling the mitochondria, STING 
staining labelling the ER and NE, and partner proteins localising to the nucleus and cytoplasm 
(Figure 4.11 B). PLA foci were quantified for all protein pairs in siRNA control treated cells and 
in cells treated with siRNAs against STING as a biological negative control, since knockdown 
of STING should prevent PLA foci from forming (Figure 4.11 C). Surprisingly, in cells treated 
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with STING specific siRNAs the average number of PLA foci for STING and partner proteins did 
not markedly decrease, with only STING + MEN1 and STING + SNRNP70 pairs showing a 
modest decrease in the number of foci per cell. This was also the case for MAVS + STING 
suggesting an issue with this assay. It is possible that this is due to non-specific staining of the 
STING antibody in cells treated with siRNAs against STING, although immunofluorescence 
staining against STING in these cells confirmed a loss of STING antibody staining (Figure 4.11 
D). The assay therefore requires further optimisation with more stringent washing steps to 
remove non-specific staining or siRNA knockdown of STING partners as an alternative 
negative biological control to STING knockdown. Alternatively, the STING (D2P2F) monoclonal 
rabbit antibody which requires methanol fixation could be used. However, this would require 
finding antibodies against partner proteins that were compatible with methanol fixation since 
the ones used in this study are only compatible with formaldehyde fixation, hence the 




Figure 4.11 – Proximity ligation assay (PLA) suggests STING interacts with NE partners. (A) 
Representative micrographs showing PLA foci in cells stained with antibodies against STING 
and MAVS (positive control) and in cells stained with antibodies against STING and 
SYNCRIP/MEN1/DDX5, but not in cells stained with secondary antibodies only (technical 
negative control). (B) Immunofluorescence staining showing expected localisation of STING 
and partner proteins and minimal background staining from secondary antibodies. (C) 
Quantification of PLA foci for STING and partners normalised to number of cells (based on 
DAPI stain) to give average number of PLA foci per cell in cells treated with control siRNA or 
depleted for STING with siRNAs against STING. > 100 cells and 10 fields of view counted per 
condition. Data representative of two independent experiments. (D) STING staining with 
antibody used for PLA confirms a loss of signal in cells treated with siRNAs against STING 
compared to control siRNA treated cells. Scale = 10 µM.  
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4.11 – Redistribution of STING partners in response to stimulation with dsDNA and poly(I:C) 
Preliminary work in the lab had suggested that SYNCRIP and MEN1 redistribute to the 
cytoplasm following immune stimulation with dsDNA or poly(I:C) (data not shown). Since I 
found that STING redistributes from the INM to ONM following immune stimulation with 
dsDNA or poly(I:C), it was speculated that STING could be involved in any such redistribution 
of partner proteins. Moreover, a redistribution of STING partners during an IIR may shed light 
on how they influence immune signalling. Interestingly, prior reports show that SYNCRIP 
redistributes from the nucleus to cytoplasm and accumulates in stress granules in response 
to treatment with phorbol 12-myristate 13-acetate (PMA) or heat shock (Quaresma et al. 
2009). While, DDX5 has been shown to redistribute from the nucleus to the cytoplasm during 
HCV (Goh et al. 2004) and JEV infection (Li et al. 2013a). Therefore, I tested whether STING 
partners that were found to influence dsDNA or poly(I:C) stimulated IIR redistributed in 
response to immune stimulation. The nuclear/cytoplasmic distribution of SYNCRIP, MEN1, 
DDX5, and SNRNP70 was measured by immunofluorescence in mock, dsDNA, and poly(I:C) 
stimulated cells. The mean intensity values of nuclear localised signal, determined by a binary 
mask created from thresholding of DAPI signal, or mean intensity values of cytoplasmic signal, 
determined based on a binary mask created by thresholding partner protein signal minus 
DAPI binary mask, were measured using ImageJ (NIH). Co-staining with anti-IRF3 antibody was 
used where compatible with the STING partner antibody to confirm induction of IIR and allow 
for measurement of protein distribution in immune-stimulated cells only (Figure 4.12).  
SYNCRIP was predominantly nuclear in all conditions tested (73.6 % nuclear in mock 
stimulated cells) but partially redistributed to the cytoplasm in cells stimulated with dsDNA, 
~4.3 % more cytoplasmic compared to mock stimulated cells, although such redistribution 
was only modest, with most of the protein still present in the nucleus (69.3 % nuclear in 
dsDNA stimulated) (Figure 4.12 A). Since the SYNCRIP antibody recognises multiple SYNCRIP 
isoforms and the homologous hnRNP R protein, this assay does not show if a particular 
isoform of SYNCRIP changes distribution and moreover, changes in distribution could be 
masked by recognition of the nuclear localised hnRNP R. Similarly, MEN1 localised 
predominantly to the nucleus in all conditions but became slightly more cytoplasmic, ~3.5 %, 
in cells stimulated with poly(I:C) compared to mock stimulated cells (72.2 % nuclear in mock 
and 68.7% nuclear in poly(I:C) stimulated cells). No significant change in distribution was seen 
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in cells stimulated with dsDNA (70.2% nuclear), an unexpected finding given that MEN1 was 
found to influence IIR stimulated by dsDNA but not poly(I:C) (Figure 4.12 B). DDX5 localisation 
was not altered by immune stimulation with either dsDNA or poly(I:C), remaining almost 
entirely nuclear, >80 % nuclear in all conditions (Figure 4.12 C). SNRNP70 was also 
predominantly localised to the nucleus in all conditions, 66.8 % in mock and 66.3 % in dsDNA 
stimulated cells but became significantly more nuclear in cells stimulated with poly(I:C), 
71.9%, although again this effect was quite modest, ~6.1 % more nuclear (Figure 4.12 D).  
That these partners exhibited some redistribution could indicate a potential role of 
redistribution in IIR signalling as similarly small changes in phosphorylation state of proteins 
can have dramatic changes in a cellular phenotype. However, without further experimental 
evidence this remains speculative and the ~5 % shifts in distribution do not provide strong 
evidence that redistribution is associated with STING partner roles in innate immune 
signalling. As an alternative approach to measure the nuclear/cytoplasmic distribution of 
STING partner proteins in unstimulated and immune stimulated cells, nuclear and cytoplasmic 
fractions could be prepared, and Western blotting performed to determine localisation of 
partner proteins between nucleus and cytoplasm. This would be particularly informative in 
the case of SYNCRIP since the antibody used recognises multiple SYNCRIP isoforms which are 
reported to localise differently between nucleus and cytoplasm, the Q1 isoform is 
predominantly cytoplasmic while Q2 and Q3 are mostly nuclear, as well as the homologous 






Figure 4.12 – Nuclear/Cytoplasmic distribution of STING partners in mock and immune 
stimulated cells. (A) Nuclear/Cytoplasmic ratio of mean intensity values from SYNCRIP 
antibody staining in mock, dsDNA, or poly(I:C) stimulated cells (cells fixed 2 h post 
transfection). Representative micrographs show IRF3 and SYNCRIP staining in mock and 
dsDNA stimulated cells (nuclear IRF3 staining confirms innate immune stimulation, cells 
without nuclear IRF3 staining in dsDNA/poly(I:C) transfected cells were not measured). (B) 
Nuclear/Cytoplasmic ratio of mean intensity values from MEN1 antibody staining in mock, 
dsDNA, or poly(I:C) stimulated cells (cells fixed 2 h post transfection). Representative 
micrographs show MEN1 staining. (C) Nuclear/Cytoplasmic ratio of mean intensity values 
from DDX5 antibody staining in mock, dsDNA, or poly(I:C) stimulated cells (cells fixed 2 h post 
transfection). Representative micrographs show IRF3 and DDX5 staining. (D) 
Nuclear/Cytoplasmic ratio of mean intensity values from SNRNP70 antibody staining in mock, 
dsDNA, or poly(I:C) stimulated cells (cells fixed 2 h post transfection). Representative 
micrographs show SNRNP70 staining. Ordinary one-way ANOVA with Dunnett’s multiple 
comparisons test. ** p < 0.01, *** p < 0.001, ns = not significant p > 0.05. Error bars show 
standard deviation. Scale = 10 µM. 
4.12 – Chapter Summary 
In this chapter I investigated the role in IIR of several STING partners with potential links to 
IRF3/7 transcription factors. The most congruent findings show that SYNCRIP is a positive 
regulator of IIR triggered by dsDNA with SYNCRIP knockdown reducing activation of an NF-
κB/AP1 induced luciferase promoter, the activation of IRF3, and the expression of 
endogenous IFNβ and CCL5. The mechanism through which SYNCRIP mediates these effects 
remains unclear since an interaction between SYNCRIP and STING through 
coimmunoprecipitation could not be confirmed, although SYNCRIP and STING PLA indicates 
the proteins are in close proximity. SYNCRIP partially redistributed to the cytoplasm following 
immune stimulation with dsDNA but not poly(I:C), and because SYNCRIP effects were specific 
to dsDNA-stimulated IIR this data suggests that SYNCRIP could modulate the cGAS-STING DNA 
sensing pathway in the cytoplasm, upstream of IRF3 activation. MEN1 knockdown 
consistently impaired IIR signalling induced by dsDNA but not poly(I:C), with IRF3 activation 
and IFNβ and CCL5 expression reduced. That MEN1 knockdown reduced activation of the NF-
κB/AP1 luciferase reporter is slightly surprising because MEN1 has been reported to interact 
directly with and inhibit NF-κB subunits(Heppner et al. 2001). It is possible that MEN1’s 
function in activation of IRF3 is enough to counteract its repression of NF-κB explaining why I 
find it to be a positive factor for the induction of IFNβ. Since the cGAS-STING pathway 
primarily drives IRF3 activation over NF-κB activation in humans (de Oliveira Mann et al. 
2019), MEN1 could play a role in promoting IRF3 activation while simultaneously depressing 
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NF-κB to promote this outcome. As for the reduction in NF-κB/AP1 luciferase reporter 
activation with MEN1 knockdown, it is difficult to explain why NF-κB activity is not higher 
since it should be derepressed in the absence of MEN1. However, it is possible that most of 
the activation of this reporter through cGAS-STING activation comes via the AP1 transcription 
factor family and MEN1 is required for optimal activation of this pathway. DDX5 on the other 
hand appears to be a negative regulator of IIR, since DDX5 knockdown increased the 
expression of IFNβ stimulated by both dsDNA and poly(I:C). However, not all assay results 
agree with DDX5 being a negative regulator in dsDNA stimulated IIR since DDX5 knockdown 
also impaired activation of IRF3 and both luciferase reporters. These findings could be 
explained by considering that DDX5 knockdown appeared to cause a partial reduction in 
STING protein levels and so negative effects of DDX5 knockdown could be an indirect effect 
of reduced STING levels and impaired cGAS-STING signalling. Knockdown of SNRNP70 
consistently impaired IIR stimulated by dsDNA in all assays suggesting that SNRNP70 is a 
positive factor in the cGAS-STING pathway. Intriguingly SNRNP70 may function 
antagonistically in IIR triggered by dsRNA since IRF3 activation was increased in SNRNP70 
knockdown cells following poly(I:C) stimulation as much as in DDX5 knockdown cells. 
However, no effect was seen on IFNβ expression in SNRNP70 knockdown cells stimulated with 
poly(I:C), this could be because the timepoint at which IFNβ expression was measured was 
too early (4 h) and a difference might be seen at a later timepoint. A function for SNRNP70 in 
IIR stimulated by dsRNA would be supported by the finding that SNRNP70 becomes 
significantly more nuclear in cells stimulated with poly(I:C). Evidence from PLA is also 
strongest for an SNRNP70-STING interaction because the biggest discrepancy in average PLA 
foci per cell was seen for this pairing between siRNA control and cells treated with siRNAs 
against STING. Although, co-immunoprecipitation and PLA do not strongly support the 
interaction between STING and the partner proteins identified by cross-linking 
immunoprecipitation and mass spectrometry, there is some indication that at least MEN1 and 
SNRNP70 interact with STING since some MEN1 was pulled down by anti-STING antibody and 
STING knockdown partially reduced the number of PLA foci for both MEN1-STING and 
SNRNP70-STING pairs. 
While I have demonstrated that SYNCRIP, MEN1, and SNRNP70 are positive regulators of 
STING mediated IIR stimulated by dsDNA the mechanisms through which they effect IIR have 
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not been resolved. Likewise, I have shown that DDX5 is a negative regulator of IIR stimulated 
by dsDNA or poly(I:C) but have not resolved a mechanism through which DDX5 mediates 
these effects. Future experiments should investigate whether knockdown of these proteins 
affects levels of STING activation to determine whether they function upstream or 
downstream of STING. For example, levels of STING dimerization and phosphorylation, 
hallmarks of STING activation, following immune stimulation with dsDNA should be 
determined by Western blotting. Additionally, the percentage of cells with STING perinuclear 
foci, indicative of STING activation, in dsDNA stimulated cells knocked down for STING 
partners could be measured by immunofluorescence.  
Interestingly, DDX5 has recently been reported to be a negative regulator of type-I IFN 
responses stimulated by infection with the RNA virus, vesicular stomatitis virus (VSV), or the 
DNA virus, HSV-1, with DDX5 knockdown resulting in significantly higher IFNβ protein levels 
in mouse peritoneal macrophages infected with these viruses (Zan et al. 2020). My data 
showing that DDX5 knockdown results in higher levels of IFNβ mRNA following immune 
stimulation with dsDNA or poly(I:C) and that DDX5 knockdown restricts HSV-1 proliferation 
agree with this study. Moreover, the authors of this study show that levels of IRF3 
phosphorylation are elevated in VSV infected DDX5 knockdown cells in agreement with my 
data showing that levels of IRF3 phosphorylation are elevated in poly(I:C) stimulated DDX5 
knockdown cells. Additionally, the authors identify the serine/threonine-protein phosphatase 
2A catalytic subunit β (PP2A-Cβ) as an interactor of DDX5 and IRF3 and propose that DDX5 
deactivates IRF3 by recruiting PP2A-Cβ to dephosphorylate IRF3 and thus inhibit type-I IFN 
responses (Zan et al. 2020). However, the exact molecular mechanism through which this 
occurs remains to be elucidated. 
In order to reveal the direct mechanisms through which NE STING partners influence IIR, 
future studies should seek to identify interactors of STING partner proteins tested here 
through immunoprecipitation and mass spectrometry, comparing unstimulated cells to cells 
stimulated with dsDNA or poly(I:C). Furthermore, direct binding of dsDNA or poly(I:C) by 
partner proteins should be tested for example, by stimulating cells with biotin labelled 
dsDNA/poly(I:C) and performing co-immunoprecipitation experiments.  Although only DDX5 
was found to affect IFNβ induction following immune stimulation with poly(I:C), it is still 
possible that other STING partners are involved in IIR stimulated by dsRNA but are not 
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required for IFNβ induction following immune stimulation with poly(I:C) thus, whether they 
bind to poly(I:C) should be tested. Indeed, STING is required for restriction of many RNA 
viruses but is not necessary for induction of type-I IFN responses stimulated by poly(I:C). 
Although, whether STING is required for full induction of type-I IFN during RNA virus infection 
remains disputed (Ishikawa and Barber 2008; Zhong et al. 2008; Ishikawa et al. 2009; Sun et 
al. 2009; Sun et al. 2012; Yu et al. 2012; Aguirre et al. 2012; Li et al. 2013b; Holm et al. 2016; 
Franz et al. 2018). Therefore, it is possible that STING NE partners recognise dsRNA and 
through STING mediate antiviral effects that are distinct from IFNβ induction. 
Poly(I:C) is commonly used as a synthetic analogue of viral dsRNA to stimulate IFN responses 
and has been shown to primarily stimulate three dsRNA sensors: TLR3, RIG-I, and MDA-5 (Kato 
et al. 2006; Kato et al. 2008; Dauletbaev et al. 2015; Palchetti et al. 2015). Interestingly, 
different lengths of poly(I:C) have been shown to principally stimulate different dsRNA 
sensors with MDA-5 primarily activated by longer poly(I:C) >~1 kb while RIG-I primarily senses 
shorter lengths of poly(I:C) ~0.3-1 kb (Kato et al. 2008). I tested several formulations of 
poly(I:C) from different manufacturers and found that all induced the accumulation of IRF3 in 
the nucleus following transfection (data not shown). When run on an agarose gel these 
poly(I:C) formulations showed a range of sizes that varied between manufacturers (Figure 
4.13). In the end I opted to use a poly(I:C) formulation produced by Sigma-Aldrich which 
consisted of poly(I:C) of lengths ranging from ~0.5-1.5 kb since this length of poly(I:C) is 
principally recognised by RIG-I, and STING has been shown to interact with RIG-I but not MDA-
5 and thus is proposed to restrict viruses sensed by RIG-I but not those sensed exclusively 
through MDA-5 (Ishikawa and Barber 2008; Zhong et al. 2008; Ishikawa et al. 2009; Maringer 
and Fernandez-Sesma 2014; Ran et al. 2014).  
In addition to the activation of IRF3, poly(I:C) has also been shown to activate NF-κB driven 
inflammatory responses in airway epithelial cells (Dauletbaev et al. 2015) or to induce 
apoptosis in a TLR3 dependent manner in prostate cancer cell lines (Palchetti et al. 2015). 
Interestingly, the manner in which poly(I:C) is delivered to cells has been shown to effect 
which response dominates. Palchetti et al. found that poly(I:C) transfected using 
Lipofectamine 2000 or poly(I:C) added alone to cell culture medium is taken up through 
endocytosis where it sensed by TLR3, before being released into the cytoplasm where it 
activates RIG-I and MDA-5 sensors in the prostate cancer cell lines, PC3 and DU145. However, 
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transfected poly(I:C) localises more strongly in endosomes and drives more apoptosis through 
TLR3 than poly(I:C) delivered to cells without lipofectamine. Conversely, Dauletbaev et al. 
found that poly(I:C) delivered using liposome transfection more readily escaped endosomal 
compartments to stimulate RIG-I while poly(I:C) delivered without liposome transfection was 
retained in endosomes and signalled more through TLR3 to activate IRF3 and through an 
unidentified receptor to activate NF-κB. Thus, cell type used and mechanism of poly(I:C) 
delivery can activate different signalling pathways. In the future, both mechanisms of poly(I:C) 
delivery should be compared in the context of STING partner knockdown to determine 
whether this reveals a requirement of STING partners in signalling through a particular 
pathway in response to poly(I:C) stimulation. It is possible that differences in poly(I:C) used in 
experiments explain why I did not see redistribution of SYNCRIP to the cytoplasm following 
immune stimulation with poly(I:C) which had been described previously in the Schirmer lab 
(data not shown).  
. 
Figure 4.13 – Poly(I:C) displays a range of lengths that vary between manufacturers. (A) 
Poly(I:C) purchased from Sigma-Aldrich (SIGMA), InvivoGen (LMW - low molecular weight, 
HMW - high molecular weight), and Tocris Bioscience was run on an agarose gel to determine 
the range of lengths of the different poly(I:C) formulations. Poly(I:C) from Sigma-Aldrich was 
chosen for use in experiments. 
In summary, I have shown that NE STING partners, SYNCRIP, MEN1, and SNRNP70 are novel 
positive regulators of IIR triggered by dsDNA transfection and that DDX5 is a negative 
regulator of IIR stimulated by dsDNA or poly(I:C). However, one of the hypotheses at the start 
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of this chapter was that RNA-binding partners of STING in the NE could provide a mechanism 
through which STING antagonises RNA viruses. Since initial results stimulating STING partner 
knockdown cells with poly(I:C) did not indicate a positive role in regulating IIR for STING 
partners while in cells stimulated with dsDNA STING partners do play a positive role in 
regulating IIR, dsDNA triggered immunity was the main focus of this chapter. However, as 
discussed above just because STING partners are not involved in promoting IFNβ responses 
stimulated by transfected poly(I:C) does not mean that they do not play a role in STING 




Chapter 5  
SYNCRIP is a novel antagonist of influenza A virus (IAV) 
5.1 – Introduction 
In the previous chapter I explored the role of several NE STING partners in innate immune 
responses, showing that SYNCRIP, MEN1, and SNRNP70 promote innate immune signalling 
stimulated by dsDNA and that DDX5 antagonises immune signalling stimulated by dsDNA or 
poly(I:C). However, none of the partner proteins tested appear to promote immune signalling 
stimulated by poly(I:C), a dsRNA mimic. This could be taken to refute my initial hypothesis 
that NE STING partners might be involved in STING’s antagonism of RNA viruses since many 
of them are RNA binding proteins and so could be involved in sensing viral RNA. Nonetheless, 
it is possible that STING partners could still be involved in the antagonism of RNA viruses 
despite not being required for IFNβ induction in cells stimulated with poly(I:C) since STING 
appears to be involved in antagonising RNA viruses through mechanisms independent of IFNβ 
induction (Ishikawa et al. 2009; Li et al. 2013b; Franz et al. 2018). For example, it has been 
demonstrated that STING inhibits cellular translation in response to RNA virus infection or 
poly(I:C) transfection (Franz et al. 2018). Moreover, unlike transfection with poly(I:C), 
infection with an RNA virus presents the host cell with a more complex immune challenge 
which can activate STING-mediated signalling through different mechanisms. This includes 
through the detection of cytoplasmic dsDNA as a result of mitochondrial DNA leakage during 
infection with the RNA viruses, dengue virus (DENV), encephalomyocarditis virus (ECMV), or 
influenza A virus (IAV) (Aguirre et al. 2017; Sun et al. 2017; Moriyama et al. 2019), or through 
the recognition of virus-cell membrane fusion during IAV infection (Holm et al. 2016). 
Therefore, I proposed to test whether any of the STING partners found to be involved in 
innate immune signalling stimulated by either dsDNA or poly(I:C) played a role in antagonism 
of an RNA virus.  
Initially, I had wanted to use positive-sense single-stranded (+ssRNA), negative-sense single-
stranded (-ssRNA), and double-stranded RNA (dsRNA) viruses for infections, speculating that 
the different RNA genomes would provide a range of potential ligands to stimulate an innate 
immune response. However, it proved difficult to locally source multiple viruses and the 
expertise to work with them and so only IAV was used to test whether any of the STING 
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partners are involved in restricting RNA virus infection. Influenza viruses are -ssRNA viruses 
belonging to the Orthomyxoviridae family and are the causative agents of the respiratory 
disease influenza in birds and mammals. Three genera cause disease in humans, with the type 
A viruses the most virulent and causing the most severe disease. Influenza A viruses also infect 
birds and pigs, amongst other mammals, which cause them to be particularly dangerous since 
emergent viruses, which have novel surface glycoproteins against which human populations 
have little pre-existing immunity, have been known to arise from wild and farm animal 
reservoirs. The IAV genome is made up of eight -ssRNA segments packaged in viral 
ribonucleoprotein (vRNP) complexes which encode 10 major polypeptides but also several 
accessory gene products (Pinto et al. 2020). vRNPs consist of an individual viral RNA strand in 
an anti-parallel double helix structure bound by the viral polymerase at 5’ and 3’ ends and 
coated with nucleoprotein (NP) along its length (Fodor 2013; Te Velthuis and Fodor 2016). 
During infection, the IAV virion binds to sialic acid containing attachment factors on the cell 
surface through the viral glycoprotein, haemagglutinin (HA) (Sieben et al. 2020). The virion 
then enters the cell through endocytosis after engaging receptor-tyrosine kinases such as the 
epidermal growth factor receptor (EGRF) and is trafficked to the endosome. Within the 
endosome, the lowered pH causes a conformational change in HA that exposes the HA fusion 
peptide triggering fusion of viral and endosome membranes. vRNPs are consequently 
released into the host cell cytoplasm and trafficked to the nucleus where replication and 
transcription occur (Samji 2009; Dou et al. 2018). Replication within the nucleus is uncommon 
for an RNA virus but is part of what made using IAV to test whether NE STING partners restrict 
RNA viral proliferation more appealing, since a nuclear localisation of a viral RNA sensor could 
more readily allow for detection of IAV infection.  
Like all viruses, influenza viruses seek to antagonise the host innate immune response to allow 
for more successful replication and spread. Thus, much work has already been done on how 
the virus targets host proteins to inhibit the innate immune response.  The non-structural 
protein 1 (NS1) encoded by influenza viruses is the major antagonist of host cell immune 
responses, primarily through repression of the type-I/III IFN response (Ayllon and García-
Sastre 2015). NS1 consists of two functionally distinct domains joined by a short linker region, 
an N-terminal dsRNA binding domain (amino acids 1-73) and a C-terminal effector domain 
required for multiple protein-protein interactions (amino acids 85-end). Research indicates 
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that NS1 exerts its antagonistic effects at multiple levels in the IFN response signalling 
pathway triggered by cytosolic dsRNA: through inhibition of RIG-I signalling preventing IRF3 
and NF-κB activation; through binding CPSF30 to inhibit cellular mRNA polyadenylation and 
thereby the expression of cellular genes such as IFN; and by preventing activation of protein 
kinase R (PKR) and 2’-5’-oligo-adenylate synthetase (OAS) host immune response proteins 
(Ayllon and García-Sastre 2015).  
RIG-I is a key PRR which recognises cytoplasmic dsRNAs with 5’-triphosphates and upon 
activation binds to the MAVS adaptor protein, leading to the activation of IRF3, NF-κB, and 
AP1 (c-Jun/ATF-2) transcription factors which are critical for the induction of IFN gene 
expression (Yoneyama and Fujita 2009). RIG-I activation requires ubiquitination by the E3 
ubiquitin ligases TRIM25 (Gack et al. 2007) and RIPLET (Oshiumi et al. 2009) resulting in RIG-I 
oligomerisation and subsequent interaction with MAVS through the caspase activation and 
recruitment domains (CARDs) of both RIG-I and MAVS (Hou et al. 2011). IAV NS1 has been 
shown to bind TRIM25 (Gack et al. 2007) and RIPLET (Rajsbaum et al. 2012) thereby 
suppressing RIG-I ubiquitination and downstream signalling. However, not all IAV strains 
efficiently block RIG-I mediated signalling and IFNβ transcription. Specifically, NS1 proteins 
from seasonal H3N2 and H2N2 viruses do not block activation of IRF3 and IFNβ transcription, 
while the NS1 proteins from H5N1 viruses and some seasonal H1N1 viruses do block IRF3 
activation and IFNβ transcription (Kuo et al. 2010). Intriguingly, TRIM25 binding activity is 
retained by NS1 proteins that do not suppress RIG-I signalling demonstrating that TRIM25 
binding does not always lead to inhibition of IRF3 activation (Kuo et al. 2010) 
As another means of suppressing the IFN response, the NS1 protein of several strains of IAV 
bind to the CPSF30 protein which is required for polyadenylation of host pre-mRNAs and 
production of mature mRNAs. In doing so NS1 blocks the production of IFNβ and other 
antiviral proteins since pre-mRNAs cannot be processed and therefore no translation can 
occur (Nemeroff et al. 1998; Noah et al. 2003). However, the NS1 proteins encoded by some 
H1N1 strains lack this ability and so rely on suppression of RIG-I signalling to inhibit IFN 
production (Kochs et al. 2007; Ayllon and García-Sastre 2015). 
NS1 has also been shown to inhibit the activity of other antiviral proteins including PKR and 
OAS. PKR belongs to a family of eukaryotic translation initiation factor 2-alpha (eIF2α) kinases 
which phosphorylate eIF2α in response to a range of stimuli thereby inhibiting translation. 
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PKR is constitutively expressed in a latent form that is activated upon dsRNA binding leading 
to translational inhibition (Bevilacqua and Cech 1996). Moreover, PKR is also an interferon 
stimulated gene, so its expression is increased following stimulation with IFN. In addition to 
antagonising RNA virus infection through translational repression, PKR appears to be required 
for optimal IFNβ induction through RIG-I/MDA-5-MAVS signalling pathways (Pfaller et al. 
2011; Hur 2019). NS1 binds PKR through an interaction that involves NS1 residues 123-127 
which is thought to prevent the activating conformational change that occurs in PKR following 
dsRNA binding (Li et al. 2006; Min et al. 2007). OAS is another interferon stimulated gene 
which upon activation by dsRNA binding synthesises 2’-5’-oligoadenylate chains that activate 
latent RNase L. Active RNase L degrades ssRNA in the cytoplasm restricting viral proliferation 
(Hornung et al. 2014) and in turn  RNA fragments generated by RNase L may serve as ligands 
of the RIG-I-MAVS pathway, amplifying antiviral signalling (Malathi et al. 2007). NS1 does not 
directly bind to OAS or RNase L but it is proposed that NS1 sequesters dsRNA ligands away 
from OAS preventing its activation, since the replication of an IAV encoding an NS1 RNA-
binding mutant (R38A) is enhanced in the absence of RNase L (Min and Krug 2006).  
In this chapter, I first tested if HT1080 cells are competent for IAV infection and proliferation 
since I had established that this cell line has a functional cGAS-STING pathway, and then used 
this to confirm findings from previous studies that STING restricts IAV. Subsequent screening 
of NE STING partners for an effect on IAV infection identified SYNCRIP as a novel restriction 
factor of IAV. Because SYNCRIP has multiple splice variants and it was difficult to be certain 
that all splice forms were knocked down by siRNA treatment, I further generated a SYNCRIP-
/- HT1080 cell line by CRISPR/Cas9 gene editing that confirmed that SYNCRIP restricts IAV in 
HT1080 cells. I also tested STING and SYNCRIP for an interaction during infection with IAV by 
co-immunoprecipitation and tested by RNA-immunoprecipitation whether SYNCRIP or STING 
bind viral RNA. SYNCRIP levels and localisation were also measured over the course of 
infection as this could inform on SYNCRIP function during infection.  
5.2 – IAV infects and replicates in HT1080 cells 
Since HT1080 cells had been used for most assays assessing whether STING partners 
contribute to innate immune response and confirmed to have a functional cGAS-STING 
pathway it would be ideal to use them for IAV infection experiments. However, IAV typically 
infects cells of the respiratory system and most in vitro models use lung cell lines; so whether 
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IAV would infect HT1080 cells, a fibrosarcoma cell line, was not known. Therefore, I first 
tested whether the mouse-adapted strain of IAV, A/Puerto Rico/8/1934 H1N1 (referred to as 
PR8 from now on), would infect and proliferate in HT1080 cells (Figure 5.1 A). After 24 h cell 
supernatants contained significantly more virus as measured by an increase in the number of 
plaque-forming units (PFU) per mL, demonstrating that IAV replicated and produced progeny 
virus in HT1080 cells (Figure 5.1 A and B). IAV infection in HT1080 cells was also visualised by 
immunofluorescence using antibody against viral protein NP (Figure 5.1 C). Earlier during 
infection NP staining was mostly localised to the nucleus indicating vRNA replication and 
transcription are taking place, while at later timepoints during infection NP staining mostly 
localised to the cytoplasm indicative of assembly of progeny virions as would be expected 
with productive IAV infection. Western blotting against viral proteins, NP and NS1, in IAV 
infected lysates collected at the indicated timepoints during infection also shows that IAV 
replicates in HT1080 cells (Figure 5.1 D).  
  
Figure 5.1 – Influenza A virus (IAV) infects and proliferates in HT1080 cells. (A) Example 
plaque assay showing formation of viral plaques on a confluent monolayer of MDCK cells 
stained with toluidine blue. Serial dilution of supernatant from infected HT1080 cells collected 
at 0 and 24 hours post infection (hpi) shows that supernatants collected at 24 hpi contain > 
1000x more infectious particles than at 0 hpi. (B) Quantitation of plaque forming units (PFU) 
per mL of supernatant calculated from plaque assays such as those shown in (A) shows that 
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PR8 infects and proliferates in HT1080 cells. PFU is calculated by counting the number of 
plaques at a dilution that yields between 10 and 100 plaques divided by the dilution factor, D, 
of that well multiplied by the volume, V, of diluted virus added to each well during the plaque 
assay (PFU/mL = no. of plaques/(D x V). MOI is multiplicity of infection, the number of PFU per 
cell used in initial infection. Unpaired t-test, * p < 0.05, n = 3. (C) Immunofluorescence 
micrographs showing infection of HT1080 cells with IAV (PR8) MOI – 1, NP is viral 
nucleoprotein expressed only in infected cells. Scale = 10 µM. (D) Western blotting of HT1080 
cell lysates collected at multiple time points during infection show successful viral infection 
with infected cells expressing viral proteins NP and NS1, MOI – 1. 
5.3 – STING restricts IAV growth in HT1080 cells 
STING knockdown enhances IAV replication in murine embryonic fibroblasts (MEFs) (Franz et 
al. 2018) and chicken DF-1 cells (Cheng et al. 2015), and IAV titres are significantly higher in 
the lungs of infected STING knockout mice compared to wild type mice (Moriyama et al. 
2019). However, whether STING knockdown results in higher viral titres in IAV infected human 
cells has not been tested, although since IAV infection has been shown to activate STING 
dependent IFN induction in human cell lines (Holm et al. 2016; Moriyama et al. 2019) it is 
expected that STING knockdown would result in higher IAV titres compared to control siRNA 
treated cells. Indeed, in HT1080 cells treated with siRNAs against STING and infected with IAV 
(PR8) titres were significantly higher 16 hpi compared to control cells (Figure 5.2 A). 
Interestingly, this appears to be a strain specific effect since in cells infected with IAV strain, 
A/Udorn/1972 (H3N2) (referred to as Udorn from now on), no significant difference was seen 
in viral titres from infected cells treated with control or STING-specific siRNAs (Figure 5.2 B). 
This could be as a result of differences in how the NS1 proteins of PR8 and Udorn strains 
antagonise the IFN response. The NS1 of Udorn is able to bind to CPSF30 and therefore 
prevent translation of host mRNAs such as IFN whereas the NS1 of PR8 lacks this binding 
capability (Kochs et al. 2007; Ayllon and García-Sastre 2015). Instead PR8 NS1 primarily exerts 
it negative effects on IFN induction through inhibiting RIG-I signalling (Mibayashi et al. 2007; 
Opitz et al. 2007). Conversely, Udorn NS1 does not inhibit RIG-I signalling and IRF3 activation 
(Kuo et al. 2010; Krug 2015). In Udorn infected cells any STING-mediated antagonism of viral 
growth is presumably inhibited by NS1; so whether or not STING is present does not affect 
viral proliferation, whereas in PR8 infection STING is able to restrict viral growth through 
mechanisms which are not successfully overcome by PR8 NS1. 
121 
 
Figure 5.2 – STING restricts influenza A virus (IAV) strain PR8 but not Udorn. (A) PR8 viral 
titres from infected control (siCTL) and STING knockdown (siSTING) HT1080 cells show that 
titres are significantly higher 16 hours post infection (hpi) in siSTING cells compared to siCTL 
cells (bar chart, left panel). Time course experiment shows viral growth in siCTL and siSTING 
cells (right panel). MOI – 3. Unpaired t-test, * p < 0.05, n = 5 (B) Udorn viral titres from infected 
siCTL and siSTING cells show that titres are unaffected at 16 hpi in siSTING cells compared to 
siCTL cells (bar chart, left panel). Time course experiment shows viral growth in siCTL and 
siSTING cells (right panel). MOI – 3. Unpaired t-test, NS (not significant) p > 0.05, n = 3.     
5.4 – SYNCRIP restricts IAV growth in HT1080 cells 
With IAV confirmed to proliferate in HT1080 cells and STING knockdown shown to increase 
IAV PR8 titres in infected cells, I next tested whether any NE STING partners, found to have a 
role in innate immune responses in the previous chapter, also had an effect of IAV 
proliferation. HT1080 cells treated with siRNAs against STING partners were infected with PR8 
at an MOI of 0.01 and viral titres in cell culture supernatants measured at 24 hpi. Titres from 
cells treated with siRNA against SYNCRIP were significantly higher (~3.5x) than from cells 
treated with control siRNA (Figure 5.3 A). Infections were initially performed using a low MOI 
so that not all cells were infected allowing for multiple rounds of viral growth cycles and 
subsequent infections of uninfected cells in the culture. However, titres from HT1080 cells 
treated with siRNAs against STING partners and infected with IAV at low MOI were quite low 
(< 10,000 PFU/mL at 24 hpi). Therefore, the effect of SYNCRIP knockdown on IAV proliferation 
was separately confirmed in cells infected at a higher MOI of 3 in which all cells in the culture 
should be simultaneously infected. Titres from cells treated with siRNA against SYNCRIP were 
significantly higher (~3x) than from cells treated with control siRNA at 16 hpi in cells infected 
with PR8 at MOI of 3 (Figure 5.3 B).  
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Figure 5.3 – STING partner SYNCRIP restricts influenza A virus (IAV) strain PR8. (A) PR8 viral 
titres measured from infected control (siCTL) and STING partner knockdown HT1080 cells show 
that titres are significantly higher at 24 hours post infection (hpi) in SYNCRIP knockdown cells 
compared to siCTL cells. MOI – 0.1. Ordinary one-way ANOVA with Dunnett’s multiple 
comparisons test. ** p < 0.01, ns (not significant) p > 0.05. n = 3. (B) PR8 viral titres measured 
from infected control (siCTL) and SYNCRIP knockdown (siSYNCRIP) HT1080 cells confirms that 
titres are significantly higher in SYNCRIP knockdown cells compared to siCTL cells in at 16 hpi 
in cells infected at a higher MOI of 3 (Bar chart, left panel). Time course experiment shows 
viral growth in siCTL and siSYNCRIP cells (right panel). MOI – 3. Unpaired t-test. * p < 0.05, ns 
(not significant) p > 0.05.  
5.5 – SYNCRIP knockdown effect on IAV titres is increased in cells infected with IAV (PR8) 
NS1 mutants 
Since IAV is able to antagonise the host cell immune response it is possible that SYNCRIP 
antiviral effects are reduced by the virus. NS1 is the principal protein used by IAV to 
antagonise the host cell defences and so SYNCRIP knockdown cells were also infected with 
PR8 NS1 mutant viruses. Both a virus encoding a mutant NS1 in which the R38 and K41 
residues are mutated to alanine (R38K41A) and a virus encoding an NS1 truncation mutant 
with only the first 81 amino acids (N81) grew to higher titres in SYNCRIP knockdown cells than 
control cells, when compared to cells infected with PR8 with wild type NS1, ~4x and ~6x higher 
for R38K41A and N81 mutants respectively (Figure 5.4). Although an unpaired t-test 
comparing mean titres in SYNCRIP and control knockdown cells infected with R38K41A gives 
a p value just above the 0.05 threshold of significance (Figure 5.4 A), a ratio-paired t-test gives 
a strongly significant difference (p = 0.0008). This difference in significance with different tests 
is due to a large variance in the titre values between biological repeats for both control and 
SYNCRIP knockdown samples. Since SYNCRIP knockdown titres are consistently ~4x higher 
than control titres for each biological repeat, the ratio-paired t-test is an appropriate 
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statistical test to perform and supports a significant difference between samples. 
Interestingly the difference in IAV titres between SYNCRIP and control knockdown samples 
was greatest for the N81 NS1 mutant (Figure 5.4 B). The R38K41A NS1 mutant lacks capability 
for dsRNA binding and is unable to interact with RIG-I, TRIM25 and RIPLET, greatly diminishing 
its ability to block IFN production (Wang et al. 1999; Rajsbaum et al. 2012; Ayllon and García-
Sastre 2015). Conversely the N81 NS1 mutant is able to bind dsRNA but lacks the entire 
effector domain which is required for most protein-protein interactions including with 
TRIM25 and PKR, impairing its ability to restrict IFN production. That the difference in mutant 
virus titres between control and SYNCRIP knockdown cells (~4x higher R38K41A, ~6x higher 
N81) is increased relative to the difference in wild type PR8 titres between control and 
SYNCRIP knockdown cells (~3x higher) suggests that SYNCRIP could be partially involved in the 
RIG-I signalling pathway since both mutant viruses lack the ability to impair RIG-I signalling. 
The N81 virus is also impaired in its ability to antagonise PKR which may explain why the 
difference in N81 titres is even greater between control and SYNCRIP knockdown cells (Li et 
al. 2006; Min et al. 2007) and could suggest that SYNCRIP is also involved in PKR mediated 
viral antagonism. 
 
Figure 5.4 – Effect of SYNCRIP knockdown on influenza A virus (IAV) titres is increased in 
HT1080 cells infected with PR8 encoding NS1 mutants. PR8 viruses encoding mutant NS1 
proteins R38K41A (A) and N81 (B) grow to significantly higher titres in SYNCRIP knockdown 
cells compared to control knockdown cells (siCTL) at 16 hpi (bar charts, left panels), ~4x higher 
for R38K41A and ~6x higher for N81 mutant viruses. Time course experiments shows viral 
growth in siCTL and siSYNCRIP cells (right panels). MOI – 3. Unpaired t-test. * p < 0.05, ns (not 
significant) p > 0.05. n = 3. 
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5.6 – Simultaneous knockdown of SYNCRIP and STING increases IAV titres compared to 
knockdown of STING alone 
Since knockdown of STING increased viral titres of PR8 but not Udorn infected cells, whether 
knockdown of SYNCRIP affects proliferation of the Udorn was also tested. Amongst other 
differences with PR8, Udorn expresses an NS1 protein capable of binding CPSF30 and in doing 
so inhibiting cellular translation. Similar to knockdown of STING, SYNCRIP knockdown did not 
have a significant effect on Udorn proliferation 16 hpi in in HT1080 cells infected with an MOI 
of 3 (Figure 5.5 A). This could suggest that STING and SYNCRIP restrict IAV through related 
mechanisms, although it is also possible that Udorn is able to overcome separate inhibitory 
effects of both proteins. To test whether SYNCRIP and STING restrict IAV through the same 
pathway, simultaneous knockdown of SYNCRIP and STING was tested for an effect on PR8 
proliferation. In cells treated with siRNAs against SYNCRIP and STING PR8 grew to significantly 
higher titres (ratio-paired t-test) compared to cells treated with control and STING siRNAs 
(Figure 5.5 B). This suggests that SYNCRIP at least partially restricts IAV independently of 
STING. However, it is also possible that SYNCRIP exerts antiviral effects through multiple 
mechanisms only some of which are dependent on STING. Simultaneous knockdown of STING 
and SYNCRIP was confirmed by Western blotting (Figure 5.5 C). It should be noted that STING 
protein levels in SYNCRIP and STING double knockdown cells are slightly lower than in control 
siRNA and STING knockdown cells. Thus, another possible explanation for the increase in IAV 
titres seen in SYNCRIP and STING double knockdown cells compared to STING only knockdown 




Figure 5.5 – Dual knockdown of SYNCRIP and STING results in higher viral titres compared 
to STING knockdown alone. (A) Udorn titres are not significantly higher in SYNCRIP 
knockdown cells (siSYNCRIP) compared to control knockdown (siCTL) cells at 16 hpi (bar chart, 
left panel). Time course experiment shows viral growth in siCTL and siSYNCRIP cells (right 
panel). MOI – 3. Unpaired t-test. ns (not significant) p > 0.05. n = 3. (B) Simultaneous 
knockdown of STING and SYNCRIP result in higher viral titres (IAV PR8) compared to STING 
knockdown cells at 16 hpi (bar chart, left panel). Time course experiment shows viral growth 
in STING and SYNCRIP knockdown cells compared to STING only knockdown cells (right panel). 
MOI – 3. Ratio-paired t-test. * p < 0.05. n = 2. (C) Western blotting confirms knockdown of 




5.7 – An interaction between SYNCRIP and STING during IAV infection cannot be identified 
by immunoprecipitation 
Although I was unable to see an interaction between SYNCRIP and STING by co-
immunoprecipitation of endogenous proteins (Figure 4.10) this could reflect that the 
interaction identified in initial the mass spectrometry experiment used to identify NE STING 
partners was pushed by overexpression of STING and possible altered interactions of the 
STING-GFP.  It is also possible that since a reverse cross-linking approach was used the 
interactions are quite indirect and this was only picked up because another protein that binds 
STING directly also binds another protein that binds SYNCRIP directly. However, it is also 
possible that a more direct interaction occurs that is just transient or happens under certain 
conditions such as virus infection. If this latter possibility was true, then infection with IAV 
might drive a STING-SYNCRIP interaction. Therefore, immunoprecipitation with STING or 
SYNCRIP antibodies was performed on whole cell lysates from mock or IAV (PR8) infected 
HT1080 cells 3 hpi. Endogenous STING and SYNCRIP did not co-immunoprecipitate one 
another even with IAV infection (Figure 5.6 A). It is possible that an interaction between 
SYNCRIP and STING cannot be seen by immunoprecipitation against endogenous proteins but 
might be seen with overexpressed proteins. Therefore, FLAG-tagged SYNCRIP constructs of 
isoforms Q1 and Q3, which were the isoforms most depleted by SYNCRIP siRNA treatment, 
were overexpressed in HEK293T cells along with a STING-GFP construct (in order to more 
closely follow the experimental set-up used in the mass spectrometry experiment) and whole 
cell lysates were used for immunoprecipitation. Western blotting using an anti-FLAG antibody 
confirmed that SYNCRIP-FLAG constructs were expressed and produced proteins of the 
expected molecular weight for both SYNCRIP Q1 and Q3 isofroms, ~66 kDa and ~73 kDa 
respectively (Lamin A expected molecular weight ~70 kDa) (Figure 5.6 B). 
Immunoprecipitation was then performed using anti-FLAG and anti-GFP antibody on HEK293T 
cell lysates from mock and IAV infected cells transiently overexpressing STING-GFP and 
SYNCRIP Q1-FLAG (Figure 5.6 C) or SYNCRIP Q3-FLAG (Figure 5.6 D). No co-
immunoprecipitation was evident from cells overexpressing STING-GFP and either FLAG-
tagged SYNCRIP isoforms. Immunoprecipitation and Western blotting in non-transfected cells 




Figure 5.6 – Co-immunoprecipitation experiments do not show an interaction between 
SYNCRIP and STING during influenza A virus (PR8) infection. (A) Endogenous SYNCRIP and 
STING do not co-immunoprecipitate in IAV (PR8) infected HT1080 whole cell lysates. (B) 
Western blotting confirms expression of FLAG-tagged SYNCRIP isoforms Q1 and Q3 in 
HEK293T cells. (C) SYNCRIP Q1-FLAG and STING-GFP do not co-immunoprecipitate in mock or 
IAV (PR8) infected HEK293T whole cell lysates. (D) SYNCRIP Q3-FLAG and STING-GFP do not 
co-immunoprecipitate in mock or IAV (PR8) infected HEK293T whole cell lysates. Cells infected 
with IAV (PR8) at MOI of 5 and whole cell lysates collected at 3 hours post infection. MOI of 5 
was used to be confident that all cells in culture were infected with IAV (E) FLAG and GFP 
antibodies do not recognise proteins in non-transfected HEK293T whole cell lysates (same 





5.8 – SYNCRIP and STING do not bind IAV mRNAs from segment 5 and 7 
SYNCRIP is a conserved RNA-binding protein involved in a number of fundamental RNA 
processes including pre-mRNA splicing (Mourelatos et al. 2001; Chen et al. 2008), mRNA 
editing (Blanc et al. 2001), mRNA transport (Bannai et al. 2004; Kanai et al. 2004), translation 
(Kim et al. 2012), and mRNA degradation (Kuchler et al. 2014). Functionally, SYNCRIP binds to 
a diverse range of RNA sequences including, polyA sequences (Svitkin et al. 2013), UCUAUC-
containing splicing regulatory elements (Kabat et al. 2009), and GGCU/A sequences present 
in a subset of miRNAs that are sorted into exosomes by a mechanism dependent on SYNCRIP 
(Santangelo et al. 2016; Hobor et al. 2018). More specifically in the context of RNA virus 
infection, SYNCRIP has been shown to bind to hepatitis C virus (HCV) (Kim et al. 2004; Liu et 
al. 2009) and murine hepatitis virus (MHV) RNA (Choi et al. 2004), although in these viruses it 
plays a pro-viral role promoting viral RNA translation (HCV) and replication (HCV and MHV). 
Therefore, I postulated that SYNCRIP may bind to IAV RNA and since SYNCRIP knockdown 
promotes IAV infection that SYNCRIP binding of IAV RNA could restrict viral infection, 
potentially through activating STING signalling. As a way to assess whether SYNCRIP or STING 
bind viral RNA during IAV infection, a native RNA immunoprecipitation (RIP) assay was 
performed. Since both SYNCRIP and STING antibodies successfully immunoprecipitate their 
target proteins (Figure 5.6 A), antibodies against endogenous proteins were used. STING has 
been reported not to bind the dsRNA mimic, poly(I:C), and so it was principally included as a 
negative control, however, whether STING binds IAV RNA has never been directly tested so it 
is possible STING could bind to specific viral RNA features or sequences. Cell lysates were 
collected from mock and IAV infected cells (3 hpi, MOI of 5) and immunoprecipitation 
performed in the presence of RNase inhibitors. Total RNA was isolated using TRIzol reagent 
and mRNA subject to reverse transcription to make cDNA. Primers were designed against two 
different IAV genome segments, segment 5 and segment 7 which encode NP and M1/M2 
proteins respectively, and PCR performed to produce specific amplicons for segment 5 (1, 1.5, 
and 0.5 kb) and segment 7 (0.75 and 1 kb). Primers were designed against segment 5 and 7 
RNAs specifically since NP and M1 proteins are particularly abundant during IAV infection with 
NP required for packaging of the viral genome and M1 protein forming the matrix underlying 
the viral envelope, thus segment 5 and 7 mRNAs were also predicted to be more abundant 
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(Dou et al. 2018). All primer pairs successfully produced amplicons of expected size for both 
segments 5 and 7 as shown by a discreet band identified in input lanes of IAV infected cell 
lysates but not mock infected cells (black arrowheads - Figure 5.7 A, segment 5 and Figure 5.7 
B, segment 7). However, no amplicons were detected by PCR in either SYNCRIP or STING 
immunoprecipitation lanes indicating that neither SYNCRIP nor STING bind to IAV mRNAs 
produced from segment 5 or 7. To rule out the possibility that RNA had degraded during the 
immunoprecipitation steps, total RNA was also isolated from the first washes after antibodies 
were incubated with cell lysates. Assessment of RNA integrity shows that 28S and 18S rRNAs 
are intact in all wash samples as well as inputs (Figure 5.7 C) and this indicates that IAV 
segment 5 and 7 mRNAs should also be intact. Although this assay would suggest neither 
SYNCRIP nor STING bind to viral RNA there are several caveats of this method. Firstly, native 
RIP was performed using endogenous proteins and if there are transient or weak RNA-
SYNCRIP/STING interactions these might be better identified if cross-linking was performed 
prior to cell lysis or if SYNCRIP and STING were overexpressed as tagged proteins. Secondly, 
it is possible that SYNCRIP or STING bind IAV RNAs other than mRNAs produced from segment 
5 or 7, since only mRNA was reverse transcribed to make cDNA from total extracted RNA and 
only primers to produce amplicons from these segments were used for PCR. Thus, if SYNCRIP 
or STING bound other viral RNA species/segments this experiment would not identify them. 
Thirdly, it is possible that binding of viral RNA by SYNCRIP or STING alters the epitope 
recognised by the antibodies used for immunoprecipitation preventing the pulldown of 
proteins bound to RNAs, the use of tagged proteins for RNA pulldowns would alleviate this 
problem. However, since this assessment of vRNA binding by SYNCRIP did not yield positive 




Figure 5.7 – RNA-immunoprecipitation experiments do not show an interaction between 
SYNCRIP or STING with tested segments of influenza A virus (PR8) mRNA. Endogenous 
SYNCRIP and STING were immunoprecipitated from mock or IAV (PR8) infected whole cell 
lysates 3 hpi. Total RNA associated with pulled down proteins was isolated using TRIzol 
reagent and mRNA reverse transcribed to make cDNA. PCR using primers against viral mRNAs 
from segment 5 (A) or segment 7 (B) identify viral mRNA in infected whole cell lysates used as 
inputs for immunoprecipitation but not SYNCRIP, STING, or control IgG pulldown samples or 
mock infected whole cell lysates. Three amplicons were designed against segment 5 (1, 1.5, 
and 0.5 kb) and two amplicons against segment 7 (0.75 and 1 kb). (C) RNA integrity was 
checked after pulldowns with antibodies by extracting total RNA in the first washes of whole 
cell lysates incubated with antibodies and protein G DynabeadsTM. Total RNA run on agarose 
gel confirms that 28S and 18S rRNA are intact suggesting little or no RNA degradation 
occurred during antibody incubation steps. 
5.9 – SYNCRIP protein levels and localisation during IAV infection 
The interaction between virus and host can be thought of in the context of an evolutionary 
arms race in which host cells have evolved to detect and restrict viral infection, while viruses 
have evolved to inhibit host cell detection and improve proliferation (Hoffmann et al. 2015). 
As already mentioned, the NS1 protein of IAV is a major antagonist of the host cell immune 
response through inhibition of RIG-I activation and IFN translation (Ayllon and García-Sastre 
2015). Furthermore, the HA fusion peptide binds STING directly preventing STING 
dimerization and activation during infection with IAV (Holm et al. 2016). Since I have found 
that SYNCRIP restricts IAV infection it is reasonable to speculate that IAV strains with 
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mutations that enable the inhibition of SYNCRIP antiviral functions will be selected. This is 
supported by the finding that IAV grows to higher titres in SYNCRIP knockdown cells compared 
to control cells infected with PR8 NS1 mutant strains relative to cells infected with wild type 
PR8 (Figure 5.3 and 5.4). That no such difference is seen for control and SYNCRIP knockdown 
cells infected with Udorn (Figure 5.5) might suggest that Udorn has evolved to be able to 
restrict SYNCRIP antiviral functions more effectively than PR8. In order to look at whether IAV 
targets SYNCRIP, I assessed SYNCRIP protein levels by Western blotting during infection with 
PR8, anticipating that SYNCRIP might be degraded during the time-course of infection. 
However, no reduction of SYNCRIP isoforms was apparent in cells infected with PR8, marked 
by the detection of NS1 and NP protein at later timepoints, compared to mock infected cells 
or earlier timepoints (Figure 5.8 A). It is possible that no changes in SYNCRIP protein levels 
during infection were detected because only a subset of cells are infected and so any changes 
in infected cells are masked by a background of mostly non-infected cells. Therefore, 
immunofluorescence against viral protein NP was performed to assess the proportion of cells 
that were infected 24 hpi and different MOI were used to get more cells infected. When using 
an MOI of 3 as for detection of viral protein in cell lysates, surprisingly few cells stained 
positively for NP protein in HT1080 cells, since an MOI of 3 should result in nearly all cells in 
culture being infected (Figure 5.8 B). HEK293T cells similarly infected at an MOI of 3 showed 
more NP positive cells 24 hpi, although notably not all cells were infected as would be 
expected at this MOI. The proportion of NP positive cells at 24 hpi could be increased in 
HT1080 cells by increasing the inoculum to an MOI of 10, although still some cells remained 
infected. Therefore, it is possible that when assessing whole cell lysates for an effect on 
SYNCRIP protein levels during infection any decrease or increase was not seen at an MOI of 
3. That HT1080 cells are less readily infected than HEK293T cells is interesting and could be 
due to a lower abundance of suitable cell surface receptors for IAV to bind or because HT1080 




Figure 5.8 – SYNCRIP protein levels do not change during influenza A virus (IAV) infection. 
(A) Western blotting shows that SYNCRIP protein levels are unaltered during infection with 
IAV (PR8) compared to mock infected cells, staining against NP and NS1 viral proteins confirms 
IAV infection. MOI – 3. (B) Immunofluorescence against NP in IAV (PR8) infected HEK293T and 
HT1080 cells shows that most HT1080 cells are not infected at an MOI of 3 and even increasing 
to an MOI of 10 does not result in all cells showing infection. MOI indicated in figure, cells fixed 
and stained 24 hpi. Scale = 10 µM. 
Since no alteration in SYNCRIP protein levels was evident by Western blot, I also used 
immunofluorescence staining to study the localisation of SYNCRIP during an infection time 
course with IAV. Although, immunofluorescence is not especially suitable for commenting on 
protein abundance, any changes in SYNCRIP localisation could be informative as to the 
mechanism through which SYNRIP restricts IAV infection. No consistent difference was seen 
for SYNCRIP localisation in IAV infected cells compared to mock infected cells (Figure 5.9 A). 
However, in several cells infected with IAV, SYNCRIP localisation to the cytoplasm appears 
reduced relative to non-infected cells in the same field of view (Figure 5.9 B, white arrows). 
This phenotype was only seen at later timepoints during infection (16 and 24 hpi) and was not 
apparent in all infected cells. From this data it is not possible to say whether this change in 
SYNCRIP localisation by immunofluorescence is actually reflective in a redistribution to the 
nucleus or a reduction in cytoplasmic SYNCRIP as a result of specific isoform degradation. 
Alternatively, cell membrane integrity may be compromised at later timepoints during 
infection leading to a loss of protein from the cytoplasm, or epitopes recognised by anti-
SYNCRIP antibody could be masked at specific time points during infection. Nonetheless, 
whether or not SYNCRIP localisation changes during infection or whether specific SYNCRIP 
isoforms are targeted during infection warrants further study. In particular, future 
experiments should use expression of FLAG-tagged isoforms of SYNCRIP to evaluate whether 
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particular isoforms change distribution during infection. As noted in the previous chapter, the 
different isoforms of SYNCRIP localise to different cellular compartments, with the Q1 isoform 
predominantly cytoplasmic while Q2 and Q3 are mostly nuclear, while the highly homologous 
hnRNP R also recognised by the SYNCRIP antibody is a nuclear protein (Chen et al. 2008; 
Cappelli et al. 2018). Since the Q1 isoform is the most depleted by siRNA treatment (Figure 
4.3) and there is some evidence that cytoplasmic SYNCRIP staining is reduced during IAV 
infection I would hypothesise that the Q1 isoform is required for restriction of IAV and may 




Figure 5.9 – SYNCRIP localisation during influenza A virus (IAV) infection. (A) In most infected 
cells (marked by NP antibody staining) SYNCRIP localisation is not altered at various time 
points in infection. (B) In some cells, at later timepoints in infection (16 and 24 hpi), SYNCRIP 
antibody staining appears more nuclear with a loss of cytoplasmic staining (white arrows) 
compared to non-infected cells (no NP staining) in the same field of view. Scale = 10 µM. 
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5.10 – Generation of SYNCRIP-knockout HT1080 cells 
In order to confirm that the effect of SYNCRIP knockdown on IAV titres was a result of 
reducing SYNCRIP protein levels and not an indirect effect of the siRNA itself, I decided to 
generate a SYNCRIP knockout cell line using CRISPR/Cas9. Two guide RNAs (gRNA) targeting 
exons 3 and 6 of the SYNCRIP gene in the human genome were selected using the Synthego 
CRISPR Design Tool (Synthego, CA 
https://www.synthego.com/products/bioinformatics/crispr-design-tool) (Figure 5.10 A). 
Both exons are included in the majority of SYNCRIP isoforms and so knockout should affect 
all major isoforms (Q1, Q2, and Q3). Two gRNAs were designed because gRNA#1, which 
targets a region in exon 3, was not predicted to have high activity while gRNA#2, which targets 
a region in exon 6, was predicted to have high activity but does not target an early exon and 
may result in truncated SYNCRIP proteins which retain some activity. gRNAs were cloned into 
individual plasmids which co-express Cas9 fused to GFP allowing for selection of positively 
transfected cells based on GFP signal (Ran et al. 2013). HT1080 cells were transfected either 
with plasmids encoding gRNA#1 or gRNA#2 alone or with both plasmids and subject to 
fluorescence activated cell sorting (FACS) 24 h after transfection. Cells were gated to select 
for GFP-positive single cells and sorted to single cells in a 96-well plate (Figure 5.10 B). After 
growing up single cells, clones were screened by Western blotting using anti-SYNCRIP 
antibody. Although the success rate of growing up single cells to colonies was quite low, 
several clones were identified that showed a loss of SYNCRIP immunoreactive bands (Figure 
5.10 C). Notably, the highest molecular weight band detected by the SYNCRIP antibody which 
is most likely an isoform of hnRNP R was not lost in any of the SYNCRIP knockout clones, 
confirming my earlier suggestion that this band is not a SYNCRIP isoform. Both clones that 
were transfected with gRNA#2 alone (2H6 and 2E2) retained weak SYNCRIP immunoreactive 
bands around the same molecular weight of Q3, Q2, and Q1 isoforms and so are likely not 
pure clones derived from a single cell. This can occur when GFP positive (and so Cas9 
expressing) cells which have not been edited or are only edited at one allele, are sorted and 
then subsequently divide and because Cas9 and gRNA are present in the cell for several days 
after transient transfection of CRISPR plasmid editing occurs in only one of the daughter cells 




Figure 5.10 – Generation of SYNCRIP knockout HT1080 cell lines by CRISPR/Cas9 gene 
editing. (A) Schematic showing two guide RNAs (gRNA) designed to target human SYNCRIP 
gene. Exons marked in blue and numbered 1 – 12, introns coloured grey. Black arrowheads 
show site of double-strand break. (B) Example FACS scatterplots showing gating for sorting of 
Cas9-GFP positive cells. Since Cas9-GFP and gRNA are encoded by the same plasmid, GFP 
positive cells are the only cells in which genome editing should occur. Gating left to right is as 
follows: scatter-plot 1 forward scatter area (FSC-A) and side scatter area (SSC-A) to select 
intact cells based on size and complexity, scatter-plot 2 FSC-A and forward scatter width (FSC-
W) to select single cells, scatter-plot 3 FSC-A and Alexa Fluor 488-A to select GFP positive cells, 
scatter-plot 4 Alexa Fluor 488-A and Alexa Fluor 488-W to select GFP positive single cells, and 
histogram to gate the medium GFP expressing cells and leave out the highest and lowest 
intensity GFP positive cells. Table shows number of cells (events) within each gate and 
percentage of these in total cell population. (C) Western blotting showing SYNCRIP protein 
levels in colonies grown from FACS sorted single cells compared to wild type HT1080 cells. 
Western blotting confirms knockout of SYNCRIP (SYN) in several colonies with undetectable 




5.11 – IAV proliferation in SYNCRIP-knockout cells 
Having generated SYNCRIP-knockout HT1080 cells I next wanted to test the proliferation of 
IAV in a subset of these clonal cell lines. Clones 1H7, 2H6, 1+2B11 were chosen as SYNCRIP-
knockout cell lines to test while clone 1+2G4 was chosen as a SYNCRIP+/+ cell line that had 
undergone the same treatment as knockout clones but still expressed all major SYNCRIP 
isoforms (Figure 5.11 A). All these cell lines were also confirmed to express similar levels of 
STING and so any differences between them would not be a result of variable levels of STING 
expression. Immunofluorescence staining in these cells using an anti-SYNCRIP antibody shows 
that in clones 1H7 and 1+2B11 any cytoplasmic signal is completely lost while clone 1+2G4 
retains cytoplasmic staining. Some cytoplasmic staining is still evident in clone 2H6 again 
indicating that this clone retains some SYNCRIP expression. All clones show strong nuclear 
signal likely equivalent to the highest molecular weight band recognised in Western blotting 
with SYNCRIP antibody, which is probably hnRNP R. All four clones were infected with IAV 
(PR8) at an MOI of 3 and viral titres at multiple time points during infection determined by 
plaque assay. Surprisingly, only in SYNCRIP knockout clone 1H7 infected cells did IAV grow to 
significantly higher titres than the SYNCRIP+/+ control clone 1+2G4 at 16 hpi (Figure 5.11 C and 
D). IAV titres were slightly higher in SYNCRIP-knockout clone 1H7 compared to the control, 
~2.5x higher, which was not quite as strong as the effect seen with SYNCRIP siRNA knockdown 
in which titres were ~3x higher compared to control cells (Figure 5.3). That IAV titres grown 
in clones 2H6 and 1+2B11 are no higher than titres grown in the control clone 1+2G4 at 16 
hpi is unexpected and does not support the data seen for increased IAV titres in SYNCRIP 
knockdown cells compared to control knockdown cells. That only one of the SYNCRIP 
knockout clones replicates the siRNA results could suggest that SYNCRIP function is more 
complex, and this therefore requires further investigation.  Firstly, it is possible that the effect 
seen for SYNCRIP knockdown on IAV titres is an indirect effect of the siRNA treatment and not 
the reduction in SYNCRIP protein levels detected by Western blotting. Therefore, SYNCRIP 
siRNA knockdown experiments should be repeated using a different siRNA. Secondly, it is 
possible that the lack of a difference between IAV titres grown in SYNCRIP knockout clones 
2H6 and 1+2B11 compared to IAV titres grown in control clone 1+2G4 is a result of off-target 
gene editing directed by the gRNAs used. It is interesting to note that both of these clones 
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were edited using gRNA#2, which could explain why an increase in viral titres was seen in 
clone 1H7 which was edited using gRNA#1 only. It is also possible that clones 2H6 and 1+2B11 
are not complete SYNCRIP knockouts and so retain some SYNCRIP protein which is functional 
in restricting IAV. Indeed, cell lysates from clone 2H6 retain immunoreactive bands detected 
by SYNCRIP antibody, albeit at lower levels than in the control clone 1+2G4. It is also possible 
that the process of generating knockout clones impaired some aspect of immune signalling 
and so even the control clone 1+2G4 is ineffective in restricting IAV and so no difference in 
titres is seen between this clone and SYNCRIP-knockout clones 2H6 and 1+2B11. In order to 
resolve these inconsistencies, more SYNCRIP-knockout clones should be screened for an 
effect on IAV titres. Furthermore, titres from clones should be compared to those from wild 
type HT1080 cells infected in parallel as well as a control clone which still expressed SYNCRIP 
to rule out the possibility that IAV grows to higher titres in all CRISPR clones regardless of 
SYNCRIP expression. Infection experiments could also be repeated using IAV PR8 NS1 mutants 
since the difference in viral titres was enhanced between SYNCRIP knockdown and control 
knockdown cells (Figure 5.4). Since not all of the SYNCRIP knockout clones tested showed an 
increase in IAV titres, sequencing around the gRNA cut sites was performed to verify the 
Western blotting data showing SYNCRIP knockout (Figure 5.11 E). Amplification of a 500 bp 
region around the gRNA#1 site of genomic DNA isolated from clones was successful and 
sequencing confirmed that gene editing had occurred in clones 1H7 and 1+2B11. In the case 
of 1H7 an homozygous insertion of 145 nt was detected which results in a frameshift and 
knockout, while for 1+2B11 there is a 4 nt deletion which will also result in a frameshift. 
Unfortunately, I was unable to amplify a region around the gRNA#2 cut site and so whether 
any editing occurs in clones treated with this gRNA cannot be stated. In the future it will be 
essential to perform this sequencing in order to determine the status of the SYNCRIP genomic 
sequences in clones treated using gRNA#2 (2H6, 1+2B11, 1+2G4). Finally, it would also be 
pertinent to confirm that SYNCRIP-knockout clones retain functional dsDNA and dsRNA 
sensing pathways by transfecting cells with dsDNA or poly(I:C) and measuring IRF3 activation 




Figure 5.11 – Influenza A titres are significantly higher in one but not all SYNCRIP knockout 
HT1080 cell lines. (A) Western blotting confirms detectable levels of STING protein in selected 
SYNCRIP knockout clones. (B) Immunofluorescence shows loss of SYNCRIP staining from the 
cytoplasm of SYNCRIP knockout clones 1H7 and 1+2B11 but only partial reduction in 2H6, likely 
corresponding to low levels of SYNCRIP detectable by Western blot for this clone (A). Scale = 
10 µM. (C) IAV (PR8) titres are significantly higher (~2.5x) in SYNCRIP knockout clones 1H7 
compared to control SYNCRIP positive clone 1+2G4 but are unaffected in SYNCRIP knockout 
clones 2H6 and 1+2B11 at 16 hpi. (D) Time course experiments shows viral growth in SYNCRIP 
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knockout clones compared to SYNCRIP positive clone (1+2G4). MOI – 3. Ordinary one-way 
ANOVA with Dunnett’s multiple comparisons test. * p < 0.05. n = 3. (E) Sequencing of 
amplicons around the sgRNA#1 cut site produced from genomic DNA isolated from SYNCRIP 
knockout clones. Wild-type (WT) genomic sequence. 
5.12 – Chapter Summary 
In this chapter I have screened several newly identified NE STING partners for a role in 
restricting RNA virus infection, showing that SYNCRIP is a novel antagonist of IAV in HT1080 
cells, with IAV growing to higher titres in SYNCRIP knockdown cells. This seems to be a strain 
specific effect with only the H1N1 PR8 strain replicating to higher titres and not the H3N2 
Udorn strain. Moreover, I have also confirmed that STING restricts IAV with the PR8 strain 
growing to higher viral titres in STING knockdown cells. Interestingly, STING knockdown 
similarly had no effect on Udorn proliferation suggesting that STING and SYNCRIP could 
restrict IAV through similar mechanisms. Alternatively, it is possible that SYNCRIP and STING 
mediate their antiviral effects independently of one another and that Udorn is able to inhibit 
both while PR8 is not. That PR8 titres were increased in cells treated with both SYNCRIP and 
STING siRNAs simultaneously compared to cells treated with STING siRNAs (and control siRNA 
so final siRNA concentrations were the same) would suggest that SYNCRIP is able to restrict 
IAV independently of STING. In support of this interpretation of the data an interaction 
between STING and SYNCRIP was not seen by co-immunoprecipitation experiments during 
viral infection.  
One potential limitation of this study is the use of HT1080 cells, a fibrosarcoma cell line. Since 
IAV typically infects cells of the respiratory system a more appropriate cell line to use would 
be a lung cell line. Nonetheless, IAV was confirmed to infect HT1080 cells and so the findings 
presented in this chapter are still informative. The A549 epithelial cell line derived from a lung 
adenocarcinoma was initially considered for use in IAV infection experiments. However, A549 
cells do not express detectable levels of STING protein (Figure 3.1) and since I wanted to test 
whether STING partners were involved in restricting an RNA virus, I postulated that any 
partner protein functions in viral restriction would require STING. It would now be interesting 
to confirm that SYNCRIP knockdown affects proliferation of IAV in A549 cells or another lung 
cell line. Since A549 cells do not express detectable levels of STING protein this would further 
inform as to whether STING is required for SYNCRIP antiviral functions. 
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The NS1 protein of IAV is thought to be the major antagonist of the host cell immune response 
and has been shown to inhibit the IFN response through several different mechanisms (Ayllon 
and García-Sastre 2015). There are some key differences between the NS1 proteins of PR8 
and Udorn which affect the inhibition of the IFN response. PR8 NS1 does not bind to CPSF30 
as a result of amino acid differences at positions 103 and 106 (S103/I106 PR8) compared with 
Udorn NS1 (F103/M106) (Kochs et al. 2007; Ayllon and García-Sastre 2015), and so does not 
inhibit cellular mRNA polyadenylation and expression of cellular genes while Udorn does. On 
the other hand, PR8 inhibits RIG-I signalling and IRF3 activation (Mibayashi et al. 2007; Opitz 
et al. 2007) while Udorn NS1 does not inhibit IRF3 activation (Kuo et al. 2010; Krug 2015). That 
PR8 titres are increased in SYNCRIP or STING knockdown cells but Udorn titres are not 
increased could indicate that both SYNCRIP and STING are involved in restricting viral 
infection independently of the RIG-I signalling pathway since PR8 NS1 restricts RIG-I 
activation. However, this restriction is not total so some activation of STING and SYNCRIP 
could still occur, which would explain why SYNCRIP knockdown enhanced the titres of PR8 
NS1 mutant viruses which are incapable of inhibiting RIG-I, relative to wild type PR8. These 
results could indicate that SYNCRIP at least partially restricts IAV through a mechanism 
involving the RIG-I signalling pathway. Interestingly, STING has been reported not to be 
required for IFN expression during RNA virus infection but instead to restrict viral infection 
through a mechanism resulting in translational inhibition (Franz et al. 2018). This STING-
dependent mechanism required RIG-I/MDA-5 but was distinct from the well-described PKR 
mediated inhibition of translation. My results showing an increase in PR8 titres in STING 
knockdown cells are consistent with a STING-dependent mechanism of viral restriction. 
However, that PR8 titres were elevated in STING knockdown cells compared to control 
knockdown cells suggests either PR8 NS1 cannot completely inhibit this STING mediated viral 
restriction or that STING also functions outside of RIG-I mediated signalling in its restriction 
of IAV. In order to test whether the NS1 proteins of PR8 and Udorn strains account for the 
differences seen in titres with SYNCRIP or STING knockdown I tried to make a recombinant 
PR8 virus encoding the Udorn NS1 protein by swapping the NS1 encoding genome segments 
from the two strains when producing the virus. I used a reverse genetics system to produce 
virus, in which individual plasmids encoding each of the 8 genome segments of IAV are 
simultaneously transfected into HEK293T cells resulting in the formation of functional virions 
(De Wit et al. 2004). Therefore, generation of the chimeric virus only required swapping PR8 
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segment 8 (encodes NS1/NEP) for Udorn segment 8. However, while this was tried several 
times, the virus generated was consistently of too low concentration to use in experiments. 
It would be interesting to try and optimise production of this virus in the future as it would 
reveal whether differences in the NS1 proteins explain the lack of effect with SYNCRIP or 
STING knockdown on Udorn viral titres. Alternatively, segment 8 of PR8 could be used to 
create a chimeric IAV with the other genome segments coming from Udorn. 
As well as NS1, the fusion peptide (FP) of IAV has recently been shown to have 
immunosuppressive activity in the monocytic THP-1 cell line (Bahrami et al. 2016) and to bind 
to STING thus inhibiting IFN responses specifically triggered by fusogenic liposomes (Holm et 
al. 2016). Although the FP is highly conserved across IAV strains, there are three amino acid 
differences between the FP of PR8 and Udorn (Figure 5.12) and it is possible these differences 
affect the immunosuppressive qualities of the two FP during infection, explaining differences 
in PR8 and Udorn viral titres between control and STING knockdown cells. Interestingly, the 
recombinant FP (Flu ISU) found to inhibit STING dimerization (Holm et al. 2016) is more similar 
to the FP of Udorn than PR8 so it is possible that Udorn FP is more effective at inhibiting STING 
than that of PR8 which could explain differences in viral titres seen for the two viruses. This 
could be tested by infecting with a chimeric IAV in which the HA of PR8 is replaced with Udorn 
or vice versa.  
 
Figure 5.12 – Fusion Peptides of PR8 and Udorn compared to recombinant fusion peptide 
found to inhibit STING dimerization. Amino acid sequences of HA fusion peptides from PR8 
and Udorn strains compared to recombinant Flu ISU fusion peptide found to bind STING and 
inhibit dimerization in (Holm et al. 2016). Residues in PR8 and Udorn fusion peptides that differ 
from recombinant Flu ISU are highlighted in yellow. 
In order to better understand the mechanisms through which STING and SYNCRIP restrict PR8 
it would be interesting to look at IRF3 activation and IFNβ expression in cells treated with 
siRNAs against STING or SYNCRIP and infected with PR8. This would reveal whether either 
STING or SYNCRIP are required for IRF3 activation and IFNβ expression in HT1080 cells 
infected with IAV. Although I did not establish whether SYNCRIP is targeted by IAV during 
infection, some cells show a loss of SYNCRIP staining from the cytoplasm at later timepoints 
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in infection which could hint at a mechanism through which SYNCRIP restricts IAV or that IAV 
is targeting SYNCRIP in the cytoplasm to inhibit antiviral effects. Western blotting experiments 
against SYNCRIP should be repeated either infecting at a higher MOI to ensure a larger 
proportion of cells are infected or using a different cell line which is more readily infected by 
IAV, such as HEK293T or A549 cells, to see if there are any differences in SYNCRIP levels during 
infection. It would also be interesting to repeat immunofluorescence experiments using 
individual FLAG-tagged SYNCRIP isoforms so that whether a particular isoform is redistributed 
during infection could be better quantified. For this it would be pertinent to start with Q1 and 
Q3 isoforms as these are the isoforms knocked down by siRNA treatment. 
Whether IAV targets SYNCRIP to restrict its antiviral properties could also be investigated by 
performing co-immunoprecipitation assays to assess binding of SYNCRIP by NS1. 
Interestingly, SYNCRIP has been identified as an interactor of NS1 from PR8 but not Udorn 
strain in pulldown experiments followed by mass spectrometry (Pichlmair et al. 2012; Bösl et 
al. 2019). This is supportive of my findings that SYNCRIP plays a role in IAV infection and might 
explain why only a difference in PR8 viral titres was identified in SYNCRIP knockdown cells 
and not Udorn viral titres. For example, SYNCRIP antiviral functions might need to be targeted 
by PR8 NS1 but not Udorn NS1 in the same way PR8 inhibits RIG-I but Udorn does not because 
Udorn NS1 inhibition of CPSF30 prevents host cell mRNA translation so upstream signalling 
pathway activation becomes irrelevant.   Moreover, SYNCRIP has been identified as being a 
significantly differentially expressed gene in a meta-study which analysed cell-based gene 
expression profiles during IAV infection from ten published studies again suggesting a role for 
SYNCRIP during viral infection. Interestingly, in this meta-study SYNCRIP gene expression was 
down-regulated in some of the datasets and up-regulated in others perhaps indicating that 
SYNCRIP is up-regulated by the host cell but targeted by IAV for down-regulation (Forst et al. 
2017). If binding between SYNCRIP and PR8 NS1 can be confirmed through co-
immunoprecipitation, subsequent experiments should look at whether Udorn NS1 is unable 
to immunoprecipitate SYNCRIP and vice versa before point mutation studies to identify 
residues required for any such interaction. 
While RNA immunoprecipitation experiments failed to identify binding of viral mRNAs 
encoded by IAV segments 5 and 7 the use of endogenous protein and lack of cross-linking in 
these experiments may not have been sensitive enough to identify an interaction between 
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SYNCRIP and viral RNA. RNA immunoprecipitation should therefore be repeated with 
overexpressed FLAG-tagged isoforms of SYNCRIP and the use of UV or formaldehyde 
crosslinking prior to immunoprecipitation to preserve RNA-protein interactions. Furthermore, 
primers should be designed against all segments of the IAV genome in case SYNCRIP is binding 
to specific viral mRNAs. 
Finally, HT1080 SYNCRIP knockout cell lines showed mixed results for SYNCRIP having an 
effect on IAV titres with only clone 1H7 growing higher viral titres compared to the control 
SYNCRIP clone. Further clones should be screened to better clarify whether SYNCRIP knockout 
affects IAV titres. However, prior to doing this all clones should be sequenced at the gRNA 
target sites in the SYNCRIP gene to confirm whether gene editing has taken place. Although 
Western blotting suggests that SYNCRIP knockout has occurred in many clones due to a loss 
of SYNCRIP antibody immunoreactive bands, two of the clones tested with IAV infection 
retained weak immunoreactive bands which could explain why IAV titres were no higher in 
these cell lines compared to the control cell line. IAV infections of SYNCRIP knockout clones 
should also be repeated with a wild type HT1080 control to rule out the possibility that even 
SYNCRIP positive clones are impaired in their ability to restrict IAV infection. Once SYNCRIP 
knockout cell lines are verified and providing that IAV grows to higher titres in SYNCIRP 
knockout cells compared to SYNCRIP positive cells, it will be necessary to perform rescue 
experiments by transiently expressing different isoforms of SYNCRIP to see if they restrict IAV 
proliferation. These experiments should reveal if a particular isoform is critical for viral 
restriction and may inform on which domains of SYNCRIP are required for antiviral activity.  
Considered together, my data show that STING restricts IAV infection and identify SYNCRIP as 
a novel viral antagonist. Future experiments should focus on establishing the mechanism 
through which SYNCRIP exerts its antiviral effect. In particular whether SYNCRIP interacts with 
NS1 should be confirmed through immunoprecipitation experiments and whether SYNCRIP 
binds viral RNA should be investigated more thoroughly. Moreover, immunofluorescence 
experiments studying localisation of SYNCRIP during infection should be performed using 





Chapter 6  
Discussion 
 
The work described in this thesis demonstrates unequivocally for the first time that a pool of 
endogenous STING is present in the inner nuclear membrane in addition to localising to the 
outer nuclear membrane and its well-known localisation throughout the ER. Moreover, I have 
shown through several assays that some partners of STING in the nuclear envelope are novel 
regulators of immune responses stimulated by both dsDNA and dsRNA ligands. Finally, NE 
STING partner SYNCRIP which has multiple functions in RNA processing is shown to be a 
restriction factor of the RNA virus, influenza A. These findings affect the way we should think 
about the roles STING plays as the key adaptor protein in dsDNA stimulated IIR as well as its 
functions in restricting RNA viruses. 
6.1 – Implications of an inner nuclear membrane pool of STING 
The identification of an INM pool of STING has implications for the interpretation of previous 
data from many labs describing STING functions. While cytoplasmic sensing of dsDNA by the 
cGAS-STING pathway is likely unaffected by STING’s presence in the INM, the nuclear pool 
could also provide a mechanism for virus detection of transcripts in the nucleus to separately 
activate IIR so that the contribution of the cytoplasmic pool to measured effects might be 
exaggerated. Furthermore, a cGAS-independent function of STING in sensing DNA damage 
has been described (Dunphy et al. 2018). In this study Dunphy et al. found that DNA damage 
induced by etoposide treatment results in a STING-dependent response that is distinct from 
that of cytosolic dsDNA stimulated STING responses in human keratinocytes. Etoposide 
treatment resulted in a distinct signalling response to DNA damage compared to cytosolic 
dsDNA stimulated IIR. As well as activating an IFNβ response which was independent of cGAS 
but still required some trafficking of STING to perinuclear foci and TBK1 function, etoposide 
treatment activated a strong NF-κB signalling response, with upregulation of a distinct set of 
NF-κB dependent genes such as IL-6 and CCL20 inflammatory cytokines. Interestingly, this NF-
κB dominant signalling response did not require redistribution of STING to perinuclear foci or 
the activity of cGAS and TBK1. Instead, this response required the DNA damage kinase ATM 
and PARP-1 and resulted in the assembly of a STING-IFI16-TRAF6-p53 signalling complex 
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which primarily activated NF-κB signalling. Moreover, this response is distinct from the 
delayed cGAS-STING response that occurs due to the sensing of cytosolic DNA originating 
from micronuclei (Glück et al. 2017; Mackenzie et al. 2017; Harding et al. 2017), with IFNβ, IL-
6, and CCL20 gene expression occurring within 4 h of DNA damage and peaking after 8-12 h. 
Dunphy et al. propose that such a signalling complex assembles in the ER because both TRAF6 
and p53 accumulate in membrane fractions 2-4 h after etoposide treatment and IFI16, TRAF6, 
and p53 are all able to shuttle between nucleus and cytoplasm. However, my data showing 
that STING is present in the INM suggest that such a complex could initially form at the INM 
since all components are present in the nucleus and this is the site of DNA damage. It would 
therefore be interesting to test whether INM localised STING is required for such a response 
and to test whether STING localisation within the NE changes following etoposide induced 
DNA damage. 
While I found that knockdown of STING in HT1080 cells did not result in elevated HSV-1 titres, 
likely explained by a recent report suggesting that the TLR3-TRIF pathway is mainly 
responsible for antagonism of STING in HT1080 cells (Latif et al. 2020), STING has been shown 
to be involved in the restriction of herpesviruses including HSV-1 and Cytomegalovirus (CMV) 
(Ishikawa et al. 2009; Orzalli et al. 2012; West et al. 2015; Reinert et al. 2016). All 
herpesviruses are nuclear replicating and as such sensing of viral DNA occurs at least partially 
in the nucleus, principally through the DNA sensor IFI16 (Orzalli et al. 2012), although the 
recent reports establishing that cGAS also localises to the nucleus (Orzalli et al. 2015; Gentili 
et al. 2019; Volkman et al. 2019) would suggest that nuclear cGAS could also be involved in 
the recognition of viral DNA in the nucleus. Thus, it would make sense that a pool of STING at 
the INM would be activated first by nuclear recognition of herpesvirus DNA in by cGAS/IFI16 
and could initiate immune responses before activation of ER resident STING. Herpesvirus 
infection is also detected by cGAS and IFI16 in the cytoplasm due to release of genomic DNA 
from proteasomal degradation of viral capsids (Horan et al. 2013) as well as the detection of 
mtDNA released as a consequence of viral induced mitochondrial stress (West et al. 2015). 
IFI16 has been shown to associate with  to  herpesvirus DNA in both the cytoplasm and 
nucleus (Kerur et al. 2011; Orzalli et al. 2012; Horan et al. 2013; Orzalli et al. 2013) and to 
associate with STING following immune stimulation with dsDNA or herpes simplex virus 
(HSV1) infection to activate antiviral gene expression (Unterholzner et al. 2010; Horan et al. 
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2013). Moreover, at least in a subset of human cells, cGAS and IFI16 act cooperatively to 
induce immune responses to cytosolic DNA and DNA viruses, with both proteins required for 
full STING activation and induction of IFN (Orzalli et al. 2015; Almine et al. 2017; Jønsson et 
al. 2017). Therefore, at least in cells other than HT1080 fibrosarcoma cells, STING at the INM 
could be the first site of STING activation following detection of nuclear replicating DNA 
viruses. In support of a nuclear function of STING during HSV-1 infection, in their earlier study 
Orzalli et al. found that IFI16 did not relocalise from the nucleus to cytoplasm during HSV-1 
infection of human fibroblasts and moreover, in experiments in which cells were infected with 
a higher MOI there was an increase in nuclear STING as by detected by cellular fractionation 
and Western blotting (Orzalli et al. 2012).   
STING at the NE redistributes similarly to STING localised throughout the ER following immune 
stimulation with dsDNA, as seen by immunofluorescence showing a loss of NE STING staining 
and accumulation in perinuclear foci in my studies. Moreover, I have shown that STING in the 
INM relocalises to the ONM within 2 h of dsDNA stimulation using smFRAP microscopy. The 
simplest explanation for this would be that cGAMP produced by cGAS sensing of cytoplasmic 
DNA, enters the nucleus and activates STING similarly to STING in the ER. Alternatively, 
plasmid DNA may enter the nucleus and be detected by nuclear localised cGAS. While plasmid 
DNA is typically thought to only enter the nucleus following nuclear envelope breakdown 
during mitosis, it has been shown that plasmid DNA can actively be transported into the 
nucleus by importins in the absence of mitosis (Bai et al. 2017). For example, biotin-labelled 
plasmid DNA microinjected into the cytoplasm of terminally differentiated rat myotubes is 
able to enter the nucleus and direct gene expression (Dowty et al. 1995). A number of so 
called ‘DNA nuclear targeting sequences’ or DNTs have been shown to direct targeting to the 
nucleus of plasmids microinjected into the cytoplasm including the SV40 enhancer sequence 
which has been shown to contain binding sites for multiple ubiquitously expressed 
transcription factors. The transcription factors that recognise such sequences bind the 
plasmid DNA in the cytoplasm and then NLSs in these transcription factors are recognised by 
transport receptors that in the process of transporting the transcription factors also carry the 
plasmid DNA into the nucleus (Bai et al. 2017). The pcDNA3.1 plasmid used in my experiments 
to stimulate IIR against dsDNA contains the SV40 enhancer sequence and so could be directed 
to the nucleus and be recognised by nuclear DNA sensors including cGAS. That said, 
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transfected DNA must enter the cytoplasm first and so an IIR is extremely likely to be initiated 
from cytoplasmic DNA sensing before this process of nuclear transport has time to occur. 
However, it would be interesting to test if cGAS/other nuclear DNA sensors could initiate IIR 
in the nucleus by nuclear delivery of biotin-labelled DNA by microinjection. Likewise, whether 
STING redistributes from the INM to ONM in response to nuclear microinjection of DNA or 
herpesvirus infection should be tested using single molecule FRAP. Interestingly, previous 
work in the Schirmer lab found that STING mobility at the NE was increased in cells 2 hpi with 
HSV-1 compared to mock infected HT1080 cells stably expressing STING-GFP using FRAP 
(Dixon et al. 2020) (Figure 1.5). Since FRAP of NET proteins has been shown to principally 
measure translocation through nuclear pores this likely indicates a redistribution of STING 
from the INM to ONM as seen with dsDNA stimulation (Zuleger et al. 2011). Intriguingly, in 
this experiment HSV-1 infection did not result in the accumulation of STING in perinuclear 
foci. This could be explained by HSV-1 protein ƴ134.5 inhibition of STING translocation to 
perinuclear foci (Pan et al. 2018) or since STING appears not to be the principal antagonist of 
HSV-1 infection in HT1080 cells (Latif et al. 2020). Nonetheless, that STING mobility in the NE 
was found to increase with HSV-1 infection points to a specific NE role for STING in HSV-1 
infection that warrants further investigation.  
I also found that STING in the INM redistributed to the ONM following immune stimulation 
with the dsRNA mimic, poly(I:C). This is an especially intriguing finding given that STING’s 
functions in the restriction of RNA viruses remain to be fully elucidated and that STING is not 
required for the induction of IFNβ in response to poly(I:C) transfection (Ishikawa and Barber 
2008; Franz et al. 2018). However, Franz et al. have shown that STING is partly responsible for 
translational inhibition triggered by infection with the RNA virus, vesicular stomatitis virus 
(VSV), or transfection of poly(I:C), as determined by polysome analysis. The mechanism of 
STING translational inhibition could not be resolved but is distinct from translational inhibition 
mediated by PKR, which phosphorylates eIF2α inhibiting translational initiation (Sidrauski et 
al. 2015). Thus, STING redistribution from the INM to ONM following immune stimulation 
with poly(I:C) could be related to STING-dependent translational inhibition, particularly given 
that no obvious changes are seen in STING localisation throughout the ER. It would now be 
pertinent to test whether STING redistribution in the NE that occurred with poly(I:C) 
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stimulation also occurs during infection with an RNA virus such as VSV or influenza A virus 
(IAV). 
Previous work in the Schirmer lab uncovered a role for STING in promoting chromatin 
compaction, with levels of STING expression positively correlating with levels of compacted 
chromatin (Malik et al. 2014). Furthermore, STING overexpression was also associated with 
an increase in histone 3 lysine 9 trimethylation (H3K9me3) at the nuclear periphery. Thus, it 
seems that STING in the INM directs changes in chromatin structure. Several other NETs have 
been shown to tether genomic loci to the nuclear periphery (Meaburn et al. 2007; Zuleger et 
al. 2013; Robson et al. 2016). In fact, in a previous study from the Schirmer lab, Zuleger et al. 
found that overexpression of a STING-RFP construct in HT1080 cells caused a slight effect on 
the recruitment of a lacO array inserted into chromosome 5 to the nuclear periphery. 
Although this was not pursued further because other NETs had stronger effects on 
chromosome repositioning, it would now be interesting to investigate whether STING at the 
INM is involved in recruiting particular genomic loci to the nuclear periphery. Whether any 
recruited loci are released as a result of STING redistribution from INM to ONM during IIR 
would be a particularly exciting angle to explore. For example, in resting cells STING at the NE 
might hold loci encoding immune response genes at the nuclear periphery in a 
transcriptionally repressive environment. Following activation by either dsDNA or dsRNA 
ligands, STING redistribution to the ONM could release such loci into a more transcriptionally 
active nuclear compartment, aiding the expression of immune response genes.   
One question raised by my data showing that STING is present in the INM is, how is STING 
targeted to the INM? Localisation of transmembrane proteins to the INM has been proposed 
to occur via several mechanisms (Zuleger et al. 2012; Katta et al. 2014; Dixon and Schirmer 
2018), however, two principal models explain targeting of most NETs. In the first, NETs diffuse 
passively in the ER membrane to the ONM and then through the peripheral channels of the 
NPC into the INM, followed by retention at the INM through binding nuclear lamins, 
chromatin, and/or other proteins (Worman et al. 1988; Senior and Gerace 1988; Ye and 
Worman 1996; Brachner et al. 2005; Brachner and Foisner 2011; Boni et al. 2015; Ungricht et 
al. 2015). Alternatively, trafficking of some NETs to the INM has been shown to depend, at 
least partially, on nuclear localisation signal (NLS) dependent receptor-mediated transport, in 
which karyopherins that are required for central channel active transport are also required 
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for active transport of membrane bound NETs (King et al. 2006; Lusk et al. 2007; Ma et al. 
2007; Zuleger et al. 2011; Meinema et al. 2011; Mudumbi et al. 2020). In the case of LBR and 
LAP2β which both contain an NLS, a recent study by Mudumbi et al. showed that these 
proteins traffic through the NPC simultaneously accessing central and peripheral channels 
and deletion of the NLS of either restricts their trafficking to the peripheral channel of the 
NPC (Mudumbi et al. 2020). In the case of STING, earlier work in the Schirmer lab 
demonstrated that STING fails to target to the NE in Lamin A/C knockout MEFs (Malik et al. 
2010) suggesting an interaction between STING and Lamin A/C in STING retention at the INM, 
though this could be consistent with both modes of translocation. My data showing that FRET 
occurs in cells transfected with STING-RFP and Lamin A-GFP also supports the notion that 
STING interacts with the nuclear lamina and suggests that binding of STING to lamins could 
explain its INM localisation. The idea that Lamin A/C plays a role in targeting/retention is 
further supported by its identification as a STING interactor in the cross-linked pulldown, mass 
spectrometry experiment; however, this experiment also identified lamins B1 and B2 as 
STING interactors which is not necessarily consistent with the first experiment in the lamin 
A/C knockout MEFs since the other lamins were still present. Also, determining whether 
STING interactions with lamins are really direct will require in vitro interaction studies using 
bacterially expressed STING and Lamin fragments to map the domains required for 
interaction.  
Interestingly, STING also contains a predicted bipartite NLS in its N terminus (amino acids 14-
46) according to an NLS prediction tool (Kosugi et al. 2009) which might suggest that its 
mechanism for INM localisation is the receptor-mediated route (Figure 6.1). However, this 
NLS spans the first transmembrane domain of STING and so whether it could be recognised 
by karyopherins is questionable. Moreover, the N terminal domain of STING is only 18 amino 
acid residues long and so this would not be able to reach into the central channel of the NPC 
through which karyopherins transport their cargo (Mudumbi et al. 2020). Nonetheless, in 
support of this idea both importin β1 and importin α2 were identified as STING interactors 
and so whether STING traffics to the INM in an NLS-dependent manner should be tested as 
this will be important for understanding mechanisms for signalling and activating innate 
immune responses (IIR) that may require its translocation between the nucleus and 
cytoplasm. For example, point mutation of the basic residues in STING’s predicted bipartite 
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NLS should abrogate its function if indeed it is receptor mediated and STING mutant targeting 
could be assessed by immunofluorescence in conjunction with detergent pre-extraction assay 
or by immunogold-EM. Alternatively, the dominant-negative Ran GTPase mutant, Q69L, could 
be used to inhibit NLS-dependent transport (Zuleger et al. 2011) and localisation of STING at 
the INM assessed. In doing so, if one could separate pools of STING at the NE and ER it would 
be incredibly valuable in dissecting potential NE-specific functions of STING discussed above. 
STING also contains a predicted nuclear export signal (NES) at amino acid residues 54-60 
(LQLGLLL), although this is embedded within the second transmembrane domain and so it 
seems improbable that this sequence really functions as an NES since it would not be able to 
bind the soluble exportin CRM1 (La Cour et al. 2004). 
 
Figure 6.1 – STING contains a predicted bipartite nuclear localisation signal (NLS). (A) Amino 
acid sequence of human STING showing predicted bipartite NLS (red), amino acid residues 14-
46. (B) Consensus sequence of a bipartite NLS in which two clusters of basic residues (blue) are 
separated by a 10-12 amino acid linker. X indicates any amino acid, (K/R)3-5 represents at 
least three of either lysine or arginine in five consecutive amino acids. Predicted bipartite NLS 
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of STING with basic amino acids coloured blue. Note that the linker region of bipartite NLS of 
some proteins has been shown to be longer than the classical 10-12 amino acids. (C) Schematic 
of STING structural domains showing localisation of predicted NLS (red). Transmembrane 
(TM), cyclic dinucleotide binding (CDN), and C terminal tail (CTT) domains and the residues 
they encompass are shown. NLS predicted using cNLS mapper tool(Kosugi et al. 2009). 
Schematic based on STING cryo-EM structure determined by Shang et al.(Shang et al. 2019) 
 
6.2 – The nuclear envelope STING interactome is distinct from that of STING in the ER 
Much of the work completed in this thesis was founded on a mass spectrometry dataset of 
co-immunoprecipitated STING-GFP from isolated cross-linked NEs. When this experiment was 
performed less was known about STING’s functions other than its critical role in immune 
responses stimulated by cytosolic DNA through activation of the key immune transcription 
factor IRF3. Therefore, we focussed on investigating IIR functions of NE STING partners that 
were found to have indirect links to IRF3/7 transcription factors according to the Human 
Protein Reference Database (HPRD, Johns Hopkins University). However, several other 
proteins were identified by mass spectrometry which could be interesting for further study 
based on more recently identified roles of STING in the DNA damage response, chromatin 
compaction, and inhibition of translation in response to RNA virus infection. By plotting 
normalised spectral counts for proteins detected in the STING-GFP sample compared to the 
mock transfected sample the proteins most enriched in the STING-GFP sample can be 




Figure 6.2 – The STING-GFP NE interactome is distinct from STING in the ER. (A) Relative 
abundance of proteins identified by mass spectrometry in STING-GFP and mock pulldown 
samples were plotted against one another as normalised spectral counts (dnormS = 
normS/sum(normS)). Where normS is the number of spectra divided by protein molecular 
weight (in hundreds of kDa) and sum(normS) is the sum of normS in that sample. Proteins 
below dashed line are enriched in STING-GFP pulldown sample. (B) Most enriched proteins in 
STING-GFP pulldown sample after histone variants shown in (A). STING NE partners known to 
interact indirectly with IRF3/7 are highlighted in blue. Mass spectrometry experiment 
performed by Poonam Malik, Ravi Badwe, and Eric Schirmer; normalisation of data by Jose de 
las Heras; graphs plotted and data analysis by me. 
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Interestingly the interactome of STING in the NE seems to be distinct from that of STING in 
the ER since our mass spectrometry data identified only 4 of a reported 102 STING interactors 
according to the HitPredict database of experimentally identified physical protein-protein 
interactions (López et al. 2015) (see Table 6.1). These are: CCDC47 (Li et al. 2011), an ER 
resident transmembrane protein proposed to be involved in calcium homeostasis (Thapa et 
al. 2018); DDX41, which has been shown to bind to dsDNA and STING and promote STING 
signalling (Zhang et al. 2011; Lee et al. 2015); histone H2B, which was recently reported to 
associate with IFI16-BRCA1 complexes in the nucleus which redistribute to the cytoplasm and 
associate with STING during infection with herpesviruses KSHV or HSV-1 (Iqbal et al. 2016); 
nucleoprotein TPR, which was identified as a STING interactor during HSV-1 infection (Shang 
et al. 2018). Notable STING interactors such as TBK1, IFI16, IRF3, MAVS, RIG-I, and STIM1 were 
not identified by mass spectrometry in the STING-GFP immunoprecipitated samples. This is 
unsurprising for MAVS which localises to the mitochondria and STIM1 which is resident in the 
ER since isolated NEs were used for pulldowns. Meanwhile IFI16 and IRF3 are only reported 
to associate with STING following immune stimulation and similarly STING-TBK1, STING-
MAVS, and STING-RIG-I interactions are enhanced during IIR (Ishikawa and Barber 2008; 
Zhong et al. 2008; Tanaka and Chen 2012; Liu et al. 2015a; Almine et al. 2017). Since many 
known STING interactions only occur during an immune response or are enhanced following 
immune stimulation it would be worth performing pulldowns of STING from isolated NEs after 
immune stimulation with dsDNA, poly(I:C), or viral infection to identify partner interactions 
that are enhanced during an immune response to different immune stimuli. Moreover, 
HEK293T cells are impaired in their dsDNA sensing capability, and lack detectable expression 
of cGAS and IFI16, and express only very low levels of STING (Sun et al. 2013; Orzalli et al. 
2015; Jønsson et al. 2017), thus, other known STING interactors may also not be expressed in 
the HEK293T cell line and so they would not be detected in our mass spectrometry dataset. 
Therefore, it would be now prudent to identify the NE STING interactome in additional cell 
lines which have a functional cGAS-STING pathway to ensure all potential interactors can be 





Table 6.1 – Experimentally validated STING interactors identified in NE STING mass 
spectrometry 
gene_name isoform p.mock s.mock p.STING-GFP s.STING-GFP 
CCDC47   0 0.0 2 2.0 
DDX41*   0 0.0 4 4.0 
H2B HIST1H2BO 0 0.0 8 22.0 
  HIST2H2BF 0 0.0 8 17.0 
TPR   0 0.0 4 4.0 
*DDX41-STING interaction identified in mouse. p, peptide s, spectra. 
As well as a few previously reported STING interactors, our mass spectrometry dataset also 
includes several well-known NE proteins which were enriched in STING-GFP pulldown 
samples compared to mock samples: Lamin A/C (LMNA), Lamins B1 and B2 (LMNB1, LMNB2), 
LAP2α and LAP2β/ƴ (TMPOα, TMPOβ/ƴ) (see Table 6.2). An enrichment of these but not NE 
proteins, SUN2, Nesprin2, or LBR in STING-GFP pulldown samples suggests that interactions 
with nuclear lamin proteins and LAP2 isoforms are specific as opposed to simply pulling down 
the most abundant NE proteins because SUN2 and nesprins repeatedly were recovered at 
much higher spectral abundance than LAP2 in experiments identifying the NE proteome 
(Schirmer et al. 2003; Korfali et al. 2012). That STING pulled-down LAP2α is interesting since 
this LAP2 isoform is a nucleoplasmic protein sharing only its N-terminus with the other 
membrane associated LAP2 isoforms (Foisner and Gerace 1993; Furukawa et al. 1998). LAP2β 
binds lamin B at the NE while LAP2α binds A-type lamins in the nucleoplasm (Dechat et al. 
1998; Dechat et al. 2000) and so an interaction with both could suggest that STING interacts 
with the N-terminal domain of LAP2. However, equally they could have been pulled down by 
virtue of a direct association with lamin proteins. That STING-GFP did not pulldown Nesprin 
proteins supports the interpretation of STING’s resistance to detergent extraction in the NE 
being due to an interaction with the nuclear lamina rather than ONM localised Nesprin 








Table 6.2 – Well-known NE proteins identified in NE STING mass spectrometry 
gene_name protein_name p.mock s.mock p.STING-GFP s.STING-GFP 
LMNA Lamin A/C 6 11.0 28 48.0 
LMNB1 Lamin B1 9 10.0 17 23.0 
LMNB2 Lamin B2 0 0.0 6 9.0 
TMPO LAP2α 0 0.0 7 18.0 
TMPO LAP2β/ƴ 3 4.0 13 28.0 
SUN2 SUN2 3 3.0 1 1.0 
SYNE2 Nesprin 2 1 1.0 0 0.0 
LBR LBR 2 2.0 0 0.0 
p, peptide s, spectra. 
Several proteins involved in the DNA damage response or DNA repair pathways were also 
identified as partners of STING in the NE (Table 6.3). Notably, these include PARP1, which was 
found to be required for recognition of etoposide induced DNA damage and assembly of a 
STING-IFI16-TRAF6-p53 signalling complex (Dunphy et al. 2018), as well as, subunits of the 
DNA-PK complex (DNA-PKcs, Ku70, and Ku80) which have been shown to activate STING-
dependent IFNβ induction (Ferguson et al. 2012; Wang et al. 2017a). It is therefore probable 
that STING at the NE is involved in mediating these responses to DNA damage. It would now 
be interesting to test whether these interactions are enhanced following etoposide induced 
DNA damage by pulldowns of STING from isolated NEs or nuclei. Additionally, proximity 
ligation assays could be performed with and without etoposide treatment to assess whether 
interactions between STING and DNA damage response proteins occur at the INM. 
Table 6.3 – DNA damage response and repair proteins identified in NE STING mass 
spectrometry 
gene_name protein_name p.mock s.mock p.STING s.STING 
PARP1 PARP1 37 62.0 44 106.0 
PRKDC DNA-PKcs 17 17.0 18 20.0 
TOP1 DNA topoisomerase I 20 41.0 32 82.0 
TOP2A 
DNA topoisomerase 2-
alpha 25 41.0 32 51.0 
LIG3 DNA Ligase III 2 2.0 9 9.0 
PARP2 PARP2 0 0.0 8 10.0 
XRCC6 Ku70 1 1.0 5 5.0 
MRE11 MRE11 0 0.0 1 1.0 
XRCC1 XRCC1 0 0.0 1 1.0 
HMGB2 HMGB2 0 0.0 1 1.0 
RUVBL2 RUVBL2 0 0.0 2 2.0 
ACTL6A ACTL6A 0 0.0 1 1.0 
p, peptide s, spectra. 
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Although, the Schirmer lab previously identified a role for STING in chromatin compaction, 
with STING protein levels correlating with the amount of compacted chromatin and STING 
overexpression increasing levels of chromatin compaction, the mechanism through which 
STING mediates this effect is unclear. STING-GFP pulldown samples were most enriched for 
histone proteins with histone H1 and H2B variants particularly enriched compared to mock 
pulldown samples (Figure 6.2 A and Table 6.4). Interestingly, these histone variants have been 
reported to have immune functions. In particular, HIST1H1C is reported to antagonise IAV 
replication through interacting with IRF3 and upregulating IFNβ expression with HIST1H1C 
phosphorylation promoting IRF3 binding to the IFNβ promoter and methylation of HIST1H1C 
bringing nucleosomes into closer proximity to the IFNβ promoter and inhibiting IRF3 binding 
(Liu et al. 2017). While histone H2B has an extrachromosomal function in promoting dsDNA 
stimulated immune responses by forming complexes with IFI16-BRCA1 and with cGAS and 
STING during infection with herpesviruses (Iqbal et al. 2016). Additionally, H2B was reported 
to interact with MAVS and upregulate IFNβ expression following stimulation with dsDNA 
(Kobiyama et al. 2010). Thus, STING interaction with these histones at the INM could direct 
histone modifications which promote innate immune signalling or modification of these 
histones could affect interactions with STING at the NE leading to its activation and 
redistribution from the INM to ONM. 
Table 6.4 – Histone proteins identified in NE STING mass spectrometry 
gene_name protein_name p.mock s.mock p.STING s.STING 
HIST1H1C Histone H1.2 7 28.0 13 104.0 
HIST1H1E Histone H1.4 7 28.0 13 103.0 
HIST1H1D Histone H1.3 6 26.0 10 97.0 
HP1BP3 HP1BP3 6 9.0 23 77.0 
HIST1H1T Histone H1.6 3 17.0 5 50.0 
HIST1H1B Histone H1.5 0 0.0 5 7.0 
H1F0 Histone H1.0 2 3.0 4 8.0 
H1FX Histone H1x 1 2.0 4 10.0 
H2AFY 
Core histone macro-
H2A.1 10 21.0 17 55.0 
H2AFY2 
Core histone macro-
H2A.2 11 21.0 19 61.0 
HIST2H2AA3 Histone H2A type 2 0 0.0 6 26.0 
HIST1H2BO Histone H2B type 1-O 0 0.0 8 22.0 
HIST2H2BF Histone H2B type 2-F 0 0.0 8 17.0 
p, peptide s, spectra. 
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Multiple chromatin modifying proteins were also enriched in the STING-GFP pulldown 
samples which could implement epigenetic chromatin modifications seen with STING 
overexpression (Malik et al. 2014). These include bromodomain proteins BRD2 and BRD3, 
knockdown of which results in reduced expression of multiple inflammatory cytokines in 
macrophages following immune stimulation with LPS (Nicodeme et al. 2010). Additionally, 
BAZ2A a subunit of the nucleolar remodelling complex which mediates the formation of 
perinucleolar heterochromatin was identified and could have a similar function at the NE 
(Guetg et al. 2010). Curiously, nucleolin (NCL) which is predominantly localised to the 
nucleolus bound to pre-ribosomal RNA was also identified as one of the most enriched 
proteins in the STING-GFP pulldown samples. STING interactions with such nucleolar proteins 
could hint at the mechanism through which STING is able to direct inhibition of cellular 
translation during infection with RNA viruses (Franz et al. 2018), since the nucleolus is the site 
of ribosome biogenesis. 
Table 6.5 – Chromatin modifiers identified in NE STING mass spectrometry 
gene_name protein_name p.mock s.mock p.STING s.STING 
BRD2 BRD2 12 20.0 26 64.0 
BRD3 BRD3 5 7.0 20 42.0 
BRD4 BRD4 10 12.0 11 30.0 
KIAA0020 KIAA0020/PUM3 3 4.0 25 50.0 
BAZ2A BAZ2A 4 4.0 23 28.0 
MECP2 MECP2 0 0.0 10 19.0 
HELLS HELLS 1 1.0 14 16.0 
RSF1 RSF1 2 2.0 10 12.0 
p, peptide s, spectra. 
Finally, while undertaking the research submitted in this thesis, another research group 
separately published a NE STING interactome on bioRχiv (Cheradame et al. 2020). In this study 
Cheradame at al. report that STING partially localises at the INM in breast cancer cell lines 
and interacts with several DNA damage response proteins including DNA-PKcs, Ku70, and 
Ku80. Interestingly, they also show that depletion of STING results in reduction of 53BP1 and 
ƴH2AX foci and that STING colocalises with these foci following treatment with the DNA 
damaging agent mafosfamide. Thus, they conclude that STING is involved in the DNA damage 
response and DNA repair. While they similarly show that STING is present in the INM by 
immunogold-EM, this is only done with tagged and overexpressed STING and so my data is 
the first to show that endogenous STING partially localises at the INM. Moreover, they did 
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not investigate whether STING localisation within the NE changes in response to different 
stimuli. I would thus consider my data and theirs to be complementary and supportive of each 
other. To identify NE STING partners in their study, MCF7 breast cancer cells were stably 
transfected with a FLAG-STING-HA construct from which nuclei were isolated and treated 
with benzonase before immunoprecipitation using an anti-FLAG antibody. This differs slightly 
from the approach used in our study in which HEK293T cells were transiently transfected with 
a STING-GFP construct, NEs isolated and treated with DNase/RNase, and then reversibly 
cross-linked before immunoprecipitation using an anti-GFP antibody. Therefore, I decided to 
compare their STING NE interactome to ours to see if these two approaches identified the 
same binding partners. Cheradame et al. identified 126 high confidence interactors of NE 
localised STING and similarly did not identify canonical STING interactors (e.g. TBK1, IFI16, 
IRF3, MAVS, RIG-I, STIM1). Comparing their dataset to ours 57 of their 126 top hits are present 
in our mass spectrometry dataset (Figure 6.3, red highlight), with 34 of those proteins 
enriched in the STING-GFP pulldown sample compared to mock. SYNCRIP, SNRNP70, and 
UBTF proteins that we identified as NE STING partners with indirect links to IRF3/7 
transcription factors were identified as enriched in STING pulldowns by Cheradame et al. 
while DDX5, TCERG1, and RPS27A were also identified but did not make the cut-off of being 
statistically significantly enriched in their study. Thus, their mass spectrometry data supports 
our identification of these proteins as NE STING partners. While the datasets do not overlap 
completely, this can be explained by the different cell lines and approaches used for 





Figure 6.3 – NE STING partners identified by Cheradame et al. are present in our mass 
spectrometry dataset. (A) Relative abundance of proteins identified by mass spectrometry in 
STING-GFP and mock pulldown samples were plotted against one another as normalised 
spectral counts (dnormS = normS/sum(normS)). Where normS is the number of spectra divided 
by protein molecular weight (in hundreds of kDa) and sum(normS) is the sum of normS in that 
sample. Proteins below dashed line are enriched in STING-GFP pulldown sample. (B) Most 
enriched proteins in STING-GFP pulldown sample after histone variants shown in (A). STING 
NE partners known to interact indirectly with IRF3/7 are highlighted in blue. NE STING 




6.3 – How do NE STING partners function in IIRs?  
In this thesis I have shown that several NE STING partners are involved in the IIR with SYNCRIP, 
MEN1, SNRNP70, and RPS27A all found to be required for proper immune signalling following 
immune stimulation with dsDNA. While DDX5 appears to function antagonistically in immune 
signalling stimulated by either dsDNA or dsRNA ligands, with its knockdown leading to 
elevated IFNβ mRNA levels after immune stimulation with either plasmid DNA or poly(I:C). 
However, the mechanism through which these proteins mediate their effects on IIR signalling 
has not been completely elucidated and could occur at a number of levels in the signalling 
pathway.  
Firstly, proteins could be directly involved in DNA/RNA sensing and the activation of 
downstream signalling partners. As all of these proteins predominantly localise to the 
nucleus, except for SYNCRIP for which isoforms Q2 and Q3 localise to the nucleus while Q1 
localises to the cytoplasm, we initially proposed that these proteins could function in sensing 
of viral DNA or RNA in the nucleus. That said, transfection of dsDNA or poly(I:C) used to 
stimulate IIR in this study initially results in the release of transfected material into the 
cytoplasm and hence the initiation of IIR signalling likely occurs here. Indeed, in the cGAS-
STING pathway, transfection of dsDNA results in the formation of cGAS foci around 
cytoplasmic DNA which initiates the production of cGAMP to activate STING (Hu et al. 2019). 
For SYNCRIP, MEN1, and SNRNP70 cytoplasmic localisation is also evident and so they could 
directly sense cytoplasmic DNA/RNA without requiring redistribution from the nucleus. In 
contrast, DDX5 is almost exclusively localised to the nucleus and so it is less likely to be 
involved in directly sensing DNA/RNA in the cytoplasm, particularly as no redistribution of 
DDX5 to the cytoplasm was evident after transfection with DNA or poly(I:C). Although, DDX5 
has been shown to shuttle between the nucleus and cytoplasm and so could, under certain 
circumstances, be involved in cytoplasmic DNA/RNA sensing (Wang et al. 2009). Whether 
SYNCRIP, MEN1, DDX5, or SNRNP70 bind to transfected DNA/RNA in the cytoplasm and/or 
nucleus should be tested in the future by transfecting biotin labelled DNA/poly(I:C) and 
performing pulldown assays on nuclear and cytoplasmic cellular fractions. 
Although when this study was started the notion of nuclear pathogen DNA/RNA sensors was 
novel and unexplored, over the last few years several proteins have been identified that 
function in nuclear DNA sensing and activation of STING signalling. These include IFI16, which 
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in conjunction with cGAS recognises plasmid DNA and HSV-1 genomic DNA at least partially 
in the nucleus as well as in the cytoplasm (Orzalli et al. 2015); hnRNPA2B1 which binds HSV-1 
genomic DNA in the nucleus and subsequently relocalises to the cytoplasm where it activates 
TBK1-IRF3 signalling, as well as separately promoting translation of cGAS, IFI16, and STING 
mRNAs (Wang et al. 2019); and NONO which recognises HIV-2 capsids in the nucleus and 
associates with nuclear cGAS enabling the recognition of HIV-2 DNA (Lahaye et al. 2018). 
Therefore, there is a precedent for nuclear DNA sensors, and it is likely that the proteins 
identified here could also fulfil such a role and this should be investigated further. 
The next stage at which NE STING partners could influence IIR signalling in response to 
cytoplasmic DNA could be at the level of cGAS activation. For example, NE STING partners 
could assist detection of dsDNA by cGAS or the formation of phase separated signalling foci 
(Du and Chen 2018). Several proteins have already been reported to act with cGAS to promote 
cGAMP production and downstream signalling including: G3BP1, which promotes cGAS 
oligomerisation and primes it for DNA sensing (Liu et al. 2019), ZCCHC3, which binds dsDNA 
and enhances cGAS dsDNA binding (Lian et al. 2018), and IFI16, which augments cGAS 
production of cGAMP (Jønsson et al. 2017). Thus, whether NE STING partners interact with 
cGAS or are required for efficient cGAMP production should be tested in the future by 
immunoprecipitation assays and detection of cGAMP levels should be assessed by 
quantitative mass spectrometry. 
Downstream of cGAS, NE STING partners could be required for the activation of STING, STING 
translocation out of the ER, or recruitment of kinases to STING signalling complexes to 
activate IRF3, NF-κB, or AP-1 transcription factors. Knockdown of SYNCRIP, MEN1, DDX5, or 
SNRNP70 were all found to inhibit activation of IRF3 as measured by levels of IRF3 
phosphorylation and accumulation of IRF3 in the nucleus following immune stimulation with 
dsDNA. Thus, these proteins are likely playing a role in immune signalling upstream of IRF3 
activation which would explain the data showing that their knockdown impairs IFNβ and CCL5 
expression following immune stimulation with dsDNA, since IRF3 is required for induction of 
these genes. To determine whether NE STING partners are required for functional STING 
signalling complexes, levels of STING phosphorylation (S366) and accumulation of STING in 
perinuclear foci should be measured by immunoblotting and immunofluorescence, 
respectively, following partner knockdown and immune stimulation with dsDNA. Additionally, 
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it would be interesting to measure levels of endogenous NF-κB activation after partner 
knockdown to support findings from the luciferase assay which showed that knockdown of 
SYNCRIP, MEN1, DDX5, or SNRNP70 reduced activation of an NF-κB activated luciferase 
reporter. While this was attempted by measuring accumulation of NF-κB (p65) in the nucleus 
of HT1080 cells after transfection of dsDNA, little or no nuclear accumulation of NF-κB was 
detected 4 h after stimulation. This could be due to reports that transfection of dsDNA more 
strongly activates STING mediated IRF3 activation rather than NF-κB activation (Dunphy et al. 
2018; de Oliveira Mann et al. 2019), in agreement with my luciferase assay data showing less 
activation of the NF-κB luciferase reporter compared to the IFNβ luciferase reporter. 
Therefore, for this purpose it would be better to use etoposide treatment to induce DNA 
damage and STING signalling since this was found to more robustly activate NF-κB (Dunphy 
et al. 2018). Alternatively, NF-κB (p65) phosphorylation and accumulation in the nucleus could 
be measured at a later timepoint post-immune stimulation by plasmid DNA transfection. 
Levels of TBK1 activation, the kinase required for phosphorylation of IRF3 in activated STING 
signalling complexes (Liu et al. 2015a), should also be determined with STING partner 
knockdown and following immune stimulation by measuring levels of phosphorylated TBK1 
by Western blot, since STING partners could be required for proper TBK1 activation or 
recruitment. Ubiquitination of STING has also been shown to be important for regulation of 
STING activity (Motwani et al. 2019) and so whether STING ubiquitination is altered in the 
absence of NE STING partners could also be tested.  
Alternative mechanisms through which NE STING partners might influence IIR 
Finally, it is possible that NE STING partners exert the effects on IRF3 activation and IFNβ 
expression through a novel mechanism or mechanisms. SYNCRIP is a member of the 
heterogenous nuclear ribonucleotide (hnRNP) family of proteins and is a multifunctional 
protein which is involved in the regulation of multiple aspects of RNA maturation including: 
splicing (Mourelatos et al. 2001; Chen et al. 2008), mRNA editing through association with 
APOBEC1 (Blanc et al. 2001; Shimizu et al. 2014; Beuck et al. 2016), vesicle-based mRNA 
transport through interaction with synaptogamins (Mizutani et al. 2000), sorting of miRNAs 
into exosomes (Santangelo et al. 2016; Hobor et al. 2018), competing with PABP for polyA 
binding and thus inhibiting translation (Svitkin et al. 2013), transcript-specific translational 
inhibition in myeloid cells stimulated with IFNƴ as a component of the GAIT complex 
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(Mukhopadhyay et al. 2009; Arif et al. 2012; Arif et al. 2018), and the regulation of HCV and 
MHV viral replication (Choi et al. 2004; Kim et al. 2004; Liu et al. 2009). Therefore, SYNCRIP 
could affect levels of IRF3 phosphorylation or IFNβ mRNA expression through these functions.       
MEN1 is a tumour suppressor and regulates multiple signalling pathways including inhibiting 
the activity of NF-κB (Heppner et al. 2001) and AP1 (JunD) transcription factors (Agarwal et 
al. 1999). In some cell lines/organs MEN1 functions as a transcriptional repressor yet in others 
it is a transcriptional activator (Matkar et al. 2013). For example, MEN1 is an essential 
component of the MLL/SET1 histone methyltransferase complex that tri-methylates lysine 4 
of histone H3, an activating chromatin mark which promotes transcription (Yokoyama et al. 
2004; Milne et al. 2005). Interestingly, in the original study that identified MEN1 as directly 
interacting with JunD and thereby inhibiting JunD mediated transcription, co-expression of c-
Jun and MEN1 led to increased activity of an AP1 driven luciferase reporter (Agarwal et al. 
1999). Since an AP1 transcription complex heterodimer of ATF2/c-Jun is required for 
induction of IFNβ (Wathelet et al. 1998) the loss of MEN1 inhibiting activation of the IFNβ 
promoter triggered by cGAS-STING signalling, as seen in my results, would be consistent with 
these findings. In this context, MEN1 could normally be interacting with and repressing 
activity of JunD but not c-Jun, following immune stimulation with dsDNA c-Jun is required for 
induction of IFNβ, however, in the absence of MEN1 JunD is now free to form AP1 complexes 
and compete with c-Jun for doing so, thus resulting in less ATF2/c-Jun complexes to activate 
IFNβ and this reduces levels of IFNβ expression. However, this does not explain the reduction 
in IRF3 phosphorylation I see in MEN1 knockdown cells stimulated with dsDNA, suggesting 
that MEN1 has additional functions in IIR signalling beyond regulating NF-κB and AP1 
transcription factors. 
In the case of DDX5 which was recently reported to be a negative regulator of type-I IFN 
responses against RNA or DNA virus infection, with DDX5 knockdown resulting in higher levels 
of IFNβ protein levels in mouse macrophages (Zan et al. 2020), it has been suggested that 
DDX5 deactivates IRF3 by recruiting PP2A-Cβ to dephosphorylate IRF3 and thus inhibit type-I 
IFN. Interestingly, DDX5 is a positive regulator of the replication of multiple RNA viruses 
including HCV, Japanese encephalitis virus (JEV) and human immunodeficiency virus 1 (HIV-
1) (Goh et al. 2004; Li et al. 2013a; Zhou et al. 2013; Cheng et al. 2018). Conversely, DDX5 
appears to be a negative regulator of some DNA viruses and restricts Myxoma virus (MYXV) 
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replication in human cell lines (Rahman et al. 2017), as well as Hepatitis B virus (HBV) 
replication in human cancer cells (HeLa and A549) (Zhang et al. 2016), but a positive regulator 
of other DNA viruses including HSV-1 (Zan et al. 2020). My data showing that DDX5 
knockdown results in higher levels of IFNβ mRNA and IRF3 phosphorylation following immune 
stimulation with poly(I:C) are consistent with DDX5 being a positive regulator of RNA viruses, 
potentially through inhibiting IRF3 activation by recruitment of PP2A-Cβ. However, DDX5 
function in the case of dsDNA stimulated immune responses appears more complex with 
luciferase assay data showing that DDX5 knockdown decreases IFNβ or NF-κB luciferase 
construct activation and levels of IRF3 phosphorylation, while endogenous levels of IFNβ 
mRNA increased and HSV-1 proliferation was restricted. DDX5 is a DEAD-box RNA helicase 
family member and known to be involved in most aspects of RNA metabolism including 
translation, splicing, transcriptional regulation, ribosome biogenesis, mRNA export, and 
micro-RNA processing (Liu 2002; Wilson et al. 2004; Lin et al. 2005; Zonta et al. 2013; 
Dardenne et al. 2014). Thus, it is possible that DDX5 knockdown disrupts one or more of these 
fundamental RNA processes resulting in an alteration of IRF3 phosphorylation and IFNβ mRNA 
levels during an IIR. However, the closely related DDX17, which was also identified in our mass 
spectrometry dataset, has been shown to function partially redundantly with DDX5 in these 
processes (Germann et al. 2012; Dardenne et al. 2014) and so it is likely that DDX5 also 
performs a specific function in IIR triggered by DNA/RNA.  
SNRNP70/U1-70K associates with U1 splicesomal RNA and Sm proteins, forming the U1-
snRNP core component of the spliceosome which is essential for the recognition of the pre-
mRNA 5’ splice site and assembly of the spliceosome (Hinterberger et al. 1983; Pomeranz 
Krummel et al. 2009; Kondo et al. 2015). Depletion of SNRNP70 could therefore disrupt 
expression of other innate immune signalling proteins by inhibiting transformation of pre-
mRNA into mRNA. However, Western blotting against STING and cGAS showed that SNRNP70 
knockdown did not affect protein levels and similarly IRF3 protein levels were not altered in 
SNRNP70 knockdown cells. Therefore, the core components of the cGAS-STING signalling 
pathway remain intact in SNRNP70 knockdown cells and this coupled with the reduced 
expression of IFNβ and activation of IRF3 I see in SNRNP70 knockdown cells suggests SNRNP70 
plays a role in IIR signalling. Importantly, the IFNβ gene lacks intronic sequences and so does 
not undergo splicing in its expression pathway (Zago et al. 2009), so SNRNP70 knockdown 
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effects on IFNβ levels are likely independent of its role in splicing. Further testing of protein 
expression and activation of other known components of the cGAS-STING signalling pathway, 
such as the kinase TBK1, are required to rule out the possibility that SNRNP70 knockdown 
indirectly affects IIR signalling as a consequence of disrupted spliceosome function.  
RPS27A is a component of the 40S subunit of the ribosome, encoded by the RPS27A gene the 
protein is expressed as a fusion protein with ubiquitin which is cleaved into the RPS27A 
protein and ubiquitin monomer (Kenmochi et al. 1998). While RPS27A knockdown 
significantly reduced induction of IFNβ and NF-κB luciferase reporters, its role in IIR was not 
investigated further here since knockdown caused high levels of cell death. However, RPS27A 
has been proposed to perform extra-ribosomal functions in promoting cell proliferation in 
leukaemia cell lines (Wang et al. 2014a). More intriguingly, RPS27A was recently identified as 
a candidate nuclear DNA-sensor in a study which identified proteins binding to biotinylated 
HSV-1 genomic DNA and that relocalised from the nucleus to the cytoplasm (Wang et al. 
2019). Although the authors of this study did not focus on the role of RPS27A here and instead 
focused on another candidate DNA-sensor, hnRNPA2/B1, identifying it as a novel nuclear viral 
DNA sensor which activates cGAS-STING signalling (Wang et al. 2019). That their strategy 
identified RPS27A as one of 23 candidate HSV-1 nuclear DNA sensors and that I found that 
RPS27A knockdown impaired IFNβ and NF-κB luciferase reporter activation suggest it may 
play a role in DNA sensing and the cGAS-STING pathway, a function which should now be 
investigated. Moreover, hnRNPA2B1 was also identified as a NE STING partner in our mass 
spectrometry dataset (mock sample: 3 peptides, 7 spectra, STING-GFP sample: 7 peptides, 12 
spectra) (Figure 6.2 B) while Wang et al. found that it immunoprecipitated the constitutive 
STING binding partner, TBK1 (Zhang et al. 2019; Wang et al. 2019). Although, they did not test 
whether hnRNPA2B1 immunoprecipitated STING itself, their data and ours suggest that 
hnRNPA2B1 is a component of STING signalling complexes and their data supports our 
approach for identifying NE DNA/RNA sensors.  
Currently, one of the outstanding questions in the cGAS-STING field is how nuclear resident 
cGAS is able to detect dsDNA in the cytoplasm. While cGAS also has a cytoplasmic pool, recent 
studies suggest that the larger proportion of cGAS resides in the nucleus (Orzalli et al. 2015; 
Gentili et al. 2019; Volkman et al. 2019; Sun et al. 2021). Some nuclear cGAS is exported to 
the cytoplasm in response to DNA stimulation in a manner dependent on a cGAS nuclear 
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export signal (NES) and the nuclear export receptor CRM1 (Sun et al. 2021) and, 
correspondingly, inactivation of CRM1 or mutation of the cGAS NES results in a failure of this 
pool to leave the nucleus and severely attenuates the IFN response following cytosolic DNA 
immune stimulation (Sun et al. 2021). Therefore, it is unclear how cytosolic DNA results in the 
translocation of cGAS from the nucleus, although it is possible that in resting cells cGAS 
translocates back and forth between cytoplasm and nucleus and binding to DNA in the 
cytoplasm results in cGAS aggregation and accumulation in the cytoplasm. Similarly, it is 
unclear how NE STING partners contribute to IIR signalling in the cytoplasm when they exist 
predominantly in the nucleus. One possibility is that STING redistribution from the INM to 
ONM following immune stimulation alters STING-partner interactions allowing them to 
function in IIR signalling. We had initially hypothesised that STING could direct the 
redistribution of NE partners to the cytoplasm through physically trafficking them through the 
peripheral channels of the NPC, because preliminary data from the lab suggested that 
SYNCRIP and MEN1 redistributed from the nucleus to the cytoplasm following immune 
stimulation with plasmid DNA or poly(I:C) in a manner dependent on STING. However, my 
immunofluorescence experiments testing NE STING partner localisation during IIR showed 
only modest alterations in NE STING partner distributions following immune stimulation with 
DNA/poly(I:C). Therefore, this hypothesis was not pursued further. However, it is possible 
that the issues with antibodies recognising multiple isoforms of Syncrip as well as the cross-
reactivity I noted in chapter 4 with hnRNP R reduced the effects observed.  Accordingly, it 
would be interesting to investigate this hypothesis further through the use of fluorescently 
tagged protein constructs and using biotinylated DNA/poly(I:C) to determine whether NE 
STING partners associate with transfected nucleic acids. Moreover, I only looked at whether 
an alteration in protein localisation occurred 2 h post-immune stimulation, thus, it would be 
worth testing different timepoints (both earlier and later) to see if a redistribution occurs. 
Additionally, different immune stimuli could be tested such as DNA damage through 
etoposide treatment, nuclear microinjected DNA/poly(I:C), and viral genomic DNA/RNA in 
order to further elucidate the role of NE STING partners in IIR.   
6.4 – How does SYNCRIP antagonise influenza A virus? 
One of the major findings of the work presented in thesis is that SYNCRIP is a novel antagonist 
of the RNA virus influenza A (IAV), with IAV replicating to higher titres in SYNCRIP knockdown 
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and SYNCRIP knockout HT1080 cells. Interestingly, this appears to be a strain-specific effect 
with a loss of SYNCRIP only benefitting the H1N1 PR8 strain of IAV and not the H3N2 Udorn 
strain. Moreover, this effect was greater in PR8 mutant strains which have a defective NS1 
protein, the main protein used by IAV to inhibit the host immune response. This suggests that 
the role SYNCRIP is playing in IIR against IAV infection is antagonised by NS1. In support of this 
notion, SYNCRIP has been identified as an interactor of NS1 from the PR8 but not the Udorn 
strain in pulldown experiments followed by mass spectrometry (Pichlmair et al. 2012; Bösl et 
al. 2019). This could explain why I only see a difference in IAV titres with SYNCRIP knockdown 
for the PR8 strain but not the Udorn strain. It is also consistent with the differences reported 
for how the NS1 proteins of these two strains antagonise innate immune signalling i.e. PR8 
NS1 inhibits IRF3 activation to prevent IFNβ expression while Udorn NS1 targets host cell 
mRNA translation to downregulate IFNβ expression; thus, it may be that the Udorn strain has 
no need to target SYNCRIP. These findings, coupled with my data showing that SYNCRIP is 
required for optimal IRF3 activation, and IFNβ and CCL5 expression in cells stimulated with 
dsDNA, could suggest that SYNCRIP is similarly involved in the activation of IRF3 and 
subsequent induction of immune response genes during IAV infection. Further evidence of 
SYNCRIP playing a role in IAV infection comes from a meta study which analysed cell-based 
gene expression profiles during IAV infection from ten published studies and found that 
SYNCRIP is a significantly differentially expressed gene during IAV infection (Forst et al. 2017). 
Interestingly, in this study SYNCRIP gene expression was found to be down-regulated in some 
of the datasets and up-regulated in others, perhaps indicating that SYNCRIP is up-regulated 
by the host cell but targeted by IAV for down-regulation (Forst et al. 2017). 
Despite showing that SYNCRIP is a novel factor in restricting IAV infection, the mechanism 
through which it does so requires further investigation. Based on my own research and what 
is already known about SYNCRIP functions from the literature several mechanisms might 
explain how SYNCRIP is able to antagonise viral infection. Firstly, it is possible that SYNCRIP is 
involved in STING-dependent dsDNA sensing of mtDNA in the cytoplasm released as a 
consequence of IAV infection (Moriyama et al. 2019). My data showing that SYNCRIP is 
required for optimal activation of IRF3 and IFNβ expression in response dsDNA transfection 
would support this since both transfection and mtDNA leakage result in the release of dsDNA 
into the cytoplasm. Secondly, STING has been shown to inhibit cellular translation in response 
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to infection with the RNA virus, VSV, or poly(I:C) stimulation through a mechanism that was 
independent of PKR and eIF2a (Franz et al. 2018). Given that we identify SYNCRIP as a partner 
of STING at the NE and that SYNCRIP is known to regulate translation (Kim et al. 2004; Cho et 
al. 2007; Kim et al. 2012; Svitkin et al. 2013; Lai et al. 2017), it is possible that SYNCRIP is 
responsible for restricting translation downstream of STING during RNA virus infection. 
Specifically, SYNCRIP is able to bind to the 5’ UTR of mRNAs to upregulate translation of some 
mRNAs (Kim et al. 2012; Lai et al. 2017), and/or to increase internal ribosome entry site (IRES)-
dependent translation through binding IRES sites (Kim et al. 2004; Cho et al. 2007), and/or to 
compete with PABP for binding to poly(A) tails of mRNAs thereby inhibiting translation 
(Svitkin et al. 2013). It would thus be interesting to test whether translation is affected in 
SYNCRIP knockdown cells following IAV infection or poly(I:C)/dsDNA transfection. This could 
be done using polysome profiling to determine the quantity of ribosomes bound to mRNAs in 
each condition. 
Another mechanism through which SYNCRIP might influence IIR and inhibit IAV infection 
could be through packaging of miRNAs/mRNAs/cGAMP into extra-cellular vesicles (EV) for 
cell-to-cell transport. SYNCRIP is known to facilitate the sorting of specific miRNAs into EVs 
(Santangelo et al. 2016; Hobor et al. 2018) and so it is conceivable that it may be involved in 
sorting miRNAs with immune modulatory functions into EVs that could prime neighbouring 
cells for viral defence. Similarly cGAMP is packaged into EVs and viral particles of cells infected 
with DNA viruses or HIV-1 (Bridgeman et al. 2015; Gentili et al. 2015). Therefore, it would be 
interesting to test whether SYNCRIP can bind cGAMP or is involved in packaging cGAMP into 
EVs or viral particles. In addition to future experiments to unpick the mechanism through 
which SYNCRIP restricts IAV infection, whether SYNCRIP restricts the proliferation of other 
RNA viruses and DNA viruses should be tested. While SYNCRIP knockdown did not strongly 
affect HSV-1 viral titres in my experiments, this could have been due to a report that the cGAS-
STING signalling pathway is not the principal signalling pathway through which HT1080 cells 
restrict HSV-1, instead relying on TLR3-TRIF mediated immune signalling (Latif et al. 2020). 
Thus, assuming that SYNCRIP restricts viruses in a manner dependent on STING, SYNCRIP 
knockdown in another cell line, such as THP-1 cells, should be tested for an effect on HSV-1 
proliferation. My data, showing that SYNCRIP is a restriction factor of IAV adds to a literature 
already reporting SYNCRIP functions during viral infection. Interestingly, SYNCRIP is a pro-viral 
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factor during murine hepatitis virus (MHV) or HCV infection with SYNCRIP promoting virus 
RNA replication (Choi et al. 2004; Liu et al. 2009). Additionally, SYNCRIP promotes translation 
of HCV RNA through directly binding HCV mRNA and promoting IRES-dependent translation 
(Kim et al. 2004). Since IAV does not rely on IRES-dependent translation for production of viral 
proteins but instead IAV mRNAs acquire 5’ mRNA caps from the host cell and so translation 
occurs in a cap-dependent manner (Plotch et al. 1979; Plotch et al. 1981; Garfinkel and Katze 
1992), this could explain why SYNCRIP can be pro-viral in the case of HCV infection but anti-
viral during IAV infection. 
Intriguingly, several other hnRNP family members are also involved in antagonising viral 
infection (Valente and Goff 2006; Wang et al. 2014b; Wang et al. 2019; Kaur and Lal 2020), 
perhaps most notably hnRNPA2B1 which, in addition to being a nuclear sensor of HSV1 DNA 
(Wang et al. 2019), also binds to IAV NS1 and inhibits IAV replication partly through 
suppressing NS1 protein/RNA levels (Wang et al. 2014b). hnRNPA2B1 and SYNCRIP are also 
both involved in sorting of specific miRNAs into exosomes (Villarroya-Beltri et al. 2013; 
Santangelo et al. 2016), albeit recognising slightly different RNA sequences, making them two 
of only four proteins so far identified to have this capability (Hobor et al. 2018). These 
functional similarities could indicate that SYNCRIP and hnRNPA2B1 function in IIR and viral 
restriction through similar mechanisms. 
6.5 – Final Remarks 
The initial goal of this project was to investigate the role of STING in the NE. In the work 
submitted in this thesis, I have shown for the first time that a pool of endogenous STING 
resides in the INM and that STING localisation within the NE changes following immune 
stimulation with either dsDNA or, somewhat surprisingly, the dsRNA mimic poly(I:C). These 
findings have implications for the role STING plays in immune responses stimulated by nuclear 
DNA damage or DNA virus infection, as well as promoting chromatin compaction from the NE. 
Moreover, they could provide insight as to how STING functions in restricting cellular 
translation after immune stimulation with poly(I:C) or RNA virus infection. A key question to 
answer going forward will be to determine how STING localises to the INM, since this should 
enable the separation of ER and INM STING pools to better investigate STING function 
specifically within the INM. Moreover, in this work I have identified SYNCRIP, MEN1, DDX5, 
SNRNP70, and to a lesser extent RPS27A and AATF, as novel modulators of the cGAS-STING 
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immune signalling pathway. SYNCRIP, MEN1, DDX5, and SNRNP70 all effect IFNβ mRNA levels 
and IRF3 phosphorylation after immune stimulation with dsDNA while DDX5 also negatively 
regulates IFNβ mRNA levels after immune stimulation with poly(I:C). Further, experiments will 
be required to elucidate the exact mechanisms through which these proteins influence innate 
immune signalling. Finally, I have shown that SYNCRIP is a novel restriction factor of the RNA 
virus IAV, specifically antagonising the proliferation of the H1N1 strain, PR8, but not the H3N2 
strain, Udorn. A finding that coupled with experiments showing that PR8 mutant strains 
expressing a defective NS1 protein are more strongly impaired by the presence of SYNCRIP, 
hints at a role for SYNCRIP in promoting IRF3 activation during IAV infection. I have also re-
examined our NE STING mass spectrometry dataset to identify other protein candidates in 
the interactome that could mediate STING functions in the DNA damage response, chromatin 
compaction, and translational inhibition. Future experiments should seek to determine how 
the NE STING interactome changes following stimulation of cells with different immune 
stimuli including dsDNA transfection, etoposide treatment, poly(I:C) transfection, DNA virus 
infection, or RNA virus infection. 
Considered together, my data are consistent with the notion that STING plays a wider role in 
immune signalling than its initial description as an adaptor protein in cytosolic dsDNA sensing, 
initiating different responses based on diverse inputs from DNA damage to RNA virus 
infection. The wide range of STING nuclear partners and the finding that STING translocates 
out of the nucleus with poly(I:C) or dsDNA treatment potentially provide novel mechanisms 
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Table 1 – Mass Spectrometry top hits 
spectral counts/mw = normS (mw expressed as 100x kD) p = number peptides  
dnormS = normS/sum(spectral 
counts)  
s = spectral counts with 
pep_score >=25 
= 220 proteins  198 - STING-GFP peptides >=2    







(STING/mock) p.mock s.mock p.STING s.STING 
average. 
abundance 
HIST1H1C 0.0198 0.0474 2.3911 7 28 13 104 0.0336 
HIST1H1E 0.0194 0.0459 2.3682 7 28 13 103 0.03265 
HIST1H1D 0.0176 0.0423 2.4018 6 26 10 97 0.02995 
NCL 0.0144 0.0365 2.5310 24 73 38 287 0.02545 
DEK 0.0056 0.0165 2.9372 9 16 20 73 0.01105 
HIST2H2AA3 0.0000 0.0180 Inf 0 0 6 26 0.009 
HIST1H2BO 0.0000 0.0154 Inf 0 0 8 22 0.0077 
HP1BP3 0.0022 0.0122 5.5078 6 9 23 77 0.0072 
HIST2H2BF 0.0000 0.0119 Inf 0 0 8 17 0.00595 
BRD2 0.0034 0.0071 2.0601 12 20 26 64 0.00525 
UBTF 0.0020 0.0085 4.1845 7 12 25 78 0.00525 
RSL1D1 0.0025 0.0072 2.9327 7 9 19 41 0.00485 
EBNA1BP2 0.0013 0.0084 6.4377 2 3 14 30 0.00485 
RBMX 0.0025 0.0071 2.8510 4 7 10 31 0.0048 
CCDC86 0.0004 0.0092 24.4632 1 1 13 38 0.0048 
SNRNP70 0.0026 0.0066 2.5035 6 9 18 35 0.0046 
MFAP1 0.0003 0.0088 30.2571 1 1 15 47 0.00455 
PSIP1 0.0005 0.0081 16.0942 2 2 22 50 0.0043 
LMNA 0.0022 0.0063 2.8092 6 11 28 48 0.00425 
KIAA0020 0.0008 0.0066 8.0471 3 4 25 50 0.0037 
RPS27A 0.0000 0.0069 Inf 0 0 7 13 0.00345 
SRSF2 0.0018 0.0050 2.7897 2 3 4 13 0.0034 
TMPO 0.0012 0.0054 4.5064 3 4 13 28 0.0033 
BRD3 0.0013 0.0051 3.8626 5 7 20 42 0.0032 
CDK11B 0.0016 0.0048 2.9613 7 10 28 46 0.0032 
H1FX 0.0013 0.0043 3.2188 1 2 4 10 0.0028 
RBM28 0.0011 0.0037 3.5407 5 6 21 33 0.0024 
VRK1 0.0000 0.0045 Inf 0 0 13 21 0.00225 
HNRNPR 0.0013 0.0031 2.4678 5 6 14 23 0.0022 
IGHG1 0.0000 0.0040 Inf 0 0 3 15 0.002 
HNRNPK 0.0006 0.0032 5.4720 2 2 11 17 0.0019 
PAF1 0.0008 0.0029 3.8626 3 3 13 18 0.00185 
NOP2 0.0010 0.0025 2.4678 5 6 14 23 0.00175 
MECP2 0.0000 0.0035 Inf 0 0 10 19 0.00175 
RBMXL1 0.0000 0.0035 Inf 0 0 7 15 0.00175 
SRSF5 0.0010 0.0025 2.5751 1 2 4 8 0.00175 
NOP58 0.0008 0.0023 3.0043 3 3 10 14 0.00155 
LYAR 0.0007 0.0024 3.5407 2 2 9 11 0.00155 
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HIST1H1B 0.0000 0.0030 Inf 0 0 5 7 0.0015 
RRP1B 0.0000 0.0028 Inf 0 0 15 24 0.0014 
REXO4 0.0003 0.0025 7.7252 1 1 7 12 0.0014 
RNPS1 0.0000 0.0028 Inf 0 0 6 10 0.0014 
CTDSPL2 0.0006 0.0020 3.5407 1 2 7 11 0.0013 
KIF22 0.0004 0.0021 5.1502 2 2 12 16 0.00125 
HDGFRP2 0.0004 0.0020 4.8283 1 2 12 15 0.0012 
TMPO 0.0000 0.0023 Inf 0 0 7 18 0.00115 
CKAP4 0.0000 0.0022 Inf 0 0 11 15 0.0011 
DDX5 0.0002 0.0020 9.0128 1 1 11 14 0.0011 
KPNA2 0.0000 0.0022 Inf 0 0 10 13 0.0011 
HSPA1A 0.0004 0.0018 4.1845 2 2 10 13 0.0011 
ILF3 0.0005 0.0016 3.4334 3 3 9 16 0.00105 
UHRF1 0.0007 0.0014 2.0922 4 4 10 13 0.00105 
GPATCH4 0.0000 0.0021 Inf 0 0 7 11 0.00105 
RRP1 0.0000 0.0020 Inf 0 0 7 11 0.001 
C16orf88 0.0000 0.0019 Inf 0 0 9 10 0.00095 
BOLA2 0.0000 0.0019 Inf 0 0 1 2 0.00095 
HELLS 0.0002 0.0016 10.3003 1 1 14 16 0.0009 
MCM7 0.0004 0.0014 3.8626 2 2 11 12 0.0009 
TAF15 0.0005 0.0013 2.5751 1 2 6 8 0.0009 
ZRANB2 0.0000 0.0018 Inf 0 0 6 7 0.0009 
NPM1 0.0000 0.0018 Inf 0 0 4 6 0.0009 
DDX17 0.0002 0.0015 7.0815 1 1 10 11 0.00085 
GNL3 0.0000 0.0017 Inf 0 0 8 11 0.00085 
SYNCRIP 0.0004 0.0013 2.8970 2 2 6 9 0.00085 
SRSF10 0.0005 0.0012 2.5751 1 1 2 4 0.00085 
RBBP7 0.0000 0.0016 Inf 0 0 6 8 0.0008 
BAZ2A 0.0003 0.0013 4.5064 4 4 23 28 0.0008 
FTSJ3 0.0000 0.0015 Inf 0 0 10 15 0.00075 
PARP2 0.0000 0.0015 Inf 0 0 8 10 0.00075 
NOP56 0.0002 0.0013 5.7939 1 1 8 9 0.00075 
CENPB 0.0000 0.0015 Inf 0 0 7 10 0.00075 
LEO1 0.0002 0.0013 6.4377 1 1 6 10 0.00075 
SUZ12 0.0002 0.0012 6.4377 1 1 8 10 0.0007 
HNRNPD 0.0004 0.0010 2.5751 1 1 2 4 0.0007 
SNRPD3 0.0000 0.0014 Inf 0 0 1 2 0.0007 
MCM2 0.0003 0.0010 3.5407 2 2 8 11 0.00065 
LMNB2 0.0000 0.0013 Inf 0 0 6 9 0.00065 
DDX50 0.0004 0.0008 2.2532 2 2 7 7 0.0006 
SDAD1 0.0002 0.0010 5.1502 1 1 6 8 0.0006 
GTF2I 0.0000 0.0012 Inf 0 0 11 14 0.0006 
C14orf21 0.0000 0.0012 Inf 0 0 8 9 0.0006 
C17orf85 0.0000 0.0012 Inf 0 0 7 9 0.0006 
RRS1 0.0000 0.0012 Inf 0 0 4 5 0.0006 
KRT74 0.0000 0.0012 Inf 0 0 3 7 0.0006 
TCL6 0.0000 0.0012 Inf 0 0 1 2 0.0006 
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LIG3 0.0003 0.0008 2.8970 2 2 9 9 0.00055 
KRT75 0.0000 0.0011 Inf 0 0 4 7 0.00055 
HNRNPA1L2 0.0000 0.0011 Inf 0 0 2 4 0.00055 
HNRNPAB 0.0000 0.0011 Inf 0 0 2 4 0.00055 
TPX2 0.0000 0.0010 Inf 0 0 9 9 0.0005 
KIF20A 0.0001 0.0009 5.7939 1 1 8 9 0.0005 
SCML2 0.0000 0.0010 Inf 0 0 7 8 0.0005 
CANX 0.0000 0.0010 Inf 0 0 5 7 0.0005 
DNTTIP2 0.0002 0.0008 4.5064 1 1 5 7 0.0005 
KRT72 0.0000 0.0010 Inf 0 0 2 6 0.0005 
RSF1 0.0002 0.0007 3.8626 2 2 10 12 0.00045 
RFC1 0.0002 0.0007 2.8970 2 2 9 9 0.00045 
MCM4 0.0002 0.0007 4.5064 1 1 7 7 0.00045 
MCM6 0.0002 0.0007 4.5064 1 1 6 7 0.00045 
KRI1 0.0000 0.0009 Inf 0 0 5 8 0.00045 
XRCC6 0.0002 0.0007 3.2188 1 1 5 5 0.00045 
HSPA5 0.0002 0.0007 3.2188 1 1 5 5 0.00045 
HIRIP3 0.0000 0.0009 Inf 0 0 4 6 0.00045 
SURF6 0.0000 0.0009 Inf 0 0 3 4 0.00045 
MTA2 0.0000 0.0008 Inf 0 0 6 6 0.0004 
API5 0.0000 0.0008 Inf 0 0 5 5 0.0004 
HNRPDL 0.0000 0.0008 Inf 0 0 2 4 0.0004 
CWC22 0.0001 0.0006 4.5064 1 1 5 7 0.00035 
STRBP 0.0000 0.0007 Inf 0 0 3 5 0.00035 
CDCA7 0.0000 0.0007 Inf 0 0 3 3 0.00035 
SLC9A2 0.0000 0.0007 Inf 0 0 1 7 0.00035 
SNRPA1 0.0000 0.0007 Inf 0 0 1 2 0.00035 
THOC4 0.0000 0.0007 Inf 0 0 1 2 0.00035 
TCOF1 0.0002 0.0004 2.2532 2 2 6 7 0.0003 
LARP7 0.0000 0.0006 Inf 0 0 4 4 0.0003 
HSPA1L 0.0000 0.0006 Inf 0 0 4 4 0.0003 
DDX41 0.0000 0.0006 Inf 0 0 4 4 0.0003 
PNN 0.0000 0.0006 Inf 0 0 3 5 0.0003 
CKAP2 0.0000 0.0006 Inf 0 0 3 5 0.0003 
AATF 0.0000 0.0006 Inf 0 0 3 4 0.0003 
LUC7L3 0.0000 0.0006 Inf 0 0 3 3 0.0003 
NAP1L1 0.0000 0.0006 Inf 0 0 3 3 0.0003 
CLASRP 0.0000 0.0006 Inf 0 0 2 5 0.0003 
RPL4 0.0000 0.0006 Inf 0 0 2 3 0.0003 
AZGP1 0.0000 0.0006 Inf 0 0 2 2 0.0003 
SRSF12 0.0000 0.0006 Inf 0 0 1 2 0.0003 
SF3B1 0.0000 0.0005 Inf 0 0 6 7 0.00025 
ACIN1 0.0001 0.0004 3.8626 1 1 6 6 0.00025 
CUL4B 0.0000 0.0005 Inf 0 0 5 5 0.00025 
KPNB1 0.0000 0.0005 Inf 0 0 5 5 0.00025 
GTPBP4 0.0000 0.0005 Inf 0 0 4 4 0.00025 
YTHDC1 0.0000 0.0005 Inf 0 0 4 4 0.00025 
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CHAF1A 0.0001 0.0004 2.5751 1 1 4 4 0.00025 
GNL2 0.0000 0.0005 Inf 0 0 3 4 0.00025 
GTF2F1 0.0000 0.0005 Inf 0 0 2 3 0.00025 
CDCA7L 0.0000 0.0005 Inf 0 0 2 3 0.00025 
TMEM173 0.0000 0.0005 Inf 0 0 2 2 0.00025 
  0.0000 0.0005 Inf 0 0 1 3 0.00025 
YBX1 0.0000 0.0005 Inf 0 0 1 2 0.00025 
KDM1B 0.0000 0.0004 Inf 0 0 4 4 0.0002 
PPIG 0.0000 0.0004 Inf 0 0 4 4 0.0002 
SRRT 0.0000 0.0004 Inf 0 0 4 4 0.0002 
EZH2 0.0000 0.0004 Inf 0 0 4 4 0.0002 
GANAB 0.0000 0.0004 Inf 0 0 4 4 0.0002 
SFRS18 0.0000 0.0004 Inf 0 0 3 4 0.0002 
HSPA8 0.0000 0.0004 Inf 0 0 3 3 0.0002 
TOR1AIP1 0.0000 0.0004 Inf 0 0 3 3 0.0002 
RNF6 0.0000 0.0004 Inf 0 0 3 3 0.0002 
LUC7L2 0.0000 0.0004 Inf 0 0 2 2 0.0002 
RRP8 0.0000 0.0004 Inf 0 0 2 2 0.0002 
RCOR1 0.0000 0.0004 Inf 0 0 2 2 0.0002 
LUC7L 0.0000 0.0004 Inf 0 0 2 2 0.0002 
GLTSCR2 0.0000 0.0004 Inf 0 0 2 2 0.0002 
GRWD1 0.0000 0.0004 Inf 0 0 2 2 0.0002 
RUVBL2 0.0000 0.0004 Inf 0 0 2 2 0.0002 
KRT84 0.0000 0.0004 Inf 0 0 1 3 0.0002 
RBM23 0.0000 0.0004 Inf 0 0 1 2 0.0002 
AHCTF1 0.0001 0.0002 3.2188 1 1 5 5 0.00015 
ATAD5 0.0000 0.0003 Inf 0 0 6 6 0.00015 
BCORL1 0.0000 0.0003 Inf 0 0 5 5 0.00015 
TCERG1 0.0000 0.0003 Inf 0 0 4 4 0.00015 
PRPF40A 0.0000 0.0003 Inf 0 0 3 3 0.00015 
ZNF512B 0.0000 0.0003 Inf 0 0 3 3 0.00015 
MEN1 0.0000 0.0003 Inf 0 0 2 2 0.00015 
HSPD1 0.0000 0.0003 Inf 0 0 2 2 0.00015 
HSPA9 0.0000 0.0003 Inf 0 0 2 2 0.00015 
CCDC47 0.0000 0.0003 Inf 0 0 2 2 0.00015 
HSPA2 0.0000 0.0003 Inf 0 0 2 2 0.00015 
RANGAP1 0.0000 0.0003 Inf 0 0 2 2 0.00015 
DNAJC21 0.0000 0.0003 Inf 0 0 2 2 0.00015 
SCMH1 0.0000 0.0003 Inf 0 0 2 2 0.00015 
GLYR1 0.0000 0.0003 Inf 0 0 2 2 0.00015 
SMARCD1 0.0000 0.0003 Inf 0 0 2 2 0.00015 
UTP18 0.0000 0.0003 Inf 0 0 2 2 0.00015 
MLLT1 0.0000 0.0003 Inf 0 0 2 2 0.00015 
SFPQ 0.0000 0.0003 Inf 0 0 2 2 0.00015 
MSL3 0.0000 0.0003 Inf 0 0 2 2 0.00015 
SMARCD2 0.0000 0.0003 Inf 0 0 2 2 0.00015 
SF3A3 0.0000 0.0003 Inf 0 0 2 2 0.00015 
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DPYSL5 0.0000 0.0003 Inf 0 0 1 2 0.00015 
RAI1 0.0000 0.0002 Inf 0 0 3 5 0.0001 
SCAF11 0.0000 0.0002 Inf 0 0 3 3 0.0001 
INTS3 0.0000 0.0002 Inf 0 0 3 3 0.0001 
SMARCA2 0.0000 0.0002 Inf 0 0 3 3 0.0001 
ADNP 0.0000 0.0002 Inf 0 0 2 2 0.0001 
NOC2L 0.0000 0.0002 Inf 0 0 2 2 0.0001 
TTF1 0.0000 0.0002 Inf 0 0 2 2 0.0001 
U2SURP 0.0000 0.0002 Inf 0 0 2 2 0.0001 
C19orf29 0.0000 0.0002 Inf 0 0 2 2 0.0001 
ESF1 0.0000 0.0002 Inf 0 0 2 2 0.0001 
RBM25 0.0000 0.0002 Inf 0 0 2 2 0.0001 
DNMT3A 0.0000 0.0002 Inf 0 0 2 2 0.0001 
HSP90B1 0.0000 0.0002 Inf 0 0 2 2 0.0001 
TRIM28 0.0000 0.0002 Inf 0 0 2 2 0.0001 
MPHOSPH10 0.0000 0.0002 Inf 0 0 2 2 0.0001 
POTEJ 0.0000 0.0002 Inf 0 0 2 2 0.0001 
DDX42 0.0000 0.0002 Inf 0 0 2 2 0.0001 
DDX23 0.0000 0.0002 Inf 0 0 2 2 0.0001 
VCP 0.0000 0.0002 Inf 0 0 2 2 0.0001 
ITPR2 0.0000 0.0002 Inf 0 0 1 7 0.0001 
BRDT 0.0000 0.0002 Inf 0 0 1 2 0.0001 
TMEM214 0.0000 0.0002 Inf 0 0 1 2 0.0001 
BPTF 0.0000 0.0001 Inf 0 0 4 4 0.00005 
TPR 0.0000 0.0001 Inf 0 0 4 4 0.00005 
TNRC18 0.0000 0.0001 Inf 0 0 3 3 0.00005 
MLL 0.0000 0.0001 Inf 0 0 2 3 0.00005 
TIMELESS 0.0000 0.0001 Inf 0 0 2 2 0.00005 
SRCAP 0.0000 0.0001 Inf 0 0 2 2 0.00005 
CECR2 0.0000 0.0001 Inf 0 0 2 2 0.00005 
ZMYND8 0.0000 0.0001 Inf 0 0 2 2 0.00005 
TCF20 0.0000 0.0001 Inf 0 0 2 2 0.00005 
KIF4A 0.0000 0.0001 Inf 0 0 2 2 0.00005 
CENPF 0.0000 0.0001 Inf 0 0 2 2 0.00005 
MYH4 0.0000 0.0001 Inf 0 0 1 3 0.00005 
MYH8 0.0000 0.0001 Inf 0 0 1 3 0.00005 
MYH1 0.0000 0.0001 Inf 0 0 1 3 0.00005 
NAV3 0.0000 0.0001 Inf 0 0 1 2 0.00005 
VARS 0.0000 0.0001 Inf 0 0 1 2 0.00005 
VWA3A 0.0000 0.0001 Inf 0 0 1 2 0.00005 
COL5A1 0.0000 0.0001 Inf 0 0 1 2 0.00005 
 
